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Ascending Aorta Atherosclerosis Isa Reliable
Marker for Coromuy Artery Disease in
Advmced-Age Patients 997-38.287A
Association of Plasma HomocysteineWith
ExtracranialCarotid Arterial Disease in Older
Peranns 997-63.288A
Atherosclerosis Progression in Subjects With and
Without PostangioplaatyRestenosis in QUIET
1038-7O.418A
Characterization of AtheroscleroticLesions by
Magnetic Resonance Imaging: Comparison
With IntravascularUltrasound and Histology
1023-108.336A
Cigarette Smoking Is Associated With Increased
MonocyteAdhesion to Endothelial Cells:
ReversibilityWith L-Argininebut Not With
VitaminC 986-77.264A
Comparison of Circulating VonWillebrand Factor
Levels and AcethylcolineResponsiveness as
Markers of Endothelial Dysfunction in
Hypertensiveand Athemsclerntic Patients
741-5. 190A
ConvertingEnzyme Inhibition ImprovesEndothelial
Dysfunction in Humans by Increasing Nitric
Oxide Activity 743-2.192A
Correlation Between Oxidized Low Density
Lipoproteinsand CoronaryArtery Disease in
Heart Transplant Patients 808-1.*402A
Could DobutamineEchocardiographyas a Method
of PerioperativeCardiac Risk Stratification
Minimize Cardiac Events in Patients
Undegoing Abdominal Aortic Aneurysm
Resection? 984-24.260A
Decreased Cholesterol Esterificationby fJ-Blocker
Agents in Human Oxidized Low-Density
Lipoprotein 1027-174.343A
Deficiencyof Cell Adhesion Molecules Rotects
Against Atherosclerosis in Mice 960-109.
153A
Determinants of Coronary Arterial Remodeling
Patterns: An IntravascularUltrasound Study
798-6.391A
Diabetes Mellitus Is Associated Witb Coronary
Artery Calcification in Sudden Cardiac Death
1092-66. 516A
Different Effects of HomroneTherapies on
Low-DensityLipoproteinOxidation in
PostmenopausalWomen 725-4.86A
Doppler DerivedCardiac Output by Stress
EchocardiographyPredicts Multivessel
Cornnary Artery Disease 984-6.259A
Effect of 17~-Estmdiol Treatment on Intimal
Apoptosis and Cell Roliferation in an
Experimental Atherosclerosis Model 961-120.
155A
Effect of Atbernsclerntic Plaque Topographyon
Coronary Anery Remodeling: An Intravascular
Ultrasound Study 942-151.125A
Effects of Homrone Therapy on Fibrirrolytic
Potential in Postmenopausal Women 919-65.
42A
Effects of Oxygen Radicals on Human Lipoprotein
(a) and Low Density Lipoprotein Peroxidation
and Metabolism 964-89. 160A
Expression of Adhesion Molecules on Microvessek
in Advanced Human Atherosclerotic Plaques:
Alternative Pathways for Leukocyte
Recruitment 96O-108.153A
Fibrinogen Is an Independent Predictor of Total
Mortality in Patients With Peripheral Vascular
Disease 761-1.218A
Frequency of Potential Cardiac Sources of Emboli in
Transient Ischemic Attack Peripheral Embolus
and Amaumsis Fugax 757-5.213A
Hemocysteine Is Increased in Patients With Diffuse
Atherosclerosis 943-136.126A
High Plasma Hornocysteine Is a Riak Factnr for
VascularComplications of End-Stage Renal
Disease and Enhances the Adverse Effects of
Smoking and Diabetes 943-135.126A
High Rates of Apnptosis in Human Coronary
Atherosclerotic Lesions Lacking Compensatory
Enlargement 733-6.179A
High-Homocysteine Concentration a Risk Factor for
Atherosclerotic Complications of End Stage
Renal Disease May Be Normalized by High
Doses of Folic Acid 919-68.43A
Homocysteine, a Risk Factor for Atherosclerotic and
Thrombcembolic Vascular Disease, Is Higher in
Patients Wbo Have Undergone Orthotropic
Cardiac Transplantation 999-152.290A
Hyperhomocysteinemia Isa Risk Factor for Arterial
EndotfzelialDysfunction 920-89.45A
Improved Fibrinolytic Profile by Estrogen in
Postmenopausal Women: Endothelium Verzus
Liver 785-1.372A
Improvementof Atherosclerosis of the Thoracic
Descending Aorta by Cholesterol Lowering
Therapies in Patients with Hyperlipidemia
969-32.232A
In VivoGender Differences in Coronary Artery
Plaque Morphology Assessed by Intravascular
Ultrasound 747-3.198A
Increased Expression of Plasminogen Activator
Inhibitor Type 1 (PAI-1) Predisposesto
Atherosclerosis in Corpulent, Insulin Resistant
(JCR:LA-CP) Rats That Mimic Derangements
in Type 11Diabetes 769-2.229A
Increased Lipnlysis of Triglyceride-Rich
Lipoproteins Enhances Artery Wall Permeability
and Lipoprotein Retention 964-64. 159A
Inducible Nitric Oxide Synthase Is Associated With
Thrombi After Experimental Angioplasty and in
Advanced Human Com,naryAtherosclerotic
Plaques 734-3.179A
InflammatoryCytokines in Stable Versus Unstable
Angina 970-38.233A
Intravascular Ultrasound Tissue Characterization
Predicts Local Vasoreactivity in Early Coronmy
Atherosclerosis 906-43.20A
Lack of Association of the Angiotensin Converting
Enzyme DD Genotype With Peripheral Vascular
Disease 943-138. 127A
LDL Cholesterol and Angiographic Pmgressinn in
the QUIET Trial 725-1.85A
Lessons From the West of Scntland Coronary
Prevention Study (WOSCOPS): Who Should Be
Treated? 7184.76A
Morphological Correlates to the Clinical
Classification of Unstable Angina 798-1.390A
N-Acetylcysteine Impmves Coronary Vascular
Endothelial Dysfunction 1052-133.444A
Nipradilol, a Nitric Oxide Releasing Beta-Blocking
Agent, Revemes the Severity of Myucardial
Injury After Ischemia Reperfusion in
Cholesterol-Fed Rabbits 1027-175.343A
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Patient and Plaque Characteristics Associated With
Coronary Artery Remodeling: An Intravascular
Ultrasound Analysis 942-132. 124A
Plaque Extrusion During Balloon Angioplasty: New
Evidence From X-Ray Microtomography 749-1
.200A
Plaque Rupture in Men Is Associated With High
Serum Cholesterol 921-111.47A
Plaque Rupture Is an Infrequent Cause of Sudden
CormraryDeath in Women 798-3.391A
POSCH Five-YearPosttrial Follow-Up Report
969-37.233A
Relation Between Cardiovascular Risk Factora and
Atherosclerotic Plaque of the Thoracic Aorta: A
Large Prospective Study Using Multilane
Transesophageal Echcmrdiography 1024-117.
337A
Retinal VascularAbnormalities in Patients With
Artery Disease 987-91.265A
Risk Factor Correlates for CormraryArtery Calcium
Using ElecrrmrBeam Tomographyin
Asymptomatic Menand Women 1092-67.
516A
Soluble Cell Adhesion Molecules Are Regulated by
Plasma Cholesterol in Familial
Hypercholesternlemia 921-112.47A
Stenting of ChrmricallyOccluded Superficial
Femoral Arteries Using Palmaz Biliary Stents
Significantly Improves Long-TermPatency
1075-135.485A
Suppression of Atherosclerotic Development in
Watanabe Heritable Hyperlipidemic (WHHL)
Rabbits Treated With an Oral Antiallergic Drug,
Transilast 958-43. 151A
The Cost-Effectiveness of Pwventing Initial
Coronaty Events With Pravastatirr Results of
the West of Scotland Coronary Prevention Study
Ecnnomic Analysis 968-54.168A
The Effect of Azithmmycin in Postmyocardial
Infarction (MI) Patients With Elevated
CfdamydiaPneumonia Antibody Titres 755-2
.209A
The Effect of Remodeling on Distensibility in
Arbemsclerotic FemorrdArteries: A Postmortem
IntravascularUltrasound Snrdy 733-1.177A
The Role of Protein-nrosine Phosphorylation and
Matrix Metallopmteinase Production in the
Proliferation of Smnuth Muscle Cells 941-166.
L24A
The Severity of Coronary Artery Calcification by
Ulrrafast Computed TomographyPredicts
Patients With Stress-Induced Myocardial
Ischemia 800-2.393A
There Are No Morphometric Differences in
CormraryAtherosclerosis Between Men and
Women: An Intravascular Ultrasound Study
7474.198A
Time Course and Magnitude of Vascular
Remodeling in Early and Advanced Coronary
Atbemsclerosis 733-2.178A
Triglyceride Levels Cnrrclate With Microvascular
but Not Epicardial Endothelial Dysfunction
After Heart Transplantation 808-4.402A
Vasa Vasomm Density in Human Atherosclerotic
Plaque: A Morphological Quantitative Study
Using Higb Resolution 3-D Microtomography
Scan 798-4.391A
VascularEndothelirdGruwth Factor Is Unregulated
by Hydrngen Peroxide in Vascular Smooth
Muscle Cells and Overexpressed in
Atherosclerotic Tissue 703-6.55A
VascularRemodeling Is Not Evident in Coronary
Artery Disease During the First Year Following
Trarrsplantation 953-149.142A
Atrial fibrillation
A Case Contrnl Study of Mortality After
RadiofrequencyAblation of the Atrial
VentricularJunction 748-4.199A
A Prospective Randomized Trial of Bachmann’s
Bundle Pacing for the prevention of Atrird
Fibrillation 717-3.74A
A prospective Study to Predict the Transition From
Paroxysmal Atrial Fibrillation to Chronic Atrial
Fibrillation by Signal-Averaged
Electrocardiography 912-18.31A
A Randorrjzed ProspectiveStudy of Dual Site Atrial
Pacing for the Preventionof AerialFibrillation
732-4. 177A
A Survey of Atrial Fibrillation in Family Practice:
The West Birmingham Atrial Fibrillation Project
967-61.166A
Accuracy of ElectroanatomicalMapping of Atrial
Fibrillation Using a New Nonfluoroscopic
Mapping System 102O-74.331A
Anatomic Determinantsof Atrial Fibrillation Cycle
Length in Canines With Chronic Atrial
Fibrillation 775-5.359A
Atrial ArrhythmiaDetection: Initial ExperierrceWith
a SubcutaneousElectrode Array 957-174.
149A
Atrial Ectopic Activity Prior to the Onset of
Paroxysmal Atrial Fibrillation 742-3.191A
Atrial Mapping and Effectivenessof a Right Atrial
Catheter Ahlation in Patients With VagalAtrial
Fibrillating 732-2.176A
Atrial Stunning Occurs After Electrical
Cardioversionbut Not After Chemical
Cardioversion 1OOO-85*292A
Automated BoundaryDetection for Left Atrial Area
in Patients With Maze Procedure for Atrkd
Fibrillation 1071-39.477A
Bachmann’sBundle Permanent Pacing Shortens
Intra-Atrial Conduction Time: Will It Decreaae
Paroxysmal Atrial Fibrillation? 981-139.253A
Biahial Linear and Fncal Ahlarionfor Restoring
Sinus Rhythm in Patients With Refractory Arrial
Fibrillation: Initial Experience With a
Two-StugedProcedure 732-1.176A
Cardiac Cormactility in Atrial Fibrillation ISCycle
Length Dependent 1000-83.291A
Change in Mean RR Internal Prior m the Onset of an
Episcde of AtriaJ Fibrillation 742-6.191A
Chronic Arnal Dilatation Induces Prolongationof
AtrirdRefractoriness and Atrial
Tachya.rrhyrhmias709-6.63A
Chronic Rapid Pacing Causes Sustained Atrial
Fibrillation and Over Expression of Cx43
Channel Protein in Dog Atria 957-177.150A
Clinicat Testing of a Dual Cbambcr Combined Atriat
and VenrncularDefibrillator 1069.1W.473A
ComparativeEvaluationof Automatic Mude
Switching Algorithms in Rare Control During
Atrial Fibrillation 717-6.75A
Comparison of Right Ahial ActivationDuring
Coronary Sinus Ostial Pacing With Dual Site
Right Atrial and Biatrial Pacing 981-141.253A
Cost-Effectivenessof Inpatient Initiation of
AntiarrhythmicTherapy for Supraventricular
Tachycardias 936-103.112A
Decreased Incidenceof Stroke in Atrial Fibrillation
Patients Atler a MAZE Rocedure 931-81•
105A
Decreased Levels of Iwch mRNA in Patients With
Chronic Atrial Fibrillation but No Changes in
the Sarcoplasmic Reticulum Calcium ATPase
and Phospholamban 941-142.122A
DefibrillationWith Different Energy Levels and
During Sleep: Impact on Pain Perception 745Jt
.195A
Different Mode of Recoveryof Atrial Contraction
Between the Right and Left Atria After Maze
Procedure: Dependenceon Diseaae Etiology
1071-38.477A
Do IndividualPatients Exhibit a Consistent Pattern
of Onset of ParoxysmalAtrial Fibrillation?
1067-91.470A
Does Multilobularityof Left Atrial Appendage
Represent an Additional Risk for Thmmbus
Formation in Atrial Fibrillation? 757-3.212A
Double External Shocks for Refractory Atrial
Fibrillation 1069-106.474A
Dual Current Pathways for Internal Atrial
Defibrillationin Sheep: Marked Reduction in
DefibrillationThresbold 745-5.195A
EchocardiographicAssessment of Left Aerial
AppendageFunction ImmediatelyBefore and
24 Hours After Successful Cardioversionfor
Atrial Fibrillation 1071-41.478A
Effect of Different Sites of Atrial Pacing on Lncal
Atrial Conduction Delay in Patients With Atrial
Fibrillation 1067-92.47OA
Effect of Intranasal Butorphanol on”Discomforr
During Internal Atrial Defibrillation 1069-107.
474A
Effect of Left Atrial Appendage on Left Ventricular
Filling Dynamics: A Computational Model
1015-133*321A
Effect of Parasympathetic Tone on the Internal Atrial
DefibrillationThreshold in Humans 1069-103.
473A
Effects of Pilsicainide in Cardioversion or
Maintaining Sinus Rhythm for Patients With
Chronic Arrial Fibrillation 1051-136.443A
Efficacyand Safety of Coronary Sinus Ostial Pacing
for Suppression of Atrial Fibrillation 717-5.
74A
Epicardial Maps in a Canine Model of Chronic
AerialFibrillation After Linear Ablation Lesions
982-116.253A
Esmolol Reduces Atrial Defibrillation Thresholds: A
Randomized, Placebo-Controlled Stady
1OOO-89.292A
Evidence for Involvementof the Atrial Inserth of
Accessory Pathways in the Genesis of Atrird
Fibrillation 775-4.359A
Exaggerated Dispersion of P-Ta and Ta-T Interval as
a Predictor of Atrial Fibrillation 742-4.191A
Failure of Multisite High-FrequencyBurat Pacing to
TerminateLaboratory-InducedAcute Aerial
Fibrillation 1067-9O.47OA
Flecainide Versus Sotalol for Immediate Conversion
of Atrial Fibrillation 1067-95.471A
Functional Mechanisms Underlying
Tacbycardia-InducedSustained Atrial
Fibrillation in a Cbmnic Dng Model 982-120.
254A
HemodynamicChanges During AerialFibrillation
and Intact AV Node Conduction Compared to
VentricularPacing at the Same Rate 1OOO-88.
292A
Higher Energy External Cardioversion of Refractory
Atrial Fibrillation 732-6. 177A
How Should Atrial Sensitivity Be Programmed for
Optimal Automatic Mode Switching? 957-175.
149A
Identificationof the Firat Locus for Familial Amid
Fibrillation Utilizing a Rapid Novel Pooled
DNA Strategy 407-1.2A
Impaired Quality of Life in Patients With Arrial
Fibrillation Is Not Related to AF Frequency or
Duration 936-106. 113A
Improved Safety of Transvenous Atrial Defibrillation
During Wide QRS Tachycardia by Introduction
of a Delay Interval 745-2. 195A
In the Goat, ChrmricAV Shunt EvenmrdlyLeads to
Electrical Remodeling and Induction of
Sustained Atrial Fibrillation 709-1.62A
Incidence of Atrial Arrhythmias in Patients With
Proven Isthmus Blnck After Radiofrequency
Ablation of Inferior Vena Cava-Tricuspid Ring
for Common Atrial Flutter 913-128.33A
Induction of Sinus Node Dysfmrctionand Atrial
Fibrillation by Rapid AerialPacing in Sheep
709-4.63A
Left Atrial “Preexcitation” Is Not Useful in
Preventing the Induction of Atrial Fibrillation
Fmm the High Right Atrium 1067-93.471A
Local Capture by Atrial Pacing of Chronic AtriaJ
Fibrillation in Human Beings 982-118.254A
Mapping of Arrial Activation and Tachyarrhythmias
Using a Nonconract Right Arrial Catheter
102O-7O.33IA
Mecbanism of Onset of Induced Sustained Atrial
Fibrillation in the Canine Sterile Pericarditis
Mudel 982-123.255A
Multichannel Mapping of Arrial Activation
Sequences After Internal AerialDefibrillation
Shocks 982-122.255A
NoninvasiveEstimation of Pulmonary Artery Wedge
by Doppler Echocnrdiographyin Patienta With
Heart Failure and Arrial Fibrillation 1048-178.
438A
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Nourheumatic AerialFibrillation and Left Atrial
Thrombus Formation: Relation Between Leti
Atrial Appendage Function, Clinical, and
Hematological Findings 1097-76*526A
Novel Pacing Sites Interfere With Pacemuker
Diagnostics for Atrial Fibrillation Detection
957-173.149A
Older Patients With Nonvalvul~ Atrial Fibrillation
Have Lower Left AerialAppendage Velocities
Despite Higher Left VentricularEjection
Fraction and Similar Left AerialSize 951-132.
139A
Pain Threshold for Internal Cardioversion With Low
or No Sedation 936-105. 113A
Plasma Nitric Oxide Levels Are Decreased in
Patients With Arrial Fibrillation 936-108.113A
Prediction of Atrial Fibrillation Following
Pacemaker Implantation: Use of the
Electropbysiological Evaluation 981-138*
252A
Propafenone as a Single Oral Loading Dose Vs.
Placebo in Recent Onset Arrial Firbirllaton: Is it
Safe? 1051-139*443A
Prophylactic Low-Dose Amiodarone VersusPlacebo
to Prevent AerialFibrillation in Patients
Undergoing Cornnary Artery Bypass Graft
Surgery 998-145.289A
Prophylaxis of AtriaIFibriOation Following
Electrical Curdioversion:A Prospective
Randomized Study Comparing Low-Dose and
VeryLow-Dose Amiodsrone to Propafenone:
Preliminary Results 936-104. 113A
Radioftequency Catheter Ablation of the Right
Atrium for Contrnl of Atrial Fibrillation
Refractory to Antiarrhythmic Drugs 732-3.
176A
Recent-Onset Atrial Fibrillation: Placebo-Controlled
Evaluation of the Efficacy of Propafenone in
Elderly Subjects 1051-14O*443A
Regional Atrial Conduction Delays Varyfor Short
Coupled Premature Beats During Single and
Dual Site Atrial Pacing 981-140.253A
Relation of Left Atrial Appendage Function,
Thrombus Formation, and Stroke Risk in
Patients With Atrial Fibrillation: The Stroke
Prevention in AerialFibrillation (SPAF) III
Study 757-2.212A
Reproducibility and Lnng-Tetm Change of the P
Wave-TriggeredSignal-AveragedECG 912-13
.30A
Right Atrial Multipolar Catheter Ablation of Atrial
Fibrillation in a Pace-Induced Goat Mndel
913-124.32A
Selective Upregulation of Inositol
l,4,5-Trisphosphate Receptor/Calcium Release
Channel in Attial Fibrillation 703-5.54A
Size or Function: Which Correlates Best With Left
Aoiul Appendage Pathology? 979-166*250A
Spontaneous Conversionof Attial Fibrillation to
Fhttter in Man: A Stereotypical Pattern of
Organization 775-3.359A
Spontaneous Reinitiation of Atrial Fibrillation
Following Transvenous Attial Defibrillation
1000-87.292A
The Chrnnic Atrial Fibrillation Canine Mndel: A
New Approach to Increase Yield and Efficiency
1067-94*471A
The DIGAF Smdy (Digoxitrin Artial Fibrillation):
Reversion of Atrial Fibrillation With High-Dose
Digoxin (Preliminary Results) 732-5.177A
Tbe Effect of Balloon Mitral Commissumtomy on
Atrial Rbytbm 766-3.225A
The Effectiveness of Oral Flecainide and
Propafenone in the Cardioversionand
Prophylaxis of PrrroxysmalAtrial Fibrillation
1051-137*443A
The Impact of Wurfarinon Clinical Outcomes in
Heart Failure 1017-143.325A
The Rate and Variabilityof Fibrillatory Activity
Predict Persistence of Attial Fibrillation (AF) in
Humans 1OOO-86*292A
Therapy Delivery With the METRIX Automatic
Arrial Defibrillation System: Threshold Stability
and Shnck Safety 7204.78A
Transcatheter Ablation of Chronic Atrial Fibrillation
in the Canine Rapid Attial Pacing Model: Is the
Cure WorseThan the”Disease? 913-125.32A
TranscatbeterAblation of the AVJunction:
Elecrrophysiologicand Pathologic Correlations
913-122.31A
TransesophagealEcbocurdiographicRisk
Stratificationfor Cortical and Petforrding
Infarctions in Patients With Arrial Fibrillation
1097-74.525A
Use of MultipnlscConfomral Catheters to Produce
Linear Trammural Lesions in tbe Atria With
RadiofreqencyEnergy 913-126.32A
Valueof Signal AveragedP-WaveDurueion
(SAPWD) in Predicting Atrial Fibrillation After
Thoracic Surge~ 742-5.191A
Atrial flutter
A Multielectrode Catheter Designed for Ablation
Across the TA-IVCAtrial Isthmus: Preliminary
Results in Canines 748-6.200A
Abnormalitiesof Left Atrial Reservoir,Conduct, and
Booster Pump Functions in a Rapid Pacing
Model of Atrial Myopathy 758-1.213A
Alteration uf Typical Amid Fhmcr Circuit After
ApprtrentBidirectional Conduction Blnck
Through the Isthmus Between the Inferior Vena
Cava Tricuspid Amtulus 913-127.33A
Assessment of Posterior Right Atrial Conduction in
Patients With Atrial Flutter Using a
Multielectrode“Basket” Catheter 1020-76.
332A
Body Surface Mappingof Counterclockwise and
Clockwise ~pical Atrial Fluttcrin Man 742-2*
190A
ConductionVelocityin the Right Atrium and
TV-IVCIsthmus Is Slower in Patients With
AtritdFlutter Compamd to Those Without Attial
Fhttter 775-1.358A
Glohal ActivationPatterns During Higb Density
Electro-AnatomicalMappingof Atrial Flutter
102O-72.331A
Identificationof a Defect of Ablation Line During
RadiofmquencyAblation of AerialFlutter
748-2.199A
Incidence of Atcial Arrhythmias in Patients With
Proven Isthmus Block After Radiofmquency
Ablation of Inferior VenaCava-TricuspidRing
for Common Atrial Fhttter 913-128.33A
Left Atria] AppendugeContraction VelocitiesAre
Neither Regular in Frequencynor Unifortrrin
Amplitude Despite ApparentlyWell Organized
Electrical Activation in Arnal Flutter 1000-84.
291A
Mapping of Ardal Activationand Tachysrrbythmias
Using a Nuncontact Right Atrial Catheter
102O-7OO331A
New Insights Regarding the Arrial Flutter Reenrmnt
Circnit in the Canine Sterile PericurditisMndel
982-121l254A
Reappmisal of Optimal Initisl Energy for External
Cardioversionof Atrial Flutter 936-107.113A
Regional AtrirdConduction Delays Varyfor Short
Coupled Pmmatare Beats During Single aad
Dud Site Attiul Pacing 981-140.253A
ReversaJof D-SoeaIolEffects on Excitable Gap
Composition in Canine AtrirdFhrtterby
AutonomicNeurohormones 1019-79.329A
SpnntarteousConversionof Arrial Fibrillation to
Fhttter in Man: A StereotypicalPattemof
Organization 775-3.359A
Timing of Shnck During Atrial FhrtterCycle
Predicts Outcome of Internal Catdioversion
1069-105.473A
Variabilityof Right Attial Activation During
Coronary Sinus Pacin: Implications for
RadiofreqtrencyAblation of AerialFhttter
102O-75.332A
Atrial function
A New Left Arrial Pump Operating in High Herut
Rate: Atrial Contraction FavorablyInduces
EurlyOpening of Mitml Valve in Tachycsrdia
1014-156o318A
Abnormalities of Left Atrial Resetvoir, Conduct, and
Bnoster Pump Functions in a Rapid Pacing
Model of Atrial Myopathy 758-1.213A
An Unexpected Pattern of Anterior AV Nndal Input
(’Fast Patbway’) and Atrial Septal Activation
During Sinus Rhythm 982-125.255A
Assessment of Left Attial Pressure-VolumeRelation
Using Retrograde Left Atrial Catheterization
and Echocardiographic Automatic Botmdaty
Detectinn 1015.134.322A
Ardal Pacing: What Effect on Cardiac Function?
935-73.112A
Atrial Stunning Occurs After Electrical
Cardioversion but Not After Chemical
Cardioversion 1OOO-85.292A
Automated Boundary Detection for Left Atrial Area
in Patients With Maze Procedure for Attial
Fibrillation 1071-39.477A
Comparison of Monotherapy for Reduction of Left
AtriaI Size in Mikt-to-Modetate Hypertension:
Results of a Multicenter Trial 1076-59.487A
Contribution of Left Attial Function to Exercise
Capacity in Patients With 1diopatbicDilated
Cardiomyopathy 1098-162.528A
Different Mode of Recovery of Atsial Contraction
Between the Right and Left Atria After Maze
Procedure: Dependence on Disease Etiology
1071-38.477A
Effect of Left Atrial Appendage on Left Ventricular
Filling Dynamics: A Computational Mndel
1OI5-133.321A
Feasibility of Estimation of Left Atnal Complimrce
by Systolic PnlmommyVenousFfow
Propagation Velocity 1003-116.297A
Functional Mechanisms Underlying
Tachycardia-InducedSustained Atrial
Fibrillation in a Chronic Dog Model 982-120.
254A
Left Atria] Appendage Contraction Velocities Are
Neither Regular in Frequency nor Uniforrrrin
Amplitude Despite Apparently Well Organized
Electrical Activation in Atrial Flutter 1000-g4.
291A
Left Atrial Dysfunction in Left Ventricular
Restrictive Physiology 10714O.477A
Leti Ahial Inflow Propagation Rate: A New
Transesophageal Echncardiographic Index of
Preload 1071-42.478A
Linear Ablation Frnm Tricuspid Anmdus to
Eustachian Valve and Ridge Is Adequate for
Patients With AtrirdFlutter: Extending Ablation
Line to the Inferior Vena Cava Is Not Necesssry
748-3. 199A
Lnne Fossa Ovalis Memhrane Aneurysm Is an
Infrequent Finding in Adults Witb
Cardioembolic Cerebral Events” 1071-44.478A
Low Incidence of Late Morbidity Caused by Aoial
Anatomy After StmrdardOrthotropicHean
Tmusplantatinn 978-172.249A
Nonrheumatic Atrial Fibrillation and Left Aerial
Thrombus Fomtation: Relation Between Left
Atrial Appendage Function, Clinical, and
Hematological Findings 1097-76.526A
Normal Left Aerial Systolic Function Utilizing the
Cross-Sectional Three-Axis Vnlume Estimation
1003-117.298A
Older Patients With Nonvalvulsr Atrial Fibrillation
Have Lower Left AtrirdAppendage Velocities
Despite Higher Left VentricularEjection
Fraction and Similar Left Attial Size 951-132.
139A
Size or Function: Which Correlates Best With Left
Atrial Appendage Pathology? 979-166.250A
The Dependence of the E Wave on Pulmonuty
VenousFlow: Mathematical Solution With In
VivoVerification 1003-111.296A
The Rate and Variability of Fibtillatory Activity
predict Persistence of Atrial Fibrillation (AF) in
Humans 1OOO-86.292A
Transesophageal EchocnrdiographicEvaluation of
Left Atrial AppendugeFunction During DDD
and VW Pacing 935-74. 112A
I(EX Abstract title, Session-abstract number. page number
J A C CFebruary 1997 SUBJECT INDEX 593A
Atrial natrirrreticpeptide (factor) - see also
Natriuretic pepsides, atrial
A Neutral Endopeptidase Inhihitor Suppresses
Atherogenesis and Improves Endothelial
Function in Hypercholesterolemic Rabbits
986-73.263A
Candoxatril Improves Exercise Capacity in Patients
With Chronic Heafi Failure Receiving
Angiotmrsin-ConvertingEnzyme Inhibition
727-3. 169A
Design, Synthesis, and In VivoActions of a Novel
Chimeric Peptide to B-Type (BNP) and C-Type
(CNP) Natriuretic Peptides 1074-118*483A
Differences Between Responses to Felodipine in
Heart Failure With and Without Coronary
Disease:’V-HeFT 111996-70.285A
Differential Regulation of VentricularANPand BNP
Synthesis in Compensated and Overt Heart
Failure 908-168.25A
Effects of Carperitide (a-Human Atrial Natriuretic
Peptide) Patients With Acute Heart Failure:
Comparative Study on Tolerance Between
Carperitide and Nitroglycerin 996-75.286A
Increased Plasma Levels of Adrenomedullin in
Patients With HypertrophicCardiomyopathy
1062-76*462A
Long-TermInhibitory Effects of Endogenorrs
Natriuretic Peptide Activities on Cardiorenai
and Neurohumoral Factors in tiearr Failure
908-167.24A
Sympathetic Activity Responses to ANP in Human
Heart Failure 762-6*220A
Atrioventricrdarnode
An Unexpected Pattern of Anterior AVNodal Input
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Aernbic Capacity, Parasympathetic Modulation, and
Orrhostatic Tolerance in YoungAthletes
989-11O.27OA
Altered Autonomic Bafance With Crrrvedilolin
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Myncardial Infarction 1034-56.413A
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Ilb/lI1a Receptor Blnckade During Coronary
Intervention in the EPILOGTrial 974-84.240A
Increased Thrombin Activity in Patients With
Unstable Ischemic Syndromes Correlate With
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Clomipramine Challenge DnrirrgTilt Testing in
Patients With Histnry of Neumcardiogenic
Syncope 1066-87.469A
Transient Tachycardia Superimposed on Bradycardia
Prolongs Depolarization in Isolated Canine
VerrtricularMyncytes 709-3.62A
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Antiarrhythmic Dofetilide Can Be Modulated by
PbarrnacologicAgents Influencing [Ca2+]i
811-4*405A
Tbe Impact of Target Lesion Calcium Distribution
on the Magnitude and Pattern of Palmaz-Schatz
Stent Expansion 994-46.280A
The Second Messenger Inositol
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PRAISE Heart Failure Trial 1017-I48.326A
Chronic Amludipine Treatment Reduces Infarct Size
irrAtherosclerotic Rabbits 958-38.150A
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Normal Myocardium 1068-113.472A
Route to Chaos in VentricularFibrillation Revealed
by Tissue Size Reduction 406-3.2A
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109O-93.514A
The Isoelectric WindowAfter DefibrillationShocks:
Is It Tmly Electrically Quiescent? 745-1.195A
TransmembrauePotential Properties of Cells at the
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Contrast VenographyIs a Safe and Effective
Approach to Implantation of Pacemaker aad
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Cardiology Information: The LIMIT Project and
an ECG Monitor Object Pmtotypc 814-2*407A
Nuclear Cardiology Telemedicine:Evaluationof
Results After 11Months and 531 Studies
1095-63*523A
On-Line VideoTelecommunicationBetween
Cardiac Catheterization Laboratories:A New
Technologyto Facilitate Clinical Trials 1250-1
.7A
Remote AngiographicConsultation Using High Data
Transfer Rate Satellite and Terrestrial Network:
Proof of Concept 814-3.408A
Telemanagementof CongestiveHeart Failure:
Results of Daily Weight and SymptomTracking
977-177.247A
Using the Internet to SynchronizeDistributed
Medical Databases 915-121.36A
Wireless Palmtop TechnologyEnbamcesCardiac
Patient Data Management 1251-1.7A
Computer-assisted irrstruction
A Dynamic Graphical ArrhythmiaTrainer 1251-2*
8A
EchocardiographyWitb Steganographyon the
Internet 915-117.35A
ELECTRA: A MATLAB”-Based Electrogram
Analysis Toolbox 1022-55*334A
Feral EchocardiographyHomepage 1253-2.8A
In VivoValidationof a New Three-Dimensional
VectorMedel of Distarrcein Human Corona~
Arteries 915-120.35A
ITCAre: A Computer Expert System for the
Management of PostPercutaneousTransluminal
CoronaV AngioplastyPatients 1022-51.333A
Software for Receiver Operating Characteristic
(ROC): Analysis and Evahrationof Sensitivity
irrrdSpecificity 1022-56.335A
Three-DimensionalMRI Reconstructionsof
Congenital CardiovascularDisease With
Personal Computers 915-116.35A
Congenital heart disease- see rrlsoHeart defects,
congenital
An Analysis ofrhe Outcome of Umbrella Closure of
Patent Ductus Arreriosus in Children 954-137.’
144A
Balloon Angioplastyof Native Coarctation in
Adolescents and Adults, Two to 10-Yeer
Follow-Up Results 1037-79.417A
Can We Predict Aortic InsufficiencyAfter the Ross
Procedure? 932-69. 106A
CardiopulmonaryInteractionsAfter Fontan
Operations: Augmentationof Cardiac Output
Using Negative Pressure Ventilation 932-88.
108A
Course in tbe Intensive Care Unit After Right
Ventriculotomyand NeonataJRepair of
Congenital Heart Disease 932-84*I07A
Criticaf Pulmonary ValveStenosis in the Neonate:
Initial Results and Follow-UpUsing an
Umbilical Artery Snare Assisted Approach
954-141l144A
EchucsrdiographicHemrrdynamicPredictors of
SurvivalAfter Two-VentdcleRepair in Infants
With Critical Aortic Stenosis 751-3.203A
Effect of Prenatal Diagnosis of Critical Left Heart
Obstruction on Perinatal Morbidity and
Mortulity 932-83.106A
EndogenousNitric Oxide-RelatedCompnunds in
Whole Blood Are Increased in Patients With
Congenital Heart Defects With Pulmonary
Hypertension 1043-67.429A
Fetal EchocardiographyHomepage 1253-2.8A
Heart Transplantation in Cbildren With Visceral
Heterntaxy and Complex Congenital Heart
Disease 932-65. 105A
Impaired Pulmonary VascularRelaxation in
Tetralogyof Fallot 1043-66.429A
ImprovedOverall (Pre and Post) Cardiac Transplant
Suwival in Infancy: Strategies to Regulate
PulmonaryResistarrce 932-64.105A
In VivoCharacterizationof FonranPathway Flow
Dynamics by MultidimensionalPbase Contrast
Magnetic Resonance Imaging 721-4.80A
Indications, Techniques,and Results of Revision of
the Fontan Prncedure 751-1.203A
Iscbemia and InfarctionContribute to Right
VentricularDysfunctionNoted 10to 20 Years
After the Mustard Operation for Transposition
of the Great Arteries 794-1.385A
Magnetic Resonance Imaging for the Assessment of
Intracardiac Baffles and Extracardiac Conduits
in Congenital Heart Surge~ 932-87. 107A
Management and Outcomes of Right Atrial
Isomerism: 26-Yesr Experience 794-2.385A
Mode of Death in Adults With Congenital Heart
Disease 794-6.386A
New Insight Into the Determinants of Mitral
Regurgitation After Arrio-VentricularCsnal
Repair: A Three-Dimensional
EchocardiographicStudy 721-3.80A
One Thousand Patients With Adult Congenital Heart
Disease: Causes of Death and Lessons Le~ed
794-4.385A
Outcome of Lateral Tunnel Fontan Fenestration
932-89.108A
Predictive Valueof Serum Cardiac Troponin T
(cTnT) in Pediatric Patients at Risk for
Myncardial Injury 1043-68.429A
Pulmonary Balloon Valvuloplasty-InducedAcute
Changes in Right Coronary Blood Flow Velocity
Pattern 954-140.144A
Reduced Mortality in Eisenmenger’s Having
Noncardiac Surgery 1065-I56.467A
Respiratory Syncytial Virus in Congenital Heart
Disease 911-155.29A
Restenosis Versus Late Diameter Increase After
Balloon Angioplasty of Branch Pulmonary
Artery Stenosis 954-143. 145A
Sarcoplasmic Reticulum Calcium-ATPase mRNA
Level Decreases in Pressure-Overloaded Fetal
Larub Ventricle 1043-65.429A
Should Dobutamine Stress Echocardiography
Replace CoronaxyArreriographyfor Assessment
of CormraryArte~ Disease After Heart
Transplantation in Children? 721-2.79A
Stent Reconstruction nf Occluded/Obstructed
Iliofemoral Veinsand Inferior VenaCava to
Reestablish Access for Future Cardiac
Catbeterization and Cardiac Surgery 729-1.
171A
Surgical Repair of Intermpted Aortic Arch With
VentricularSeptal Defect 932-67. 106A
Three-Dimenional Reconstruction of Anomalous
Pulmonaty Veinby Gated Inflow Magnetic
Resonance Angiography 1087-17O.5O9A
Three-Dimensional Echncardiographic Study of
Right VentricularRemodeling, Mass, and
Function in Patients With Transposition of the
Great Arteries After AerialSwitch Operations
939-110*118A
Three-Dimensional MRI Reconstnrctions of
Congenital Cardiovascular Disease With
Personal Computers 915-116.35A
Transcatheter Occlusion of Patent Ductus Arteriosus
and Aorto-Pulmonary Collaterals Using the
Gianturco-Gritla VascularOcclusion Device
729-3. 172A
Why Does the Aorta Dilate in Marfan Patients?
1065-16O*468A
Contractile prnteins
Clinical Significanceof Elevated Levels of Cardiac
TroponinT Detected by Second Generation
Assay in Patients With Congestive Heart Failure
93O-I73.1O2A
Downregulationin Hibernating Myocadium Is a
Time-Dependent Process and Preservation of
Structural Integrity Requires Enrly
Revascularization 1015-128.32OA
Relative Expression of Cardiac Troponin T Isoforms
in Control and Failing Human Left Ventricles
1016-152*323A
Contractility
AbnorrrrrdCalcium Handling Prnperry Progresses
From the Adjacent to Remote Noninfarcted
MyocardiumAfter Myocardial Infarction
1084-136*5O2A
Arrial Function Assessment for Bicaval and Biatrial
Anastomoses: Magnetic Resonance Imaging
Using Automatic Csrdiac Analysis and Ffow
Measurement 1023-106.336A
Cardiac Contractility in Arrial Fibrillation Is Cycle
Lengtb Dependent 1OOO-83.291A
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Cardiomyocytes Isolated From the Stunned Rat
Heart Do Not Manifest Contractile Dysfunction
945-32*129A
Chronic Alterations in SR Calcium Uptake Protein
Expression in Pigs With Collateral-Dependent
Hibernation Myocardium 945-33.129A
Cytoskeleton Disruption Results in
Electromechanical Dissociation in Rat
VentricularCardiomywytes 811-2.404A
Downregulation in Hibernating Myncadium Is a
Time-Dependent Process and Preservation of
Structural Integrity Requires Early
Revascularization 1015-128-32OA
Echocardiographic Evidence of Tmrrsmuml
Contraction Gradient: The Role of Ventricular
Geomeo’yto Maintain Normal Chamber
Function in Human Hypertension 965-80.
161A
Effects of Critical Coronary Stenosis on Systolic
Left VentricularFunction Quantifiedby
Pressure-VolumeRelations During Dobutamine
929-168.99A
Force-Frequencyand Relaxation-Frequency
Relationships in Hypertropbied Hearts of
Children 1062-8OO463A
Force-FrequencyRelationship in Normal Subjects
aadin Patients With Heart Failure 1084-145*
504A
In Vivo Validationof Quantitative Tissue Doppler
EchocardiographyUsing Simultaneous
Hemodynamics 1049-164*439A
NG-Monomethyl-L-Arginine(L-NMMA) Improves
Left VentricularSystolic Function Late After
CardiopulmonaryBypass in Neonatal Pigs
929-163.99A
Positive Inotropic Effects of Amiodarone on Isolated
Cardiac Myocytes 918-IOO*41A
Postischemic Myocardial Contractile Dysfunction in
the Double Heart Mndel: Role of
Catecholamines 990-34*272A
Relation Between Regional Contraction and
Perfusion During Stress aad 15 to 45 Minutes
After Stress in Ischemic and Nonischemic
Myocardial Regions 1026-113.342A
Ryanodine Restitutes Frequency Potentiation of
Contractile Force in Failing Human
Myocardium 104O-3OO423A
Sarcolemma-Related Abnormalities of
Excitation-Contraction Coupling in
Cardiomyocytes From Dogs Witb Heart Failure
811-1l404A
Shorr-TemrAcute Expnsure to Increased
ExtracellukrcCalcium Induces prolonged
Contractile Dysfunction in Normal Isolated Rat
Cardiomyocytes 929-169.1OOA
Stable Cardiodepcressaat Mediators Are Released
After Myocardial Ischemia During Reperfusion
1055-32*448A
Tbe Effect of Inhaled Nitric Oxide and Inhaled
ProstaglarrdinEI on Left Ventricular
Contractility in an Experimental Model of
Pulmonary Hypertension 91O-174*27A
The Effects of Verapamilon Fetal Cardiac
Mechaaics 954-1480146A
Three-Dimensional Mapping of Myncardial Velocity
Gradient: A New Approach to Quantify
Regional Left VentricularContractile Reserve
917-55.38A
Contrast echocardiography
A Multicenter Trial Comparing FS069 and
ALBUNEX@for Left VenrncularEndocardial
Border Delineation 1094-25*519A
Abnormal Perfusion During Acute and Delayed
IneracoronaryMyocardial Contrast
EchocardiographyAfter Myocardial Infarction:
Comparison With Thallium SPECT and
Dobutamine Echocardiography 1073-53*482A
Analysis of Transmural Myocardial Intensity
Profiles Produced hy New Dodecafluoropentrrae
Microbubbles: Implications Regarding
Determinants of Opacification 1OO4-105*299A
Antigen Binding Characteristics of Antibodies
Coupled to TargetedAcoustically Reflective
Immunoliposomes 1OO4-109*3OOA
Assessment of Collateral Blood Flow Distribution
During Myocardial Ischemia With Stress
Myucardial Contrast Echocardiographyin
Humans 793-3.384A
Attenuation of Echo-ContrastUsing AlbrmexIs
Linearly Related to Exposed UltmaoundPower
1OO4-128*3O1A
Carrthe Physiologic Significanceof aCormmry
Stenosis Be Assessed On-Line During Aortic
Root Injection of Albunex@?764-3.222A
Cold TemperatureAugments Albumin Microbubble
Adbercnce to Cardioplegia-PerfusedHumarr
Coronary EndothelialCells 1OO4-126*3O1A
Comparison of Second Harmonic aad Fundamental
Imaging during Albunex Administrationon Left
VentricuhuOpacificationin Low-Ecbogenic
Patients 1094-3OO52OA
Contrast IntravascularUltrasound Imaging Improves
Detection of In-Stent Neointima After
Palmaz-ScbatzCnrorraryStent Implantation
1049-172*441A
Detection of Changes in MyocardialPerfusion With
Contrast EchoCardiographyUsing Intmcoronary
Injections of Alb.nex 812-3.406A
Effects of Residual Flow on the RecoveryRoom
Myocardial Smnning: A Myocardial Contrast
EchocardiographicStndy 9024.13A
Enhancementof Left VentricularEndocardialBorder
DelineationWirb Sonicated Human Albumin
(Infoson’”)hrtirsionDuring DobutamineStress
Echocardiography:Useful or Useless? 1094-27
.519A
Fluid Viscosity Affects tbe Persistence aad Size of
EchocardiograpbicContrast Agents: Insighta
Into the Mechanism of Resonance-Induced
Micmbubble Desnuction 1OO4-125O3O1A
HarmonicTriggered ImagingFollowingIntravenous
Ultrasound Contrast in the Assessment of
Patients FollowingAcute Myocardial Infarction
rmdTbrombolyticTberapy: Implication of
Resting Contrast Defects 1072-27.479479A
HeterogeneousReperfusion, Assessed by Myocardial
Contrast EcbocardiographyDuring Myocardial
Infarction, Is Associated With a Substantial
Delayed Recoveryof Wall Motion 1072-30.
480A
Holmium Laser TmrrsmyucardialRevascularization
(LTMR)Attenuates Myocardial Ischemia
1072-49.481A
Immediate VersusDelayed Myocardial Contrast
Echocardiographyin Acute Myocardial
Infarction:Relation With Contractile Reserve at
DobutarrrineEcbucardiography 917-74.40A
ImprovingBicycle Stress Echo Image Quality With
Albunex 984-21.260A
Influenceof Ultrasonic Energy on Contmat
Echocardiography:Intermittent Imaging Using
AD0150 Yields Generalized Myocardial
OpaciticationWhile Continuous Imaging
Delineates IntramyucardialVessels 1004-123.
300A
Infusionof Sonicated AlbuminDuring Power
Doppler Imaging Enhances EndocardialBorder
Visualizationin Patients With Suboptimal
EchocardiographicImages 1094-29o52OA
IntracororraryEchocontrastEvrduationof
MyocardialViability After PTCA: A
Comparison With Echo DobutamineLow-Dose
Stress Test 1072-46o48OA
IntravenousDodecaflouropentaneImproves
Determinationof Left VentricularFunction
During TranstboracicEchocardiograpby
1094-28*52OA
Maaual and SerrriautomatedMeasurementof Left
VentricularVolumeUsing Real-Time,
Three-DimensionalEchocardiographyIn Vivo
705-6*57A
MicrospongeEcho CmrtrastEnhances Left Heart and
MyocardialPerfusion Studies 1OIM-108*299A
Microvascularprntection With Intravenous
Nicorandil Augments Myocardial Salvage in
Patients Wirb Acute Myncardial Infarction
947-12.134A
Myocardial Blood VolumeDecreases Atler
Exhaustion of Autoregulation: Insights With
Contrast Echncardiography 812-2.406A
Myncardial Contrast EchocardiographyCan Be Used
to Quantify Intmmyocardial Blood Volume:
New Insights Into Structural Mechanisms of
Coronary Autoregulation 812-1.405A
Quantification of Mitral Regurgitation on Contmat
Echocardiography:Application in Patients
Undergoing Catheterization 1049-168.44OA
Quantification of the Severity of Coronary Stenoses
Using VenousInjection of Minute Amounta of
AF0150 During Intermittent Harmonic Imaging
764-2.222A
Quantison’”,a New Long-Living Ultrasound
Contrast Agent: Experience in Humarr
Volunteers 1OO4-107.299A
Recovery ofhritially Impaired Myocardial Perfusion
Is Frequent After Primary PTCA for Acute
Myocardial Infarction 946-24.133A
Restoration of Myocardial Blood Flow and
Functional Improvement in Patienta With Acute
Myocardial Infarction by a K+-ATP Channel
Opener, Nicormrdil 947-8.133A
Reveraal of Endothelial Dysfunction in Dyslipidemic
Patients With Coronary Artery Disease 714-3.
70A
Safety and Efficacyof AF0150 for Cardiac Conmast
Enhancement in Nomral Subjecta: Initial Results
of a Phase I Clinical Trial 1004-122*300A
Safety and Efficacyof QW7437, a New
Fluorocarbon-BaaedEchocardiographic
Contrast Agent IOO4-106.299A
Short Pulses of Ultrasound Can Reduce
Echocontrast Reflectivity Up to 99%:
Implications for Quantitative Contrast
Echocardiography 1OO4-127*3O1A
Studies of Bubble Persistence Vs. Standard and
Harmonic Mode Acoustic Pulse Pressure for
Tbree New EchocorrtmstAgents 1004-124.
300A
Targetingand Retention of Acoustically Reflective
Immuno-Liposomes Under In Vitro Flow
Conditions 1094-46*52OA
The Effect of Significant Two- VerausOne-Vessel
Coronary Artery Disease on Resting Myncardial
Perfusion Defects Observed With Harmonic
Triggered Imaging and Intravenous Ultrasound
Contrast 764-5.223A...
The Resting Myocardial Contrast Defect Seen With
Extended Time Intervals Between Frame Rates
Following Intravenous Microbubbles Correlates
Best With Infarct Size 107247.480A
The Safety and Efficacy of Intravenous
Pertluomcarbon Exposed Sonicated Dextrose
Albumin in 110Patients When Using
Conventional or Transient Response Imaging
107248 *48OA
TrarmientRespnnseSecond Harmonic Imaging
Using Intravenous FS069 Can Quantify
Coronary Stenoses Without the Need for
Pharmacologic Stress 764-1.222A
Use of Micmbubble Destruction as a Novel
Approach for Quantification of Myncardial
Perfusion With Contrast Echocardiography
During VenousIrrtirsionof Contrast 406-5.2A
Visual Assessment of Reactive Hyperemia During
Coronary Angioplasty by MyncardirdContmat
Echocrrrdiography 7644.222A
Contrast media
Antigen Binding Characteristics of Antibodies
Coupled to Targeted Acoustically Reflective
Immunolipnsomes 1OO4-109.3OOA
Assessment of Vascular and Cellular Integrity in
Reperfused Infarcted Myomrdium Using
Gadolinium-EnhancedMR Imaging 800-4.
394A
Attenuation of Echo-Contrast Using Albunex Is
Linearly Related to Exposed Ultrasound Power
1004-128*301A
Cold TemperatureAugments Albumin Microbubble
Adherence to Cardioplegia-Perfosed Human
Coronary Endothelial Cells 1OO4-126*3O1A
Contrast Intravascular Ultrasound Imaging Improves
Detection ofhr-Stent Neointima After
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Palmaz-Schatz Coronary Stent Implantation
1049-172*441A
Detection of “No Reflow” Zones in Repertlrsed
Myocardial Infarction: MR Contrast Agents
Versusa Standard Fluorescent Tracer 1055-35.
449A
Effects of Large Doses of Contrast Medium in
Complex CormmryInterventions 928-13.97A
Fluid Viscosity Affects the Persistence and Size of
EchocardiographicContrast Agents: Insights
Into the Mechanism of Resonance-Induced
MicrobubbleDestruction 1OO4-125*3O1A
Large Amount of Nonionic Contrast Media Lead to
an Increasing Thrombogenic Potential After
PTCA 1OO8-162*3O7A
Simultaneous Assessment of Function and Perfusion
in Experimental Coronary ActeryStenosis Using
Fast MRI 759-3.215A
sNdkS of Bubble Persistence Vs. Standard and
Harmonic Mode Acoustic Pulse Pressure for
Three New Ecbocontrast Agents 1004-124.
300A
Targetingand Retention of Acoustically Reflective
Immuno-Licosomes Under In Vitro Flow
Conditions” 1094-46*520A
Transient Response Second Harmonic Imaging
Using Intravenous FS069 Can Quantify
Coronary Stenoses Without the Need for
PbarnracologicStress 764-1.222A
Use of Microbubble Destruction as a Novel
Approach for Quantificationof Myocardial
Perfusion With Contrast Echocardiography
During VenousInfusion of Contrast 406-5.2A
What Predicts Contrast NephropathyAfter Corona~
Intewention? Insights From the IMPACTII
Trial 1082-10*5OOA
Coronary artery disease
677C+T Mutation of tbe 5,10-Methylene
TetrahydrofolateReductase Gene: Relationship
With Occlusive Coronary Disease 919-69.43A
A Comparative Study of Tmponin I and TroponinT
Release in Acute Myocardial Infarction 990-35
.272A
A Comparison After One-YearFollow-Up of Costs,
Mortality, arrdMorbidity Between Muldvessel
PTCA Performed as a Single Session or
Performed Staged Procedure 1012-15.315A
A Mutation in the Methylenetctmbydrofolatc
Reductase Gene Is Not Associated With
Increased Risk for Coronary Artery Disease or
Myocardial Infarction 723-4.83A
A Randomized Study of Cutting Balloon Versus
ConventionalBallcar Angioplasty: Preliminary
Results 713-6.69A
A Simple Clinical Classification Can Identify
Patients at Risk for Adverze Patient Outcomes
(APO) From Diagnostic and Interventional
Procedures: A prospective Evaluation 1032-42
l350A
Acute and One-YearResults After Rotational
Atherectomy for Complex Coronary Disease
1012-9*314A
Acute Emergency Department 2-D
Ecbocardiographyand TC99M Terrofosmin
SPECT Imaging in Patients With Chest Pain and
Nondiagnostic ECG 756-6.211A
Acute Myocardial Perfusion Imaging for Chest Pain
Reduces the Length of Cardiac Work-Up: A
Randomized Trial 1095-59~522A
Acute Procedural Complications After Rotational
Atherectomy Are Predicted by Strip Chart
Recordings: Results Frum STRATAS 1081-5.
499A
Adenosine SPECT in Patients Without Known
Coronary Artery Disease: Prediction of Cardiac
Events and Test Utilization 768-6.225A
Altered Plaque Distribution in HypertensivePatients
1053-18*447A
ArrginalChest Pain in VeryElderly Patients With
Severe Aordc Stenosis: Dues It Predict
Coronary Artery Disease? 950-178-139A
Antecedent Angina Pectoris and In-Hospital
Outcome After Myocnrdial Infarction in Patients
Receiving Thmmbolytic Tberapy: The Second
National Registry of Myocardial Infarction
(NRMI 2) 924-36*90A
Are STRESS Results Generalizable? The NACI-PSS
Experience 108O-33.495A
Assessment of IntermediateCoronary Stenosis by
Relative Coronary Flow VelocityReserve
906-62*21A
Association of TransformingGrowth Factor-Beta
Isofomrs With Coronary Plaque in Patients With
Coronary Ischemia 961-121.155A
Atrupine Is Not Necessmy for DobutamineStress
Echocardiography 704-2.55A
Biphasic Response to Dobutaminepredicts Recovery
VentricularFunction After Revascularization:
Implications of Time Course of Recovery in
Diagnostic Performance 984-1.258A
Blood Troponin-TConcentrations Correlate With
Coronary Artery Disease arrdAbnormal
Hemosrasis, Fibrirrolysis,and Endotbelial
Activation in Cardiac Allograft Recipients
808-3*402A
Botb Repetitive Stunningand Hibernation Are
present in Chronic Ischemic Left Venrncular
Dysfunction:Serial Flow-FunctionStudies in a
Chronic Canine Model 1072-45.48OA
Can Sequential Exercise Testing Distinguish
Ischemic Heart Disease From SyndromeX?
966-75.165A
Can the Physiologic Significanceof a Coronary
Stenosis Be Assessed On-Line During Aortic
Root Injection of Albunex@? 764-3*222A
Cardiac Allograft Rejection Is an IndependentRisk
Factor for Graft Coronary Artery Disease Late
After Transplantation 999-153.290A
Cardiogenic Shock: SurvivalRates From the
National Registry for Emergency
CardiopulmonaryBypass Investigators 804+
398A
CardioprotecriveEffect of Alcohol: Increased
Surface-LncalizedFibrirrolyticActivity in
Cultured Human EndothelialCells 919-67.43A
Carotid Atherosclerosis as a Predictor of the Extent
of Comnmy Artery Atherosclerosis 943-137.
127A
Changes in Coronary Flow Spatial Velocityprofile
Demonstrated in Humans by Digital Computer
Analysis of TEE Doppler Color Flow 779-1•
363A
Chlamidia Pneumonia Infection and
AthereoscleroricCoronary Disease 1078-125.
491A
Cholesterol ScreeningAccording to American
College OfPhysicians (ACP) Guidelines: Who Is
Missed? 767-1.226A
Chronic CoronaryArtery Occlusion: Reduction of
Restenosis- and Reocclusion-Ratesby Stcnt
Treatment 802-3.396A
Chronic Estrogen Therapy Impmves Exercise Time
to Myocardial Ischemia in Postmenopausal
WomenWith Coronary Artery Disease 747-5.
198A
Clinical and AngiographicOutcome of
Intracomnary Stent Placement in Acute
Myocardial Infarction 903-10*14A
Clinicaf, Angiographic,and Ultrasound Predictors of
Stent Expansion After High-Pressure
Implantation 992-22.275A
Color Kinesis in tbe Interpretationof Dobutamine
Stress Echucardiography 938-94.117A
Combined Antiplatelet pretreatment Whh Aspirin
and TiclopidineReduces In-Hospital Cardiac
Events FollowingElectiveCoronary
Angioplasty 928-17.98A
ComparativeResults of Short VersusLong Stenting
1036-87*415A
Comparison of Clinical and EconomicOutcomes of
Radial Vs. Femoral Access Sites in Comnmy
Stenting 1036-89*416A
Comparison of DobutamineStress
Echucarrfiographyand 99m- Technetium
Sestamibi SPECT MyocardialPerfusion
Scintigraphyfor the Diagnosis of Coronruy
Artery Disease in HypertensivePatients
965-1OO.162A
Comparison of Patients With Exercise Induced
Angina VerzusThose With Silent Ischemia
During Exercise Testing 966-76.165A
Compensato~ Enlargement of Coronary Arteries
After Directional Coronary Atherectomy 733-3
l178A
Complete Myocardial Revascularization With
Transmyocardial Laser as an Adjunct to CABG
Without Cardiopulmonary Bypass 952-134.
141A
Computerized, Automatic PressrrrcSensor and
InflatorDevice (CAPSID): A New Technique
for Safer, Gradual Dilatation of Coronary
Stenosis and PTCA Pressure VolumeCurve
Analysis 928-10. %A
Cooperative Cardiovascular Project (CCP):
Underuse of Quality Indicators for Acute
Myocardial Infarction in Medicare Patients in
New YorkState 738-2. 185A
Coronary Blocd Flow Respunse to Rapid Atrial
Pacing Is Not Nitric Oxide-Mediated When
Coronary Atherosclerosis, or Its Risk Factors, Is
Present 1096-77.523A
Coronary Stenting of Small Coronary Arteries:
Preliminary Results of a Pilot Study With the
2.5MM Micmstcnt AVE 904-46. 16A
Correlation Between Oxidized Low Density
Lipoproteins und Coronary Ar@y Disease in
Hemt Transplant Patients 808-1.402A
Correlation of Technetium-99m-SestamibiLung
Uptake With Coronary Artery Disease Sevecity
and Left VentricularFunction 985-28*261A
Cutting Balloon Angioplasty Vs. Plain Old Balloon
Angioplasty: Randomized Study in Type B/C
Lesions (CAPAS) 106O-149.458A
Detecting Coronary Artecy Disease: Value and
Cost-Effectivenessof NoninvasiveTests 966-66
.163A
Detection of Mildand Severe Corona~ Artery
Stenoses by Di yridamole 201Thallium Vs.
fDipyridamole ‘mTc-Tetrofosmin 1050-160.
442A
Developinga Standard Dataset for Intewentional
Cardiology 1012-160316A
Diabetic Coronary Artery Disease in 1996 780-1.
365A
Diagnostic Accuracy of Dobutamine Stress
Echocardiographyin Patients With Left Bundle
Branch Block: A Multicenter Study 917-75.
40A
Diagnostic Dobutamine Stress Testing Is Dependent
on Stage Duration 966-70. 164A
Diagnostic Use of Markers of Myocardial Injury and
IntracoronaryThmmbus in Patients Presenting
to a EmergencyDepartment With Possible
Acute Coronary Syndromes 946-4.131A
Diastolic Left VenrncularFunction in Patients With
Refractory Angina Pectocis After Low-Dose
Intermittent Umkinase Therapy 1058-5*454A
Differences in Lipid Management Across the
Spectrum of Acute Coronary Artery Disease
806-2*400A
Diminished Myocardial Blood Flow Response
During Mental Stress Occurs in Regions With
Abnormal Coronary Flow Reserve Independent
of Coronary Anatomy 103547.414A
Dobutamine Stress Echo Test Results: Relationship
to Coronary Stenosis Severity 1025-83.338A
Dobutamine-AtropineStress Echucardiography Is
Accurate for Predicting the Extent of Coronary
Artery Disease 917-70.39A
Donor Heart Ischemic Time Is a Risk Factor for
Early Manifestation of Allografr Coronary
ArtecyDisease 808-2.402A
Dynamic Positron Emission TomographyUsing
(R,S)-[F-18] 6-Thiaheptadecanoic Acid Detects
Preserved Myocardial Viability in Regions With
Reduced Perfusion 1002-101.295A
ECG Criteria Differentiating Between Pruximal
VermrsDistal Occlusions of the Left Anterior
Descending Coronary Artery 1044-103.43OA
EchocardiographicDiastolic Function: A Sensitive
NoninvasiveApproach for the Detection of
Coronary Artery Disease in Women 747-2.
197A
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Echocardiographyaad Fatty Acid Single Photon
Enrission Tomographyin Predicting
PostrevascularizationReversibility ofRegional
Left VentriculwDysfunction 103546.413A
Economic AssessmentofPlatelet Glycoprotein
IIb/IIIa ReceptorBlockade During Coronary
Intervention intbe EPILOGTrial 974-84.240A
EffectofAtherosclerotic Plaque Topographyon
Coronary Artery Remodeling: An Intravascular
Ultrasound Study 942-151.125A
EffectofSix-Month Amiiipemic Therapyon
Coronary Lesions andClinical Events inpatients
With Coronary Heart Disease 969-33.232A
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Value 1025-9O.34OA
No Variable on Transesopbageal Echocardiography
Performed at the Time of Stroke Pre@cts Future
Stroke of Death: A Prospective Smdy 757-1l
212A
Older Patients Witb Nonvalvular AerialFibrillation
Have Lnwer Left Atrial Appendage Velocities
Despite Higher Left Ventricular Ejection
Fraction and Similar Left Atrial Size 951-132.
139A
Postmyocardial Infarction Testing in the Elderly:
Results in 190,135Patients 777-5.362A
Quantification of Mitral Valve Prolapse by-”-
Three-Dimensional Echocardiography:
Correlation With Biomecbanical Characteristics
of Excised ValveTissue 784-4.371A
Quantitative Analysis of Patent Ductus Arteriosus
Shunt by Transesopbageal Imaging the Flnw
ConvergenceRegion 916-82.37A
Quantitative Assessment of Regional Left
VentricularFunction by Tmnsesophageal Tissue
Doppler Echocardiography 1070-21.476A
Regional Coronary Vasomotionand Distribution of
Left VentricularHypcrtrophy in Hypertropbic
Cardiomyopathy 942-153.126A
Regional Myocardial Wall Stress by
Transesophageal Echocardiograpby and Finite
Element Analysis 1OO3-119.298A
Relation Between Cardiovascular Risk Factors and
Atherosclerotic Plaque of the Tboracic Aorta: A
Large prospective Study Using Multilane
Transesophageal Echocardiography 1024-117.
337A
Relation of Left Arrial Appendage Function,
Thrombus Formation, and Stroke Risk in
Patients With Atrial Fibrillation: Tbe Stroke
Prevention in Arrial Fibrillation (SPAF) III
Study 757-2.212A
Risk of Vascular Events During Follow-Up in
Patients With Aortic Arch Atherosclerosis
944-46.127A
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Role of hrtmoperativeTransesophageal
Echocardiographyin 43 Consecutive Patients
Undergoing Can3iacMass Removal 916-80.
36A
Role nf the TmrrsesophagealEchncardiographyin
the Marragementof the Patients With Congenital
Heart Disease 916-78.36A
Short Pulses of Ultrasound Can Rednce
EchucomraarReflectivity Up to 99%:
Implications for Quanrhative Contrast
EchoCardiography 1OO4-I27.3O1A
Size or Function: Which Correlates Best With Leti
Atrinl Appendage Pathology? 979-166*250A
Special Role of Trmsesophageal Echo (TEE) in
Surgery for Congenital Left VentricularOutflow
Tract (LVCJf’)Obstruction 1087-172*5O9A
TEE for Cardiovascular Source of Emboli:
Determination of Pretest Ptohability Using TTE
and Presence of Atrial Fibrillation 1097-75*
526A
The Feasibility and Incremental Valueof
Tk-Dimensional IrrrraopcrativeTEE in Vnlve
Surgery: A Prospective Strrdyin 40 Consecutive
Patients 784-3.371A
The Link Between Coronary Blnud Flow and
Myncardial ContractileReserve in Viable
Myncardium: A Doppler Transesophagenlmrd
Transthoracic EchucardiographyStudy 779-2.
364A
Tbe Quantitative Measure of Spontaneous Echo
Contrast as a Predictor of Left Arrial Mechanical
‘Function 1049-17O.44OA
Three-Dimensio.ai l?chocardiographicStudy of
Right VentricularRemodeling, Mass, and
Function in Patients With Trnrrspositionof the
Great Arteries After Atrial Switch Operations
939-11O*118A
Tbree-Dimensional Echocardiographyfor
Determining tbe Mechanisms of Aortic
Regurgitation:Comparison With Surgical and
Pathological Findings 730-1*173A
Three-Dimensional Trrmsesophagerd
Echncardiographyfor Determining Aortic Valve
Ama in ValvulaIAortic Stenosis: A Prospective
ClinicaJ Study 408-3.4A
Tissue Doppler Imaging in Quantitative Assessment
of VentricularFunction in Normals 1049-163*
438A
TransesopbagealDoppler Evaluation of Proximal
CornrrarvFlow: Reference Nornral Valuesaad
Physiological Correlations 779-4.364A
Transesophageal Dynamic Three-Dimensional
Reconstruction of Flow Jets in Assessing
Prosthetic Mitral ValveFunction 730-4.174A
Tmnsesophageal Echo-Doppler fnr Study of
Coronary Flow Reserve: Feasibility and
Normalcy Criteria 779-3.364A
Transesophageal Echocardiograpbic Abnormalities
FoRowingLung Transplantation 1048-174*
437A
TrrmsesophagealEchucardiographic Evaluationof
Left Atrial Appendage Function During DDD
and VVI Pacing 935-74. 112A
TmnsesophagealEchccardio~aphic Evaluationof
Proximal CormraryArtery Stennsis With
Optimized Stenosis Detection Algorithms
779-5.364A
TransesophagealEchc-cardiographicRisk
Stratification for Cordial and Perforating
Infarctions in Patients With Atrial Fibrillation
1097-74*525A
Vahreof EchncardiograpbicAutomated On-Line
Quantificationof Aortic Elastic Properties for
the Identification of Patients With Coronary
Artery Disease 1049-169*44OA
Vahreof Transthoracic Ecbw~dingrapby in a
Trauma Unit 1024-118*337A
VaryingMorphologyof Mitral ValveCommissrrres,
Commissural Fusion and Orifice in Mitral
Stenosis, Mitral Regargitatinn, and Cnmbined
Lesions in Rheumatic ValveDisease: A
Three-Dimensional EchncardiographicStudy
784-2*371A
Eehocardingraphy,tranathorack
A Multicenter TrinlComparing FS069 and
ALBUNEX” for Left Venticrdar Endocardial
Border Delineation 1094-25.519A
A New NoninvasiveMerhodto Determine
Combined Systolic and Diastolic Ventricular
Function: Evaluation in NorrrrtdCbiMrenand
Dilated Cardiomyopathy 1087-168*5O8A
A Prospective Study to Predict the Transition Fmm
ParoxysmalArrial Fibrillation to Chronic.Awial
Fibrillation by Signal-Averaged
Elecrrneardiography 912-18.31A
A Simple Bedside Clinical Echucardiographic
Algorithm ISVerySpecificof Severe Pulmonm’y
Embolism:,A ProspectiveStudy in 43 Cases
963-105*158A
Accnracyof Color Kinesis for Qrramirarive
Evaluationof Regional Wall Motion During
DobutnmineStress Test 939-121.120A
Accurate Mitral VrdveArea Assessment in Patients
With Mitral Stenosis by Tbree-Dimensionrd
Echncardiography 784-6.372A
Acute EmergencyDepartment2-D
Echucardiographyand TC99M Tetmfosmin
SPECT Imaging in Patients Witb Cbest Pain and
Nnndiagnostic f3CG 756-6.211A
Age-Related Aorric StiffeningCorrelates With
Diastolic Fmrction 997-39.287A
Altered SarcoplasmicReticulum Ca2+ ATPase
Expression in Compensated Cardiac
Hypcrtrophy 758-3.214A
Amplitudes and Durations of Propagated Mitral
Flow Waves Are Related to Left Ventricular
Diastolic properties: In Vitro Findings 1093-51
.517A
An EchncardiographicStudy of the Mitral Valvein
Patients Who Fail auIncrease the Mitral Valve
Area After PercutaneousMitral Valvuloplasty:
Role of Commissures and SubvalvularDisease
1037-8O.417A
An OptimrdMethod for Calculating Mitral Valve
Area in Patients With MitrrdStenosis by the
flow ConvergenceMethnd: In Vitro Study and
Clinical Validation 1025-88.339A
Analysis nf a ModifiedFlow ConvergenceEquation
for Calculation of Anrtic Regurgitant Ftow Rate:
A Numerical Study 1093-53.518A
Aortic RegurgitationIs Frequently Frcsent in
Patients With Familial Hypercholesternlemia
1085-39o5O5A
Application of Doppler Tissue Imaging for the
Evaluationof Left VentricularRelaxation and
the Estimation of Filling Pressures 1049-162.
438A
Assessment of Mitral Regurgitationby Quantitative
Doppler: Comparison to MagrreticResonance
Imaging 1025-92*34OA
AerialPacing: What Effect on Cardiac Function?
935-73.112A
Atropine Is Not Necessary for DnbutamineStress
Echocardiography 704-2.55A
Biochemical Screeningfor Left Ventricular
Dysfunction 1009-134.309A
Calculation of the IntrmnyocardialRelative Gradient
of tbe Diastolic VelocityProfileby
ComputerizedPulsed DopplerTissue Imaging
Analysis of the Left VentricularMyocardial
WaORelaxation Under Physiologic Conditions
107O-22.476A
Can “LeftVentdcularEjection Time” Still Be Used
as a Marker of Crhical Aorric Stenosis?
1093-55.518A
Can Left VentricularDiameters Be Used to Assess
Left VentricularRemodeling? 1003-11O.296A
Can Patients With Severe Aortic Stenosis Undergo
Noncardiac SurgeryWith Acceptable Risk?
950-158.138A
Can the Physiologic Significancenf a Coronary
Stenosis Be Assessed On-Line During Aortic
Runt Injection of A1bunex@?764-3.222A
Cbamcterization of Left VentricularEnd Systolic
Stress in YoungAdults: The CARDIA Study
1(X)9-131*308A
Clinical Significanceof ST Segment Elevation
During DobmamineStress Echncardiography:
ComelationWith Coronary Angiography
9i7-52.37A
Clinical, Echocardiographic, and Exercise Predictors
of Outcome in a prospective Study of Valvulnr
Aortic Stenosis 950-155. 137A
Color Dnppler Imaging of the Proximal Jet Is a Good
Reflector of VenaContract Area of Regurgitant
Jets: In Vitro Studies Using Laser-Induced
FluorescenceImaging 1025-94.341A
Comparison of Color Dnppler M-Mede Indices to
Established Pulsed Doppler Indices of Left
VentricularDiastolic Function 1OO3-118.298A
Comparison of Effective Orifice Areas Derived
Using the Duppler Continuity Equation to
Directly VisrmlizedVenaContractaAreas: In
Vitro Studies Using Laser-Induced Fluorescence
Imaging 711-1.65A
Comparison of Second Harmonic and Fundamental
Imaging during Albunex Administration on Left
VentricularOpacification in Low-Echogenic
Patierrts 1094-30. S2OA
Concealed Phase of Familial Arrhytbmogenic Right
VemricularCardiomyoparhy (ARVC): Early
Recognition and Lnng-TrmnFollow-Up 744-3.
194A
Contrast EchucardiographyVersus Sesfmrribi
SPECT to Detect Stunned Myocardium in
Patients Treated With Primary PTCA for Acre
Myocardial Infarction 1072-28.479A
Corclation of Scar Thickness to Myncardial Viability
in Patients With Healed MyrrcardialInfarction
939-t 20.120A
Decrease of MitrrdRegurgitation With Heart Failure
Treatment Is Due to a Reduction in the
RegurgiranrOrifice 1003-112.296A
Demographics and Correlates of Five-YearChange
in EchocardiographicLeft Ventricular Mass in
young Adults: The CARDIA Study 1009-133.
309A
Depressed MidwaOShortening Precedes Chamber
Dysfunction in Pressure Overload 1062-82.
464A
Detection OfChM18eSin Myocardial Perfirsion With
Contrast EchncardiographyUsing Intracoronary
Injections of Albunex 812-3.406A
Determinants of Pulmonary Venous Flow Pattern in
Patients With Cbronic Heart Failure 1071-43.
478A
Detenrrinants of Regional Myocardial Dysfunction
Following Rotational Cnmnary Atberectomy
1012-12*315A
Deterrrrinantsof Tricnspid Regurgitation in Primary
Pulmonary Hypertension 916-81.37A
Deternrinationof Left VentricularAneurysm Surface
Area by Dynamic Three-Dimensional
Ecbucardiograpby 939-117.119A
Diagnostic Accuracy of Pediatric Echucardiogrmns
Performed in Adult Lahuratories 721-1.79A
Different Effects of Exercise and Dobutamine Stress
on Regional and Global Left Ventricular Shape
1025-85o339A
Digital Acoustic Analysis: A Cost-Effective
Alternative to Echocardiography for Evaluating
Systolic Murrnura 1022-54.334A
Dilated Cardiomyopathy Related to Human
ImmunndeficiencyVirus Infection: A Clinical
and Echncardiographic Study 765-1l223A
Direct Calculation of 3-D Flow Convergence Surface
Area Fmm 3-D Color Doppler Flow Maps for
Computing Aortic Regurgitant Flows: A
Chronic Animal Study 730-6.174A
Distinctive Hemudynamic Features of the Freestyle
Aortic Bioprostbesis as Compared to Stented
Bioprosthesis 1064-168*466A
Dn Alterations in Load aad Cardiac Output Affect
Regional Shape and Global Geometry of a
Normal Left Ventricle? A Quantitative
EchncardiographicShape Analysis Study
939-118.119A
DobrrtmrrineEcho and Positron Emission
Tomographyfor Assessing Viability in Patients
With Ischemic Heart Failure 1OO3-113.297A
DobrrtamineStress Echo Test Results: Relationship
to Coronary Stenosis Severity 1025-83.338A
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Dobutarnine-AtropineStress EchocardiograpbyIs
Accurate for Predicting the Extent of Coronary
Artery Disease 917-70.39A
Does Flow Reversal Within Intramyocardial
Coronary Vessels Occur During Systole?
Detection of Biphasic Flow in Intmrnyocurdial
Vessels by Transtboracic Echo 779-6.365A
Does Mitral Regurgitation Affect the Validityof the
Interpretation of Diastolic Filling Parameters? A
Quantitative EcbocardiographicStudy 909-106
.26A
Doppler Echocardiographic Study of the Internal
Thoracic Arteg After Coronary
RevasculurizationUsing Mini-Thorachotomy
Technique: Diagnostic Accuracy und Follow-up
Changes 979-161.249A
Doppler Tissue Imaging Is aReiiable Techniquefor
the Diagnosis ofMild AcuteRejectionin Heart
TransplantRecipients 1049-161o438A
Duration ofPulmonary VenousAtriaJReveraalarrd
Mitral a-WaveCan Predict Elevated End
DiastolicPressure in Children 1087-169.5O8A
Dynamic Three-Dimensional Trsrrsthoracic
EchocrirdiograpbicEvahrationofrhe TotalMass
ofthe Left VentricleUsing Three Different
MyocurdialTissueEncodingTechniques
1094-48*521A
Esrly Left VentricularMassRegression Measuredly
3-D EchucrrrdiograpbyinHypertensiveSubjects
Is AssuciatedWitbImprovement of
Doppler-MeaauredMitral Intlow 1076-62*
487A
Early Left VentriculrrrMassRegression Measuredby
3-D Ecbocardiographyin HypertensiveSubjects
Is Indepen&ntofReducrion inLeftVentricular
Volume 1062-81.463A
Early RevascularizationofAsymptomatic Patients
Witba Totally Occluded Infurct-RelatedArtery
Imprnves Left VenrricularRemodeling 926-25.
92A
EchucurdiographicFeaturesof Chronic Chagas’
HeurrDisease 765-2.223A
EchocurdiographicHemodynarnicPredictorsof
SurvivaIAfterTwo-VenticleRepair inInfants
With Crhical Aortic Stenosis 751-30203A
Ecbocardiographic Right VentricularVolumesUsing
a Crescentic, Difference-of-EllipsoidsModel
1048-175*437A
Echocardiographyand Fatty Acid Single Photon
Emission Tomographyin Predicting
Postrevascularization Reversibility of Regional
Left VentricularDysfunction 1035-46.413A
EchocardiographyCan Predict the Developmentof
Severe Mitral RegrrrgitationAfter Percutsrreous
Mitml ValvuloplastyWith the Inoue (Single
Ballocm)Technique 1037-77.417A
Echocardiography Has Reduced the Need of Cardiac
Catheterization in Patients Witb Aortic Stenosis
Prior to Aortic Surgery 1025-89*339A
Effect of Vesnarinoneon Cardiac Function in
Patients With Severe Congestive Hesrt Failure
1OI7-142O325A
Effects of Repeated Late Exercise-Induced
Myncardial Stunning on Left Ventricular
Function 1015-126*32OA
Enoximone Echocardiographyfor Identificationof
Viable Myocrrrdiumin Patients With Ischemic
VentricularDysfunction: Comparison With
Dobutamine Echocurdiographyand Positron
Emission Tomography 917-72.39A
Evaluation of Recovery Process of Denervated but
Viable MyocurdiumAfter Acute Myocardial
Infarction Using DobutarrrineStress
Echocardiography 984-20.259A
Evaluation of Signal-AveragedCardio@mography
for tbe Detection of Ischemic Ventricular
Dysfunction 1022-57.335A
Evaluation of Tricuspid Regurgitant Severity:
Echocardiographic and Clinical Correlation
1025-96*341A
Exercise Echocardiography:Treadmill Versus
Supine Bicycle 773-5.356A
Feasibility of Estimation of Left Atrial Compliance
by Systolic PulmonuryVenousFlow
Propagation Velocity 1003-116*297A
Fetal EchocardiographyHomepage 1253-2.8A
Harmonic TriggeredImaging FollowingIntravenous
Ultrasound Contrast in the Assessment of
Patients Following Acute Myucardial Infarction
and ThrombolyticTherapy: Implication of
Resting ContrastDefects 1072-27*479479A
Heterogeneityof Contraction und Relaxation
Velocitiesof NorrnafHumzmMyocardium
Assessed by Tissue Doppler Echo 1070-19.
475A
How Does Interstitial, Myocardial, and Perivascular
Fibrosis Contribute to Left Venrrictdsr
Dysfmrctionin Hypertension? 929-171. lOOA
“Hypoplastic” Left Ventricle,or Simply a Squashed
Ventricle? 721-6.80A
Identificationof Abnormalities in Left Ventricular
Shape Despite Normal Volumessnd Function in
Chronic Aortic Regurgitationby Quantitative
Shapes Analysis: An EurlyMurkerof Left
VerrtricularDecompensation 909-103.26A
Identificationof Coronary Artery Stents Using
Three-Dimensionally
Acquired,Two-DimensionallyDisplayed
TrrrnsthoracicEchucardiography 939-112.
118A
Impact of Respiratory Variationson Ventricular
InteractionStudied by Doppler Tissue Imaging
1049-165.439A
Importanceof ScarrlineOrientation for Color
Doppler M-Mcde Diastolic InflowPatterns and
Pressure Gradient Calculations 1049-166.
439A
Impmved Accuracyof Mitral Regurgitant Flow Rate
Calculation Using a Hemielliptical Isovelucity
Surface Area: Clinical Studies 711-2.65A
ImprovedDiagnostic Method fnr Detecting Left
VentricularApical Injury 939-119.120A
Improvementof Diastolic Left VenrdculurFunction
by DobutamineIs Associated With the Presence
of Viable Mywmrdiumin Patients With
Ischemic Cardiomyopathy 1015-122.319A
In VivoValidationof QuantitativeTissue Doppler
EchocardiographyUsing Simultaneous
Hemodynamics 1049-l&l.439A
Infectious Endocsrditis Related to Human
ImmurmdeficiencyVirus Infection: A Clinical
and EchocardiogmpbicStudy 807-3.401A
Influenceof Low HDL-C on Progression of
Coronary Artery Disease and Response to
FhrvastatinTberapy 969-31.232A
Infusion of SonicaredAlbuminDuring Power
Doppler Imaging EnhancesEndocardial Border
Visualization in Patients With Suboptimal
EchocardiographicImages 1094-29.52OA
Insigbts Fmm Tbrce-DimensionalEchocardiography
Into the Mecbarrismof Functional Mitral
Regurgitation:Direct In VivoDemonstration of
Leaflet TetheringGeometry 939-114.119A
Insights Into the Left VentricularRelaxation Process
From the Analysis Mitral E WaveAcceleration
Time 979-164.250A
Intra- and PostoperativeDoppler Assessment of Left
Internal Mammary Artery Flow and Graft
Patency in Patients UndergoingMinimally
InvasiveComnsry Artery Bypass Surgery
979-162.249A
IntracormraryDobutamineEchucardiogmpbyto
Evaluate Multivessel Coronary Artery Disease
704-5*56A
Is “Fractional Shortening-VelucityRatio” a Possible
Alternativeto Continuity Equation in Assessing
Aortic Stenosis Severity? 711-3.65A
Is Effective‘OrificeArea of Mitral Stenosis Variable
With Flow? A Color M-Mode Flow
ConvergenceAnalysis 1093-56.518A
Is Insulin Action a Determinant of Left Ventricular
Relaxation in UncomplicatedHypertension?
965-102. 163A
Is Left VentricularMass Greater in African
AmericsrrsCompared With Whites in Families
With a History of PrematureCoronary Heart
Disease? 1OO9-I32.3O9A
Is Long-TermEvolutionof Left VentricularFilling
Modifiedby AntihypertensiveTreatment?
103O-49*347A
Is the VenaContracta Area for Stcnotic and
Regurgitant Orifices Dependent on
Hemodynamic Variables? An In Vitro Study
Using Laser-Induced Fhrorcscence Imaging
1018-36.32$A
Is Transesophageal !+hocardiography the Imaging
Modality of Choice in Patients With Cerebrul
Ischemia to Rule Out a Curdiac Source of
Embolus? A Cost-Effective Study 757-6.213A
Ischemia-InducedChanges in QT-Peak Dispersion
During Dipyridamole Stress Echocardiography
722-5. 81A
Left AerialDysfunction in Left Ventricular
Restrictive Physiology 107I4O.477A
Left VentricularApical Remodeling in Chagas’
Heart Disease Disrupts the Optimal Global
Prolate-Ellipsoid LV Geometry: Evidence From
a QuantiruriveEchocardiographic Regional and
Global Shape Analysis Study 1OO3-121.299A
Left VentricularDiastolic Filling in Relation to
Diastolic Bloud Pressure in Treated
Hypcrtensives With and Without Ischemia: A
Test oftbe ‘J’ Curve Theory 754-3.208A
Left VenrricukwDiastolic Function in HOCM After
Successful Nonsurgical Septal Reduction 796-5
l388A
Left VenrriculurEjection Fraction in Patients With
Normal and Distorted Left Ventricular
Geometry: Three-Dimensional
EchocardiographyVersus Biplane Muditied
Simpson’s Method With Comparison to
RadiomrclideAngiography 705-3.57A
Left Ventricular Intracavitary Gradients Are an
Underreported Cause of Systolic Murmur in
Adults 1062-78.463A
Left VenrriculurOutflow Tract Gradient a Potential
Cause for Dyspneain the Elderly 1062-77.
462A
Left VentricularPosterior Wall 2-D Mode Curdiac
Ultrasound Measurements Are the Most
Sensitive of Devercux’s Left VentricularMass
Formula Parameters to Detect Treatment Effects
in Hypertensive Patients 965-81. 161A
Left VentricularThrombosis in Patients With Acute
Myocardial Infarction Admitted to GISSI.3
Trial 702-2.52A
Left VentriculucVolumeby 2-D Echocardiography:
Better Preoperative Assessment for Left
VenrriculurFunction in Patients With Mitral and
Aortic Regurgitation 1093-57.519A
Long-TermEchucurdiogruphicAssessment of
Restenosis After Bulloon Mitral
Cnmmissurotomy 766-5.225A
Longitudinal Rotational Tomographic Approach for
In VivoDetermination of Left Ventricular
Mass-Comparison of a New Three-Dimensional
Echocardiogrsphic Methnd to Anatomy
1094-49o521A
Low-LevelBicycle Exercise Echocurdiography
Identifies Myocardial Viability as Well as
Dobutamine Echocardiography in Patients With
a Recent Myocardial Infarction 753-5.207A
Lower Rate of False Positive Exums in Young
Women With Dobutamine Stress
EcbocardiographyCompared to Persantine
Thallium 773-3.356A
Manual and Semiautomated Measurement of Left
VentricularVolumeUsing Real-Time,
Three-Dimensional Echucardiography In Vivo
705-6.57A
Mitral Regurgitation Index: A Composite of Clinical
Factors to Measure Severity 1070-24.477A
Model-Based Image Processing of Tmrrsmitral
Doppler E-Waves Can Differentiate
Hypertensive Fmm Normals 1022-52.334A
Multivariate Predictors of Biomechanical properties
in Myxomatous Mitml ValveDisease 1018-33.
327A
Myucardial Blnod VolumeDecreases After
Exhaustion of Autoregulation: Insights With
Contrast Echocurdiogruphy 812-2.406A
N-Terminal Pmatrial Natriuretic Factor: Relation to
Long-TermPrognosis in Patients With
Idiopathic Heart Failure 1084-144.5O4A
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“Natural Histories” of Mitral ValveProlapse
1085-42*5O6A
Near Normalization of Left VentricukwMass
FollowingToronto Stentless Porcine Valve
Aortic ValveReplacement 793-6.384A
New Insight Into the Determinants of Mitral
Regurgitation After Arrio-VentricularCanal
Repair: A Three-Dimensional
EchucardiographicStudy 721-3.80A
New Real-Time Interactive Cardiac Magnetic
Resonance Imaging System Is Useful in
Subjects With Suboptimal Echocardiographic
Studies 759-5.216A
Normal Left Atrial Systolic Function Utilizing the
Cross-Sectional Three-Axis VolumeEstimation
1003-117.298A
Occult Cardiac Abnormalities Are Not Uncommon
in Critically IOPatients: Echocardiographic
Evaluation of467 Consecutive Patients
Admitted to a Medical Intensive Care Unit
1048-177*438A
Postmenopausal Hormone Replacement Therapy and
Left VentricularMass and Geometry 1003-115
.297A
PosrtreadmiOVersus Supine Bicycle Exercise
Echocardiographyin Detecting Myocardial
Ischemia: A Randomized, Single-Blind
Crossover Trial 917-54.38A
Preservation of the SubvalvulacApparatus Improves
Long-TerarLeft VentricularDimensions rmd
Pulmonary Artery Pressure in Patients
Undergoing Mitral ValveRepair or Replacement
Despite Comparable Left VentricularEjectinn
Fractions 998-144.288A
Prevalenceand Mechanism of Ischemic Mitral
Regurgitationby Echocardiography 909-107.
26A
primary Pulmonary Hypertension: Prognostic Value
of a Doppler Derived Index Combining Systolic
and Diastolic Time Intervals 916-79.36A
Prognostic Value in a Negative Stress
Echocardiogramfor Cardiac Events in Patients
Undergoing Renal or Liver Transplantation
1025-86*339A
Progression of Mitral Regurgitation and Left
VentricularRemodeling: A Quantitative Doppler
EchocardiographicStudy 793-5.384A
Prospective Reproducibility of art Autonomous
Boundary Detection (ABD) Method in Healthy
YoungAdults 1094-26.519A
ProspectiveValidationof an Autonomous Boundary
Detection Method in YoungHealthy Adults
1094-45*520A
pulmonary VenousFlow VelocityMeasurements for
the Quantitative Assessment of Mitral
Regurgitation 711-4066A
Quantificationof Mitral Regurgitation nn Contrast
Echocardiography:Application in Patients
UnderdoingCatheterization 1049-168*44OA
Quantison’ , a New Long-LivingUltrasound
Contrast Agent: Experience in Human
Volunteers 1OO4-107*299A
Quantitation of Mitral Regurgitation: A New
Echo/DopplerTechrrique 1025-93*34OA
QuarrtitativeEchocardiographicAnalysis of
Regional and Global Shape of the Human Right
Ventricle: 1)Description of the Method arrd2)
Characterization of Normal Right Ventricular
Shape 1003-114.297A
Rapid Image Acquisition and Automated
Determination of Left VentricularCavity
Boundary for Precise and Accurate Volumetry
by Clinical Three-Dimensional
Echocardiography 705-4*57A
Reduced Arterial Compliance Predicts
Cardiovascular Risk in Patients With Arterial
Hypertension 754-1l207A
Reducing Aortic Regurgitation From Discrete
StrbaorticStenosis: Modified Surgical Method
and Results 751-5.204A
Regional Wall Stress Following Myocardird
Infarction Estimated by
Echocardiography-BasedStructural Analysis
1015-125*320A
Relationship of QT Dispersion to Left Ventricular
Hypertrophyin Patients With Hypertension
103O-45O346A
Relative Contributionof Transmittal and
IntraventricularPressure Gradients During Early
Diastolic Filling 929-17O.1OOA
Reproducibilityand Day-to-Day Variabilitiesof
Three-DimensionalEchocardiographyfor Left
VentricularVolumesand Ejection Fraction
Calculation With Comparison to Magnetic
Resonance Imaging 705-2.56A
RevascularizationImprovesSurvival in Patients
With SevereLeft VentricularDysfunctionand
Contractile Reserve by DobrrtamineStress
Echocardiography 753-1.206A
Safety nf Dobutamine-AtrupineStress
Echocardiographyin Patients With Ventricular
Tachycardia 917-76.40A
Severity and MorphologicAbnormalitiesof Aortic
and Mitral Regurgitationin the Elderly: The
CardiovascularHealth Study (CHS) 951-130.
139A
Should We Search for a Flow IndependentIndex of
Aortic Stenosis? 1025-95o341A
SimplifiedContinuity Calculation of Aortic Valve
Area Using Continuous WaveDoppler Only:
Correction for Three-DimensionalValveShape
711-5.66A
Software for Segmental Analysis of Color Kinesis
Images: New Tool for Objective Evaluationof
Regional Left VentricularFunction 1250-2.7A
Studies of Bubble Persistence Vs. Standard and
Harmonic Mode Acnustic pulse Pressure for
Three New EchocnntrastAgents 1004-124.
300A
Subclinical Involvement of Left Ventricular
Dimensions in Relatives of a Patient With
Familial Hypertrophic Cardiomyopathy
744-5
Surgical Remodeling of the Left Ventriclein Severe
Dilated Cardiomyopathy:Short-TermResults nn
Geometry and Diastnlic Filling 735-4.181A
The Dependenceof the E Waveon Pulmonary
VenousFlow: Mathematical Solution With In
Vivo Verification 1003-111 .296A
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With Site of Origin Assessed Using Activation
Sequence Mapping 912-17.31A
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the Identificationof the Culprit Vessel in Inferior
Wall Myocardial Infarction 1044-105.43OA
ST-SegmentElevation in Leads I and aVL in Acute
Anteroseptal Myocardial Infarction Is an
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Identificationof the First Locus for Familial Arrial
Fibrillation Utilizing a Rapid Novel Pooled
DNA Strategy 407-1.2A
Genetics
A Gene Locus for ArrhythmogenicRight Ventricular
CardiomyopathyMaps to Chromosome 17pl-q3
408-2*4A
A Missense Mutation of the eNOS Gene in patients
With Coronary Heart Disease and Its Possible
Interaction With ACE LIDGene Polymorphism
for Coronary Risk 941-147. 123A
A Mutation in the Methylenetetrahydmfolate
Reductase Gene Is Not Associated With
Increased Risk for Coronary Arte~ Disease or
Myncardial Infarction 723-4.83A
A Role for the Myotonin Kinase Gene in Dilated
Cardiomyopathy? 7444.194A
ACE Gene Polymorphism in Patients With Familiar
Hypercholesterolemia: Comparison With Infarct
Patients and Healthy Controls 723-3.82A
Aldosterone Synthase Gene Polymorphism Predicts
Left VentricularSize and Function in Persons
Fme of Hemt Disease 1074-122.484A
Angiotensin-ConvertingEnzyme Gene
Polymorphism Predicts the Depressor Effect of
Exercise Therapy in Hypertensive 724-5.84A
Angiotensin-ConvertingEnzyme Genotypes and
Risk for Myocardial Infarction in Women 723-5
l83A
Apolipoprotein-Ebut Not Angiotensin-Converting
Enzyme Gene Polymorphism Is Associated
With Myocardial Infarction 723-1.82A
Association of the Insertion/Deletion Polymorphism
of the Angiotensin Converting Enzyme Gene
and Angiotensin Converting Enzyme Inhibitor
Cough in Patients With Congestive Heat Failure
976-150.244A
Deletion Polymorphism of ACE-Gene Affects the
Endothelium Dependent Vasndilation in
Untreated Hypertensive Patients 724-3.84A
EnvironmentalFactor Is More Important Than
Angiotensinogenand Angiotensin Converting
Enzyme Gene Polymorphism in the
Pathogenesis of Coronary Spasm 962-114.
157A
Familial Influences on QT and QTc Dispersion
722-6.82A
Gene Polymorphism of Methylenetetrahydrofolate
Reductase (MTHFR) as a Novel Coronary Risk
Factor 769-6.229A
Gene Transfer of a Human Hypertrophic
CardiomyopathyMutation Into Adult Cardiac
Myocytes Induces Sarcomere Disarray and
Impairs Contractility 726-3.87A
Identificationof the First Locus for Familial Atrial
Fibrillation Utilizing a Rapid Novel Pooled
DNA Strategy 407-1.2A
Impaired Lipolysis of VeryLow Density
Lipoproteins in Type III Hyperlipoproteinemia
96487. 160A
Increase of High Density Lipoproteins (HDL) in
Postmenopausal Women With Estrogen
Replacement (ER)Tberapy Is Detemrined by
Genetic Polymorphism of Serum
HDL-Arylesterase 813-4.407A
Less Myocrrrdialbut More Cerebral Ischemic Events
in African Americans Than Caucasians With
Acute Coronary Syndromes: Results From
GUSTO-II 946-5.131A
Magnetic Resonance Imaging Accurately Estimates
Cardiac Mass in a Transgenic Mouse Model of
Hypertrophy 1029-I64.346A
Molecular Analysis of the HERG-Gene in 48
Unrelated Long QT Syndrome Patients:
Genotype/PhenotypeCorrelation in Two
Families With Novel Mutations 737-2. 184A
Mutations in a Novel Gene Pruduce the Holt-Oram
Syndrome and Cardiac Septation Defects 726-4
l87A
Naturally-OccurringSilent Sequence
Polymorphisms in the Human ~ Myosin Heavy
Chain Gene 1029-162.345A
Race and Sex Differences in the Genetic Regulation
of Adolescent Blood Pressure: Tbe MCV Twin
Study 1077-68*488A
Subclinical Involvementof Left Ventricular
Dimensions in Relatives of a Patient With
Familial Hypertruphic Cardiomyopathy 744-5.
194A
The Absence of D Allele of the ACE ID Genotype
Prevents Restenosis After Coronary Stenting: A
Quantitative Angiographic Study 1011-3.311A
The ACE Deletion Insertion Polymorphism and
Hypertension: An Association Analysis in the
Framingham Heart Study 724-2.84A
The AfricmrOrigin of the Common Mutation in
African American Patients With Glycogen
Storage Disease Type 11(GSD 11) 726-6.87A
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Glucose
Assessment of Glucose Utilization in the Insolated
Rat Heart Using
1,3,4,6-tetra-acetyl-2-[F-18]-2-deoxy-D-glucose
(acetyl-FDG)andIns.lin 1OO2-104O295A
Delayed FDGImagingImproves Myncardial/B1ood
PonlCmrmast 1047-I46.436A
Developmental Changes in Myocardial Glucose
Metabolism in Nonhuman Primates Using
Positron Emission Tomography 1002-103.
295A
Effects ofLeft Bundle Branch BlnckonCardiac
PET Imaging 1047-145.436A
Fasting Bloodghrcose Level Is an Independent
Predictor of Cardiovascular Mortality in Heakhy
Norwegian Men: Results From 22-Year
Fo11ow-UP 1054-8*447A
Increased Myncardial Uptake of 2-Deoxyglucose
During Reperfusion: Role of the Trmrslncation
of GLUT4 945-36. 130A
Inhibition of Glycolysis Impairs Ventricular
Relaxation but Not Peak Systolic Pressure in
Neonatal Pig Hearts 1043-64o428A
Modulation of LDL Particle Size After an Oral
Glucose Load Is Associated With Insulin
Release 964-88.160A
Open Artery Reperfusion Produces Distinct Patterns
of Myncardial Blood Flow-Glucose Metabolism
Mismatch 1055-36.449A
Quantitation of Myocardial F-18 Deoxyghrcose
Uptake Frcdicts Wall Motion RecoveryAfter
Revascularization 931-77.104A
Growth factors
A Mechanism of Elevated Circulating Level of Basic
FGF in Patients With Unstable Angina 769-5.
229A
Accelerated Endothelialization hy Local Delivery of
Recombinant Human VEGF Reduces In-Stent
Intimal Formation 719-4.77A
Adenoviral-MediatedGene Therapy Induces
Sustained hrtrapericardial VascularEndothelial
Growth Factor Expression in Dogs: Effect on
Myocardial Angiogenesis 941-148.123A
Angiogenic Factors Basic Fibroblast Growth Factor
and Angiogenin in Advanced Heart Failure
Patients 1083-119.501A
Association of Transforming Growth Factor-Beta
IsoforrnsWitb Coronary Plaque in Patients With
Coronary Ischemia 961-121l155A
Basic Fibroblast Gruwth Factor Isa Coronary
Vasoconstrictorin Experimental
Hypercholesterolemia 961-118.155A
Beneficial Hemndynamic Effects of Acute
Insulin-Like Growth Factor-I in Patients With
Chronic Heart Failure 996-71l285A
Identification of Five Hypoxia-Inducible
RNA-Protein Binding Sites Conserved in Rat
and Human VascularEndothelial Growth Factor
mRNA 901-32.llA
Local Infusion of VascularEndothelial Growth
Factor Following Coronary Angioplasty in
Swine 1039-98.42OA
Lncally Delivered VascularEndotbelial Grnwth
Factor (VEGF) Does Not Inbibit Neointimal
Proliferation in the Porcine Restenosis Mndel
701-6.52A
Mechanisms of the IGF-1 Positive MonotropicAction
809-3.403A
Participation of TGF+I in Platelet-Mediated
Cardioprotection During Myocardial
Ischemia-Reperfusion 929-167.99A
Pharrrracodynarnicsof Basic Fibroblast Growth
Factor: Effect of Route of Administration on
Regional Distribution 959-46.152A
Potentiation of Human VascularSmootb Muscle Cell
Gruwtb by Pericardial Fhrids From Patients
With Unstable Angina 97040.234A
pulmonary Artery Banding Upregulates Vascular
Endothelial Growth Factor and Its Flkl Receptor
in Pig Hearts 941-141. 122A
The Pericardium as a Repository for an Angiogenic
Growth Factor: Effect of InrrapericardirdBasic
Fibrnblast Growtb Factor on Myocardial
Collateral Development 961-116.154A
The Role of Protein-TyrosinePhosphorylationand
Marnx Metalloproteinase Prediction in the
Proliferationof Smooth Muscle Cells 941.166.
124A
Treatment of Ischemic-RepcrfnsionDarnage to the
Latissimus Dorsi Muscle After Cardiomyoplasty
Mobilization 958-42.151A
Unregulated Arterial Expression of the Estrogen
Receptor After Balloon Injury: Role in TGF-~
Mediated Repair? 1039-97.42OA
VascularEndotbelial Growth Factor Is Upregulated
by HydrogenPeroxide in VascularSmeoth
Muscle Cells and Overexpressedin
AtheroscleroticTissue 703-6.55A
Health education
Identifying the Late Presenter: Criteria for
RefucusirrgHeart Attack AwarenessPublic
Education Programs. ObservationsFrom the
National Registry of Myocardial Infarction-2
(NRMI-2) 933-58*108A
Quantificationof Passive Expmition to Tobacco
Smoke of Newborn Babies, Cbildrcn, and
Adults 1054-12*448A
Health services
Angioplasty (PTCA): Outcomes in the Veterans
Adrrrinistration(VA)and the Private Sector
(WashingtonState) 923-141.50A
Can Clinical VariablesBe Determined and Outcome
Models Be DevelopedFrom a Claims Database?
799-6.393A.
Changes in Functional Health for Women Versus
Men One YearFollowing PTCA orCABG
928-15.97A
Comparison of Tbree Coronary Bypass Mortality
Prediction Mndels: Results From the National
CardiovascularNetwork 1064-17O*466A
Cost-Effectivenessof LDL-C Reduction in Medicare
ManagedCare CHD Patients: Implications From
tbe ScandinavianSimvastatin Survival Study
(4S) 767-2.226A
Determinants of Long-TernrCardiovascularDnrg
Use After Myncardial Infarction:Does Country
Make a Difference? 1078-126o491A
Does Nuclear Testing Yield Incremental Information
for the Prediction of Death in Patients With
Normal Rest ECG: A Multicenter Study of5,554
Patients With Stable Angina 949-25.136A
Factors Associated With PostoperativeLmrgthof
Stay After Coronary Artery Bypass Graft
Surgery 1981Through 1995 998-147*2119A
Gender and Quality of Life in African Americans
With Congestive Hemt Failure 930-156. 101A
Hospital Outcomes in Heart Failure Are Superior at
a Large TertiaryCare TeachingInstitution
968-55.168A
Low IndividualOperator Coronary Interventional
(CI) VolumeIs Not Associated With Worse
Outcome 928-14.97A
Nurse Practitioner Managed Angina Clinic Improves
Qurdityof Life 968-57.168A
Once Daily Medications ImproveQuality of Life in
Stable Angina: Six-Month Follow-Up 968-52*
167A
Operator VolumearrdOutcomes in 12,899
PercutaneousCoronary Interventions 792-1l
382A
Outcome of Acute Myocardial Infarctionby
Physician Specialty 799-3.392A
profilingPhysician Work in Coronary Angioplasty:
New Methods Using the Resource-Based
Relative ValueScale 1012-17.316A
Regional Variationin Postrnyocardial
InfarctionTesting:Results in 190,237Patients
799-5.392A
Ten-YearTrends in Congestive Heart Failure
HospitalizationRates: Duration and Outcome
923-139*50A
The EconomicConsequences of a New Therapy
Depcrrdon the Typeof ReimbursementPlan
1010-141l311A
The Financial Impact of Stenting Is Dependent on
Clinical Efficacyand Payer Mix 1032-44.35OA
The Influenceof InsuranceTypeon the Use of
Procedures, Medications, and Hospital Outcome
in Patients With Unstable Angina 1010-140.
31OA
Treatment of Heart Failttrc in the National
Ambulatory Medical Care Survey (NAMCS)
968-56.168A
Using Prolonged Risk-Adjusted Postoperative
Length of Stay (RAPOLOS) to Measure
Comparative Surgical Perforrrrancein CABG
Pmcedtrres931-76. 103A
Heart block
Effects of Leti Bundle Branch Block on Cardiac
PET Imaging 1047-145.436A
How to Trigger P-Waves in the Helter-ECG for
Accurate PR-Interval Measurement? 1252-1.
8A
Neonatal Congenital Heart Surgery Increases the
Risk of Acquired Atrioventricular Blnck:
Implications for Early Elective Repair 774-1.
357A
Recovery of.%rrgically Induced Heart Bluck in
Congenital Heart Disease 774-2.357A
VentriculophasicModulation of AVNode
Conduction in Humans 408-4.4A
Heart catheterization
Assessment of Left Atrial Pressure-VolumeRelation
Using Retrograde Left Atrial Catheterization
and Echocardiographic Automatic Boundary
Detection 1015-134.322A
Diagnostic Content of Digital Coronary
Arteriograrns Is Unaffected hy 12:1 Image
Compression 915-119.35A
Follow-Up Results of the Multiinstitutional Phase I
FDA Supervised Clinical Trials of Transcatheter
Occlusion of Atrial SeptrdDefects With
Buttoned Device 954-135.143A
Is “Fractional Shortening-VelncityRatio” a Possible
Alternative to Continuity Equation in Assessing
Acalic Stenosis Severity? 71I-3.65A
Is tbe Right VentricularEndomyocardial Biopsy
Superior to the Left and Biventricular
Endomyocardial Sampling? 907-145.22A
Outcome After TmrrscatheterValvotomyfor
Pulmonary Valve Atresia and Intact Septum in
Neonates and Infants 729-6.173A
Patient Preference for Cardiac Catbeterization via
the Transradial Vs. Transfemoral Appruach
IOIO-I37.31OA
Reopening After Successful Coil Occlusion for
Patent Ductus Aretenosus 729-4* 172A
Ten-YearNatural History of InvasiveProcedures for
Heart Disease in California: 1983-1993
101O-135.3O9A
TrarrscatheterOcclusion of Patent Ductus Arteriosus
and Aorro-ptdmonaryCollaterals Using the
Gianturco-Grifka Vascular Occlusion Device
729-3. 172A
Transhepatic Therapeutic Cardiac Catheterization: A
Novel Apprnacb for the Interventionalist 729-2
. 172A
Upright Posture With a Flexible Femoral Sbeatfr:
Safety and Cost Results Frum 900 Patients in the
“Heads Up” Trial 993-8.278A
What Predicts Contrast Nephropathy After Cornrrary
Intervention? Insights From the IMPACT II
Trial 1082-10.5OOA
Heart conduction system
Mndel-Based Computer Analysis of
Electmpbysiologic Studies Using a Novel
Semiquantitative Three-Dimensional Model of
Cardiac Electrnphysiology: Validation With
Extrastimulus Testing During Supraventricular
Tachycardia 814-1.407A
Prngnosis in Patients With Left Bundle Branch
Block and Nornral Dipyridamole ThaOium-201
Scintigraphy 105O-156.441A
Sinus Nude Dysfunction Following Modified Fontan
Operation (Total Cavo-PuImonaryConnection)
954-146.146A
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Heart defects, congenital
A Mathematical Meebcdof Predicting Peak to Peak
Gradients Frum Doppler Echocardiogmphy in
Obstmctive Lesions 1043-69.43OA
Abnormal Histology of the Pulmonary Vasculaturc
in Neonates With Pulmonary Atresia and
VentricularSeptal Defect 1065-155.467A
ASD and PFO Closure in Adults With the Second
Generation ASDOS Device 954-136.143A
Biventricular Dysfunction in Fetuses With
Congenital Heat Disease 1087-167.5O8A
Comparison of Lateral Tunnel and Extra-Cardiac
Conduita in Total CavopulmonaryConnections:
A Fluid Dynamics Study 751-2*203A
Detection of Segmental Aordc Distensibility
Alterations by Magnetic Resonance Velocity
Mapping in the MrufmrSyndrome 1023-107.
336A
Diagnostic Accuracy of Pediatic Echocardiograms
Performed in Adult Laboratories 721-1.79A
Dees Mitral Regurgitation Progress Following
Repair of Aoioventricular Canal Defects?
932-66*106A
EcbocardiographicDeterminants of Successful
Deployment of the Das’”Angel WingsT”Atrial
Septal Defect (ASD) Closure Device 916-77.
36A
Effect of Prenatal Diagnosis of Critical Left Heatt
Obstmction on Perinatal Morbidity and
Mortality 932-83*106A
Efficiencyof Metabolic Screening in Childhond
Cardiomyopathies 911-160*30A
Elective primary Repair of Acyanotic Tetralogy of
Fsllot in Early Infancy: Overall Outcome and
Reduced Need for Transinrmlar Patcbing
932-86.107A
Follow-Up Results of the Multiinstitutional Phase I
FDA Supervised Clinical Trials of Transcatbeter
Occlusion of AtrirdSeptal Defects With
Buttoned Device 954-135.143A
Light snd Electron Microscopy of Dilated Great
Arteries in Congenital Heart Disease 1065-158
.467A
Management and Outcomes of Right Atria]
Isomerism: 26-YearExperience 794-2.385A
Mortality in Potential Arterial Switch Candidates
With d-Transposition of the Great Arteries
932-68*106A
Neonatal Congenital Heart Surgery Increases the
Risk of Acquired AtrioverrtricularBlock:
Implications for Early Elective Repsir 774-1.
357A
One Thousand Patients With Adult Congenital Heart
Disease: Causes of Death and Lessons Lesmed
794-4.385A
Outcome After TrmrscatheterValvotomyfor
pulmonary ValveAtresia and Intact Septum in
Neonates and Infants 729-6.173A
Outc6me of Lateral Tunnel Fontan Fenestrstion
932-89*108A
Outcome of Patients With Pulmonary Atresia and
VentricularSeptal Defect Atler Neonatal
Surgety 932-85*107A
Outcome of StmrtImplantation Into the Arterial Duct
in Cyanotic Neonates 954-138. 144A
Persistence of Anti-HLA Antibodies Beyond One
Year in Children Receiving Ctyopreserved
ValvedAllografrs at Surgery 932-9OO1O8A
Quantitative Arrslysis of Patent Ductus Areeriosus
Shunt by TrrmsesophagealImaging the Flow
ConvergenceRegion 916-82.37A
Reducing Aortic Regurgitation From Discrete
Sttbaordc Stenosis: Modified Surgical Method
rmdResults 751-5.204A
Reopening After Successful Coil Occlusion for
Patent Ducttrs Areteriosus 729-4.172A
Sntull VentricularSeptul Defects in Adults 794-3.
385A
Special Role of Transesnphageal Echo (TEE) in
Surgeryfor CongenitrdLeft VentricularOutOow
Tract (LV~) Obstruction 1087-172.5O9A
Tbe Coarse and Outcome of Pregnrmcyin Women
With SemroticLesions Due to Congenital Heart
Defects 1065-159.467A
The Fontarrprocedure in Adults: Early and Late
Results 1065-157.467A
Three-DimensionalMRI Reconstructionsof
Congenital CardiovascularDisease Wieb
PeraonalComputers 915-116.35A
Transcatheter Occlusion of Patent DUCNS.kteriosus
andAorto-l+dmonsm Collaterals Usine the
Gianturco-GrifkaVasculsr Occhrsion~evice
729-3. 172A
TrarrscatheterOcclusion of the ArrerirdDuct:
Comparison of the Results Using the Rashkind
Umbrella and Different~pes of Occlusion
Coils in 1,306Procedures From a European
Registry 729-5.172A
TranstbracicThree-DimensionalEchucardiography:
Therapeutic Decision Making Prucess of
Submterial Ventrictdsr Septal Defect 1087-171
.509A
Validationof AerialSeptal Defect Dynamic
Morphologyby Trmrsthoracic
Three-DimensionalEchocardiography 939-111
.118A
Validationof the ConductanceCatheter in the Right
Ventriclein HyperplaseicLeft Hesrt Syndrome
1043-6O*428A
VortexStructures Within the Muditied Fonemr
ConnectionPlay a Primary Role in EnergyLoss:
In Vitru Digital Psrticle Image Velocimeery
Stadies 1043-58*427A
Heart disease
A Clinical and Histologic Comparisonof Idiopathic
Giant Cell Myocarditis and Cardiac .%rcoidoisis
765-3.224A
Effect of the Pstency of Infarct-RelatedArtery on
VagalReflexes 902-3.13A
Histo~ of Injury During SyncopcIs the Most
PowerfulPredictorofEkctmphysiologic
Findingsin Patienta With Syncopeof Unknown
Origin 1OO1-82.294A
“Hypuplaatic”Left Ventricle,or Simply a Squashed
Ventricle? 721-6.SOA
Ischemia-InducedChanges in QT-PeakDispersion
During DipyridmrtoleStress Echocsrdiography
722-5.81A
Reduced Test Time by Early Identificationof
Patients Requiring Atropine During Dobutamine
Stress Echocardiography 704-I .55A
The Involvementof Apuptosis in a Varietyof
Diseases Which Cause Left Ventricular
Dysfarrction 1084-146.5O4A
Heart failure
A Clinicsl and Histologic Comparison of Idiopathic
Giant Cell Myocarditis and Cardiac Sarcoidoisis
765-3.224A
A Population Surveyof the Incidenceand Etiology
of Head Failure 1009-13O.3O8A
Abnormal Intracellular Calcium Respmrse to
Increased Frequencyof Stimulation in Failing
HumsrrHerrrrs 1016-15O.322A
Abnormalities of Left Atrial Reservoir, Conduct, and
Bcoster Pump Functions in a Rapid Pacing
Model of Atrial Myopathy 758-1.213A
ACE-I Use and Left VenrncularFunction in the
Elderly Admitted With Heart Failure: Gender
Differences 1017-136.324A
Action of Arrrlodipineon Cytokine Levels: The
PRAISE Heart Failure Trial 1OI7-I48.326A
Actuarial Estimates of Total MorrrdityMay
Underestimate SurvivalBenefit of Imphurtable
Cardioverter-DefibrOlatorsin Patients Referred
for Cardiac Tmrrspkmtation 983-132.257A
Adrenomedullin in the Evolutionof Experimental
Hesrt Failure 805-3.399A
Aerobic Capacity in Elderly Patients With Heart
Failure Due to.primruy Diastolic DysfarrctionIs
SeverelyReduced and Is Similar to Systolic
Dysfunction 1063-175.464A
Alteration of Physician Behavior in the Care of
Congestive Heatt Failure Patients in the
Community Hospital Setting Using American
College of Cardiology/AmericrmHeart
Association Guidelines 977-157.245A
Altered MyocordialExpression of Tumor Necrosis
Factor-a Atler Mechanical Support in Patients
With Severe Idiopathic Dilated Csrdiomyopatby
804-2*398A
Angiogenic Factora Basic Fihmblast Growth Factor
and Angiogenin in Advanced Heart Failure
Patients 1083-119.501A
AngioeerrsinII Receptor Antagonist Enhances the
Effects of Angiotensin Converting Enzyme
Inhibitor in Conscious Pigs With Congestive
Heart Fsilure 976-l49.244A
Antioxidants Attenuate Norepinephrine-Induced
Cardiac Sympathetic Nene Dysfunction
1083-116*500A
Assessment of Exertional Muscle Anaerobic
Metabolism by Near Infrared Spectroscopy in
Chronic Heart Failure 1041-2O.424A
Autnnomic Nervous System Dysfunction but Not
Dispersion of VentricularDepolarization Has
Prognostic Implication in Chronic Heart Failure
731-4. 175A
Baroreceptors snd Beta-Bluckers in Herat Failure
1084-141l503A
Bcdy Composition and Quality of Muscle in Chronic
Heart Failure 1098-161.527A
Both Repetitive Stunning and Hibernation Are
Present in Chronic Ischemic Left Ventricular
Dysfunction: Serial Flow-Function Studies in a
Chronic Canine Model 1072-45.4SOA
Brain NatritrreticPeptide Improves Diastolic
Functinn in the Normal and Failing Heart
908-171l25A
Brain Natriuretic Peptide Is a Marker of New York
Heart Association Classification in Out-Patient
Follow-Up of Left VentricularDysfunction
930-177. 103A
Cachexia as Independent Predictor of Survival in
Hca.rtFailure 930-157. 101A
Cachexia in Chronic Heart Failure: Leptin Mediated
Anorexia or Cytokine and Hormone Action?
1083-12OO5O1A
Calcium Transport Is Impaired in Sarcoplasmic
Reticulum of Failed Human Hearts Due to
Ischemic Cardiomyopathy Compared to
Idiopathic Dilated Cardiomyopathy 1016-149.
322A
Can Left VentricularDiameters Be Used to Assess
Left VentricularRemodeling? 1003-110.2%A
Cardiac Autoantibcdies in Idiopathic Dilated
Cardiomyopahty Are Specific Markers
Associated With Eurly Disease 7654.224A
Cardiac Dysfunction sad Outcome in Patients With
SubarachnoidHemorrhage and
ElectrocardiographicAbnormalities 934-55.
11OA
Cardiac Tissue Angiotensin Converting Enzyme
(ACE) Binding Sites Are Increased in Human
Heart Failure 770-1.230A
Cardiomyocytes Fmm Infarcted Rat Heart Manifest
Functional Downregulaeionof the Arginine
Vasopressin-Vla Receptor 104O-27.422A
Carvedilol ImprovesAutonomic Nervous System
Status Independent of Its Cardiac Effects in
Patients With Chronic Heart Failure 762-4.
220A
Carvedilol Reduces Clinical Progression in Patients
With Mcderate-to-Severe Heart Fuihrre 710-1.
63A
Central HaemodyrrsmicEffects of Endothelin-1 in
Patients With Left Ventricular Dystimction
996-72.286A
Chronic Atrial Dilatation Induces Prolongation of
Atrial Refractoriness and Atrial
Tachyarrbythmias 709-6.63A
ChiCd Determinants of Outcome in Advanced
Heart Failure: Insights Fmm the PRAISE Trial
977-158.246A
Clinical Relevance of ArterirdOxygen Saturation
Instability to Detect Breathing Disorders in
Chronic Heart Failure 752-3.205A
Clinical Significanceof Elevated Levels of Cardiac
TroponinT Detected by Second Generation
Assay in Patients With Congestive Heart Failure
930-173. 102A
Clinical Significanceof Plasma Levels of
Adrerromedullin(AM) in pulmonary
Hypcrtensinn(PH) 93O-175.1O3A
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Clinical Usefulness of a Neural Network Mndel for
Evaluation of Prognostic Factors in CHF in
Predicting Mortality 915-118035A
Clinical, Hemodynamic, and Cardiopulmonary
Exercise Test Predictors of Outcome in Patients
Referred for Heart Failure Evaluation 1098-160
.527A
Comparison Between PbenylephrineTest nnd
a-Index to Assess Baroreflex Sensitivity in
Cardiac Patients With Chronic Heart Failure
762-1.219A
Comparison of Maximal Vs. Submaximal Exercise
Protocols: The Reproducibility of the
Neurohumoral Response in Patients With Heart
Failure 1098-158*527A
Control of Cardiac Hypefirophyand Natrirrretic
Peptide Production by Endogenous Angiotensin
II in Experimental Heart Failure 1074-119.
483A
Cost-Effectiveness of Metoprolol in Idiopathic
Dilated Cardiomyopathy 1017-144*325A
Current Community Practices in Heart Failure:
Understanding the Underutilization of
Angiotensin-ConvertingEnzyme Inhibitors
1017-141l325A
Decrease of Mitral Regurgitation With Heat Failure
Treatment Is Due to a Reduction in the
Regurgitant Orifice 1OO3-1I2.296A
Decreased In VivoVascularProstaglandin Release to
Alpha-1 Adrenoceptor Stimulation in CHF
Patients 996-730286A
Decreased Type VI but Not Type V Adenylyl
Cyclase mRNA Isoform Expression in the Left
Ventricleof Rats With MyrrcardialInfarction
and Heart Failure 770-60231A
Depressed Midwall Shortening Precedes Chamber
Dysfunction in Pressure Overload 1062-82.
464A
Detection of Myocardial Viability by Dual-Isotope
Tc-99m-Tetrnfosminand 18-FOGSingle Photon
Emission TomographyAfter Acipimox to
Stimulate Glucose Uptake 788-4.377A
Determinants of Increased Tc-99m Sestamibi Lung
Uptake 1005-93.302A
Determinants of Pulmonaw VenousFlow Pattern in
Patients With Chronic Heart Failure 1071-43.
478A
Diagnostic and Prognostic Valueof Soluble
Interleukin 2 Receptor in the Semm of Patients
With Idiopathic or Ischenric Dilated
Cardiomyopathy 1083-121.5O2A
Diastolic Dysfunction Predicts Abnomral Baroreflex
Sensitivity in Heart Failure 1084-142o5O3A
Different Early Diastolic Pressure Gradients in Left
Ventricular Inflowand OutflowTracts:
Modificationby Inorropyand Ischemia
929-172*1OOA
Different Predictor in Sudden or Progressive Heart
Failure Death in Severe Heart Failure 977-178*
247A
Differential Atrial and VentricularExpression of
MyocnrdialBrnin-Natriuretic-PeptideDuring
Progressive Experimental Heart Failure
908-172025A
Differential Regulation of Cardiac Angiotensin
Converting Enzyme (ACE) Binding Sites and
ATI Receptor Density in Primary Pulmonary
Hypertension (PPH) 976-153.244A
Differential Regulation of Circulating Atrial
NattirrreticPeptide and Brain Nattiuretic
Peptide by Endogenous Endothelin During the
Progression of Experimental Heart Failure
908-169*25A
Differential Regulation of VentricularANP and BNP
Synthesis in Compensated and Overt Heart
Failure 908-168.25A
Differential Release of the Cnrdiac Natrirrretic
Peptides in Asymptomatic and Symptomatic
Human Henrt Failure 783-2.369A
Dobutamine Stress EchocardiographyCan Predict
the Improvementof Left VentricularSystolic
Function in Dilated Cardiomyopathy 907-146.
22A
Does Gender Have an Impact on Survivalof Patients
With Heart Failure? Findings From the SOLVD
Regisky 977-174.246A
Does Pulmonary HypertensionPrecardiac
TransplantationImpact on Posttransplant
Exercise Capacity? 736-4. 182A
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Hypertension 1027-176*343A
C-Myc Expression Relates to Reveraal of Ventricular
Function mrdHyp-ertrnphyin Patients With
Aordc ValveReplacement 1042-116.426A
Cardiac Phosphorus-31 Magnetic Resonance
Spectroscopy During Dobutamine Stress in Elite
Cyclists With Left VentricularHypertruphy: No
Evidence for Altered High-Energy Phosphate
Metabolism 1L3+32-98.294A
Changes in Phasic Coronary Blued Flow Velocity
Profile and Relative Coronary Flow Reserve in
Patients With Hypertrnphic Obstructive
Cardiomyopathy 1062-72o461A
Clinical and Prognostic Significance of
DipyridamoleStress Thallium-201 Perfusion
Abnormalities in Patients With ‘Hypertrophic
Cardiomyopathy 1062-71*461A
Control of Cardiac HWertrophy and Natriuretic
Peptide Reduction by Endogenous Angiotensin
II in Experimental Heart Fuilure 1074-119.
483A
Decreased Retinoid Receptor Binding in
Pressure-OverloadedMvocardium 995-67*
283A
Demographics and Correlates of Five-YearChange
in EchocardiographicLeft Ventricular Mass in
young Adulti: Tbe CARDIA Study 1OO9-133*
309A
Depressed Midwall Shortening Precedes Chamber
Dysfunction in Pressure Overload 1062-82.
464A
Determinants of MidwaOFractional Shortening in
Healthy, NorrnotensiveYouthWith Family
History of Hypertension 965-82.162A
Differences in Regional Mechanical Function
Between Concentric and Eccentric Left
VentricularHypertrophy: A Study Using
Magnetic Resonance Tissue Tagging 1062-79.
463A
Different Molecular Changes in the p-Adrenergic
Signal Transduction Pathway in Primary and
SecondmyCardiac Hypertrnphy 1029-166*
346A
Direct Evidence of Impaired Cardiac Sympathetic
Innervation in Essential Hypertension With Left
VentricularHypertrnphy 754-4*208A
Early Cardiac Changes in Children With Arterial
Hypertension 965-97.162A
EarlyLeftVentricularMassRegressionMeasuredby
3-DEchocardiographyin HypertensiveSubjects
IsAssociatedWithImprovementof
Doppler-MeasuredMitralInflow 1076-62*
487A
EarlyLeftVentricularMassRegressionMeasuredby
3-DEchncardiographyin HypertensiveSubjects
Is Independentof Reductionin LeftVentricular
Volume1062-81.463A
EchocardiographicEvidenceofTransmural
ContractionGradient:TheRoleof Ventricular
Geometryto MaintainNormalChamber
Functionin HumanHypertension965-80.
161A
EffectofChronicBradykininInfusionandChronic
Bradykinin-ReceptorBlnckadeonCardiac
Hypertrophyin AngiotensinII-TreatedRats
103O-48*347A
Force-FrequencyandRelaxation-Frequency
RelationshipsinHypertrophiedHeartsof
Children 1062-8O.463A
HowDoesInterstitial,Myucardial,andPerivascular
FibrosisContributeto LeftVentricular
Dysfunction in Hypertension? 929-171.1OOA
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Leukocytes
Characterization of 3H-Dofetilide Binding in Human
White Blwd Cells: Influence of Class III
Antiarrhythmic Drugs 109O-88.513A
Cigarette Smoking Is Amrciated With Increased
fvfortocyteAdhesion 10Er-rdothelialCMS:
Reversibility With L-Arginine but Not Wieb
ViraminC 986-77*264A
Effects of Heparin Coating nf Extracorporerd
Circuits on Release of LPS Toxicity: Modulating
proteins During Cardioprdmmrar’yBypass
1064-162*465A
Expression of Adhesion Molecules on Microvesaels
in Advanced Human Atherosclerotic Plaques:
Alternative Patbways for Leukocyte
Recrrritment 96O-108.153A
Modulation of Platelet NerrtrophilInteraction With
Pharmacological Inhibition of Fibrinogen
Binding to Platelet GPIfb/lIIa Receptor
960-111.154A
Oral L-Arginine Improves Endothelium-Dependem
Dilatation md Reduces Mnnncyte Adhesion to
Endothelial Cells in YoungMen With Cnrmrary
Artery Disease 795-6.387A
Plasma Levels of Soluhle Adhesion Molecules
VCAM-1 and L-Selectin During Acute
Myocardial Infarction 970-44.234A
Sialyl Lewis X-Containing Oligosaccharide
ImprovesEndothelial Dysfunction of
Thrombosis-Related Coronary Artery 986-78.
264A
Successful Revascrdarizationby Direct Coronary
Angioplasty Reduced the Expression of
PolymorphmrucleruLeukocyte Adbesion
Molecules of Patients Wirh Acute Myocarrfial
Infarction 1079-112.493A
The Antibody Fragment c7E3 (ReoPro’”)Binds to
Activated and Nonactivated Mac-1 on Grrmrdo-
and Monocyresand Blocks Mac-I-Mediated
Cell Adhesion and Aggregation 974-87.241A
Use of VeryLrdeArrtigerr-4(VLA4) Integrirr
Binding Blockade With Connecting Segment-1
Peptide in Prevention of Restenosis After
Balloon Angioplasty in the Rabbit
Atherosclerotic Model 1039-93.419A
Lipid mnsfifyingagents
Effect of Simvastatin on Ischemic Signs and
Symptoms in the Scandinavian Survival Study
7i8-i .75A
Lipoprntcin(a), Lipids, Aspirin, and Risk of
Myucardial Infarction in the Physicians’Health
Strrdy 718-5.76A
Older Patients in CARE Benefit Frnm Fravastrdirr
Postmyocardial Infarction 787-1.375A
POSCH Five-YearPosttrial Follow-Up Report
969-37.233A
Reduction of Plasma Lipid Peroxides During
Low-Density Lipoprotein Immrrnapheresis
921-114.47A
Lipnproteirsa
Decreased Cholesterol Esterification by &Blmker
Agents in Human Oxidized Low-Density
Lipoprotein 1027-174.343A
DriesGender InfluenceDirrretic-InducedLipid
Changes 922-150*48A
Effect of Cilostazol on Plasma Lipoproteins in
Patients With Intemrittent Clarrdication 725-3*
85A
Expanded Doses of Simvastatin: Efficacyand Safety
of 80 and 160mg in Hypercholesternlemia
806-4*400A
Impaired Lipolysis of VeryLow Density
Lipoproteins in Type III Hyperlipoproteinemia
964-87*160A
ImprovedFibrirrolyticProfile by Estrogen in
Postmenopausal Women: EndothelirrmVersus
Liver 785-1.372A
Increased Lipolysis of Triglyceride-Rich
Lipoproteins EnharrcesArtery Wall Permeability
and Lipoprotein Retention 964-64. 159A
Influenceof Hyperlipidemia on Restenosis After
Coronary Artery Stent Implantation 921-113*
47A
Influenceof Red Wine and Red Grape Juice on
Lipids and Lipid Peroxidation 921-90*46A
Joint Effects of Triglyceridesand Lipoprotein
Cbolesternl on CHD Deaths: Po1-MONICA
Warsaw Follow-Upprogram 969-35.232A
LDL Subclass Change in Familial Combined
HyperlipidemiaPatients FollowingGemfibrozil
and Niacin Treatment 921-91.46A
Lipoprotein (a) Does Not Correlate Witb Early
Atherosclerosis as Seen on Irrtracormrray
Ultrasound in AsymptomaticFamilial
Hyperlipidemia 969-34.232A
Quantity and Function of High-DensityLipoprotein
axan Indicator for Coronary Atherosclerosis
1077-69*489A
Reduction of Plasma Lipid Peroxides During
Low-DensityLipoprotein Immrrnapheresis
921-114.47A
Serum Levels of TransformingGrmvrhFactor-pi
(TGF+l) Is Depressed in WomenWith
Coronary Artery Disease 723-6.S3A
Serum Lipoprntcin (a) Level Is Related to Thrombin
Generation and CornrtaryPatency During Acrrtc
Myocardial Infarction 964-85.160A
UrirrrrryApe(a) Is a Better Predictor of Coronary
Heart Disease Than Plasma Lp(a) 723-2.82A
Lipuproteina, HDL
Incrmse of High Density Lipoproteins (HDL) in
PostmenopausalWomenWith Estrogen
Replacement (ER) Therapy Is Determined by
Genetic Polymorphismof Serum
HDL-Arylesterase 813-4.407A
Quantity and Function of Higb-DensityLipoprotein
as an Indicator for Coronary Atherosclerosis
1077-69*489A
Lipoproteins, LDL
ComelrdionBetween Oxidized Low Density
Lipoproteinsand Coronary Artery Disease in
Hean Transplantpatients g08-1l402A
Different Effects of HormoneTherapies on
Low-DerrsiryLipoproteinOxidation in
PostmenopausalWomen 7254.86A
Effects of Oxygen Radicals on Human Lipoprotein
(a) and Low Density LipoproteinPeruxidation
and Metabolism 964-89.160A
Expanded Doses of Simvastatin: Efficacyand Safety
of 80 and 160mg in Hypercholesterolemia
806-4*400A
ImprovedEndotheliumFunction of Forearm
Vn.scrdamrcAfter Lipid-LoweringTherapy
725-2.85A
LDL Cholesterol and AngiographicProgression in
the QUIET Trial 725-1.85A
LDL Subclass Change in Familial Combined
HyperlipidemiaPatients FollowingGemfibrozil
and Niacin Treatment 921-91l46A
Lipoprotein, Lipids, Aspirin, and Risk of
MyncnrdialInfarction in the Physicians’ Health
Study 718-5.76A
Mitogenic Effect of Serotorrinon VascularSmnnth
Muscle Cells Is Potentiated by Low-Density
Lipoproteins 964-65.159A
Modulation of LDLPrrrdcle Size Afterrm Oral
Glucose Load Is Associated With Insulin
Release 964-88.160A
Plasma Oxidized Low-Density Lipoprotein Is
Elevated in Patients With Angina Pectoris and
Normal Coronary Arteriograms 714-4.70A
Serum Lipids and HypertensionPotentate Coronary
VasoconstrictionWith Mental Stress 1096-81.
524A
Longitudfrsal studies
A Java-Based WorldWide Web Computer System
for Longitudinal Assessment of Health Outcome
Measures Using the Seattle Angina
Questionnaire 1254-1.9A
Changes in Functional Health for WomenVersus
Men One YearFoRowirrePTCA or CABG
928-15.97A
Five-Yea Canse of Death Analysis in the NHLBI
PTCA Registry: Results and Considerations for
EvaluatingLong-TermSurvival 1031-6I.34SA
Heart Transplarrtatinnin Canada arrdDeterminants
of Early and Late Mortality 91O-I78*28A
Lipid Profile and Outcome of Diabetic Patients With
Coronary Artery Disease in the BIPStudy
Registry 969-36.233A
Reduced Arterial Compliance Predicts
CardiovascularRisk in Patients With Arterial
Hypertension 754-1.207A
TargerLesion Revasculmization Following Coronary
Angioplasty: A Repon From tbe NHLBI PTCA
Registry 792-3.382A
Macmphages
A Long-Acting Nitric Oxide Donor Suppresses
Basal and LPS-Stimulated Tissue Factor
ProcoaguhmtActivity in Hnman
Monocyte-DerivedMacrophages 986-80.265A
Atherectomy Specimens Obtained From Patients
With Restenotic Lesions Reveal Higher
Monocyte Chemoatractant protein-l Levels
TbarrThose With De Novo Lesions 7904.
380A
Difference of HistopathologicrdFindings in Stahle
Angina and Acute Coronary Syndromes 924-31
.89A
InflammatoryCytokines in Stable VersusUnstable
Angina 970-38.233A
Neoprerin,a Semm Marker of Immune Activation, Is
Elevatedin Acme Coronary Syndromes 990-36
.272A
Suppression of Atherosclerotic Development in
Watanabe Heritable Hyperlipidemic (WHHL)
Rabhits Treated Witb an oral AntiaRergic Drrrg,
Transilast 95843. 151A
The Effect of Aziehromyciniu Postmyocardial
Infarction (MI) Patients With Elevated
Chlamydia PnerrmoniaeAntibody Titrcs 755-2
.209A
Magnesium
A Randomized Trial of Magnesium in Cardiac
Arrest 955-170. 147A
Adenosine Mediates the Infwct Size Limiting Effect
of Magnesium in Rabbits 988-98.267A
Bohrs Magnesium Infusion in Humans Is Associated
With Predominantly Unfavorable Changes in
Platelet Aggregation and Certain Hemostatic
Factors 947-11.134A
IntracellrrhwMagnesium predicts Functional
Capacity in Patients With Coronary Artery
Disease 789-6.379A
Low Intracellular Magnesium Levels promote
Platelet-Thrombus Formation in Patients With
Coronary Artery Disease 734-2.179A
Magnetic resonance imaging
A Clinical Investigationof the IrnWrtance of
Imaging Slice Lccation in Quantifying Aortic
RegurgitationWith MRI 909-109*27A
A New Animal Model for Remodeling Followed Up
With Magnetic Resonance Imaging 1023-109.
337A
Assessment of Mitral Regurgitation by Quantitative
Doppler: Comparison to Magnetic Resonance
Imaging 1025-92.34OA
Assessment of Vascular and Cellular Integrity in
ReperfrrsedInfarcted Myocardium Using
Gadolinium-EnhancedMR Imaging 800-4.
394A
Atrial Function Assessment for Bicaval and Biatrial
Anastomoses: Magnetic Resonance Imaging
Using Automatic Cardiac Analysis and Flow
Measurement IO23-106=336A
Characterization of Atherosclerotic Lesions by
Magnetic Resonance Imaging: Comparison
With IntrnvascnlarUltrasound and Histnlogy
1023-108.336A
Cbnracterizationof Different Time Courses of Left
and Right VerrtricnlarRecovery After Lung
Tmrrsplarrtation907-148.23A
Coronary Blood Flow Quantification Using
Magnetic Resonance Pbase Mapping:
Comparison With Intracoronary Doppler Flow
Measurement 1023-102.335A
Detection of “No Reflow” Zones in Reperfused
MyocrrrrfialInfarction: MR Contrast Agents
Versusa Standard Fluorescent Tracer 1055-35.
449A
Detection of Segmental Aortic Distensibility
Alterations by Magnetic Resonance Velucity
Mapping in the Marfan Syndrome 1023-107.
336A
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Differencesin RegionalMechanicalFunction
Between Concentric and Eccentric Left
VentricularHypertrophy: A Study Using
Magnetic Resonance Tissue Tagging 1062-79*
463A
Endocardial Blnod Flow in Acute Ischemia
Following Transmyocardial Laser
Revasculsrization 769-4.229A
Improved Measurement of Myocardial Venous
Bluud Oxygen Level With Magnetic Resonance
Imaging 1023-105.336A
In VivoCharacterization of Fontan Pathway Flow
Dynamics by Multidimensional Phase Contraat
Magnetic Resonance Imaging 721-4*80A
Intravenous DudecaflouropentaneImpruves
Determination of Left VentricularFunction
During Transthoracic Echucardiography
1094-28*520A
Magnetic Resonance Imaging Accurately Estimates
Cardiac Mass in aTransgenic Mouse Model of
Hypertrophy 1029-164.346A
Magnetic Resonance Imaging Assessment of
Regional Myucardial Fiber and Cross-Fiber
Strain 995-69.284A
Magnetic Resonance Imaging for the Assessment of
Intracardiac BafOesand Extracardiac Conduits
in Congenital Heart Surgery 932-87.107A
Magnetic Resonance Imaging in Patients With
ArrhythmogenicRight VentricularDysplasia
1091-94.514A
Magnetic Resonance Imaging With Taggingin
Constructive Pericarditis 907-164*24A
MicrcwascularObstruction Progresses Beyond
Corunary Occlusion and Reflow Af&r Acute
Experimental Infarction 759-4.215A
New Real-Time Interactive Cardiac Magnetic
Resonance Imaging System Is Useful in
Subjecta With Suboptimal Echocardiographic
Studies 759-5.216A
NoninvasiveVisrralizationof the Proximal Coronary
Artery Segments With New Fast
Three-Dimensional Magnet Resonance
Angiography 759-1.215A
Partial Left Ventriculectomyin Severe Idiopathic
Dilated Cardiomyopathy: Assessment of
Short-TermResults on Shape and Systolic
Function by Magnetic Resonance Imaging
759-6.216A
Quantitation of Right CormraryArtery Flow:
Navigator-Echo-BasedRespiratory-Ga(e
Magnetic Resonance Measurement Compared to
Dnppler Guidewirc Measurement 759-2.215A
RecruieableMyucardial Deformation During
DobutarnineStimulation by Magnetic
Resonance Imaging With Tagging 1023-103=
335A
Reproducibility and Day-to-Day Variabilitiesof
Three-Dimensional Echocardi6graphyfor Left
VentricularVolumesand Ejection Fraction
Calculation With Comparison to Magnetic
Resonance Imaging 705-2*56A
Resprmse to Dobutamine by Magnetic Resonance
TaggingPredicts Recovery of Dysfunctional
Myocardium Postinfarction: A Quantitative
Approach 1023-104*336A
Simultaneous Assessment of Function and Perfusion
in Experimental Corunary Artery Stenosis Using
Fast MRI 759-3.215A
Three Dimensional Current Density Reconstruction
on the Cardiac Surface by
Magnetocardiography:Evaluationof
Physiological Pattern and Comparison With
Investigations in Patients With Ischemic Heart
Disease 1OO2-99O294A
Three-DimeniortalReconsttuctionof Anomalous
PulmonaryVein by Gated InflowMagnetic
Resonance Angiography 1087-I7O*5O9A
Three-Dimensional MRI Reconstructions of
Congenital Cardiovascular Disease With
Personal Computers 915-116035A
Magnetic resortmtcespectroscopy
Blockade of Nitric Oxide Improve My@ardial
Metabolism During Ischemia Independentof
Preconditioning Effect 776-4*360A
Cardiac Phosphonrs-31Magnetic Resonance
SpeceruscopyDuring DubutamineStress in Elite
Cyclists With Left VentricularHypertrophy:No
Evidencefor Altered High-EnergyPhosphate
Metabolism 1OO2-98.294A
Cardioprutectionby the ATi-Receptor Blocker
Losartan Is Dependenton Bradykinin Receptor
Activation 988-97.267A
Essential Improvementsto a Working, Isolated Rat
Heart Mudel With Hemndynamicand NMR
SpectroscopicMonitoring 952-127.141A
Metabolic Abnormalityof Calf Skeletal Muscle Is
Impruvedby Localized Muscle Training
Independentof Blocd Flow in Chrunic Heart
Failure 1098-156.526A
Noninvasive31P Spectroscopic Assessment of
Regional Myucardial Metabolism Postinfarction
800-5c394A
Normal High Energy Phosphate Ratios in “Stunned”
HumrmMyoctmdium 1OO2-97*294A
Skeletal Muscle Metabolism During Maximal
Systemic Exercise in Patients With Chronic
Heart Failure 1098-165.528A
Medical reeord systems, computerized
A Java-Based WorldWide Web Computer System
for’LongitudinalAssessment of Health Outcome
Measures Using the Seattle Angina
Questionnaire 1254-1*9A
Developinga Standard Dataset for Interventional
Cardiology 1012-16.316A
How to Trigger P-Wavesin the Helter-ECG for
Accurate PR-Intewal Measurement? 1252-1.
8A
New “AugmentedReality” Interface Metaphors for
Cardiology Information:The LIMIT Project and
an ECG Monitor Object Prototype 814-2.407A
Membrane potentials
Transient TachycardiaSuperimposedon Bradycmdia
Prolongs Repularization in Isolated Canine
VentricularMyocytes 709-3.62A
Metabofiam
Assessment of ExertionalMuscle Anaerobic
Metabolism by Near InfraredSpectroscopy in
ChrmricHeart Failure 1041-2O.424A
Assessment of Glucose Utilization in the hrsolated
Rat Heart Using
1,3,4,6-tetra-acetyl-2-[F-18]-2-deoxy-D-glucose
(acetyl-FDG)and Insulin 1OO2-104*295A
Biochemical and MorphologicalResponses in
Adults and GrowingOrganisms After
Latissimus Dursi Conditioningfor
Cardiomyoplasty 1014-158o318A
Blockade of Nitric Oxide ImproveMyocardial
Metabolism During Ischemia Independentof
PreconditioningEffect 776-4*360A
Cardiac Phosphorus-31Magnetic Resonance
SpectroscopyDuring DobutarnineStress in Elite
Cyclists With Left VentricularHypertrophy:No
Evidence for Altered High-EnergyPhosphate
Metabolism 1OO2-98*294A
Delayed FDG Imaging Impmves Myocardial/B1ood
Pool Contrast 1047-146*436A
Effect of Ischemia and Reperfusionon
LysoplasmalogenAccumulation in an In Vivo
Canine Model 1055-34*449A
Effects of Left Bundle Branch Bluck on Cardiac
PET Imaging 1047-145o436A
Efficiencyof Metabolic Screening in Childhood
Cardiomyopathies 911-160*30A
ISF.2.Deoxygluco~e(FDG) Utilization k
Regionally Increased in Fasting Pigs With
HibernationMyocardium 945-35*130A
Increased Myocardial Uptake of 2-Deoxyglucose
During Reperiirsion:Role of the Tmnslocation
of GLUT4 945-36*130A
Myucardial Blond Flow Changes During Low-Dose
DobutamineInfusion: Relation to F-18
DeoxyghrcoseUptake 1047-I48o436A
N-Methyl-l-Deosxynojirimycin, an a-Glucosidase
Inhibitor Reduces Markedly Infarct Size in
Rabbit Hearts 988-94.266A
Normal High EnergyPhosphate Ratios in “Stunned”
Human Myocardium lMt2-97.294A
Reduced Energy Intake Is the Cause of Weight Loss
in Congestive Heart Failure Patients 10414.
424A
Reductions in Myocardial Oxygen Consumption
Following Repeated Brief Coronary Occlusions
in ChronicrdlyInstrumented Dugs: A Possible
Contributing Mechanism in Preconditioning
776-1l359A
Regional Wall Motion Abnormalities in Diabetic
Hearts Without Coronary Artery Disease
Closely Relate Microvascular Circulation
Disturbance 1015-I32.321A
Relation Between Perfusion, Metsbnlism, and
Contractile Reserve in Repetitive Myocardial
Shrnning 105O-155.441A
Skeletal Muscle B-Arenoreceptors Changes in
Chronic Heart Failure: A Beneficial Effect of
#7-BlockadeTherapy 104O-28.422A
The Impact of CormraryFlow Reserve and Insulin
Resistance on Myocardial Energy Metabolism in
Syndrome X 962-93.156A
Micracirculation
Abnormal Corunary Vasomotion in Long-Term
Smokers Depends on Duration and Dose of
Smoking 714-2.70A
Function of the Adenosine Sensitive Cormrary
Resistance in Patients Whh Mild Dilated
Cardiomyopathy 800-6.394A
Inducible Nitric Oxide Synthase Inhibition Reveraes
Impaired AreeriolarResponsiveness to
Endothelin-1 in Sepsis 795-5.387A
Regional Wall Motion Abnormalities in Diabetic
Hearts Without Coronary Artery Disease
Closely Relate Microvascular Circulation
Disturbance 1015-132.321A
Stimulated Hyperinsulinemia in Patients With
Microvasculsr Angina Is Associated With
Enhanced Red Blued Cell Na+/Li+
Counterrrarrsport 962-96.157A
The Impact of Coronary Plow Reserve and Insulin
Resistance on Myocardial Energy Metabolism in
Syndrome X 962-93.156A
Mitral regurgitation
Assessment of Mitral Regurgitation by Quantitative
Doppler: Comparison to Magnetic Resonance
Imaging 1025-92.34OA
Comparison of Three-Dimensional Echo and
Proximal Flow Convergence Methud for
Quantificationof Mitral Regurgitation 730-5.
174A
Decrease of Mitral Regurgitation Witb Heart Failure
Treatment 1sDue tu a Reduction in the
Regurgitant Orifice 1OO3-1I2.2%A
Does Mitral Regurgitation Affect the Validity of the
Interpretation of Diastolic Filling Parameter? A
Quantitative Echocardiographic Study 909-106
.26A
Does Mitral Regurgitation Progress Following
Repair of Atrioventricular Canal Defects?
932-66. 106A
Estimation of Mitral Regurgitation Using a
Hemi-Elliptic Curve-Fitting Algorithm: In Vitro
Experiments With Native Mitral Valves
909-108.27A
Evolution of Left and Right Ventricular Function
After Surgical Correction of Severe,
Nnnischemic Mitral Regurgitation 1042-117.
426A
Flexible Vs. Rigid Ring Annuloplazty: A Finite
Element Model 1042-118o426A
Improved Accuracy of Mitral Regurgitant Flow Rate
Calculation Using a Hemielliptical Isovelocity
Surface Area: Clinical Studies 711-2.65A
Influencesof Left Atrial Size on Pulmonary Venous
Flow in Patients Witb Moderate to Severe Mitral
Regurgitation 909-105.26A
Insights From Three-Dimensional Echocardiography
Into the Mechanism of Functional Mitral
Regurgitation: Direct In Vivo Demonstration of
Leaflet Tethering Geometry 939-114.119A
Left VentricularVolumeby 2-D Echucardiography:
BeeterPreoperative Assessment for Left
VentricularFunction in Patients With Mitral and
Aortic Regurgitation 1093-57.519A
Mitral Regurgitation Index: A Composite of Clinical
Factors to Measure Severity 107O-24*477A
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Mortality Remains High When VentricularSeptal
Rupture (VSR) or Acute Mitral Regurgitation
(MR) Cause Cardiogenic Shock Complicating
Acute Myncsrdial Infarction (AMI) 1061-97*
459A
Multilane TrmtsesophagealEchocnrdiography
Predicts the InvolvedScrdlop in Patients With
Posterior Flail Mitml Leaflet and Severe Mitral
Regurgitation: An IntraoperativeCorrelation
1025-91l340A
Multilane Transthoracic Echocsrdiography in
Mitrsl ValueDisorders: Echo-Anatomy and Its
Value 1025-90.340A
Prevalence and Mechanism of Ischemic Mitral
Regurgitationby Echocardiography 909-107.
26A
Prognostic Vshreof Chronotropic Reserve in
Chronic Mitral Regurgitation 989-113.271A
Progression of Mitral Regurgitation and Leti
VentricularRemodeling: A QumrtitativeDopplel
EchocnrdiographicSNdy 793-5.384A
Pulmonary VenousFlow VelocityMeasurements for
the Quantitative Assessment of Mitral
Regurgitation 711-4.66A
Quantificationof Mitral Regurgitation on Contrast
Echocardiography:Application in Patients
UndergoingCatheterization 1049-168*44OA
Qmmtitationof Mitral Regurgitation: A New
Echo/DopplerTechnique 1025-93.34OA
V02 Plateau and Ex&tional Dyspnea in Patients
With Regurgitant ValvularHeart Disease
1098-155*526A
Mitraf vafve
Absence of Severe Thickening of the Mitral Valve in
Mittal ValveProlapse Patients Who Die
Suddenly 1OI8-37*328A
EchocardiographyCan Identify Patients for Mitral
ValveRepair 1018-34*327A
Enhanced Diagnostic Accuracy of Aortic and Mitral
ValvularPerforation by Three-Dimensional
F.chocardiography 730-2.173A
Evaluationof the Configurationof the Mitral
Anmdus by Extracted Tbree-Dimensioned
Images in Patients With an Annuloplasty Ring
784-5-372A
Flexible Vs. Rigid Ring Annrdoplasty:A Finite
Element Model 1042-118.426A
Importance of Scanline Orientation for Color
Doppler M-Mode Diastolic Inflow Patterns and
Pressure Gradient Calculations 1049-166.
439A
Lmrg-Temr(Up to 11 Yenrs)Results After
Percutaneous Mitral ValvuloplastyWith Inoue
Balloon Catheter in 202 Patients 766-1.225A
Minimally InvasiveMitral ValveSurgey on Bypass
With Csrdioplegic Arrest 931-78.104A
Mitral ValveMorphology and Function Before nnd
After Left VentricularRemodeling Surgery
1018-3I.326A
Mitml-VnlveProlapse in Militmy Members:
Long-TernrFollow-Up and ClinicaJ Risk
Analysis 1085-44.5O6A
Mukiplane Transesophageal Echncardiography
Predicts the InvolvedScallop in Patients With
Posterior flail Mitral Leaflet snd Severe Mitral
Regurgitation: An Intraoperative Correlation
1025-91*34OA
MultiplnneTmnsthoracic Echncnrdiographyin
Mitral ValueDisorders: Echo-Anatomy and Its
Value 1025-9O*34OA
“Natural Histories” of Mitral ValveProlapse
1085-42*5O6A
New Insight Into the Determinants of Mitral
Regurgitation After Atrio-VenOicularCanal
Repair: A Three-Dimensional
EchncnrdiographicStudy 721-3.80A
preservation of the SubvalvulnrApparatus Improves
Long-TermLeft VentricularDimensions and
PulmonnryArtery pressure in Patients
Undergoing MitmJ ValveRepsiror Replacement
Despite Comparable Left VentricularEjection
Fractions 99g-144*288A
Quantitation of Mitral Regurgitation: A New
Echo/DopplerTechnique 1025-93*34OA
TransesophagealDynanricThree-Dimensional
Reconsmrctionof Plow Jets in Assessing
Prosthetic Mitral ValveFunction 7304.174A
Mitral valve prrdapae
Absence of SevereThickeningof the Mitral Valve in
Mitral Vslve Prolapse Pntients Who Die
Suddenly 1018-37*328A
Comparison of Three-DimensionalEcho mrd
Proximal Plow ConvergenceMethod for
Quantificationof Mitml Regurgitation 730-5.
174A
Mitral-ValveProlapse in Militmy Members:
Long-TermFoOow-Upand Clinical Risk
Analysis 108544.506A
Multivariatepredictors of BiomechanicalProperties
in Myxomatous Mitrsl ValveDisease 1018-33.
327A
“Natural Histories” of Mitral ValveProlapse
108542.506A
New Insighta Into the Pathologyof Degenetwtive
Mitral Vslve Incompetence:A
HistomoqrhometricStudy 1018-32.327A
Q.untification of Mitral ValveProlapse by
Three-DimensionedEchocnrdiograpby:
Correlation With BiomechmricalCharacteristics
of Excised VnlveTissue 784-4.371A
Mitral vafve stenosis
Accurate Mitral ValveArea Assessment in Patients
With Mitral Stenosis by Three-Dimensional
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Decreased Levels OfIK~c~mRNA in Patients With
Chronic Amid Fibrillation but No Changes in
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Cyclase mRNA Isofonn Expression in the Left
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Differential Atrial and Venoiculm Expression of
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Syndrome and Cardiac Septation Defects 726-4
l87A
Naturally-OccurringSilent Sequence
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Dobutamine Echocatdiography: Results of the
BADE Pilot Study 984-40259A
Monndonalantibodies
Abcixirrmb(ReoPro, Chimeric 7E3 Fab)
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Chronic Heart Failure: Relation to Measures of
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Thickening in the Presence of Partial or
Complete Absence of Flow Resewe:
Implicationsfor DobutamineStress
Echncardioyapby 793-1.383A
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335A
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1084-136*5O2A
Accelerated Primary Platelet Aggregation in Acute
MyncardisJ Infarction: Use of a New
AggregometryEmploying Laser-Light
Scattering System 1033-32.4O9A
Adenosine Mediates the Infarct Size Limiting Effect
of Magnesium in Rabbits 988-98.267A
Angiotensin-ConvertingEnzyme Genotypes and
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Beneficial Effects of Adenosine in Acute Myocardial
Infarction 947-7. 133A
Benefit of Previous Arrzinaon In-Hosnital Survival
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C-Reactive Protein as a Predictor of Infarct
Expansion and Cardiac Rupture After a First Q
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Cardiac Dysfunction and Outcome in Patients With
Subarachnoid Hemorrhage and
ElectrcmardiographicAbnormalities 934-55.
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NormalSubjects 791-1.380A
Clinical Usefulness of Dual SPECT Imaging of
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MyocardialViabilityAfterThrnmbolysed
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Co-Localization of C-Reactive Protein and
Complement in Human Hearts During Acute
Myocaardial Infarction 988-101.268A
Comparison of Dobueamine-AtropineStress
Echocardiographyand Exercise Thallium-201
for the Diagnosis of Myncardial Ischemia After
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Consequences of Coronary Occlusion on Changes in
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Continuous Administration of Aminoguanidine
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Difference of Histopathological Findings in Stable
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Participationof TGF-fJ1in Platelet-Mediated
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Approach 1023-104.336A
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Generation and Coronary Patency During Acute
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VagalReflexes and Left VentricularFunction in
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Myocardial irsfarction, treatment
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A Comparison of Health Care Financing
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A Double Blind Randomized Placebo Controlled
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Clinical practice: Results in 4,625 Patients From
the ALKK Angioplasty Registry 903-11.15A
Angiotensin II Type 1Receptor Expression in the
Myncardium Immediately Following
Ischemia-Reperfusion 901-34.12A
Angiotensin-ConvertingEnzyme Genotype Dries
Not Influence HypertrnphyAfter Acute
Myocardial Infarction 970-41.234A
Antimynsin ImmunoliposomesPrevent and Reverse
Cardiocyte Death Inducedby Hypoxia Up to
Five Days 988-95.267A
Arc the Results of Primary PTCA for Acute
Myocardial Infarction Different During Day and
Night? 925-44.91A
Association of Depressed 24-Hour Heart Rate
VariabilityWith Mortality in the EMIATTrial
1078-109*49OA
Association of Depressed Left VentricularEjection
Fraction With Mortality in the EMIATTrail
948-15.135A
Beneficial Effects of Adenosine in Acute Myocardial
Infarction 947-7.133A
Can Community Hospitals Prnvide EffectivePdmmy
PTCA Coverage at All Hours? 92540.91A
Captopril Reduces Thrombus Formation in Early
Postmycardial Infarction Stage 712-4.67A
Cardiac Troponin T in Patients With Renal Failure
970-43*234A
Cardiogenic Shock DevelopingWitbin 48 Houra
After Thrombolysis for Acute Anterior
Myocardial Infarction May Be Related to
Hemorrhagic Cardiac TamponadeWithout
Rupture 903-8*14A
Characteristics and Outcome of Patients With
Cardiogenic Shnck Due to Right Ventricular
Dysfunction: A Report From the SHOCK Trial
Registry 1061-98.46OA
Clinical and Angiographic Outcome of
Intracoronary Stent Placement in Acute
Myocardial Infarction 903-10*14A
Clinical Hemorrhage and Coagulation Parameters
Following Therapy With Efegatran Versus
Hepmin in the ESCALATTrial 1034-57*413A
Continuous Administration of Aminoguanidine
Inhibita Inducible Nitric Oxide Synthase and
Exerts Protective Effects in a Rabbit Mndel of
Ischemiaand Reperfusion 776-50360A
Cooperative Cardiovascular Project (CCP):
Underuse of Quality Indicators for Acute
MyocardirdInfarction in Medicine Patienta in
New YorkState 738-2*185A
Coronary Flow Reserve in Infarct Related Artery and
Left VentricularRemodeling in Patienta With
Anterior Myocardial Infarction 926-26.92A
Coronary Stenting During EmergencyAngioplasty
in High-Risk Myocardial Infarction: Data From
a Multicenter Registry 1059-147*455A
Coronary Stents ImprnvedHospital Results During
Coronary Angioplaaty in Acute Myocardial
Infarction: Preliminary Results of a Randomized
Controlled Strrdy(GRAMITrial) 763-2.221A
Cost-Effectiveness Analysis of an Early Lisinopril
Use in Patients With Acute Myocardial
Infarction: Results From GISSI-3 Trial 923-135
.49A
Decision Making in Octogenarians: Characteristics
Associated With Selection for Catheterization
Following Acute Myocardial Infarction 777-$.
361A
Determinants of Long-TermCardiovasculm Drug
Use After Myocardial Infarction: Does Courmy
Make a Difference? 1078-126.491A
Differences in predictive Power of Heart Rate
Variability in Thrnmbolyzed and
NonthrombolyzedSurvivors of Acute
Myocardial Infarction 731-2.175A
Direct Anginplasty (PTCA) for Mycardial
Infarction in a Center With Surgical Back-Up
’220 Miles Away 971-12.236A
Direct AngioplastyMay Be Less Advantageousin
Patients Presenting Early After SymptomOnset:
Results Fmm GUSTO IIb 781-1.366A
DiscrepancyBetween Actual Vs. Potential
Treatment in Acute Myncardial Infarction:Use
of Thrnmblytics, Aspirin, Beeabldcers, and
ACE-Inhibitorsin Germany 1996;MITRA
Study 903-12*15A
Do PatientaWith PreviousCABG Have Worse
Outcomes With TbrombnlyticTherapy? 781-6*
368A
Does STATReportingof Serial Serum Markers
(CK-MB and Myoglobin)Aid in Early
Detection and Treatment Decisions for Acute
Myocardial Infarction? 738-6.186A
Early ACE-InhibitorAfter Myncardial Infarction:
Prescribed Dnses of LisinopriJin GISSI-3 Trial
and Their Clinical Determinants 755-4.21OA
Early ACE-InhibitorTherapy Enhances the Benefits
of Late Coronary Artery Repatirsion on Infarct
Expansion 1079-113.493A
Early and PredischargeAspirin Administration
Among Patients With Suspected Acute
Myncardial Infarction:Current Clinical Practice
in the United States 738-1.185A
Early NoninvasiveAssessment of Reperfusionby
Myocardial Protein Release Patterns 791-2.
381A
Effects of Exercise Intensity on Short-TermExercise
Training in Patients With Acute Myocardial
Infarction 989-109*27OA
Effects of Physical Trainingon QT Dispersion and
Heart Rate Variabilityin Patients With Acute
MyncnrdialInfarction 1034-56*413A
Elective Stenting in Acute Myocardial Infarction:
PreliminaryResults oftbe Florence Randomized
Elective Steneingin Acute Comnar’yOcclusion
(FRESCO) Study 1059-166.456A
Endothelin-AReceptor Antagonism in Rats With
Myocardial Infarctionand Failure 805-1.399A
Endpoint Adjudicationby a Clinical Events
Committee Can Impact the Statistical Outcome
of a chIiCd Trial: Results Fmm GUSTO-IIb
1033-39*41OA
Evaluationof the PredictivePerformanceof a
MultidcmographicBaaed Hepmin Dosing
Prntocol in Acute CornnarySyndromes
1033-36*41OA
Harmonic Triggered hnaging FollowingIntravenous
Ultrasound Contrast in the Assessment of
Patients Following Acute MymmrdialInfarction
and ThrombnlyticTherapy: Implication of
Resting Contrast Defects 1072-27.479479A
Identificationand Managementof High-Risk
Patients With Acute Myocardial Infarction: The
National Registry of Myocardial Infarction
1078-122*491A
Identifyingthe Late Presenter: Criteria for
Refocusing Heart Atmck AwarenessPublic
Education Prngrams. Obsemations Frnm the
National Registry of Myncardial Infarction-2
(NRMI-2) 933-58*108A
Importanceof Posterior Chest Leads in Suspected
Acute Myncardial Infarction With
NondiagnosticRoutine ECG 1078-108*49OA
In-Hospital Managementof Acute Myncardial
Infarction:Results of USIK, a Nationwide
French Survey 702-I .52A
Incidence of ConductionDisturbances Complicating
Acme Myncardial InfarctionWith Amiodarnne
at Mnderate and High Doses (Observations
From GEMICA STUDY) 1028-171.345A
Increased Platelet AggregationDuring CormtaV
Thrnmbnlysisas a Predictor for Early and Late
Rencclusion 1079-115.493A
Influenceof Hypertensionand Blcod Pressure on the
SurvivalBenefit of ACE Inhibition After Acute
Myocardial Infarction 787-5.376A
IntracoronaryStent Therapy Enhances Luminal
Diameter and Reduces Residual Stenosis in a
Subset of Patients With Acute Myncardial
Infarction 971-11.236A
IntracornnaryStenting in Patients With Acute
Myncardial Infarction 1059-164.456A
IntravenousArgatroban Versus Hepadn as
Co-Medication to Alteplaae in the Treatment of
Acute Myocardial Infarction: Preliminmy
Results of the ARGAMI Pilot Study 738-4.
185A
Is It Necessary to “Miss” Acute Myncardial
Infarction in the ER? 81O-3.4O4A
Is the Benefit of Emergency PTCA for Acute
Myocardial Infarction Negated by Early
Reocclusion Before Discharge? 925-38.90A
Is There a Relationship Between the Utilization of
Cardiac Procedures for Acute Myocardial
Infarction and the On-Site Availability of Tbose
Services? 1078-107.49OA
Is There Justification for Follow-Up Symptom
Limited Exercise Myocardial Perfusion Studies
Late Postmyocardial Infarction? 746-6.197A
Late Coronary Artery Repetfusion Has Additive
Beneficial Effects on Infarct Expansion When
Combined With Early Angiotensin Converting
Enzyme Inhibitor Therapy Postmyocardial
Infarction 971-9.235A
Level of Anticoagulation Achieved in Myocardial
Infarction Patients Following Chronic
Administmtion of Fixed, Low-Dose Warfarin
Therapy: Results From the Coumadin Aspirin
Reinfarction Strrdy(CARS) 787-4.376A
Lipoprotein(a), Lipids, Aspirin, and Risk of
Myocardial Infarction in the Physicians’ Health
Study 718-5.76A
Long-TermFollow-Up of Gender Specific Outcomes
After Thrnmbnlytic Therapy for Acute
Myocardial Infarction From the GUSTO-I Trial
948-18.135A
Lytic Activity With Accelerated t-PA Assessed at
Bedside During Thrombnlytic Therapy for
Acute Myncardial Infarction 1034-54.412A
Microvascular Protection With Intravenous
Nicorandil Augments Myocardial Salvage in
Patients With Acute Myncardial Infarction
947-12.134A
Monoclinal Antibndy to C5 Inhibits C5a And C5b-9
Generation Without Inhibition of C3 Cleavage
and Significantly Limits Myocardial Ischemia
and Reperfusion Induced Tissue Damage
988-96.267A
Montreal Heart Attack Readjustment Trial
(M-HART): A Randomized Trial of
Psychosocial Intervention Following Myncardial
Infarction 1057-8.452A
Mortality Rate After Myocardial Infarction Equally
Increased in Diabetic Patients Treated With Oral
Agents and Insulin 787-6.376A
Mortality Remains High When Ventricular Septal
Rupture (VSR) or Acute Mitral Regurgitation
(MR) Cause Cardiogenic Shock Complicating
Acute Myocardial Infarction (AMI) 1061-97.
459A
Mortality Tcends After Acute Myncardial Infarction
Between the 80s and the 90s in Israel 1031-58*
348A
N-Methyl-l-Deosxynojirimycin, an a-Glucosidase
Inhibitor Reduces Markedly Infarct Size in
Rabbit Hearts 988-94.266A
Nine-YearOutcome of Patients Undergoing
Percutaneous Transluminal Cnronary
Angioplasty for Acute Myocardial Infarction:
Repmt From the 1985-1986NHLBI PTCA
Registry 772-2.354A
Nipradilol, a Nitric Oxide Releasing Beta-Blocking
Agent, Reverses the Severity of Myncardial
Injury After Ischemia Reperf’usionin
Cholesterol-Fed Rabbits 1027-175.343A
Nonblack Minorities and Outcome in the National
Registry of Myncardial Infarction 2 (NRMI 2)
1078-105.49OA
Noninvasive31PSpectroscopic Assessment of
Regional Myocardial Metabolism Postinfarction
800-5*394A
Occurrence of VentricularFibrillation During Acute
Myocardial Infarction: Prediction by Dynamic
KEX. Abstract title, Session-abstractnumber. pagenumber
‘!
JACC February 1997 SUBJECT INDEX 645A
Continuous12-LeadECGST-SegmentVariables
1044-109*431A
Outcomeof AcuteMyocardialInfarctionby
PhysicianSpecialty799-3.392A
PatientsTreatedbyCardiologistsHavea Lower
In-HospitalMortalityforAcuteMyucardial
Infarction799-1.392A
PosteriorChestLeads(VW)ST? DuringAcute
InferiorInfarctPredictsLargerInfarctandBetter
BenefitFromThrombolysis1044-107*431A
PrebospitrdThmmbolysisAfterCardiopulmonary
Resuscitationin SuspectedMyOcardird
Infarction933-61.109A
PrehospitalTlwumbolysisI AssociatedWith
SuperiorMyocardialReperfnsion:A Grampian
RegionEarlyAnistmplaseTrial(GREAT)
Subsmdy781-2.367A
PrevalenceandpredictionofNo-ReflowAfterDirect
Angioplaatyin AcuteMyocardialInfarction
925-39*90A
primaryAngioplastyVersusThrombolysisWitbtPa
in AnteriorMyucardialInfarction:ResultsFrom
a SingleCenterTrial 797-1.389A
PrimaryCoronaryAngioplastyorIntravenous
ThmmbnlysisforPatientsWithAcute
MycmrdialInfarction?AcuteandLate
Follow-UpResultsin a NewCardiacUnit
971-10*235A
PrimaryCoronaryAngioplastyVersusIntravenous
Streptokinasein AcuteMyocardialInfarction
925-42*91A
PrimaryStentImphwrtationIsSuperiortoBalloon
Angioplaatyin AcuteMyncardialInfarction:
TheResultofJapanesePasta(Ptimaw
AngioplastyVersusSrentImplantationin Acute
MyocardialInfarction)Trial 797-5.390A
PrognosticValueof BiphasicRespnnseDuring
DobutamineStressEchoAfierMyecardird
Infarction917-53.38A
QuarrtitativeAdenosineThallium-201SinglePhoton
TomographyAccuratelyPredictsRisk
FollowingAcuteMyucardialInfarction:The
ResultsofaprospectiveTrial 768-5.228A
RegionalVariationirrMyocardialInfarctionCare:
TheCooperativeCardiovascularProject
Experience777-3-361A
RegionalVariationin Postrnyocardial
InfarctionTesting:Resultsin 190,237Patients
799-59392A
ReperfusionTherapyin PostcormraryArteryBypass
GraftPatientsWithMyucardialInfarction:
ClinicalExperienceFromtheNationalRegistry
of MyucardialInfarction-2903-7*14A
RescuePTCA:AComparativeAnalysistoDirect
PTCAin a ConsecutivePatientSeries 971-80
235A
RestorationofMyucardialBloodPlowand
FunctionalImprovementinPatientsWithAcute
MyocardialInfarctionbya K+-ATPCharrnel
Opener,Nicomtrdil947-8.133A
RevascularizationAfterAcuteMyocardialInfarction
(AMI):ImpactofTreatmentSelectionon
Mortality948-17.135A
RVBranchReperfusionInfluencesOutcomeinRV
Infarction946-2*130A
SafetyandFeasibilityofprimaryStentinginAcute
MyncardialInfarction:In-Hospitaland30-Day
Resultsof thePAMIStentPilotTrial 797-4=
389A
SafetyandFeasibilityofRescuePTCAor primary
PTCAin PatientsWithAcuteMyecardial
InfarctionAdmittedto a HospitalWithout
PTCAFacilities797-60390A
Short-TermPhysicalTrainingImprevesExercise
HemodynarnicsbyReducingExercise-Related
f--eftVentricularDilatationin Postmyocardial
InfarctionPatienta789-5.379A
Significanceof BundleBrarrchBlockAfter
MyucardialInfarctioniutheTbrnmbolyticEra
1057-10*452A
SilentVersusSymptomaticResidualIschemiaAfter
ThrombolyzedMyucardialInfarctionin Patients
Rartdomizedto MedicrdTherapyor
Revasculmization948-13.134A
SodiumOzagrel,a TbmmtroxaneSynthetase
Inhibitor,PreventsAcuteRerrcclusionatrd
RestenosisFollowingPrimaryAngioplaatyin
PatientsWithAcuteMyucardirdInfarction
947-10*133A
ST-SegmentRecoveryParametersPredictiveof
Outcomein AcuteMyocardialInfarction:
VariabilityWithInfarctArteryLocationarrd
ImplicationsforTherapeuticTargeo 1034-55*
412A
Stent-AsaistedDirectBallconAngioplaatyforAcute
MyucrrrdialInfarction:Clinicalarrd
AngiographicFollow-Up903-9*14A
Stentingin AcuteMyocardialInfarction(STAMI):
Baifout,Conditional,andPlannedStems
1059-148o456A
Stentingin AcuteMyucatdialInfarction(STAMI):
Six-MonthFollow-Up1059-165o456A
Stentingin AcuteMyecardialInfarctionMay
ImproveProceduralatrdLmrg-TermOutcomes
715-6.72A
SuccessfulReperfusionWithTrarrsradial
AngioplaatySafelyResultinEarlyAmbrdation
arrdShortenHospitalStayin a Selected
SubgroupofAcuteMyocardialInfarction:The
ResultaofKamakuraPASTATrial 971-70235A
SuccessfulRevascularizationbyDirectCormraty
AngioplaatyReducedtheExpressionof
PolymoqrhonuclearLeukucyteAdhesion
MoleculesofPatientsWithAcuteMyncardial
Infarction1079-112.493A
Sulfonyhu’eaDrugUseIsAssociatedWithIncreased
EarlyMortalityDuringDirectCormrary
AngioplastyforAcuteMyc+mrdialInfarction
AmongDiabeticPatients 1079-114*493A
SuperiorityofCoronaryStentingComparedto
BallumrAngioplaatyin AcuteMyocardial
Infarction1059-163o456A
TemporalDistributionofImportantECG
Infomrationin PatientsWirbMI:WhenShould
YouTaketheNextECGAfterLytics?946-6*
131A
TheEarlyClinicalExperienceUsingtheAntologous
VeinGrafl-CoatedStentin tbeCoronary
Arteries 1036-86*415A
TheEffectof RegionalVariationandPayerStatnsin
tbeUtilizationofAcuteRepefisionTherapy
forAcuteMyucardialInfarction:ResultsFrnm
theNRMI2 781-5.367A
TheProtectiveEffectof Exercisein Acute
MyocardialInfarctionin Rat 989-111c270A
TheReductioninRateofPeti-Angioplasty
MyocardialInfarctionAfterTreatmentWith
Ift/IIIaReceptorAntagonistsIs Dependenton
MIDefinition974-85.241A
ThrombinGenerationDuringThrnmbolysisWith
tt-PAandConjunctiveTherapyWithr-Hirudin
inPatientsWithAcuteMyocardialInfarction
1079-111*492A
TimetoTreatmentInfluencesRecoveryofLeft
VentricularFunctionFollowingSuccessful
PrimruyAngioplastyinPatientsWithAcute
MyncardialInfarction772-3*355A
TransluminalExtractionAeherectomyVs.Ballon
Angioplastyin AcuteIschemicSyndromes
(TOPIT):HospitalOutcomerardSix-Month
StaNS946-230132A
TreatmentRoutinesarrdMortalityin Acute
MyccardialIufarceion:A ComparisonBetween
Minneapolis-St.Paul,USAarrdGiiteberg,
Sweden 1034-52*412A
TriageinCormraryCareUnit:AreTriagedpatients
Disadvantaged?933-5901O8A
VariationinLengthofStayandReadmissionfor
PatientsWithMyecardialInfarctionBetween
1986and1994 1031-59*348A
WhatIs theClinicalOutcomearrdImpactof
RevaacuhuizationofTIMI.2 FlowFollowing
AcuteMyocardialInfarction?797-2.389A
WithdrawalofCaptopril,AfterLmrg-Temr
Treatment,IncreasesIschemicEventsin
PostmyocardialInfarctionPatients787-3.375A
Myocarditia
A ClinicalandHistologicComparisonof Idiopathic
GiantCellMyuarditisandCardiacSarcoidoisis
765-39224A
Cardiac-SpecificOverexpressionofTumorNecrosis
Factor-uCausesLethalMyucarditisin
TmrrsgenicMice 1029-165*346A
PolymeraseChainReaction– PositiveViralGenome
andRejectionFollowingPediatricHeart
Transplantation911-1$9.29A
PruintlammatoryCytokinemRNAandRotein
Expressionin AcuteChagasicCardiomyopathy
995-60*X12A
TheRestingMyueardialContrastDefectSeenWith
ExtendedTimeIntervalsBetweenFrameRates
FollowingIntravenousMicrebubblesCorrelates
BestWithInfarctSize 1072-47o48OA
Myncrrrdium
A GeneLocusforArrhyIhmogenicRightVermicular
CardiomyopathyMapsto Chromosome17pl-q3
408-2*4A
ARolefort-heMyotonirrKinaseGenein Dilated
Cardiomyopathy?744-40194A
AbnormalitiesinLe.fiVentricularShapeOccur
DespiteNormalEjectionFractionin theHearts
ofPatientsWithSvsremicSclerusis 1015-131•
321A
CardiacTissueAngiotensinConvertingEnzyme
(ACE)BindingSitesAreIncreasedinHuman
HeartFailure770-1*230A
ClinicalSignificanceof ElevatedLevelsof Cardiac
TroponinT DetectedbySecondGeneration
Assayin PatientsWithCongestiveHeartFaihrre
93O-173*1O2A
DecreasedRetinoidReceptorBindingin
Pressure-OverloadedMyecardium995-67*
283A
Desmin-RelatedFamilialRestrictive
Cardiomyopathy:ClinicalObservationsin a
LargeKindred744-10193A
DetectionofMyecmdialViabilitybyDual-Isotope
Tc-99m-Tetrofosmina d18-FDGSinglephoton
EmissionTomographyAfterAcipimoxto
StimulateGlucoseUptake788-40377A
DifferentEffectsof ExerciseandDobutamineStress
onRegionalandGlobalLeftVentricularShape
1025-85*339A
DoAlterationsin LoadaadCardiacOntputAffect
RegionalShapeandGlobalGeometryof a
NormalLeftVentricle?A Quarrtitative
EchecardiographicShapeAnalysisStndy
939-118.119A
DobutamineEchoandPositronEmission
TomographyforAssessingViabilityin Patients
WithIschemicHeartFailure 1OO3-113O297A
DynamicThree-DimensionalTransthoracic
EchoardiographicEvaluationof theTotalMass
oftheLeftVentricleUsingThreeDifferent
MyucardialTissueEncndingTechniques
1094-48*521A
Ecto-5’-NucleotidaaeIsPhosphor’ylatedviaProtein
KinaseC in tbeCaninePreconditioned
Myecardium941-144.123A
EndomycardialBiopsyprovenCardiac
Amyloidosisin theAbsenceof
EchucardiographicFeaturesof Infiltrative
Cardiomyopathy765-6.224A
EnoximoneEchocardiographyforIdentificationof
ViableMyucardiumin PatientsWithIschemic
VentricularDysfmrction:ComparisonWith
DobutamineEchncardiograpbyandPositron
EmissionTomography917-72.39A
EvidenceforCa2+-ActivatedTrrmsientOutward
ChlorideCurrentsin VentricularCellsFrum
HumanHearts 1090-84*512A
HibernatedViableMyocardiumMr+tainsa
PhysiologicalContractileReserveThatparallels
ThatOberaervedDuringPharmacological
IntmpicSimulation989-103*269A
‘ICAM-1mRNAExpressionin Ischemicand
RepmfusedCanineMyocardium1055-31o
448A
Identificationof Abnormalitiesin LeftVentricular
ShapeDespiteNormalVolumesandFunctionin
KEYAbstmctitle,Session-abstractnumber*page number
6 SUBJECT INDEX JACC February 1997
Chronic Aortic Regurgitationby Quantitative
Shapes Analysis: An Early Marker of Left
VentricularDecompensation 909-103.26A
Inhibition of Nitric Oxide Synthesis Prevents
MyocardirdStunning Following Repetitive
Ischemiain the Intact Canine Heafi 945-37.
130A
Initiation ofTranscriptionby the Atrial Myosin
Light Chain 2PmmoterReqrtires thepresence
ofthe INRCisElement 726-5.87A
Ischemic preconditioning at aDistance: Redtrction
ofMyncardird Infarct Size by Pattial Reduction
ofBlood Supply Combined With Pacingofthe
GastrocnemiusMuscle 776-2.360A
Left VentricularApical Remodeling inChagas’
Heart Disease Disrupts the Optimal Global
Prolate-Ellipsoid LVGeometry: Evidence From
aQuantitative EchncardiographicRegional and
Global Shape Analysis Study 1OO3-121.299A
Longimdinal Rotational TomographicApproachfor
In VivoDetermination ofLeft Ventricular
Mass-ComparisonofaNewThree-Dimensional
EchocardiographicMethndto Anatomy
1094-49.521A
Magnetic ResonanceImaging Assessment of
Regional Myocardial Fiher and Cross-Fiber
Strain 995-69~2Z?4A
MicrospmrgeEchoContrastEnhances LeftHeartand
MyocardialPerfttsionStudies 1OO4-108*299A
Myocardial ContirmityBetween RightAtrium and
Left Atrium viatheCoronmy Sinus 775-2.
358A
Nataral Time Courae ofRegression ofLeft
VentricularHypertrophy 965-78.161A
Patient Selection for VentricularRemodeling
Surgery: Evolving Criteria and Outcomes
977-160*246A
Pharmacodynamics ofBasic Fibroblast Growth
Factor: Effect ofRoute ofAdministratiOn on
Regional Distribution 959-46.152A
Preliminary Observations Witb Ventricular
RemodelingSurgery forRefractory Congestive
Heart Failure 71O-4.64A
Progression of Left VentricularDilation Following
Firat QWave and Non-Q Wave Myocardial
Infarction 926-28.92A
Quantitative EchocardiographicAnalysis of
Regional and Global Shape of the Human Right
Ventricle: 1)Description of the Method and 2)
Characterization of Normal Right Ventricular
Shape 1OO3-114*297A
Regional Myocardial Wall Stress by
Transesophageal Echncardiographyand Finite
Element Analysis 1OO3-119.298A
Role of Endogenous Angiotensin II in Glucose
Metabolism and Recovery of Postischemic
Mechanical Function During Reperfusion in
Isolated Working Rat Hearts 958-40.150A
The Apoptosis Receptor FAS Is Upregulated in
Atrial Myocardium in Patients With Congestive
Heart Failure 703-4.54A
The Cloning and Characterization of a New
Regulatory Gene From Human Fetal Heart: A
Candidate for tbe Control of Myocardial
Differentiation and Growth 726-2.87A
The Inward Rectifier Contributes 4-Aminopyridine
Resistant Transient Otttward Current During the
Canine VentricularAction Potential 1090-90.
513A
The NA+-Channel-ModulatOraBDF9148 and DPI
201-106 Exert Positive Inotropic Effect Without
Direct Interaction With the Contractile Proteins
on Human Myocardium 809-2.403A
Unchanged Function and Density of
SR-Ca2+-Release Channels in the Failing
Human Myocardium Compared to Nonfailing
995-64.283A
What Is the Impact of Chronic Low Coronary Flow
Grades on Myocardial Viability? 1002-100.
295A
Myoglobin
Does STATReporting of Serial Serum Markers
(CK-MB and Myoglobin)Aid in Early
Detection and TreatmentDecisions for Acute
Myocardial Infarction? 738-6*186A
Early Combined Electrocardiographicand
Biochemical Risk Stratificationof Patients With
Unstable Coronary Artery Disease: A TRIM
Substudy 991-13.272A
Early NoninvasiveAssessment of Reperftrsionby
Myocardial Rotein Release Patterns 791-2.
381A
Myoglobinand Troparins for Noninvasive
Assessing of Coronary Reperfusion After
ThrombolyticTherapy 738-5.186A
Persistent MyoglobinElevationIs Associated With
Slower Flow in Patent Culprit Arteries
FollowingSuccessful Thmmbtdysis 946-21•
132A
Myosirr
Expression of Nonmuscle Myosin Heavy Chain-B
After Balloon Angioplaatyin Atherosclerotic
Yucat6nMicropigs 975-52.242A
Initiation of Transcriptionby the Atrial Myosin
Light Chain 2 promoter Requires the Presence
of the INR Cis Element 726-5.87A
Naturally-OccurringSilent Sequence
Polymorphisms in the Human p’Myosin Heavy
Chain Gene 1029-162.345A
Natriureticpeptides,atritd
A Comparison of Brain Natriuretic Peptide and
N-TerminalNatriuretic Peptide in tbe
Identificationof Left VentriculmDysfunction in
the Subacute Phase of Myocardial Infarction
1015-127*32OA
Biochemical Screeningfor Left Ventricular
Dysfunction 1OO9-134.3O9A
Brain NatritrreticPeptide ImprovesDiastolic
Function in the Normal and Failing Heart
908-171*25A
C-TypeNatriuretic Peptide Mediates cGMP
Generationand AntimitogenicActions in
Human Coronary VascularSmooth Muscle Cells
961-117.155A
Chronic HemodynamicEffects of Candoxatril: A
Multicenter Dose Ranging Study 727-2.169A
Control of Cardiac Hypertrnphyand Natrirrretic
Peptide Pmduceinnby EndogenousAngiotensin
II in Experimental Heart Failure 1074-119.
483A
Deleterious Actions of Dietary Sodium Restriction
Upon the Regression of Experimental
CongestiveHeart Failure 976-152.244A
Dendroaspis Natriurctic Peptide.(DNP) Is a Potent
Relaxing Agent in Isolated Canine Epicardial
Coronary Arteries 1OO7-171.3O5A
Design, Synthesis, and In VivoActions of a Novel
Chimeric Peptide to B-UPC (BNP) and C-Type
(CNP) Natriuretic Peptides 1074-1I8.483A
DifferentirdAtrial and VentricularExpression of
Myocardial Bmin-Natritrretic-PeptideDuring
ProgressiveExperimental Heart Failure
908-172.25A
DifferentialRegulation of Circulating Atrkd
Natriuretic Peptide and Brain Natriuretic
Peptide by EndogenousEndothelin During the
Progression of ExperimentalHeart Failure
908-169.25A
DifferentialRegulation of VentricularANPand BNP
Synthesis in Compensated and Overt Heart
Failure 908-168.25A
DifferentialRelease of the Cardiac Naeritrretic
Peptides in Asymptomaticand Symptomatic
Human Heart Failure 783-2.369A
Effects of Carperitide (a-Human Atrial Natriuretic
Peptide) Patients With Acute Heart Failure:
ComparativeStudy on ToleranceBetween
Carperhide and Nitroglycerin 996-75.286A
Evaluationof Plasma NatritrreticPeptides
(N-TerminalproANP,cANP(99-126),
proBNP(2246), BNP-32, CNP-22) as Markera
for Left VentricularDysfunction 930-176.
103A
Exercise Trainingat ConventionalWorkloadCan
NegativelyImpact on the Left Ventriclein Heart
Failure 1041-23.425A
ImmunocytokineModulationpredicts Adverse
Clinical Outcome in AdvancedHeart Failure
93O-158.1O1A
Increased Plasma Levels of Adrenomedullin in
Patients With Hypertrophic Cardiomyopathy
1062-76*462A
Inhibition of Nitric Oxide (NO), but Not Neutral
Endopeptidase (NEP) Augments CNP-Mediated
Coronary Relaxation in CHF 1007-170.305A
N-Terminal Roatrial Natritrretic Factor: Relation to
Long-TermPrognosis in Patients With
Idiopathic Heart Failure 1084-144.5O4A
Natriuretic Peptide Receptor Expression in the
Neoimima at the Site of Percutaneous
Transluminal CormraryAngioplasty 975-55.
242A
Plasma Atrial Natriuretic Peptidc and Brain
NatrirrreticPeptide Levels in Chronic Aortic
Regurgitation 108540.505A
Plasma BNP and N-Terminal ANPConcentrations in
Individuals With ECG Evidence of LVH: A
Population Based Study 965-77.161A
Plasma Levels of Adrenomedullin (AM) Correlate
With the Extent of pulmonary Hypertension in
patients With Mitral Stenosis (MS) 1085-41.
506A
Secretion of Brain Natriuretic Peptide in Cultured
Human Coronary Vascular Smooth Muscle
Cells: A New Autocrine and Paracrine Role for
the NaeriureticPeptide System 961-119.155A
The Endogenous NatrirrreticPeptide System
Modulates Diastolic Function in Experimental
Heart Failure 1083-117.5O1A
The Natriurctic Peptides as Diagnostic Markera of
Systolic Dysfmrction:Comparison Witb a
Simple Clinical Score 93O-178.1O3A
Urinary Excretion of Endothelin-1 in Patients With
Essential Hypertension 741-3.189A
VasodilatorEffects of Brain Natriuretic Peptide in
Coronary Conductance and Resistance Arteries
1052-134*444A
Nitratea/h’itroglycerin
A Long-Acting Nitric Oxide Donor Suppresses
Basal and LPS-Stimulated Tissue Factor
ProcoaguknrtActivity in Human
Monocytc-DerivedMacrophages 986-80.265A
A Randomized Trial for Treatment of Unstable
Angina in Patients With Restenosis
Postcoronary Angioplaaty 760-4*217A
Altered Endothelium Dependent Vasomotion After
Cardiac Transplantation: Correlation to Early
Myocardial Expression of Inducible and
Constihrtive Nitric Oxide Syntbaaes and
Endothelin in Humans 743-5.193A
Aspirin Inhibits L-NAME Induced Platelet
Deposition on an Arterial Medial Under Anerial
Flow Conditions 734-4*180A
Continuous Administration of Amirroguanidine
Inhibits Inducible Nitric Oxide Synthase and
Exerts Protective Effects in a Rabbit Model of
Ischemia and Reperfusion T76-5.360A
Decrease of Nitrate/Nitrite in Coronary Circulation
After Coronary Spasm 1096-8O.523A
Effects of Angiotensin Converting Enzyme
Inhibitors on Nitrate Tolerance During
Transdennal Application of Nitroglycerin
996-51.284A
Effects of Carperitide (a-Human Atrial Natriuretic
Peptide) Patients WitirAcute Heart Failure:
Comparative Study on Tolerance Between
Carperitide and Nitroglycerin 996-75.286A
Hypcrcholesterolemia Impairs Exercise Capacity:
Role of Nitric Oxide 406-4.2A
Induction of Cross-Tolerance to EDRFby
Nitroglycerin: Role of Intmcelltdw Levels of
Cyclic GMP 1OO7-169.3O5A
L-Arginine Attenuates the Impairment in Exercise
Capacity Due to Hypercholesterolemia 986-81.
265A
Noninvasive31PSpectroscopic Assessment of
Regional Myocardial Metabolism Postinfarction
800-5*394A
Prolonged Exposure of Canine Coronary Arteries to
a Nitric Oxide Donor Desensitizes Soluble
Guanylate Cyclase 95841.151A
Reduced Vasodilator Respmrses to Nitrnprusside or
Nitroglycerin After Diaspirin Crosslinked
K,W Abstract title, Session-abstract number. pagenumber
J February 1997 SUBJECT INDEX 647A
Hemoglobin (DCLHb’”)inOpen-Chestedswine
1OO7-175.3O6A
The PreventiveEffectof AscorbmeonNitrate
Tolmncein PatientsWith Congestive Heart
Failure 727-6.170A
TheVarmdilatorEffects of Cyclic GMP Do Not
Explain the Venoselectivityof Nitric Oxide
Donors in Humans 95945-152A
Weight Adjusted Amithmmbotic Regimens
Eliminate she Nitroglycerin-Antithmmbotic
Interaction 1034-53*412A
Norepinephrhre
ArrtioxidantsAttenuate Norepinephrine-Induced
Cardiac Sympathetic Nerve Dysfunction
1083-116*5OOA
Cardiac b2-Adrenergic Recepror Stimulation
918-101.41A
Comparison of Maximal Vs. Submaximal Exercise
prnt~ols: The Reproducibility of the
NerrrnhumoralResponse in Patients Witb Heart
Failrrrc 1098-158*527A
Consequences nf Coronary Occlusionon Changes in
Regional Interstitial Myoc~dial Neuropeptide Y
and NorepinephrhreConcentrations 990-31.
271A
Deleterious Actions of Dietary Sodium Restriction
Upon the Prngrcssion of Experimental
Congestive Heart Failure 976-152*244A
Differences Between Responses to Felodipine in
Heart Failure With and Without Comnw
Disease: V-HeFI III 996-70*285A
Direct Evidence of Impaired CrrrdiacSympathetic
Innervation in Essential Hypertension With Left
VentricularHypwtmphy 754~0208A
Hypnotic Sedation During PTCA: A Study by
Spacrral Analysis of Heart Rate Variability
1013-29*317A
Increaaedplasma Levels of Adrmromedrdlinin
Patients With HypermophicCardiomyopathy
1062-76*462A
Is Semtonin an Unexpected Cause of Arterial Graft
Spasm? DynarrsicVersus Static Evaluation of
Porcine Intemnl Thoracic Arteries 952-126*
141A
Lack of Endothelin-1 Rise May Contribute to
Tilt-Induced Syncope 1001-81.293A
Moxonidine Improves Heart Rate Variability in
Patients With Heart Failure 996-56*Z35A
Moxonidine, a Centrafly Acting Sympathetic
Inhibitor, Causes Sustained Reduction of Plasma
Norepinephrine in Heart Failure Patients 762-5
.220A
Nitric Oxide Reduces Norepinephrine Release in the
Heart During Sympathetic Stimulation in Dogs
1019-82*329A
Plasmn Adenoaine Levels Increase in Patients With
Congestive Henrt Failure 1084-138*5O3A
Reversal of D-Sotalol Effects on Excitable Gap
Composition in Canine Atrial Fhrtterby
Autonnmic Neurohorrnones 1019-79*329A
Selective Blunting in Endothelin-1 Release and
HemodynarnicResponse to Head-Up Tilt in
Heart Transplant Recipients 978-170*248A
Sympathetic Activity Resporraesto ANP in Human
Heart Fuihrrc 762-6.220A
The Hemndynemic and NerrmhumoralEffects of
Moxonidine, a Sympathetic Inhibitor, in
Congestive Heart Failure 727-5.170A
Nutrition
Aaanciatinnnf Plaama Hnmncysteine With
Extracranial Cnrntid Arterial Disease in Older
Peraons 997-63.288A
Grape Juice but Not Orange or Grapefruit Juice
$ignificnntlyInhibits In Vivo Platelet Activity
and Thrombnsia in $tenosed Canine Coronnry
Arteries 734-5*180A
High Plasma Homocysteine, in Patients With
Cnmnary Artery Disease, Can Be Reduced by
Folic Acid Supplementation 1077-64*488A
Higb-HomocysteineConcentration a Risk Factor for
Athemsclemtic Complications of End Stage
Rennl DiaenaeMay Be Normalized by High
Doses of Folic Acid 919-68.43A
Platelet InhibitoryEffect of Feeding Grape Juice but
Not Orange or Grapefruit Juice for Seven Dtrys
in Monkeys IOftf-156.303A
TbreeGlassesof Grapebut Not Orange or
Grapefruit Juice Inhibit Ex VivoPlatelet
Aggregationin Human Volunteers 767-3*226A
obesity
Determinants, Prcwdence,and Implications of Risk
Factor Clustering: Insights From rhe
FranringhmnStudy 767-5*227A
Obesity aa aRisk Factor for Transplant Coronary
Artery Disease: The IVUS Truth 999-154.
291A
Tumor Necrosis Factor- “Alpha”and Insulin
IncrcaseaPhrsminogenActivator Inhibitor-1
production in Adipocytes 919-59.42A
Oxygenconsumption
Body Compnsirionand Quality of Muscle in Chronic
Hearr Failure 1098-161.527A
Cachexia as IndependentPredictor of Survivrdin
Heart Failure 930-157. 101A
Cardiac VerarrsPeripheral Contributions to the
Age-AssociatedDecline in Aerobic Capacity
989-104*269A
Clinical Relevanceof ArteriaJOxygen Saturation
Instability to Detect Breathing Disorders in
Chronic Heart Failure 752-3.205A
Comparison of the Prognostic Vrdrteof MIBG
Uptake and Peak Exercise Oxygen Uptake in
Chronic Heart Failure 940-98.120A
DifferentialEffects on Peak Oxygen Consumption
and AnaerobicThreshold During High- Versus
Lnw-FrequencyExercise Training in patients
With Coronary Artery Disease 789-2.378A
HypercholesterolemiaImpairs Exercise Capacity:
Role of Nirric Oxide 4064.2A
Impaired %odilatory Capacity in rhe Working
SkelemlMuscle us a Determinantof Delayed
IncreaaedOxygenUptake During Exercise in
Chronic Heart Failure 1098-157.527A
ImprovedMeasurementnfMyocardial Venous
Blood Oxygen Level With Magnetic Resonance
Imaging 1023-105.336A
Intmanrtic Infusion of Oxygen in a Rabbit Model
1014-155*317A
L-Arginine Attenuates tbe Impairment in Exercise
Capacity Due to Hypercholesterolemia 986-81.
265A
Mechanne.nergeticEffects of EMD 57033 Under
Nornml and Acidotic Conditions in Isnlated,
Bleed Perfused Rabbit Hearts 809-1*402A
Oxygen ExtractionDuring Exercise Predicts the
Impmvementof Exercise Capacity After
Cardiac Rehabilitation for AcrrtcMyocardial
Infarction 989-107.269A
Oxygen Uptake Kinetics During Low-Intensity
Exercise Testing: Relevancefor Rate Adaptive
Pacemaker Programming 1045-114*432A
Predicting Mode of Death in AdvancedHeart
Failure: Performanceof a Model Designed to
Predict Survival in Patients Referred for
TranaphmtEvahratinn 977-155*245A
Prnpnsal for a Novel Minute Ventilation-BasedRate
Adaptive Pacing Algorithm 1045-1I3*432A
Relation of Maximal OxygenUptake to Left
VentricularFunction in Patients With Dilated
Cardiomyopathy 907-147*23A
Relationship Between Peak OxygenCnnsumptinn
and Right VentricrdnrEjection Frnctinn in Twn
Different, Matched, Case-Controlled Groups of
SevereCongestive Heart FailrrrsPatienta 736-5
l183A
Relationship Between the WafkTests and
Height,Weight,and Bndy Surface Area in
AdvancedHeart Failure 966-68*163A
Tbe.ExerciaeMinute Ventilationand Carbon
Dioxide Output Response to Treatment With
Captopril 1098-1630528A
Pacesnaker,artificial
A Randomized ProspectiveStudy of Dual Site Atrial
Pacing for the Preventionof AtrirrlFibrillation
732-4. 177A
Atrial ArrhythmiaDetection: Initial ExperienceWith
a SubcrrtnneousElectrode Army 957-174.
149A
Comparison of Right Atrial Activation Duting
Coronary Sinus Ostial Pacing With Dual Site
Right Arrial and Biatrial Pacing 981-141l253A
Continued Mortality and Morbidity Asmciated With
the Telectronics AccufrxAtria] J-Wire
Pacemaker Lead Following Recall: Implications
for Management of a Device Failure 717-2*
74A
Contrast VenographyIs a Safe and Effective
Approacb to Implantation of Pacemaker and
ICD Leads via the Axillary Vein 1089-129*
511A
Does Pacemaker Implantation Have a
Placebo-Effect? Results From the PIC Study
GrOUP7174* 74A
Dual Chanrb& Pacing Improves Long-Term Survival
in Elderly Prrtientsby Decreasing the Incidence
of Cardiac Death 935-72*112A
Eftlcacy and Safety of Coronary Sinus Ostial Pacing
for Suppression of Arrial Fibrillation 717-5*
74A --
Left A~kialTreexcitation” Is Not Useful in
Preventing the Induction of Atrial Fibrillation
From the High Right Atrium 1067-93.471A
Oxygen Uptake Kinetics During Low-Intensity
Exercise Testing: Relevance for Rare Adaptive
Pacemaker Programming 1045-114.432A
Predicting of Atrial Fibrillation Following
Pacemaker Implantation: Use of the
Electrophysiological Evaluation 981-138*
252A
Present Status of the AccrrfixLeads: Progression
Rates 717-1.73A
Proposal for a Novel Minnre Ventilation-Based Rate
Adaptive Pacing Algorithm 1045-I13*432A
Risk Factors for VenonsThrombosis in patients With
Permanent Tmnsvenous Pacemakers 1097-72.
525A
Safety of Transcutaneons Electrical Nerve
Simulation in PacemaJrerPatients 1089-132.
511A
The EquivalentCircuit of Pacing in the Limit as
Surface Area Goes to Zero: A Complex
Impcdence Plane Analysis 1089-133*512A
VentricularStimulation Threshold Variations During
Daily Life 1089-131.511A
Pacing
A New Left Atrial Pump Operating in Higb Heart
Rate: Atrial Contraction Favorably Induces
Early Opening of Mitrnl Vnlvein Tachycardirr
1OI4-156*318A
A prospective Randomized Trial of Bachmann’s
Bundle Pacing for the Prevention of Atrial
Fibrillation 717-3.74A
Atrial Pacing: What Effect on Cnrdiac Function?
935-73.112A
AVNode Ablation and Pacemaker Implantation
After Withdrawal of Effective Rate-Control
Medications for Chronic Atrial Fibrillation:
Effect on Qrrnfityof Life and Exercise
Performance 957-176.150A
Bachmann’s Bundle Permanent Pacing Shortens
Intra-Atrial Conduction Time: Will It Decrease
PnrnxysmalAtrial Fibrillation? 981-139.253A
Chronic Rapid Pacing Causes Sustained Atrird
Fibrillation and Over Expression of Cx43
Channel Prbtein in Dog Atria 957-177.150A
ContiriuedMortality and Morbidity Associated With
the Telectmnics Accufix AerialJ-Wire
PacemnkerLead Following Recall: Implication
for Management nf a Device Failure 717-2.
74A
Contribution nf Nitric Oxide Production to
VasomotorTone of Coronary Resistance Vessels
1096-78*523A
Do Pacemaker in Women Hinder the Interpretation
nf Routine Mammography? 1089-130.511A
Efficacyand Safety of Coronary Sinus Oatial Pacing
for Suppression of Aoial Fibrillation 717-5*
74A
Empiric VerarrsTested Antitachycardia Pacing:
Results Fmm a Prospective Study Including 200
Patients 720-3.78A
Failure of Multisite High-Frequency BrrratPacing to
TerrninarcLaboratory-InducedAcute Atrial
Fibrillation 1067-90.470A
KEY. Abstract title, Session-abstract number* pagenumber
648A SUBJECT INDEX JACC February 1997
Feasibility of Measuring tbe “Optimal
Atrioventricular Delay” 1045-111.432A
Fmrctinnal Mechanisms Underlying
Tacbymrdia-IndrrcedSustained Aedal
Fibrillation in a Chronic Dog Mndel 982-120.
254A
Heart Failure: Acute Hemcdynamic Improvement
Pruvided by Multisite BiventricuhwPacing
935-70.lllA
Importanceof tbe AVInterval During Dual Chamber
Pacing in Hypertrnphic Obstructive
Cardiomyopathy: Results From tbe PIC Study
Group 935-710111A
Is Pacing During Postinfarction Ventricular
TacbycardiaNecessary to Identify Optimal Sites
for Catheter Ablation? 786-1.374A
Long-TerrrrEffects of DDD Pacing on Hyp-ertrophy
and Left VentricularSystolic Function in
Hypertrophic Obstmctive Cardiomyopathy
796-2.388A
Minute VentilationDuring Submaximal Exercise:
Influenceon RespirrdoryDriven Rate Adaptive
Pacing 1045-112.432A
Novel Pacing Sites Interfere With Pacemaker
Diagnostics for AtrirdFibrillation Detection
957-173. 149A
Oxygen Uptake Kinetics During Low-Intensity
Exercise Testing: Relevance for Rate Adaptive
Pacemaker Progranrrning 1045-114*432A
Pacing in Hypertruphic Obstructive (PIC): A
Randomized Crossover Study 796-1.387A
PerrrranentBiventricular Pacing by aTransvenous
Appruacb 1045-11O.431A
Prediction of Atrial Fibrillation Following
Pacemaker Implrmtation:Use of the
Electrophysiological Evaluation 981-138*
252A
Present Status of tbe AccufixLeads: Progression
Rates 717-1.73A
Pmpusal for a Novel Minute Ventilation-BasedRate
Adaptive Pacing Algoritbm 1045-113*432A
Recovery of Surgically Induced Heart Blnck in
Congenital Heart Disease 774-2.357A
Regional Atrial Conduction Delays Varyfor Short
Coupled Prcmarurc Beats DuringSingle and
Dual Site Atrial Pacing 981-140*253A
Risk Factors for VenousThrombosis in Patients With
Permanent Transvenous Pacemakers 1097-72.
525A
Selective Activation of Endothelin-1 in the Left
Ventricle in Heart Failure 805-2.399A
Selective Reduction of Cardiac Pain Threshold in
Syndrome X 1058-4*454A
Thallium 201 Myucardial Perfusion in Patients With
Hypertrnphic Cardiomyopathy and DDD Pacing
796-3.388A
The Chrnnic Atrial Fibrillation Canine Model: A
New Approach to Increase Yield and Efficiency
1067-94*471A
The Equivalent Circuit of Pacing in the Linrit as
Surface Area Grresto Zero: A Complex
Impedence plane Analysis 1089-133.512A
TrwrsesopbagealEcbocardiographicEvaluation of
Leti Atrial Appendage Function During DDD
and VW Pacing 935-74o112A
VentricularStimulation Threshold VariationsDuring
Daily Life 1089-131.511A
Pathology
Absence of Severe Thickening of the Mitral Valve in
Mitral ValveProlapse Patients Wbo Die
Suddenly 1018-37*328A
Apnptosis in Cardiomyopatby 995-58.282A
Clinical and Pathological Characteristics of 161
Patients With Cardiac Tumors Diagnosed
During 1993-1994in Japan: A Multicenter
Study 967-59.166A
Co-Lucalizationof C-Reactive Protein and
Complement in Human Hearts During Acute
Myo-aardial Infarction 988-101.268A
Lon~-TerrnACEhrhibition Attenuates Cardiocyte
~poptosis in Dogs With Moderate Heart F~ihrre
770-2*230A
Morphological Correlates to the Clinical
Classification of Unstable Angina 798-1.390A
Natriuretic Peptide Receptor Expression in the
Neointima at the Site of Percutaneous
TransluminalCoronary Angioplasty 975-55.
242A
New Insights Into the Pathologyof Degenerative
Mitral ValveIncompetence:A
Histomo~hometric Study 1018-32.327A
PathologicalChanges at Site of Cornnary Stenting in
Humans 101I-5.312A
Peptides Correspmrdingto Both ffl and
Muscarinic-2ReceptorzInduced Hypertmphic
Cardiomyopathy in Rabbits 995-65.283A
Reappraisal of the Practice of Performing
SurveillanceEndomyncardialBiopies Atler
Heart Transphmtation:Decreaaed Utility for
Clinical Decision Making Over Time 1086-175
l507A
Serial Changes in Coronary Dimensions in Acute
Thrombosis in Humans: Plaque Rupture and
Erosion 760-2.216A
The Involvementof Apoptosis in a Varietyof
Diseases Which Cause Left Ventricular
Dystimction 1084-146.504A
The Participation of Fas/Fas Ligand System in
Apoptosis of Cardiomyucytes in Human Acute
Myccardial Infarction 990-37.272A
UnrecognizedExertionalHeat Illness as a Risk
Factor for Exercise-Related Sudden Cardiac
Death Among YoungAdults 1054-9.447A
Patient care
Comparison of Coronary Bypass Grafting in
Comparable DefinedGeographicPopulations in
CanadaLJnited States 101O-139.31OA
Comparison of Treatmentpatterns and Outcomes in
Heart Failure Patients Witb Systolic Versus
Diastolic Left VentricularDysfunction 710-6.
64A
ContemporaryPatterns of Practice and Outcomes in
CongestiveHeart Failure Patients Treated in a
Specialized Clinic 977-159.246A
Do Pacemakers in Women Hinder the Interpretation
of Routine Mammography? 1089-13O.511A
Early AmbulationAfter CormraryAngioplmty With
Six French Guiding Catheters and Low-Dose
Heparin 928-9.96A
MrdticenterTrial of Accurate Home Self-Testing in
Oral AnticoagulantPatients With a Novel Whole
Blnnd System 1097-73.525A
Omission of Routine ECG and CK-Monitoring
FollowingUncomplicatedCormrary
Angioplasty 993-7.278A
Optimized Oral Anticoagrrlationby Patient PT Self
MonitoringMarragement 1042-I19.426A
Over and Underuse of RevascularizationProcedures
in Italy 923-140.50A
Patient preference for Cardiac Catheterization via
the TrarrsradialVs. TransfemoralApprnach
1010-137.31fIA
Predictor of Not AdministeringTbmmbolytic
Tberapy to Eligible Patients With Acute
Myncardial Infarction 1032-41.35OA
Regional Variationin Myucardial Infarction Care:
The CooperativeCardiovascularProject
Experience 777-3.361A
Safety of TrarmcrrtaneonsElectrical Neme
Stimulation in Pacemaker Patients 1089.132.
511A
The Course and outcome of Pregnancy in Women
With Stenotic Lesions Due to Congenital Heart
Defects 1065-159.467A
Pediatric cardiac surgery
AugmentationAorric Valvuloplastyfor Aortic
Insufficiencyin Pediatric Patients 751-6.204A
Can We Predict Aortic InsufficiencyAfter the Ross
Prucedure? 932-69.106A
Comparison of Lateral Tunneland Extra-Cardiac
Conduits in Total CavopulmonaryConnections:
A Fluid Dynamics Study 751-2.203A
Course in the IntensiveCare Unit Atler Right
Verrtriculotomyand Neonatal Repair of
Congenital Hearl Disease 932-84.107A
Dues the Addition of Curvatureat the Totrd
CavopulmonaryConnection (TCPC) Site
Reduce Power Losses? 1043-59.427A
Echncardiographic Hemodynamic Predictors of
Survival After Two-VentricleRepair in Infants
With Critical Aordc Stenosis 751-3.203A
Heart Transplantation in ChikJren With Visceral
Heterotaxy and Complex Congenital Heart
Disease 932-65.105A
“Hypoplastic” Left Ventricle, or Simply a Squashed
Ventricle? 721-6.80A
ImpruvedOverall (Pre and Post) Cardiac Transplant
Survival in Infancy: Strategies to Regulate
pulmonary Resistance 932-64.105A
Ischemia and Infarction Contribute to Right
VentricularDysfunction Noted 10 to 20 Years
After the Mustard Operation for Transposition
of the Great Arteries 794-1.385A
Left Ventricuhv Dysfunction After Open Repair of
Simple Def=ts in Infants arrdChildren:
QrrantitationWith a Conductance Catheter After
Bypass 1C43-63.428A
NG.Monome~yl-L-~ginine (L-NMMA) Improves
Left VentricularSystolic Function Late After
Cardiopulmonary Bypaas in Neonatal Pigs
929-163.99A
Outcome of LateraJ‘l)nrnelFontan Fenestration
932-89.108A
Outcome of Patients With Pulmonary Atresia and
VentricularSeptal Defect After Neonatal
Surgery 932-85.107A
Perioperative Conduction and Rhytbm Disturbances
Following the Ross Prucedure in Children and
YoungAdults 1065-178.468A
Prolonged Depolarization and Inhomogeneous
Repdtrization Increase Late Sudden Death Risk
in Postoperative Tetmlogy of Fallot 722-3.81A
Recovery of Surgically Induced Heart Blnck in
Congenital Heart Disease 774-2.357A
Respiratory Syncytial Virus in Congenital Heart
Disease 911-155.29A
Sbould Dobutarnine Stress Echncardiography
Replace Coronary Arteriography for Assessment
of Coronary Artery Disease Atier Heart
Transplantation in Children? 721-2.79A
Sinus Nnde Dysfunction Following Mndified Fontan
Operzrion (TotalCavo-PulmorraryConnection)
954-146.146A
The Fate of the Neo+ulmorrary Valve After the
Arterial Switch Operation in Neonates 751-4.
204A
The Fontan Prucedrrrein Adults: Early and Late
Results 1065-157.467A
Pediatric cardiology
A New Noninvasive Method to Determine
Combined Systolic and Diastolic Ventricular
Function: Evaluation in Normal Children and
Dilated Cardiomyopathy 1087-168.5O8A
Abnormal Histology of the Pulmonary Vaaculahrrc
in Neonates With Pulmonary Atresii and
VentricularSeptal Defect 1065-155.467A
An Analysis of the Outcome of Umbrella Closure of
Patent Ductus Arteriosus in Cbildrerr 954-137.
1444
ASD and PFO Closure in Adults With the Second
Generation ASDOS Device 954-136.143A
“AtrioventricularGrcove” Tachycardias in Small
Children: Clinical Characteristics and Treatment
Strategies 954-147.146A
Determinants of Midwall Fractional Shortening in
Healthy, NorrnotensiveYoutb With Family
History of Hypertension 965-82.162A
Developmental Changes in Myocardial Glucose
Metabolism in Nonbuman Primates Using
Positrnn Emission Tomography 1CS32-103.
295A
Diagnostic Accuracy of Pediatric Echncardiogmrns
Performed in Adult Laboratories 721-1.79A
Dries the Addition of Curvature at the Total
CavopulmorraryConnection (TCPC) Site
Reduce Power Losses? 1043-59.427A
Duration of Pulmonary VenousAerialReversal and
Mival a-wave Can Predict Elevated End
Diastolic Pressure in Children 1087-I69.5O8A
Echncardiographic Determinants of Successful
Deployment of the Dasw Angel Wings”’Atrial
SeptrdDefect (ASD) Closnre Device 916-77.
36A
KEX. Abstract title, Session-abstract number. page number
JACC Febmary 1997 SUBJECT INDEX 649A
EchocardiographicRight VentricularVolumesUsing
a Crescentic, Difference-of-EllipsoidsModel
1048-175*437A
Effect of Prenatal Diagnosis of Critical Left Heart
Obstruction on Perinatal Morbidity and
Mortality 932-83*106A
Efficiencyof Metabolic Screening in Childhood
Cardiomyopathies 911-160*30A
Follow-Up Results of the Mukiinstitutional Phase I
FDA Supervised Clinical Trials of Transcatheter
Occlusion of Atrial Septal Defects With
Buttoned Device 954-135.143A
Force-Frequencyand Relaxation-Frequency
Relationships in Hypertrophied Hearts of
Children 1062-8O.463A
Heart Transplantation in Children With Viscerrd
Heterotaxy and Complex Congenital Heart
Disease 932-6501O5A
“Hypoplaatic”Left Ventricle,or Simply a Squashed
Ventricle? 721-6.80A
Inhibition of Glycolysis Impairs Ventricular
Relaxation but Not Peak Systolic Pressure in
Neonatal Pig Hearts 1043-64*428A
hrterrnediate-TemrFollow-Up Fluid Therapy in
Patients With VasndepressorSyncope 774-5*
358A
Long-TemrResults of Severe Pulmonic Stenosis
With Initial Gradient >150 mm Hg Treatedhy
Balloon Valvuloplmty 954-142.145A
Low-Temperatureand Low-Energy Radiofrequency
Modificationof Atrioventricular Node Slow
Pathway in Pediatric Patients 774-3.357A
Magnetic Resonance Imaging for the Assessment of
Intracardiac Baflles and Extracardiac Conduits
in Congenital Heart Surgery 932-87.107A
Mortality in Potential Arterial Switch Candidates
With d-Transposition of the Great Arteries
932-68*106A
Myocardial Perfusion Long-TermAfter
CormrampathySecondary to Kawasaki Disease
911-157.29A
Outcome Afier Transcatbeter WdvOtOmy’for
Pulmonary ValveAtresia and Intact Septum in
Neonates and Infants 729-60173A
Pacemaker Implantation in Children With
Hypemophic Cardiomyopathy: Indications and
Intermediate Follow-Up 774-6.358A
Polymerase Chain Reactinn - Pnsirive Viral Genome
and Rejection Following Pediarnc Heatt
Tmnsplantation 911-159.29A
Predictive Valueof Serum Cardiac Troponin T
(cTnT) in Pediatric Patienta at Risk for
Myocardial Injury 1043-68*429A
Predictors of Left VentricularGeometry in
Normotensive YouthWith Family Histories of
Essential Hypertension 965-101*163A
Race and Sex Differences in the Genetic Regulation
of Adolescent Blocd Pressure: The MCV Twin
Study 1077-68*488A
Reopening After Successful Coil Occlusion for
Patent Ductns Amteriosus 7294.172A
Respiratory Syncytial Virus in Congenital Heart
Disease 911-155.29A
Rnle of the Transesophageal Echocardiographyin
the Management of the Patients With Congenital
Heart Disease 916-78.36A
Should DobutarnineStress Echocardiography
Replace Coronary Atteriography for Assessment
of Coronary Artery Disease After Heart
Tranaplantationin Children? 721-2.79A
Stent Reconstruction of Occluded/Obstructed
Iliofemoral Veins and Inferior Vena Cavato
Reestablish Access for Future Cardiac
Catheterization and Cardiac Surgery 729-1*
171A
The African Origin of the Common Mutation in
African American Patients With Glycogen
Storage Disease~ II (GSD II) 726-6.87A
The Clinical Utility of Automatic Border Detection
in the Assessment of Myocardial Ischemia in
Pediatric Patients During DobutamineStress
Testing 1087-166-5O8A
Tilt Test Hemedynamics in Tilt Positive and Tih
Negative Children: A Comparative Study
1066-83*468A
Time and Frequency-DomainChanges of
Signrd-AveragedECGSof Children Following
TreatmentWith Anthracyclines 912-15.31A
Transbakmn IntravascularUltmsound During
Balloon Dilation of PulmonaryArtery Stenoses
and Aortic Coarctation 954-144. 145A
TmnscatheterOcclusion of Patent Ductus Artwiosus
and Aorto-PulmonmyCollaterals Using the
Giantnmo-GritlmVascularOcclusion Device
729-3.172A
Tmnscatheter Occlusion of the Arterial Duct:
Comparisonof the Results Using the Rashkind
Umbrella and Different~pea of Occlusion
Coils in 1,306Procedures From a Eumpemr
Registry 729-5.172A
TransthracicThme-DimensionrdEchocardiogmphy:
TherapeuticDecision Making Process of
Subarterial VentricularSeptal Defect 1087-171
.5(I9A
Validationof the ConductanceCatheter in the Right
Verrtdclein Hyp-explasticLeft Heart Syndrome
1043-6O*428A
Why Ones the Aorta Dilate in Marfan Patients?
1065-16O.468A
Peptides
Adrenomedrd]inin the Evolutionof Experimental
Heart Failure 805-3.399A
Brain Narnuretic Peptide Is a Marker of New York
Heart Association Classification in Out-Patient
Follow-Upof Left VentricularDysfunction
93O-177*1O3A
C-TypeNatriuretic Peptide Mediates cGMP
Generationand AntimitogenicActions in
Human Coronary VascularSmonthMuscle Cells
961-117.155A
Consequencesof Coronary Occlusion on Changes in
Regional Interstitial MyocardialNeumpeptide Y
and NorepinepbrineConcentmtinns 990-31l
271A
DifferentialRegulation of Circulating Atrial
Natriuretic Peptide and Brain Natriuretic
Pepti& by EndogenousEndothelinDuring the
Progression of ExperimentalHeart Failure
908-169025A
DifferentialRelease of the Cardiac Natriurctic
Peptides in Asymptomaticand Symptomatic
Human Hemt Failure 783-2.369A
Effect of Chronic Bradykinin Infusion and Chronic
Bradykinin-ReceptnrBlockade on Cardiac
Hypertmphy in AngiotensinII-TreatedRats
103O-48.347A
Secretion of Brain Natriuretic Peptide in Cultured
Human Coronary VascularSmnnth Muscle
Cells: A New Autocrine and Paracrine Role for
the Natriuretic Peptide System 961-119.155A
Perfcarditis
Enhanced Delineationof Pericardial Diseases by
Three-DimensionalEchoeardiography 907-163
.23A
Magnetic Resonance Imaging With Tagging in
Constmctive Pericarditis 907-164.24A
Recurrent Pericarditis and Colchicine: Ten Yearsof
Experience 907-166.24A
Pericardium
Adenoviral-MediatedGene Therapy Induces
Sustained hruapericardial VaacularEndothelial
Growth Factor Expression in Dogs: Effect on
MyncardialAngiogenesis 941-148.123A
Calcific Constrictive Pericarditis: A Passe
Phenomenon? 907-165*24A
Enhanced Delineationof Pericardial Diseases by
Three-DimensionalEchoeardiography 907-163
.23A
The Pericardium as a Repository for an Angiogenic
GmwehFactor: Effect of IntmpericardialBasic
Fibmblast Growth Factnr on Myocardial
Collateral Development 961-116.154A
Peripheral vaacrdature
AntiphospholipidAntibodies in PatientaWith
Peripheral VaacularDiseaae 761-2.218A
Arterial Sealing Device After Coronary Stenting:
Sewingor Anchoring? 108O-17O494A
Asseasmentof Long-TenrrRisk FollowingVaacular
Surgery: Developmentand Validationofa
Prognostic Scoring System in a Cohort of 1,048
Patients 1057-7.451A
Comparison of the Palmaz Stent and WaOStent
Reconstruction of CriticaJ Subclavian Artery
Stenosis 1075-138.485A
Effect of Ciloseazolon Plasma Lipoproteins in
Patients With Intermittent Claudication 725.3.
85A
Effect of Simvastatirron Ischemic Signs and
Symptoms in the Scandinavian Survival Study
718-1.75A
Effects of Acute Angioterrsin-ConvertirrgEnzyme
Inhibition on Peripheral Vasodilator Responses
to Bradykinin and Acetylcholine in Healthy
Subjects and Patients With Coronary Artery
Disease 706-1.58A
EndohrminalBypass Grafting in Leg Arteries With
the Cragg Endopm System 1: A Series of 142
Patients 108O-37.496A
EndovascularTreatment of Atherosclerotic Stenosis
oftbe IntemrdCarotid 763-5.221A
Episodic Pulmonary Edema (CHF) in Association
With Global Renal Ischemia Fmm Renal Artery
Stenosis (RAS): Successful Treatment by Renrd
Artery Stenting (PTRA) 1075-14I.486A
Evidence of Ventricularivascula Uncoupling in
Solid Organ Tmnsplant Recipients With
Hypertension 708-2061A
Lack of Assoeiationof the Angiotensin Converting
Enzyme DD Genntype With Peripheral Vascular
Disease 943-138.127A
Percutaneous Carotid Inter-fentionin Patients With
Symptomatic Coronary Artery Disease 778-3.
363A
Percutaneous HydrodynamicThrombeceomyWith
the Use of the Hydroylser System 1008-165.
308A
PicoearnideReduces Cardiovascular Eventa in
Claudicant Patients With Hypercholestemlemia:
An “a Priori” Planned Subgroup Analysis of the
ADEP Trial 987-115.266A
Preserved Endothelium Dependent Vasodilatatinnof
Peripheral Circulation in Patients Wirh Variant
Angina 962-115. 157A
primary Endoluminal Stenting for the Treatment of
Complex Iliac Artery Lesions 1075-1I7.485A
Prognostic Criteria fnr Ultrasound-Guided
Compression of Femoral Arterial False
Aneurysm: A Score Scale 1OO8-163*3O7A
Progrcssioh of Unilateral Renal Artery Stenosis Is
Associated With Deterioration in Renal
Function 987-92.266A
Racial Differences in Occult Athemsclemsis in a
High-Risk Population 813-3*407A
Reconstruction of Long Tntal Superficial Femoral
Artery Occlusions Using Multiple Wall Stents
1075-136*485A
Renal Artery Stent Placement: Clinical Utility in the
Treatment of Renal Artery Stenosis 1053-13.
446A
Retrograde Popliteal Stenting of Chronic Totrd
Occlusions in Failed Antegrade Angioplasty:
Demonstration of Improved Primary Success
and Limited Long-TermBenefit 1075-137.
4S5A
Steneingof Chmnicrdly Occluded Supeficird
Femoral Arteries Using Palmaz Bilimy Stents
Significantly Impmves Long-Term Patency
1075-135.485A
The Effect of Remodeling on Distensibility in
Atherosclerotic FemcmdArteries: A Postmortem
IntravascularUltrasound St,udy 733-1.177A
The Severity of Coronary Artery Disease Is More
Closely Correlated With Peripheral Artery
Occlusive Diseaae Thaq With Cerebmvascular
Athemsclemsis 94445.127A
The VaandilatorEffecta of Cyclic GMPDn Not
Explain the Venoselectivityof Nitric Oxide
Donors in Humans 95945.152A
KEX-Abstract title, Session-abstractnumber* page number
6 SUBJECT INDEX JACC Febmary 199’?
Pharrnacokbretics
LyticActivityWithAcceleratedt-PAAssessed at
Bedside During ThrombolyticTherapy for
Acute Myocardial Infarction 1034-54*412A
Massive Fluid Accumulation Does Not Affect the
Pharmacokirredcsof the Loop Diuretics
Furosemide and Torsemide in Patients With
Heart Failure 783-6.370A
Pharrnacodynamicsof Basic Fibroblast Growth
Factor: Effect of Route of Administration on
Regional Distribution 959-46.152A
Pharruacokirretic,Blood Pressure, and Renal Effects
of Cyclosporine SandimmmreVersus Neoral
Formulation in Heart Transplant Recipients
1086-I78*5O7A
The (R)- and (S)-Enaatiomers of Beta-Blnckers Are
Different Drugs 1027-173.343A
Pharmacology
A Sulfonylurea Aggravates Ca2+ Loading in
Metabolically Compromised Cardiomyncytes
990-32*271A
Abnormal Cardiac Fibroblasts Unmasked by
Vesnarinone:A Possible Contributor to Heart
FaikrreinAordc Regurgitation 1085-380505A
Antiplatelet Efficacyof Orafly Administered
DMP802, a GPIIb/IIIa Receptor Antagonist, in
the Conscious Dog 712-2.67A
Cardiac b2-Adrenergic Receptor Stimulation
918-101l41A
Changes in Coronary Blood Flow in Relation to
Changes in Hemndynamic Parameters During
Beta Blockade in Patients With Aortic Valve
Stenosis 950-157*137A
Characterization of 3H-Dnfetilide Binding in Human
Wbite Blood Cells: Influenceof Class 111
AntiamhythmicDrugs 109O-88.513A
Doppler Derived Cardiac Output by Stress
EchocardiographyPredicts Multivessel
Coronary Artery Disease 984-6.259A
Dual Inhibitory and Stimulator Effects of the Class
111Antiarrhyt!rmicAgent Bertosamil on
Voltage-ActivatedK+ Current of Human Atrial
Myocytes 109O-87.513A
Electrophysiologic and AntifibrillatoryEffects of
Amiodarone and Desethylamiodarmre 914-132
l34A
Elevation of an Endogenous Inhibitor of Nitric
Oxide Synthesis in Experimental Congestive
Heart Failure 104O-26.422A
Ergotamine Limits Hyperemic Myocardial Blood
Flow in Humans”7064* 58A
Hemodynamic Effects of a 24-Hour Infusion of
B-TypeNatriuretic Peptide (Natrecor@)in
Patients With Decompensated Heart Failure
996-74.286A
Incidence of Conduction Disturbances Complicating
Acute Myocardial Infarction With Amiodarone
at Moderate aad High Doses (Observations
From GEMICA STUDY) 1028-171*345A
Increased TachykirrinsSubstance P and Nearokinin
a, Not Bradykinin, Cause the ACE-hrhibitor
Induced Cough 918-98.41A
Is It Safe to Prescribe Aspirin to Patients on
ACE-Inhibitors? 783-5*370A
Isradipine Imprnves Endothelium-Mediated
Vasodilation in Patients With Hyperlipidemia
Independentof Changes in Cholesterol 920-95*
45A
Italian Multicenter Study of Nicorandil: Safety and
Efficacyof ‘Rvo-DoseRegimens in Stable
Angina Pectoris Patients 755-3.209A
Lnng-TernrCilazapril Therapy Limits Left
VentricularDiastolic Dysfunction With
Depressed Systolic Function in Myocardial
Infarcted Rats 958-44.151A
Lnnp Diuretics Enbanced Secretion of Prostacyclin
In Vitro and in Patients With Heart Failure
959-47.152A
Myocardial Prnstaglandin Receptors (EP3 Subtype)
Inhibit the Inotropic Effect of f?-Adrerrergic
Stimulation 941-140.122A
N-Methyl-l-Deosxynojirimycin, an a-Glucosidase
Inhibitor Reduces Markedly Infarct Size in
Rabbit Hearts 988-94.266A
Nitric Oxide Opens the Second Windowof
Cardioprotectionof Ischemic Preconditioning:
Role of Inductionof Heat Shock Protein
(HSP72) 901-35.12A
Safety of IntracornrraryAdministrationof C-myc
Antisense After FTCA 1013-3O.317A
Single-Dose IntramuscularAdministrationof
Extended-ReleaseAngiopeptirrReduces
In-Stent Restenosis 975-51.242A
Tbe (R)- and (S).Enantiomers of Beta-Blockers Are
DifferentDrugs 1027-173.343A
The NA+-Channel-ModulatorsBDF9148 aad DPI
201-106Exert Positive Inotrnpic Effect Without
Direct Interaction With the Contractile Proteins
on Human Myocardium 809-2.403A
The VascdilatorEffects of Cyclic GMPDo Not
Explain tbe Venoselectivityof Nitric Oxide
Donors in Humans 959-45. 152A
Phosphodies&rase inhibitors
EnoximoneEchncardiograpbyfor Identificationof
Viable Myocardiumin Patients With Ischemic
VentricularDysfunction:Comparison With
DobutamineEchocardiographyand Positron
Emission Tomography 917-72.39A
Physiology
Action Potential Voltage-ClumpReveals Important
Contributionof Ca2+ Current to
Rate-DependentChanges in Human Ventricular
Action Potentials 811-3*405A
Evidencefnr Ca2+-ActivatedTransient outward
Chloride Currents in VentricularCells Frnm
Human Hearts 109O-84*512A
Forearm VascularRespnnses During Dynamic Leg
Exercise in Patients With Chronic Heart Failure
1041-19.424A
Fractional VelocityReserve: A New Indexfor
Stenosis Severity Assessment With Good
Correlation to Fractional Flow Reserve 942-154
l 126A
ImprovedMeazrrrementof MyncardialVenous
Blond Oxygen LevelWith Magnetic Resonance
Imaging 1023-105.336A
Large Artery Stiffness and Beta Adrenergic
Relaxation in Aged Rats 951-133. 140A
Matrix MetalloprnteinaseObsemations in the Canine
Atrium and VentricleDuring Rapid Ventricular
Pacing 976-151.244A
Multiple TriggeringMechanisms of Vasovagal
Syncopc: AParient-CorrrrolledSordy 1061-101
.460A
ProlongedAdenosine ExposureElicits “Adrenergic
Stunning”in Normal Hearts via a Protein Kinase
C-DependentMechanism 929-164.99A
Regional Myncardial Wall Stress by
TransesopbagealEchocardiographyaad Finite
Element Analysis 1OO3-119.298A
The Inwmd Rectifier Contributes4-Aminopyridine
Resistant Transient Outward Current During the
Canine VentricularAction Potential 109O-9O*
513A
TransesophagealDoppler Evaluationof Prnximal
Coronary Flow: Reference Normal Valuesand
Pbysio18gicalCorrelations 779-4.364A
Plaque
A Mobile Component of the Aortic Plaque as a
Major Risk Factor for Systemic Embolism in the
Elderly 99740 .2$J7A
AngioscopicPredictors of Restenosis in Stemed
Coronary Vessels 719-2.77A
Balloon Dilation Prnmotes IrrrirnalProliferations at
NonstenoticCoronary Segments Adjacent tn
Stenotic Lesions: Serial Observationby
hrrravascrdarUltrasound 906-63.21A
Combined Alpha v Beta 3 and Platelet IRr/JIIa
IntegrinBlockade Potently Limits Neointimal
Hyperplasiaand Lumen Stenosis in the Porcine
Cornnary Injury Model 7014* 51A
Comparison of Lesion MorphologyProducing
Non-Q WaveMyocardial Infarction and
Unstable Angina 924-35*90A
Compensatory Enlargementof Cornna~ Arteries
After Directional Coronary Atherectomy 733-3
. 178A
Difference of Histopathological Findings in Stable
Angina and Acute Coronary Syndrnmes 924-31
l89A
Evahrationof CormmryVessel Wall Compliance by
Intravascular Ultrasound: Importance of Plaque
Distribution in Determining Regional
Distensibility 90644.20A
Fatal Postoperative Myocardial hrfamtion Is Often
Caused by Coronary Plaque RupNm 702-6.
53A
Gender and Hormonal Etlccts on Plaqrre
Composition and Burden as Assessed by
IntracoronaryUltrasound and
Three-Dimensional Reconstmction 906-60.
20A
“LAD-LCX Angle” as a predictor of LCX
Narrowing by Stenting orDCA for LAD Ostird
Lesions (OL) 904-30. 16A
Local Application of Paclitaxel With tbe Double
Balkxm Catheter in the Rabbit Carotid Ariery
1038-76.419A
Longitudinal Redistribution of Plaque Is an
Important Mechanism for Lumen Expansion in
Stenting 994-48.281A
Randomized Trial of Directional Cormrary
Atherectomy Vs. Balloon Angioplasty for
Chronic Total Occlusions 106O-152.459A
Risk Factors for Angiographic Extent of Cormrary
Disease 1058-6.454A
Serial Changes in Coronary Dimensions in Acute
Thrombosis in Humans: Plaque Rupture and
Erosion 760-2.216A
Thmmbogenic Potential of Human Coronary
Atherosclerotic Plaques 798-2.390A
Plasrninogenactivators
Attenuated Success Rate of Thmmbolysis for Acute
Myncardial Infarction by Reduced Endogenous
Fibrirrolysis 962-91.156A
Cardioprotective Effect of Alcohol: Increased
Surface-Localized FibrirrolyticActivity irt
Cultured Human Endothelial Cells 919-67.43A
Effects of Homrone Therapy on Fibrinolytic
Potential in Postmenopausal Women 919-65.
42A
ImprovedFibrinolytic profile by Estrogen in
Postmenopausal Women: Endothelium Versus
Liver 785-1.372A
Increased Expression of Plazminogen Activator
Inhibitor Type 1 (PAI-1)Predisposesto
Atherosclerosis in Corpulent, Insulin Resistant
(JCR:LA-CP) Rats That Mimic Derangements
in Type 11Diabetes 769-2.229A
Serial Hemostatic Factor Measurements in Coronary
Interventions for Stable Versus Unstable Angina
902-1l12A
Synergistic Augmentation of Expression of
Plasminogen Activator Inhibitor~pe I (PAI-1)
in Human Hepatoma (HepG2) Cells by Insulin
and Fatty Acids 964-83. 159A
The Augmentation of Endothelial Cell Expression of
Plasminogen Activator InhibitorType 1PA-1 by
Insulin Is Mediated by a Factor Released by
VascularSmooth Muscle Cells 919-64.42A
Urokinase Plasminogen Activator Expression After
Balloon Injury Is Associated With Adventitial
Cell Migration and Angiogenesisof the Vasa
Vasorum 790-6.380A
Platelet inhibitors
Abciximab (c7E3 Fab, ReoPro’”)With Reduced
Heparin Dosing During Coronary Intervention:
Final Results of the EPILOG Trial 739-6.187A
Abciximab (c7E3) and Angiographic Restenosis
After Coronary Stent Placement 1082-8.499A
Abciximab Decreases Botb the Incidence aod
Magnitude ofCrcatine Kinase Elevation During
Rotational Atherectomy 1082-7.499A
Addition of a Platelet Glycoprotein IIb/JIIa Inhibitor
to Heparin+Aspirin Decreases Ex Vivo
Thrombus Formation After Percutaneous
Coronary Intervention 974-83*240A
An Antiplatelet Drug, Ticlopidine, Inhibits
Heparin-IndrrcedThmmbocytopenia (HIT)
Responses as Measured by Platelet
Aggregometryand 14CSerntonin Release
712-1.66A
KEY Abstract title, Sessimr-abstractnumber. page number
JACC February 1997 SUBJECT INDEX 651A
Analysis and Comparison of Platelet Aggregation
Wifb High-Speed Rotational Atherectomy
739-2o186A
Analysis of Hospital Costs and Outcomes in
RESTORE 801-3*395A
AntiplrdeletEfficacyof Orally Administered
DMP802, a GPIIb/IIIa Receptor Antagonist, in
the Conscious Dog 712-2.67A
Benefits of Abciximab Accrue in the Full Spectrum
of Coronary Intkx’ventionulPatients: Insights
From the EPILOGTrial 993-10276A
Biodegradable Stent Coating With Polylactic Acid,
Hinrdin, and Prnstacylin Reduces Restenosis
973-61l238A
Bleeding With Coronary Artery Bypass Surgery
(CABG) in Patients Treated With a Platelet
Glycoprotein IIbAIIaInhibitor 952-128.141A
Captopril Reduces Tbrombus Formation in Early
Posonyocardial Infarction Stage 712-4.67A
Clinical and Angiographic Follow-Up of Stenting
Without Anti-Coagulation: The Ticlopidine
Aspirin Stent Evaluation (TASTE)Sfndy
927-23.95A
Clinical and Angiographic Outcome of
IntracororrmyStent Placement in Acute
Myocardial Infarction 903-IO*MA
Combined AntiplateketPretreatment With Aspirin
and TiclopidirreReduces In-Hosphal Cardiac
Events Following Elective Coronary
Angioplasty 928-17.98A
Combined Antiplatelet Therapy Without
AnticoagrdationAfter Stem Implantation: The
Ticlopidine Aspirin Stent Evrduation(TASTE)
Study 927-22.95A
Combining I1b/Ila Inhibition and Heparin for Acute
Coronmy Syndromes: Evidence of a Gradient
for Bleeding Hazard From the PARAGON
Randomized Factorially Designed Trial
1033-38*410A
Decreased Neointimal Proliferation by Inhibition of
VonWillebrand Factor Function 701-5.52A
Delaying arrdPreventing Ischemic Events in Patients
With Acute Cormrary Syndrumes Using the
Platelet Glycopmtein IIb/IIa Inhibitor Lanrifiban
1033-31.4(I9A
Economic Assessment of Platelet Glycoprorein
IIb/IIIa Receptor Blnckade During Corrnracy
Intervention in the EPILOG Trial 974-84*240A
Effectivenessof Aspirin Alone Compared With a
Combination of Ticlopine and Aspirin for the
Prevention of Subacute Stent Thrombosis After
Successful Optimized Stent Implantation 927-6
.94A
Effects of Picotamide, an Antiplafelet Drug, on
Urinary Thrnmboxane/PrustacyclinMetabolizes
and Blind Prcssrrrein Hypertensive Patients
Treated With an ACE-Inhibitor 1076-61.487A
Factors Influencing the Extent and Severity of
Tmrrsientperfusion Defects Induced by
Rotational Atherectomy 1081-2.498A
Grape Juice but Not Orange or Grapefmit Juice
Significantly Inhibits In Vivo Platelet Activity
and Tbrombusis in Stenosed Canine Cormrary
Arteries 734-5.180A
Impact of Cilostazol on IrrtimalProliferation
Following Directional Coronary Atherectomy:
A Prospective Randomized Trial 803-1.397A
Implementationof AHCPR Guidelines for Unstable
Angina in 1996:Unfonmrate Differences
Between MenandWomen.ResultsFromthe
MuMcenterGUARANTEERegistry76O-5O
217A
IncidenceandClinicalOutcomeof AbcrrptVessel
ClosureAmongpatientsReceivingAbciximab
DuringHigh-RiskPermtrrneousCoronary
Intervention:EPICTrialResults 801-I0394A
IncidenceofNerrtroperrirt/FatalThrombucytopenia
AssociatedWithOneMonthof Ticlopidine
TherapyPostcorrararyStcnting771-2.353A
IntmnasalAntiplatelet/AntitbromboticEfficacyof
thePlateletGPIIb/JIIaAntagonist,DMP754
960-1120154A
Is There a Differential Benefit nf ReoPro During
PTCA for Patients With Certain Lesion ‘l@x?
801-2*395A
LucalAdministrationofL-703,801Witha
CompositePolymerStentReducesPlatelet
Depositionin Canine Coronary Arteries
1038-71.418A
LocaJIntramural Delive~ of MK-0383,a Platelet
GPHb/JIIaReceptor Blocker,Reduces Platelet
Deposition at the Site of Arterial Injury 739-4.
187A
Low-Shear Platelet Adhesion Is Inhibitcdby GP
IIb/JIIaAmagonist DMP-728 712-3.67A
Modulationof Platelet Neutrophil Interaction With
PhrmnacnlogicalInhibitionof Fibrinogen
Binding to Platelet GPIIb/HIaRcccptor
960-111*154A
MonitoringPlatelet GPIRr/JIla-FibrinInteraction
With Tissue Factor-Activated
Thromboelastography 959-48. 1S2A
MultilinkT”Stenting, a ‘Minimalist’ApproachUsing
Aspirin Alone: No Ticlopidine,No Coumadin,
No IVUS, and No QCA 927-21.95A
PicoramideReduces CardiovascularEventain
Claudicant Patients Widr Hypercholesternlemia:
An “apriori”PlannedSubgroupAnalysisofthe
ADEPTrial 987-115.266A
Platelet Aggregationand FibrinogenBinding in
Patients Treated With Integrelinand Abciximab
During Coronary Arrgioplasty 974-88.241A
Platelet InhibitionWith Oral Antagonists to
Thromboxane,Serotonirr,and ADP Reduces
Neoimimal proliferation in a
HypercbolesternlemicCanine Comrrary
AngiophwtyModel 701-3.51A
Platelet hrhibitoty Effect of Feeding Grape Juice but
Not Orange or Grapefruit Juice for Seven Days
in Monkeys 1OO6-156.3O3A
preventionof Reocclusion After Successful Balloon
PTCAof Totally OccludedCoronary Arteries: A
ProspectiveRandomizedPilot-Study Comparing
Ticlopidine-AspirirrAssociation With Aspirin
Alune 801-5.395A
Reducing the Risk of Percutaneous Intervention
After Coronary Bypass Surgery:Beneficial
Effects of AbciximabTreatment 739-5. 187A
Reduction in Thrombogenicityof Cellrdose
Potymer-CoatedStents by Immobilizationof
Platelet-TargetedUmkirrase 7714.353A
Reduction of Recurrent Ischemia With Abciximab
During ContinuousECG-Ischemia Monitoring
in Patients With Unstable Angina Refractory to
StarrdacdTreatment (CAPTURE) 781-3.367A
Relationship of Outcomes to Treatment With
Lamifibanin Patients UndergoingfTCA:
Analysis of PARAGONA 1033-34.4O9A
TargetingPatients for ThrombusInhibition After
Angioplasty:Clinical and Economic
Implications 1082-9.5OOA
The AntibndyFragment c7E3 (ReoPro’”)Binds to
Activatedand NonactivatedMac-1 on Granulo-
and Monucytesand Blocks Mac-l-Mediated
Cell Adhesion and Ag~egation 974-87.241A
The Paradigmfor Antiplatelet Effect on Continuous
12-LeadST-SegmentRecovery in Acute
Myocardial Infarction 738-3.185A
The Reduction in Rate of Peri-Angioplasty
Myocardial InfarctionAfter Treatment With
IIb/IIIa Receptor Antagonists Is Dependent on
MI Definition 974-85.241A
Three Glasses of Grape but Not Orange or
Grapefruit Juice I~hibit Ex VivoPlatelet
Aggregation in Human Volunteem 767-3.226A
Use of Abciximab (ReoPro’”)Is Not AssWiated
With an Increase in the Risk of Stroke: Overview
of Three RandomizedTrials 974-89.241A
Use of Cilostazol, a Novel Antiplatelet Agent, as a
Post-Palmatz-SchatzSterrtingRegimen 927-1.
93A
VascularAccess Site Complications After
PercutaneousCoronary InterventionWith
Glycoprotein IIb/IIIa Receptor Inhibitor
Therapy in the EPIC Trial 993-10.278A
Platelets
Abciximab (c7E3 Fab, ReoPm’”)With Rednced
Heparin Dusing During Coronary Intervention:
Final Results of the EPILOG Trial 739-6.187A
Ahciximab Decreases Both the Incidence and
Magnitude of Creatine Kinase Elevation During
Rotational Atherectomy 1082-7.499A
Accelerated Primary Platelet Aggregation in Acute
Myocardial Infarction: Use of a New
AggregometryEmploying Laser-Light
Scattering System 1033-32.4O9A
An AneiplateletDrug, Ticlopidine, Inhibits
Heparin-InducedThrombocytopenia (HIT)
Responses as Measured by Platelet
Aggregometryand 14CSerotonin Release
712-1.66A
Analysis and Comparison of Platelet Aggregation
With High-Speed Rotational Adrerectomy
739-2. 186A
Analysis nf Hospital Costs and Outcomes in
RESTORE 801-3*395A
Aspirin Inhibits L-NAME Induced Platelet
Deposition on an Arterial Medial Under Arterial
Flow Conditions 734-4.180A
Attenuated Success Rate of Thmmbolysis for Acute
Myucardial Infarction by Reduced Endogenous
Fibrinnlysis 962-91. 156A
Bolus Magnesium Irdirsionin Humans Is Associated
With Predominantly UnfavorableChanges in
Platelet Aggregationand Certain Hemostatic
Factors 947-11•134A
Differences in Coronary Plarelet Deposition Afrer
Sferrtingand fTCA 927-5.94A
Early Refractoriness of Platelet GPIIb-IIIa in
MyocardirdInfraction Survivors 988-102*
268A
Genetic Typingof Human Platelet Antigens
(Hpa-t,2,3,4,5) Using FCR and an
OligorrrrcleotideLigation Assay in a
SemiauromaredSystem 1OO6-159.3O4A
HyperglycemiaImpairs the Ability of Human
Platelets to Mediate Vasodilarionvia Protein
Kinase C-Dependent Pathway 1006-155.303A
Increase in Mean Platelet Volumeas Parameter fnr
Resrenosis Following Successful Percutaneous
TranslumimdCormraryAngioplasty 928-18.
98A
Increased Platelet Aggregation During Coronary
Tbrombolysis as a Predictor for Early and Late
Reucchrsion 1079-115.493A
Influenceof Stent Length and Heparin Coating on
Platelet Activation: A Flow Cytometric Analysis
927-4.94A
Lucal Intramural Delivery of MK-0383, a Platelet
GPIIb/IIIa Receptor Blocker, Reduces Platelet
Deposition at the Site of Arterial Injrrry 739-4.
187A
Low Intracellular Magnesium Levels Prumote
Platelet-TbrombusFormation in Patients Wifb
Coronary Anery Disease 734-2.179A
Low-Shear Platelet Adhesion Is Inhibited by GP
Hb/IIIa Antagonist DMP-728 712-3.67A
MalondialdehydeInhibits Platelet-Mediated
Vasodilatinnby Interfering With
Platelet-Derived ADP 1OO6-158.3O4A
Moesin: A Cell Membrane protein Regulating
Receptor-CytoskeletonInteractions in Human
Platelets 960-113.154A
Participation of TGF-#l in Platelet-Mediated
Cardioprotection During Myucardial
Ischemia-Reperfusion 929-167.99A
Platelet-Dependent Tbrombin Generation in Patients
With Hypercholesternlemia 964-84. 159A
Rebound Following the Discontinuation of Heparin
Is Not Caused by HyperactivePlatelets 1033-40
l411A
Spemrine a Novel Antithrombotic Agent: Prevention
of Arterial Thrombosis in a Canine Model
1006-16O*3O4A
Spontaneous Contrast (SC), Hypercoagulability, and
Surgical Trauma 1024-116.337A
TargetingPatients for Thrombus Inhibition After
Angioplasty: Clinical and Economic
Implications 1082-9.500A
TheBenefitsof BriefAntecedentIschemiaon
Platelet-MediatedThrombosisAreMimickedby
BriefIntracorurraryAdenosineInfusion734-1.
179A
KEYAbsfmctitle,Session-abstmctnumberspage number
652A SUBJECT INDEX JACC February 1997
The MUST Trial: In-Hospital and Clinical Events at
Six Months Final Results 927-2.93A
Ticlopidine Potentates Abciximab’s Ability to
Inhibit ADP-Induced Platelet AggregationIn
Vitro 974-86.241A
Potassium
Increased QT Interval Dispmion Following
Postdialytic Decrease of Potassium and
Magnesium: A Model to Study the
DepolarizationChanges Associated to
Electrolyte Abnormalities 737-6.185A
pregnancy
Mafignant Hypertension in Women Childbearing
Age: Relationship to Previous History of
H~perrensionin pregnancy mrdContraceptive
Pill Use 754-5.208A
Quantificationof Passive Exposition to Tobacco
Smoke of Newborn Babies, Children, and
Adults 1054-12*448A
The Course and Outcome of pregnancy in Women
With Stenotic Lesious Due to Congenital Hesrt
Defects 1065-159.467A
pressure-volume t-elation
DevelopmentalChanges in Ventricular-Vaacular
Coupling in Piglets 1043-61.428A
Effect of Ryanndine on Mechanical and Relaxation
Restitution in Closed-Chest Dogs: Insights Into
Calcium Handling 758-4.214A
Effects of Critical Coronary Stenosis on Systolic
Left VentricularFunction Quantifiedby
Pressure-VolumeRelations During Dobutamine
929-168.99A
Immediate Change in Right Ventricular
End-Diastolic Pressure After Ptrlmonsry
Valvuloplasty 954-139*144A
Inhaled Niaic Oxide Is a Negative Right Ventricuhm
(RV) Inotrnpe in Primary Pulmonary
Hypertension 907-161.23A
Limitation of End-Systolic Elastance in Evaluation
of Contractile Function in Piglets 1043-62.
428A
OPC 18790ImprovesDiastolic Function in Heart
Failure 907-144022A
Response of the Intact Left Ventricle to Increased
Aftedoad DOGSNot Depend on a Concomitant
Increase in Coronary Perfusion Pressure
929-161l98A
Reversal of Donor Myocardial Dysfmrctionby
Modulation of Coronary Perfusion Pressure
978-167*2-48A
Prevention
A PrnspecriveRandomized Trial of Bachmmnr’s
Bundle Pacing for the Preventionof Arrial
Fibrillation 717-3.74A
Altering Physician Behavior in Lipid Testing rmd
Therapy: Results of a Housestaff Education
Program 921-115*47A
Benefit of Cholesterol Reduction With Pravastatin in
Postmyncardial Patienta kres~ctive of Fasting
Glucose Levels 718-2075A
CrrrotidArtery Respnnse to Systemic-InducedShear
Stress Correlates With Atherngenic Risk Factorz
944-50*128A
Determinants of Midwall Fractional Shortening in
Healthy, Normotensive YouthWith Family
History of Hypertension 965-82.162A
Does Ischemic Preconditioning (1P)Require
Repcrfusion Before the Sustained Ischemia?
901-31*11A
Ezrly Cardiac Changes in Children With Arterifd
Hypertension 965-97.162A
Fasting Blondglucose Level Is an Independent
Predictor of CrrrdiovasctdarMOetality in Healthy
Norwegian Men: Resulta From 22-Year
Fo11ow-UP 1054-8*447A
Fibrinogen Is an Independent Predictor of Total
Mortality in Patients Witb PeripherrdVascular
Disease 761-1.218A
Hibernated Viable Myncardium Maintains a
Physiological Contractile Reserve That Parallels
That Oberserved During Pharmacological
Intropic Simulation 989-1030269A
ImprnvedCnrdiovasctdarMortality With
Perioperative &Blnckade in Patients
UndergoingMajorVascult wSurgery761-6*
219A
Increase of High Density Lipoproteins (HDL) in
PostmenopausalWomenWitb Estrogen
Replacement (ER) Therapy Is Deterrrrincdby
Genetic Polymorphismof Serum
HDL-Arylesrerase 813-4.407A
Marked Reductions in Outpatient, Inpatient, and
TotalMedical Costs With Comprehensive
Work-SitePrimary preventionPmgmms
923-137.49A
Montreal HearrAtrack ReadjustmentTrial
(M-HART):A RandomizedTrial of
Psychosocial InterventionFollowingMyncardial
Infarction 1057-8.452A
Physical Activity in Diabetic Male Physicians Tends
to Negate the Excess Risk of Myncardial
Infarction 767-6.227A
Predictors of Left VentricularGeometry in
NomrotensiveYouthWith Family Histories of
Essential Hypertension 965-101*163A
PsychologicalDistress Resulting Frnm a Mosaic of
Psycho-sncial Variablesas aRisk Factor for
Acute Comnmy Syndromes 924-37*90A
Quantificationof Passive Expositionto Tobacco
Smokeof Newbnm Babies, Children, and
Adults 1054-12*448A
SecondaryCoronary PreventionAfter Firat
Presentation With Acute Ischemia or Infarction
in ASPIRE 1077-66*488A
UnrecognizedExertirmalHeat Illness as a Risk
Factor for Exercise-RelatedSudden Cardiac
Dearb Among YoungAdults 1054-9*447A
Prognosis
A Strategyof AggressiveAntiishemic Dmg Therapy
VersusCoronary Revasculruizationin High-Risk
Patients After Myocardial Infarction:Results of
a Prmpective, RandomizedTrial 7024.53A
Adcnosine SPECT in Patients Without Known
CoronaryArtery Disease: Prediction of Cardiac
Events and Test Utilization 768-6.228A
Admission Standard ECG for Early Risk
Stratificationin Patients With Unstable
CornnaryArtery Diseaze:A TRIM Strbstudy
1057-12”o453A
Amiodamne Reduces Mortalitv in Postinfarction
Patients With Depressed Ejection Fraction and
Increased Heart Rate 755-1.209A
Anatomical vs. Functional Complete
Revascularizationin Patients With Multivessel
Disease: 1YemFollow-Upin the Multivessel
PTCA MrdticenterStudy 792-2.382A
Are the Predictors of Hard Soft Events Similsr in
Patients With Stable CAD? 94O-102.121A
Association of Depressed 24-HourHeart Rate
VariabilityWith Mortrdityin the EMIATTrial
1078-109*49OA
Association of Depressed Left VentricularEjection
Fraction With Mortality in the EMIATTrail
948-15.135A
Bedside Stratificationof Mortality Risk in Acute
Myncardial InfarctionUsing Doppler
Ultrasound 756-4.211A
Benefit of Previous Angina on In-Hospital Survival
and No Benefit on Long-Teun Survival
1057-11.452A
C-Reactive Protein as a Predictor of Infarct
Expansion and Cardiac Rupture Aftera First Q
WaveAcute Myocardial Infarction 926-30.
93A
Can Clinical VariablesBe Determined and Outcome
Mndels Be DevelopedFmm a Claims Database?
799-6.393A
Cardiac Pseudoaneurysm:Clinical PmtiIe and
Outcome in 56 Cases 1015-129*321A
Clinical and Prognostic Significanceof
DipyridamoleStress Thallium-201Perfusion
Abnormalities in Patients With Hypertmphic
Cardiomyopathy 1062-71*461A
Clinical VsriablesPredict Cnsts and Resource
Utilization in Unstable Angina 10324O.35OA
Clinical, Hemodynamic,and Cardiopulmonary
Exercise Test Predictors of Outcome in Patients
Referred for Heatt Failure Evaluation 1098-160
.527A
Comparison of the Prognostic Value of MIBG
Uptnke and Peak Exercise Oxygen Uptake in
Chronic Heart Failure 940-98.120A
Comparison of Treatment Patterns and Outcomes in
Heart Failure Patients With Systolic Veraus
Diastolic Left VentricularDysfunction 710-6.
64A
Contemporary Patterns of practice and Outcomes in
Congestive Heart Failure Patients Treated in a
Specialized Clinic 977-159.246A
Cost-Effectiveness Analysis of Stress Myccardial
Perfusion Imaging in Stable Angina Patients:
Influenceof Age and Pretest Risk of Coronary
Disease 949-30. 137A
Differences in Predictive Power of Heart Rate
Variability in Tbrombolyzed and
NontbrombnlyzedSurvivors of Acute
Myncardial Infarction 731-2.175A
Different Predictom in Sudden or Progressive Heart
Faihtre Dearb in Severe Heart Failure 977-178.
247A
DipyridmnoleStress Echncardiography or
Techneritrm99mSestamibi SPECT Imaging for
Risk Stratification After Uncomplicated Acute
Myocardial Infarction? 753-6*207A
Dobutamine Echocardiography for CardiacRisk
Stratification in Patients With Cbmnic Renal
Disease: What Is the Warranty on a Normal
Study? 753-4*207A
Dobutamine Stress Echncardiography Can Predict
the Impmvement of Left Ventricular Systolic
Function in Dilated Cardiomyopathy 907-146.
22A
DriesAgeIncrease Diagnostic mrdFollow-Up Cost
of Stable Angina Patients? A Multicenter
C1inicaJStudy of 9,491 Patients Witb Perfusion
Imaging and Coronary Angiography 1095-62.
522A
Dries Gender Affect Outcome in the New
Approaches to Coronary Intervention (NACI)
Registry? 1060-151.458A
Dries Gender Have an Impact on Survival of Patients
Witb Heart Failure? Findings From the SOLVD
Registry 977-174*2-MA
Does Intracoronary Doppler Assessment of
Post-Stenotic Repertirsion Flow Enhance
Cardiac Event Prediction as Compared to Other
Postmyoxtrdial Infarction Risk Markera? 715-3
.71A
Dncs Nuclear Testing Yield Incremental Information
for the Prediction of Death in Patients With
Normal Rest ECG: AMulticenter Sttrdyof5,554
Patients With Stable Angina 949-25.136A
Downregulation in Hibernating Myncadium Is a
Time-Dependent Pmess and Preservation of
Structural Integrity Requires Early
Revascularizrrtion 1015-128o32OA
Drug-InducedChanges of Exercise Capacity
Correlate With Exercise Hemodyrramicsin
HeartFailnre 1041-22*425A
DualChamberPricingImprovesLong-TermSurvival
inElderlyPatientsbyDecreasingtheIncidence
of CardiacDeath 935-72.112A
EarlyCombinedElectrocardiographicand
BinChemicalRiskStmtificationof P&ierrtaWith
UnstableComnmyArteryDisease:A TRIM
Subsmdy991-13.272A
Effectsof Long-TermCsrvedilolAdministrationin
PatientzWithIdiopathicDilated
Cardiomyopathy1017-146*326A
Embolismin InfectiveEndncarditis:Differencesin
prostheticandNativeValveInvolvement807-1
.4431A
ExerciseEchocardiographyProvidesPrognostic
DataIncrementalto ClinicalEvaluationand
ExerciseECGin Women 773-2.356A
Exercise Thallium SPECT Pmdicta Cardiac Events
in AsymptomaricPatientsAfterCoronary
BypassSurge~ 768-1.227A
Fibrinogen,an AcutePbasePrnteinIs Nota Marker
ofTbrnmbin-or Platelet-Mediated
ProthmmboticPotentialin UnstableAngina
1033-42*411A
HeurtRateVariabilityPredictsLmrg-TenrrMortality
inChrnnicCoronmyDisease 731-5. 175A
K,?UlAbstractitle,Session-abstractnumber. pagenumber
J AFebruary 1997 SUBJECT INDEX 653A
“Hot” Unstable Angina: Is it Worse Than Subacute
Unstable Angina? Results From the
GUARANTEE Registry 1078-103o489A
Impact of Pharmacologic SPECT Perfusion Imaging
on Subsequent Utilization of Cornnary
Angiography and Outcome 1095-58*522A
Implementationof an IntemetAVorld-Wide-Web
Original Database for Supporting Multicenter
Clinical Trials 915-110.34A
In-Hospital Mortality of Acute Inferior Myocardial
Infarction: Interaction Between Age and Right
VentricularInfarction 777-10361A
Incremental Valueof DobutanrirreStress
Echncardiographyin predicting Cardiac Events
Among Patients With Lefi Ventricular
Dysfunction 753-2.206A
IndependentLmrg-TerrnPrognostic Valueof
TroponinT for Cardiac Outcome After
Noncardic Surgery 991-16.273A
Influenceof Hypertension and Bleed Pressure on the
Survival Benefit of ACE Inhibition After Acute
Myocardial Infarction 787-5.376A
Is Anterior Wall Involvement in Non-Q Wave
Myucardial Infarction Associated With Left
VentricularDysfunction? 926-29.93A
Is Preoperative Risk Assessment With Dobutamine
Stress EchneardiographyUseful Before
NonvascularSurgery? 773-6.357A
Limits of Doubtamine Echncardiography in
Prognostic Stratification of Patients Witb Firat
Uncomplicated Myneardial Infarction 984-3.
258A
Lipid Profile and Outcome of Diabetic Patients Wirb
Coronary Artery Disease in the BIP Study
Registry 969-36.233A
Long-TermFolIow-Up of Takayasu’sDisease 761-4
.218A
Lmrg-TermOutcome Following Corunary
Angioplasty: Clinical and Angiographic Results
of a 15-YearFollow-Up 792-6.383A
Long-TermPrognosis of Patients With Extensive
Severe Coronary Artery Disease and Ejection
Fraction >0.40 Unsuitable for Revascukrrization
972-18.237A
Lcmg-Termprognostic Utility of Stress
Technetium-99mSestarnibi Myncardial
Perfusion Tomographyand Cornnary
Angiography in Cornnary Artery Bypass
Surgery Patients 768-2.227A
Metroprulol Is More Effective Than d,l Sotalol for
Prevention of Recurrence of Verrrriculw
TachyarrhythmiasAfter Implantation of a
Cardioverter DetibriUatOr 745-6.196A
Mild HemudynarnicImpairment in Patients With
Heart Failure and Reduced Functional Capacity
1041-3*423A
Mortality Rate After Myocardial Infarction Equally
Increased in Diabetic Patients Treated With OraJ
Agents and Insulin 787-6.376A
Mortality Trends After Acute Myncardial Infarction
Between the 80s and the 90s in Israel 1031-58.
348A
N-TerminalPmatrial Natriuretic Factor: Relation to
Long-TermPrognosisin Patients With
Idiopathic Heart Failure 1084-144*5O4A
Negative Survival Impact of Female Gender and
Extensive Myncardial Hypuperfusion in
SyndromeX: A Multicenter Study 747-1.197A
No EthnologicDifferences in Survival Benefits From
Amiodarone in Severe Congestive Heart Failure
977-176.247A
Non-Q WaveMyocardial Infarction Is Not
IndependentlyAssociated With Worse Outcome
in the Elderly 777-2.361A
NoninvaaiveTests After Myueardial Infarction in the
‘T1-mombolyticEra: Prognostic Value and
Relative Costs 991-18.273A
Outcome of Diabetic Patients With Intermediate
Pre-Test Probability of Coronary Artery Disease
Using Exercise SPECT Thallium Imaging
1073-56*482A
Persistence of Left VentricularHypertrophy Is a
Stronger Indicator of Cardiovascular Events
Than Baseline L& VentricularMass or
Performance:A 10-YearFollow-Up 1076-63.
487A
Prediction of Outcome After Cardiac
TransplantationUsing Exercise SPECT
Perfusion Imaging 940-97.120A
Previous ComrraryArtery SurgeryHas Little
Influenceon In-HospitalOutcome in Unstable
Angina 1064-172.466A
Primary Pulmonav Hypertension:Prognostic Value
of a Doppler DerivedIndex Combining Systolic
and Diastolic Time Intervals 916-79.36A
Prognosis and Progression of Early Familial Dilated
Cardiomyopathy:A 30-MonthProspective
Study 977-173.246A
Prognostic Impact of PharmacologicalStress
Testing: Head-to-HeadComparison Between
Echoeardiographyand Myocardial Perfusion
Scintigraphy 1025-87.339A
Prognostic Influenceof Viable Myncardiumin
Patients With Left VentricularDysfunction Is
Independentof Late Potentials 972-16.237A
Prognostic Markers in Unstable Angina:
Relationship Between Trqxmin I and
C-Reactive Protein 970-39.233A
Prognostic Significanceof Moderate Exercise
Training in Chronic Heart Failure 1041-24.
425A
Prognostic Value in a NegativeStress
Echocardiograrnfor Cardiac Events in Patients
UndergoingRenal or LiverTransplantation
1025-86*339A
Prognostic Valueof Biphasic RespmrseDuring
DobutamineStress Echo After Myneardial
Infarction 917-53.38A
Prognostic Valueof ChronotropicReserve in
Chronic Mitral Regurgitation 989-113.271A
prognostic Valueof DobutanrirreStress
Echeardiography After Heart Transplantation
999-149*290A
Prognostic Valueof Dobutamine-AtmpineStress
Electrocardiographyin Patients With Chest Pain
and NorrrralResting Electrocardiograms 934-57
.111A
Prognostic Vrdueof Exercise and Adenosine
Myocardial Perfusion SPECT in the Very
Elderly 777-6.362A
Prognostic Valueof
Exercise-Redistribution-ReinfectionThallium
SPECT and Low-Dnse Dobutamine
Ecbecardiographyin Left VentricularIschernic
Dysfunction 949-27.136A
Prognostic Valueof Resting Left VentricularEjection
Fraction Early Following Successful Coronary
Artery Bypass Surgery 952-122.140A
Prognostic Valueof Routine Serial Bicycle Exercise
EchecardiographyAfter Coronary Artery
Bypass Grafting 917-56.38A
QuantitativeAdenosine Tballium-201Single Photon
TomographyAccurately Predicts Risk
Following Acute Myncardial Infarction:The
Results ofa ProspectiveTrial 768-5.228A
Reduced Mortality in Eisenmenger’sHaving
Noncardiae Surgery 1065-156.467A
RevascularizationImpmves Suwival in Patients
With Severe Left VentricularDysfunctionand
Contractile Reserve by DobutmnineStress
Echc-ardiography 753-1.206A
Sbort and Lmrg-TerrnPrognosis of Patients With
Suspected Myucardial InfarctionWho Present
With ST Depression 1078-104.489A
Significanceof Bundle Branch Block After
Myocardial Infarction in the ThrnmhulyticEra
1057-10*452A
Small Myocardial InfarctionMay Cause Late
VentricularDilation and Dysfunction Possibly
Due to Chronic Infarct Expansion 926-27.92A
Stress Induced Ischemia as a Prognostic Marker of
Future Adverse Cardiac Events in Adult
HypertruphicCaniiomyopathy 1062-7O.461A
SubmaximalResponses to DobutamineStress Are
Unhelpful in Predicting Subsequent Cardiac
Events 704-4*55A
Technetium-99mSestamibi Infarct Size Predicts
Mortality 746-3.l%A
The frnpact of Warfarin on Clinicrd Outcomes in
Heart Failure 1017-143.325A
The Influenceof Myocardial Infarction After
Angioplasty on In-Hospital and Long-Term
Survival 7724.355A
The Natural History of Heart Failure With Preserved
Left VentricularSystolic Function 977-156.
245A
The Predictive Valueof Fibrinogen, C-Reactive
Protein, and Interleukirr-6on Admission in
Severe Unstable Angina 791-3.381A
The Relative LymphocyteConcermation: A New
Prognostic Marker in End-Stage Heart Failure
93O-174.1O2A
The Relative Valueof Exercise-Eleetrncardiography
and Pharmacologic Stress Echncardiographyfor
Risk Stratification Early After Uncomplicated
Myocardial Infarction 938-93. 117A
The Relative Valueof PharrnacrdogicalStress Echo
and Exercise Stress Testing for Risk
Stratification in Hyperrensives 922-152.48A
Three-YearFollow-Up of the Metoprdol in Dilated
CardiomyopathyTrial 996-54.284A
Three-YearPatency and Late Recurrence More Than
Six Years Afk CororraryAngioplasty 792-5.
383A
TrearrnentRoutines and Mortality in Acute
Myecardial Infarction: A Comparison Between
Minneapolis-St, Paul, USA and Gbteborg,
Sweden 1034-52.412A
Usefubress of Exercise Echocardiography for
Prediction of Angina Recurrence After
Coronary Angioplasty 938-95.117A
VagalReflexes and Left VentricularFunction in
Postrnyccardial Infarction Patienta: Results
Frnm the ATRAMI Study 1078-123.491A
Validationof the Exercise-TreadmiIlScore Designed
Fmm Mark in Stable Patients With Old
Myocardial Infarction 949-26.136A
Prnstacyclin
Continuous Infusion of Pmstacyclin Improves
Plasma Markers of Endothelial Cell Injury in
Primary Pulmonary Hypertension 794-5.385A
Continuous Releases of Prostacyclin Contributes to
Resting Forearm Blnnd Flow in.Humans
920-86.44A
Effect of Ionizing Irradiation on Intimal Structure
and Endothelial Function 986-75.264A
Gender Differences in Mortality After Acute
Myocardial Infarction in the ‘90s, in Israel
813-1l406A
LcmpDiuretics Enhanced Secretion of Pmstacyclin
In Vitro and in Patients With Heart Faihre
959-47.152A
Pmstaglandbrs
Bolus Magnesium Infusion in Humans Is Assneiated
With predominantly Unfavorable Changes in
Platelet Aggregation and Certain Hemostatic
Factors 947-11.134A
Decreased In VivoVasctdar prostaglandin Release to
Alpha-1 Adrenoceptor Stimulation in CHF
Patients 996-73.286A
Effects of Picotmnide, an Antiplatelet Drug, on
Urinary Thromboxane/FkustacyclinMetabolizes
and Blond Pressure in Hypertensive Patients
Treated With an ACE-Inhibitor 1076-61.487A
MalondialdehydeInhibits Platelet-Mediated
Vasodilationby Interfering With
Platelet-Derived ADP 1OO6-158.3O4A
Myoeardial ProstaglrmdinReceptors (EP3 Subtype)
Inhibit the Inotropic Effect of fl-Adrerrergic
Stimulation 941-140. 122A
The Effect of Inhaled Nitric Oxide and Inhaled
ProstagkmdinE, on Left Ventricular
Contractility in an Experimental Mndel of
pulmonary Hypertension 91O-174.27A
Pulmonaryartery
DifferentialAttenuation of Endothelium-Mediated
pulmonary Vamdilatation in Experimental
pulmonary Embolism 761-3.218A
Light and Electrun Microscopy of Dilated Great
Arteries in Congenital Heart Disease 1065-158
l467A
KEY..Abstract title, Session-abstract number. page mrmber
6 5 4SUBJECT INDEX JACC February 1997
RestenosisVersus Late Diameter Increase After
Balloon Angioplasty of Branch Pulmonag’
Artery Stenosis 954-143.145A
Urokinase Improves Endothelium-Dependent
Relaxation in Experimental pulmonary
Embolism 963-106.158A
pulmonary circulation
Abnormal Histology nf the Pulmonary Vasculature
in Neonates With Palmonary Atresia and
VentricularSeptal Defect 1065-155.467A
Beneficial Acute Hemndynamic Effect of
Endogenous Adenosine Accumulation in
Pstients With Chronic Heart Failure 1084-148.
505A
Central Haemodynamic Effects of Endothelin-1 in
Patients With Leti VenniculurDysfmrctinn
996-72.286A. . .
Clinical s~”nificancenf Plasma Levels of
Adrenomedulljn (AM) in Pulmonary
Hypertension (PH) 93O-175.1O3A
Continuous Infusion of Prostacyclin Improves
Plasma Murkersof EndothelirdCell Injury in
Primary PulmonuryHypertension 794-5.385A
Determinants of Pulmonary VenousFlow Pattcm in
Patients With Chronic Hesz’rFailure 1071-43.
478A
Effect of Left Aoial Appendage on Left Ventricular
Filling Dynamics:.4 ComputatiomrfModel
10}5-133.321A
Hypoxemia Stimulates Release of Endotbelin-1 in
Obstructive Sleep Apnea Syndrome 1052-150.
444A
Impaired Prdmonmy VascularRelaxation in
Tetralogyof FaRot 1043-66.429A
Influences of Lefi Atrial Size on Pulmonsry Venous
Flow in Patients With Moderate to Severe Mitral
Regurgitation 909-I05*26A
Inhaled Nitric Oxide Dries Not Alter Myocardial
Functinn in a Porcine Model of Heart Failure
805-4*399A
Inhaled Nitric Oxide Improves Exercise Capacity in
Patients With Severe Heafi Failure and Rigbt
VentricularDysfunction 1041-1.423A
Inhaled Nitric Oxide Isa Negative Right Ventricular
(RV) Inotrope in Primary Pulmonary
Hypertension 907-161.23A
Preserved Pulmonary VasodilatorCapacity in
Patients With Primury Pulmonary Hypertension
Measured by Local VasodilatorApplication
1052-151l445A
pulmonary and Systemic Responses to Substance P
in Patients With Heart Failure With and Witbout
Pulmonary Hypemension 996-76.287A
Palmonary VasodilationFrom IntravenousMihinone
1sSecondary to Suppression of Transpulmonrrry
Endothelin 706-5.59A
The Dependence of the E Wave on pulmonary
VenousFlow: Mathematical Solution With In
VivoVerification 1003-111.296A
Transesophageal EchocurdiograpbicAbnormalities
Following Lung Transplantation 1048-174.
437A
Pulmonary embolism
A Randomized Single Blind Trial of Two-Hour
Regimens of Alteplase and Streptokinase in
Acute Massive Pulmonary Embolism 933-60.
109A
A Simple Bedside Clinical Echocardingraphic
Algoritbm Is VerySpecific of Severs Palmonaw
Embolism: A Prospective Stady in 43 Cases
963-105*158A
Differential Attenuation of Endothelium.Mediated
Pulmonary Vasodilatation in Experimental
Pulmonary Embolism 761-3.218A
Power Doppler Ultrrrsoundin Detectinn of Deep
VenousThrombosis 963-1040158A
Urokinase Improves Endnthelium-Dependent
Relaxation in Experimental pulmonary
Embolism 963-106.158A
pulmonary function
Clinical Relevance of Arterial Oxygen Saturation
Instability to Detect Breathing Disorders in
Chronic Heazt Failure 752-3.205A
Forced Expiatory Volumein One Second Is a
Strong and Independent Predictor of
CardiovascularDeath: Results From a 22-Year
Follow-Up Survey 967-63.167A
Similra’Efficacy(but DifferentMechanisms) on
Exercise Capacity of Losartan (LOS) and
Enalapril (EN) in Chronic Heart Failure (CHF)
752-4.205A
Pulmonary heart disease
Chmacterizationof Ditferent Time Courses of Left
and Right VentricukwRecoveryAfter Lung
Transplmrtation 907-148.23A
Continuous Infusinn of Prostacyclin Improves
Plasma Mnrkersof EndoehelialCell Injury in
primary Pulmonsry Hypertension 794-5.385A
Determinants of Tricuspid Regurgitationin Primary
PulmonaryHypertension 916-81.37A
Diastolic Dysfunction in Patients With Cystic
Fibrosis 907-162.23A
DifferentialRegulation of Cardiac Angiorensin
Convetting Enzyme (ACE) Binding Sites and
ATI Receptor Density in Primary pulmonary
Hypertension(PPH) 976-153.244A
Reduced Mortality in Eisenmenger’sHaving
NoncurdiacSurge~ 1065-156.467A
Pulmonary valve
Critical PulmonaryValveStenosis in the Neonate:
Initisl Results and Follow-UpUsing am
Umbilical Artery Snsre Assisted Approach
954-141.144A
Immediate Change in Right Ventriculuc
End-Diastolic Pressure After Palmonary
Valvuloplasty 954-139.144A
Long-TermResults of SeverePulmonic Stenosis
With Initial Gradient z 150mm Hg Treated by
BaOnnnValvuloplasty 954-142.145A
Outcome After TranscatheterValvotomyfor
PulmonaryVulveAtresia and Intact Seprnmin
Neonates and Infants 729-6.173A
PulmonuryBalloon Valvuloplasty-krducedAcute
Changes in Right Coronary Blood Flow Velocity
Pattern 954-140. 144A
The Fate of the Neo-PulmonaryVslve After the
Arterial Switch Operation in Neonates 751-4.
204A
Purkinje fibers
Role of KATPChannels on Action Pntential “
Characteristics in a Rabbit Model of Chronic
MyocardialHypoxia 958-39. 150A
QT interval
AbnormalMyocardial Adrenergic Innervation in
Patients With Acquired Long QT Syndrome
Using I-123-Metaiwlobenzylguanidine 737-3.
184A
AutonomicNervous System Dysfunction but Not
Dispersion of VentricuhwRepokrrizationHas
Prognostic Implication in Chronic Heart Failure
731-4*175A
Does Left VentricularFunctionInfluenceQT
Dispersion in Patients With Previous Myocardial
Infarctionand VentricuhwTachyamhythmias?
1088-15O.51OA
Effects of PhysicnlTraining on QT Dispersion and
Heart Rate Variabilityin Pstients With Acute
Myncardial Infarction 1034-56.413A
Fmnilial Influenceson QT and QTc Dispersion
722-6.82A
Gender Differences in QTDispersion 956-162.
148A
Gender Effects nf Quinidine on QT Interval and QT
Dispersing 1091-99.515A
Increased QT Interval Dispersion Following
Postdialytic Decrease of Potassium and
Magnesium:A Model to Study the
Repolsrizatinn Changes Assnciaeedto
Electrolyte Abnormalities 737-6.185A
IndependentAutonomicControl of the Sinus Node,
AVNode, and VenrriculurMuscle in Heukhy
YoungMen During Sleep 980-142.250A
Influencenf Autonomic Blockade on QT Dispersion
in Man 914-134.34A
Influenceof AutonomicToneon Circadian Variation
of Dispersion of Repokaization and the QT
Interval 737-4.184A
Influenceof Electrolyte Abnormalitynn Interlead
Variabilityof VentricularRepohwizationTimes
in 12-LeadECG 956-163.148A
1sQT Dispersion Affected by HeartRate or
Catecholamines? 1088-149.51OA
Ischemia-InducedChanges in QT-Peak Disncrsion
During Dipyridamole Stres; Echncrrrdi~graphy
722-5.81A
Measures of QT Dispersion From Signal Averaged
12-LeadECGSAre Better Discriminators Than
Those Measured Frnm Individual Beats
956-165.148A
Prospective Smdy of Prognostic Value of
ArrhythmngenicMarkers in Systemic
Hypertension 1030-46.347A
QT Dispersion in Healthy Subjects 1088-I34.5O9A
QT Dispersion Is Associated With Severe Reversible
Defects on Exercise Thallium Scans After an
Acute Coronary Event 722-1.81A
QTDispersinn Is Increased in Chronic Heart Failure
Patients Compared to Controls 722-2.81A
QT Dispersion Is Significantly Increased Between
6am and 8am in Heart Failure Patients: A
Possible Role in Sudden Death 1088-151.51OA
QT Dispersion: Effects of T Wave Endpoints
956-164.148A
QT Dispersion: Evidence to Favor a Vectorinl
Component 956-161.148A
Relationship of QT Dispersion to Left Ventricular
Hypertrnphy in Patients With Hypetiension
103O-45.346A
Shortening of Pmlnnged QT Dispersion After
Coronary Angioplasty 1088-152.51OA
Successful Reperfusion Is Associated With a
Decrease in Hemt Rate-Dependent Variations of
QT Intervals in Patients With Acute Myocardial
Infarction 1088-I53.51OA
Sustained Electrical Instability of Myncardium After
Exercise in Patients With Residual Ischemia
After Myncardial Infarction 702-5.53A
The Correlation of Left Ventricular Mass QT
Dispersion in Hypertensive Patients 965-99.
162A
Torsades De Pointes Associated With Intravenous
Haloperidol in Critically 111Patients: Incidence
and Influence on Length of Hospital Stay
914-133*34A
QT syndrome-inherited
Effects of a Potassium Channel Opener in KVLQT1
Long QT Gene Carriers 737-1.183A
Importance of Fmnily Pedigree Expansion and
Screening StWiiesin the Inherited Long QT
Syndrome 967-60.166A
Molecular Analysis of the HERG-Gene in 48
Unrelated Long QT Syndrome Patients:
Genotype/Phenotype Correlation in Two
Families With Novel Mutations 737.2. 184A
Quality of life
A Java-Based World Wide Web Computer System
for Longitudinal Assessment of Health Outcome
Measures Using the Seattle Angina
Questionnaire 1254-1.9A
Actual Same Day Discharge After Successful
PTCA: Outcome of the OUTCLAS-Pilot Study
1036-88.416A
An Analysis of the Outcnme of Umbrella Closure of
Patent Ductus Arteriosus in Children 954-137.
144A
AVNude Ablation and Pacemaker Implantation
After Withdrawal of Effective Rate-Control
Medications for Chronic Atrial Fibrillation:
Effect on Quality of Life mrdExercise
Performance 957-176.150A
Changes in Functional Health for Women Versus
Men One YerrrFnOowingPTCA or CABG
928-15.97A
Comparison of Coronary Bypass Gmfting in
Compamble Defined Geographic Populations in
Canadu/United States IO1O-139.31OA
DriesPacemnker ImplanrutionHave a
Placebo-Effect? Results From the PIC Study
Group 717-4.74A
Gender and Quality of Life in African Americuns
WithCongestiveHeartFailure 93O-156.1O1A
GSM-HurrdiesCan Impair ICD-Function During
Telemetry 1069-109.474A
Kflll Abstract title, Session-abstract number. page number
JACC February 1997 SUBJECT INDEX 655A
Health-Related Quality of Life in Elderly Patients
With Heart Failure Due to Primary Diastolic Vs.
Primary Systolic Left VentricularDysfunction
1063-173.464A
Impaired Quality of Life in Patients With Atrial
Fibrillation Is Not Related to AF Frequency or
Duration 936-I06*113A
ImprovedClinical Outcomes and Cost Savings From
Use of Home Intravenous Inotropic Therapy in
Advanced Heart Failure 968-51~167A
Long-TermSurvival Rate After Resuscitation With
tbe Use of Percutaneous Cardiopulmonary
suppOrt 955-169*147A
Mortality, Morbidity, Resource Use, and Quality of
. Life Following Q Vs. Non-Q Wave Infarction
and Thrombolytic Therapy: A GUSTO-I
Substudy 1078-106*49OA
Nurse Practitioner Managed Angina Clinic Improves
Quality of Life 968-57.168A
Once Daily Medications Improve Quality of Life in
Stable Angina: Six-Month Follow-Up 968-52.
167A
Pacing in Hypertrophic Obstructive (PIC): A
Randomized Crossover Smdy 796-1.387A
Patient Preference for Cardiac Catheterization via
the Transradial Vs. Transfemoral Approach
101O-I37*31OA
Postoperative Vasmrlarityand Hand Function in
Patients Following Radial Artery Harvest for
Coronary Artery Surgery 716-6.73A
Quality of Life Afrer ValveSurgery in Patients Over
Age of75 735-2*181A
Quality of Life Assessment in Advanced Congestive
Heart Failure Patients on InterrrrirrentInotropic
Infusion Program 977-175.247A
RadiofrequencyCatheter Ablariou for Management
of Symptomatic Ectopic VentricularActivity: Is
VentricularEctopy a Potential Target for
Ablation? 1021-64*332A
Relation Between Low-Intensity Exercise Capacity
and Quality of Life in Patients With Mild to
Moderate Congestive Heart Failure 752-2.
205A
The FonranProcedure in Adults: Early and Late
Results 1065-157.467A
Radioisotopes
Are There Any Differences in Detection of Coronary
Artery Disease by MyocarrfialPerfusion SPECT
irrDiabetics? 1073-55*482A
Comparison Between T1-201and Tc-99m-NOET
Myocardial Uptake During Adenosine
Hyperemia in Dogs With Mild to Moderate
Coronary Stenoses 105O-158*442A
Comparison of the Prognostic Valueof MIBG
Uptake and Peak Exercise Oxygen Uptake in
Chronic Heart Failure 940-98*120A
Detection of Mild and Severe Coronary Artery
Stenoses by Di yridamole ‘“’Thallium Vs.
Dipyridamole &‘Tc-Tetrofosmin 1050-160.
442A
Direct Evidence of Impaired Cardiac Sympathetic
Innervation in Essential Hypertension With Left
VentricularHyperrrophy 754-4.208A
Does Age Increase Diagnostic and Follow-Up Cost
of Stable Angina Patients? A Multicenter
Clinical Study of 9,491 Patients With Perfusion
Imaging and Coronary Angiography 1095-62.
522A
Effect of Inrracoronary ‘g21rridirrm(’g21r)on Late
Quantitative Angiographic Outcomes After
PTCA 1038-72*418A
Effects of ~+ Emitting Va ACT-OneNitinol Stent
on NeointimrdProliferation in Pig Coronary
Arteries 973-58.237A
Exercise SPECT Versus Exercise ECG Testing for
Diagnosis of Coronary Artery Disease in
Asymptomatic Patients 985-25.261A
i8F-.2J)eoxyglucose (FDG) Utilization IS
Regionally Increased in Fasting Pigs With
Hibernation Myoeardirrm 945-35*130A
Identificationof Lefl Main and Three Vessel
Coronary Artery Disease by Adenosine
Myocardial Tomography 985-45.262A
Incidence and Extent of DenervacedMyncardium”
After Reperfasion Tberapy for Acute
MyocrrrdialInfarctionAssessed by 1-123
MetaiodobenzylgrranidineImaging 1026-114.
342A
Induction of Progranuned Cell Death in Human
VascularSmooth Muscle Cells Following
Exposure to ~ Irradiation 790-3.380A
Is Anterior Wall Involvementin Non-Q Wave
Mycardial InfarctionAssociated With Left
VentricularDysfunction? 926-29.93A
Lefr Main Coronary Disease: Increased Sensitivity
With QuantitativeAttenuation Corrected SPECT
Perfusion Imaging 1005-91.302A
Low-Dose fl-Emitting RadioactiveStents Inhibit
Neointimal Hyperplasia in Porcine Coronary
Arteries: An Histological Assessment 973-60.
238A
Myocardial Blood Flow Vs. Tracer Uptake
Characteristics of Perfusion Tracers During
DobutamineStress 105O-159.442A
Myocardial Uptake of 99Tc-N-NoctFollowing
Reperfrrsionin Acute Myocardial Infarction:
Comparison to T1-201 1026-111.342A
Open Artery Reperfusion Produces Distinct Patterns
of Myocardial Blood Flow-GlucoseMetabolism
Mismatch 1055-36.449A
PET MyocardirdPerfusion Imaging Significantly
Reduces the Cost of Coronary Disease
Management 1047-141.435A
Prediction of Improvementof Global Function After
Revascularizationin Patients Witb Ischemic Left
VentricularDysfunction:Derectionby
F18-FhrorodeoxyghrcoseSPECT 788-6.377A
Qualitative and QuantitativeComparison of
Sestamibi SPECT Without and With Attenuation
Correction for Detection of Coronary Anery
Disease in Patients With Large Body Habitus
1OO5-9O.3O2A
RadiotherapyReduces Coronary Restenosis: Late
Fo11ow-UP 803-4.397A
Stent Margin ResterrosisAfter Coronary
Intervention:A Quantitative Analysis of
Segmental Lumen Changes in the Scripps
Radiation in Restenostic Lesion Study 719-6.
77A
Thallium 201 Myocardial Perfusion in Patients With
HypertrophicCardiomyopathyand DDD Pacing
796-3.388A
Tballium-201Rest-RedistributionSPECT to predict
Improvementof Global VentricularFunction
After Revascularization 788-2.377A
The Added Diagnostic Vahreof Auromated
QuantitativeTc-99m Sestamibi SPECT for
Detection of Coronary Artery Disease 985-30.
262A
The Diagnostic Valueof Treadmill Exercise First
Pass Regional Wall Motion Analysis Combined
With Tc-99m Sestamibi SPECT for Detection of
Coronary Artery Disease 98547.262A
Valueof MyocardirrlPerfusion Tomographyin the
Assessment of PoststenringCoronary Restenosis
768-3.228A
Radionuctide imaging
A Strategy of AggressiveAntiisbemic Drug Therapy
VersusCoronary Revascrdadzation in High-Risk
Patients After Myocardial Infarction:Results of
a Prospective, RandomizedTrial 702-4.53A
Abnormal Cardiac Sympathetic Nerve Function in
Patients Witb SyndromeX 1058-3*453A
AbnormalMyocardial AdrenergicInnervation in
Patients With Acquired Long QT Syndrome
Using I-123-Meraiodobenzylgrranidine737-3*
184A
Acute Myocardial Perfusion Imaging for Chest Pain
Reduces tbe Length of Cardiac Work-Up:A
RandomizedTrial 1095-59.522A
Adenosine SPECT in Patients Without Known
Corona@Artery Disease: Prediction of Cardiac
Events and Test Utilization 768-6.228A
Are the Predictors of Hard Sofi Events Similar in
Patients With Stable CAD? 94O-102.121A
Are There Any Differences in Detection of Coronary
Artery Disease by MyocardialPerfusion SPECT
in Diabetics? 1073-55.482A
Automated Calculation of Left VentricularEjection
Fraction From Gated Tc-99m Sesramibi
Myocardial Images Comparison to Quantitative
Echocardiography 985-46.262A
Clinical and Prognostic Significance of
Dipyridamole Stress Thallium-201 Perfusion
Abnormalities in Patients With Hypcrtrophic
Cardiomyopathy 1062-71.461A
clinical Phase I Tc-99m Ghrcaric Acid Study for
VeryEarlyVkualizarionof Acure Myocsrdial
Infarction 1056-17.451A
Clinical Usefulness of Dual SPECT Imaging of
Tc-99m Sestamibi and 1231-IPPAfor Predicting
Myocardial Viability After Thrombolysed
Myocardial Infarction 946-20.132A
Comparative Valueof Dnbutamine Stress
Thallium-201 Single Photon Emission
Computed Tomographyand Echocardiography
in the Diagnosis of Cardiac Allograft
Arteriopathy 999-150.290A
Comparison Between T1-201and Tc-99m-NOET
Myocardial Uprake During Adenosine
Hyperemia in Dogs With Mild to Moderate
Coronary Stenoses ”105O-158.442A
Comparison of Exercise and Vasodilator Stress
Myocardial Perfusion SPECT Imaging for the
Determination of Normalcy and the Effects of
Attenuation Correction 1005-92.302A
Comparison of Gated SPECT to X-Ray Contrast
Angiographic VentricularVolume
Measurements 1073-54.482A
Contrast EchocardiographyVersus Sesramibi
SPECT to Detect Stunned Myocardium in
Patients Treated With Primary PTCA for Acute
Myocardial Infarction 1072-28.479A
Correlation of Technetium-99m-SeatamibiLung
Uptake With Coronary Arrery Disease Severity
and Lefr VentricularFunction 985-28*261A
Cost-Effectiveness Analysis of Stress Myncardial
Perfusion Imaging in Stable Angina Patients:
Influenceof Age and Pretest Risk of Coronary
Disease 949-30.137A
Delay of Local Depoladzation/Repoladzarion
Prncesses After Acute Myocardial Infarction
and Impairment of Sympathetic Innervation
1091-97.515A
Delayed FOG Ima8ing Improves Myocardial/33100d
Pool Conrrasr 1047-146.436A
Detecrionof Mild and Severe Coronary Artery
:;:;:;::%%y:;:::::;::l;:;:;60.
442A
Detection of Myocardial Viability by Dual-Isotope
Tc-99m-Terrofosminand 18-FOG Single Photon
Emission TomographyAfrer Acipimox to
Stimulate Glucose Uptake 788-4.377A
Determinants of Increased Tc-99m Sestamibi Lung
Uptake 1OO5-93.3O2A
Diminished Myocardial BlcmdFlow Response
During Mental Stress Occurs in Regions With
Abnormal Coronary Flow Reserve Independent
of Coronary Anatomy 1035-47.414A
DobutarnineEcho and Positron Emisaion
Tomographyfor Assessing Viability in Patients
With Ischemic Heart Failure 1003-113.297A
Dobutamine Radionuclide Ventriculography:
Prediction of VentricularFunction Improvement
After Bypass Surgery in Patients With Ischemic
Cardiomyopathy 1073-52.481A
Dobutamine Tc-99m Sestmnibi Gated SPECT: New
Method for Mycardial Viability Assessment in
Patients With Left VentricularDysfunction and
Coronary Artery Disease 788-5.377A
Does Age Increase Diagnostic and Follow-Up Cost
of Stable Angina Patienta? A Multicenter
Clinical Study of 9,491 Patients Witb Perfusion
Imaging and Coronary Angiograpby 1095-62.
522A
Does Intracoronary Doppler Assessment of
Post-Stenotic Reperfusion Flow Ehhance
Cardiac Event Prediction as Compared to Other
Postmyocardial Infarction Risk Markera? 715-3
.71A
Does Nuclear Testing Yield Incremental Information
for the Prediction of Death in Patienta With
KEY Abstract title, Session-abstractnumber. page rnrrnber
6 SUBJECTINDEX JACC February 1997
Nomzal Rest ECG: A Mtdticentcr Study of 5,554
Patients With Stable Angina 949-25.136A
Dynamic Positron Emission TomographyUsing
(R,S)-[F-18] 6-ThiaheptadecanoicAcid Detects
Preserved Myncardial Viability in Regions With
Reduced Perfusion 1002-101.295A
EchoCardiographyand Fatty Acid Single Photon
Emission Tomographyin Predicting
Postrevasculmization Reversibility of Regional
Left Ventriculw Dysfmrction 1035-46.413A
Effects of Transmyocardial Laser Revascularization
on Myncardial Perfusion 94O-1OO.121A
Endotoxemia Alters Splanchnic Capacitance
1061-1OO*46OA
Ergotamine Limits Hyperemic Myncardial Blned
Flow in Humans 706-4*58A
Exercise SPECT Versus Exercise ECG Testing for
Diagnosis of Coronary Artery Disease in
Asymptomatic Patients 985-25.261A
Exercise Thallium SPECT Predicts Cardiac Events
in Asymptomatic Patients After Coronary
Bypass Surgery 768-1.227A
Factors Intluencingthe Extent and Severity of
Transient Pertiwion Defects Induced by
Rotational Atherectomy 108I-2.498A
Gated SPECT LVEF Measurements Using a
Dual-Detector Camera and a Weight-Adjusted
Dosage of Tballium-201 985-50.263A
Gated Technetium-99mSPECT Imaging Predicts
Myncardial Viability in Revascularized Patients
788-3.377A
Hemodynamic Benefit of Lnng-TemrInterrzzinent
UrokhraseTherapy in End-Stage Coronary
Artery Diseaze: First Results From a Gated
Blood Pool Study 1058-1*453A
Identification of Left Main and Tbree Vessel
Coronary Artery Disease by Adenosine
Myncardial Tomngrapby 985-45.262A
Impact of Pharmacologic SPECT Pertitsion Imaging
on Subsequent Utilization of Coronary
Angiography arzdOutcome 1095-58*522A
Improved Ischemia Detection by Combination of
Pbysical mrdMental Stress Testing 985-26.
261A
Interpretation of MyncardiaJPerfusion T1-201
SPECT Scans Using the Internet: A Technical
Feasibility Study 1073-57.482A
Interpretive Correlation of Myocardial Perfusion
TI-201 SPECT Scans Using the Internet: A
Clinical Feasibility Smdy 1026-115*342A
Is It Necessmy to “Miss” Acute Myncardial
Infarction in the ER? 81O-3O4O4A
Is Nonsustained VentriculwTachycardiaAssociated
With Ischemia During Stress Testing? 966-73*
165A
Is There Justification for Follow-Up Symptom
Limited Exercise Myocardial PerfusionStudies
Late Postmyocardial Infarction? 746-6.197A
Ischemia and Infarction Contribute to Right
VentriculruDysfunction Noted 10 to 20 Yearz
After the Mustard Operation for Transposition
of the Great Arteries 794-1l385A
Lack of Gender Differences in Tc-99m Sestamibi
TomographicMyocardial Perfusinn Images
Obtained With Attenuation Correction and
Enhanced Acquisition Methods 1OO5-96.3O3A
Left Main Coronary Disease: Increased Sensitivity
With Quantitative Attenuation Corrected SPECT
Perfusion Imaging 1005-91.302A
Left VenrncularEjection Fraet@nFrom Gated
SPECT Thallium Imaging: Comparable to RNA
and Superior to Cardiac Cath 985-29.262A
Leti VentricularEjection Fraction inpatients With
Normal and Distorted Left Ventricular
Genmetry: Three-Dimensional
EchocardiographyVersus BiplarreMndified
Simpson’s Methnd With Comparison to
Radionuclide Azrgiography 705-3.57A
Long-TermPrognostic Utility of Stress
Technetium-99mSestamibi Myocardial
Perfusion Tomographyand Coronary
Angiography in Coronary Artery Bypass
Surgery Patients 768-2.227A
Maximum Likelihood Restoration of Artifactually
Reduced MyncardialUptake Due to Intense
Hepatobiliary Activity 1OO5-95.3O3A
Myocardial Blood Flnw Vs. Tracer Uptake
Characteristics of PerfusionTracers During
DobutamineStress 105O-159.442A
Myocardial Uptake of 99Tc-N-NoetFollowing
Reperfusion in Acute Myocardial Infarction:
Comparison to TI-201 1026-111.342A
Negative Survival Impact of Female Gender and
ExtensiveMyncardial Hypperfusion in
SyndromeX: A Multicenter Study 747-1.197A
NormaJRest TetrofosminSPECT Imaging in
Patients With Chest Pain arrdNormal or
NondiagnosticECG in the Emergency
Department Is Associated With Lower Need for
SubsequentCardiac Catheterization arrd
Revascularization 746-1.196A
Nuclear CardiologyTelemedicine:Evacuationof
Results After 11Months arrd531 SNdieS
1095-63*523A
Outcome of Diabetic Patients With Intermediate
Pre-Test Probabilityof Coronary Artery Disease
Using Exercise SPECT Tballium Imaging
1073-56*482A
Paradoxical ScintigraphicUnderestimationof
Ischemia in Patients With a More Severe Infarct
Related Stenosis 1026-110.341A
PET Evaluationof MyocardialNorepinephrine
Uptake in Idiopathic Dilated Cardiomyopathy
1002-I02*295A
PET Mismatch Identifies Patients at Risk fnr
ArrhythmiaDeath 10354I5*413A
PET MyocardialPerfusion Imaging Significantly
Reduces the Cost of Coronary Disease
Management 1047-141o435A
Pharmacneconomicsot’Adenosineand
Dipyridamole in Myocardial Perfusion Imaging
1095-61l522A
Prediction of Improvementof Global Function After
Revascularizationin Patients With IschernicLeft
Venticular Dysfunction:Detection by
F18-Fhrorn&oxyglucoseSPECT 788-6.377A
Prediction of Outcome After Cardiac
TransplantationUsing Exercise SPECT
PerfusionImaging 940-97.120A
Predictive Valueof PET Blind Flow/Metabolism
Mismatch in Patients With Type H Diabetes
Mellitus 1047-143.435A
Predictors of Cardiac Catheterization in a
Multicenter Registry of Stable Angina Patients
1095-6O*522A
Prognosis in Patients With Left Bundle Branch
Blnck and Normal DipyridamoleThallium-201
Scintigraphy 105O-156.441A
Prognostic Impact of PharmacologicalStress
Testing: Head-to-HeadComparison Between
Echncardiographyand Myncardial Perfusion
Scintigraphy 1025-87*339A
Prognostic Influenceof Viable Myocardiumin
Patients With Left VentricularDysfunction Is
Independentof Late Potentials 972-16*237A
Prognostic Valueof Dobutamine-AtropineStress
Electrocardiographyin Patients With Chest Pain
and Normal Resting Electrocardiograms 934-57
l111A
Prognostic Valueof RadionuclideVentriculography
With Inotropic Stimulation in Patients With Left
VentricularDysftmction 1073-51.481A
Prognostic Valueof Resting Left VenwictdarEjection
Fraction Early Following Successful Coronary
Artery Bypass Surgery 952-122.140A
Qualitative and QuantitativeComparison of
Sestamibi SPECT Withnut and With Attenuation
Correction for Detwtion of Coronary Artery
Disease in Patients With Large Bndy Habitus
1OO5-9O*3O2A
Quantitationof MyocardirdF-18 Denxyglucose
Uptake Predicts WaOMotion RecoveryAfter
Revascularization 931-77*104A
Quantitative AdenosineThallium-201Single Phnton
TomographyAccurately Predicts Risk
FollnwingAcute Myncardial Infarction:Tbe
Results ofa ProspectiveTrial 768-5.228A
Quantitative Assessment of the Effects of Acute
Ischemiaon Myncardium in Unstable Coronary
Artery Disease by Fatty Acid Metabolic
Imaging 746-5.197A
Regional Thickening on Gated Tomographyfor
Detection of Reversible Ischemia in Severe
Stress Perfusion Defects: Comparison With
Resting and 24-Hour Redistribution
ThaUium-201Images 985-48.263A
Regional Variation in Rates of Cardiac
Catheterization in Stable Angina Patients
Undergoing Myocardial Pertusion Imaging
1032-38*349A
Relation Between Regional Contraction and
Perfusion During Stress and 15 to 45 Minutes
After Stress in Ischemic and Nonischemic
Myocardial Regions 1026-113.342A
Simultaneous Myoardial Blond Flow Estimation
Using 13H-NH3-PETarrdthe Argon Inert Gas
Tecfmiquein Humans 1047-142.435A
SPECT Myncardial Perfusion Imaging in Patients
Wbo Have Undergone Coronary Artery Stenting
768-4.228A
Sustained Myccardial Metabolic Damage After
Coronary Reperfusion: One-Year Follow-Up
Study Using IZ.1.BMIppSPECT 1026-112*
342A
Technetium-99mSestamibi Infarct Size Predicts
Mortality 746-3o 1%A
Technetium-99m-TetrofosminMyocardial SPECT:
Evaluation of Two Different Protocols in Daily
ClinicaJ Practice 985-27.261A
Thallium-201 Rest-Redistribution SPECT to Predict
Improvementof Global Ventricular Function
After Revascularization 788-2.377A
The Added Diagnostic Value of Automated
Quantitative Tc-99m Sestamibi SPECT for
Detection of CormzaryArtery Disease 985-30.
262A
The Diagnostic Value of TrcadmiOExercise First
Pass Regional WaOMotion Analysis Combined
With Tc-99m Sestarnibi SPECT for Detection of
Coronary Artery Disease 985-47.262A
The Measurement of Myncardial Blood Flow With
Positron Emission TomographyIs Highly
Reproducible 1047-144.435A
The Myncardial Ischemic Burden in Silent and
Painful Exertional Ischemia by ‘gmTc-Sestamibi
Tomography 1035-48*414A
The Physiological Circulatory Response to
Combined Pbysical Exercise and Mental Stress
736-6.183A
The Severity nf Coronary Artery Calcification by
Ultrafast Computed TomographyPredicts
Patients With Stress-Induced Myncardial
Ischemia 800-2.393A
Validationof An Autnmated Methndnlogy for
Determining Left Ventricular Ejection Fraction
From Gated SPECT 98549.263A
VaIneof Myncardial Perfusion Tomographyin the
Assessment of Poststenting Coronary Restenosis
768-3.22SA
Receptors,@adrertergic
Different Molecular Changes in the &Adrenergic
Signal Tmnsductinn Pathway in Primary and
SecondaU Cardiac Hypertrophy 1029-166.
346A
Large Artery Stiffness and Beta Adrenergic
Relaxation in Aged Rats 951-133*140A
Skeletal Muscle B-Arenoreceptors Cbanges in
Chronic Heart Failure: A Beneficial Effect of
~-Blockade Therapy 1040-28.422A
Unchanged Function and Density of
SR-Ca2+-Release Channels in the Failing
Human Myocardium Compared to Nonfailing
995-64*283A
Receptors, endogenousubstances
Abnormal Endothelin-1 Sensitivity With
Preservation of Nitric Oxide Activity in Patients
With Syndrome X 743-6.193A
Cardiomyocytes From Infarcted Rat Heart Manifest
Functional Downregulation of the Arginine
Vasopressin-Vla Receptor 104O-27.422A
Cardiovascular Actions of Steroid Hormones:
Purificationand Sequencing of the First putative
Steroid Membrane Receptor 703-3.54A
KEK. Abstract title, Session-abstractnumber l page number
JACC February 1997 SUBJECT INDEX 657A
Early Refractoriness of Platelet GPIIb-IIIa in
Myocardial Infraction Survivors 988-102.
26SA
Endogenous Induction of Plaaminogen Activator
Inhibitor in Rabbits by Angiotensin II and Its
Hexapeptide (3-8) Fragment 941-145.123A
Modulation of Platelet Neutrophil Interaction With
Pharmacological Inhibition of Fibrinogen
Binding to Platelet GPIIb/IIIa Receptor
960-111l154A
Peptides Corresponding to Both 61 arrd
Muscarinic-2 Receptors Induced Hypcrtrnphic
Cardiomyopathy in Rabbits 995-65.283A
Proteinase Activated Receptor-2 (PAR-2)Mediated
Mitogenic Responses Are Induced by Human
Mast Cell Tryptases 1074-125*484A
Srmng Positive and Negative Cis-Acting Elements
Control EndotftelinB Receptor Expression
1074-121.483A
The Apoptosis Receptor FAS Is Upregtdated in
AerialMyocardium in Patients With Congestive
Heart Failure 703-4.54A
Reentzy
Demonstration of Sustained Reentry in the Mouse
Heart 1019-99*33OA
Generation aad Maintenance of Reentrant Wave
Fronts During VentricularFibrillation in Human
Hearts With Dilated Cardiomyopathy:Role of
NonuniformAnisotropy 408-5.4A
Mechanism of Onset of Induced Sustained Atrial
Fibrillation in the Canine Sterile Pericarditis
Model 982-123.255A
New Insights Regarding the Atrial Flntter Reentrant
Circuit in the Canine Sterile Pericarditis Model
982-121.254A
Route to Chaos in VentricularFibrillation Revealed
by Tissue Size Reduction 406-3.2A
Timing of Shock During Atrial Flutter Cycle
Predicts Outcome of Internal Cardioversion
1069-105*473A
TransmembmnePotential Properties of Cells at the
Core of Reentry in Isolated CatrineRight Atria
982-1M*255A
Rehabilitation
Differential Effects on Peak Oxygen Consumption
and Anaerobic Threshold Dnring High- Versus
Low-FrequencyExercise Training in Patients
With Coronary Artery Disease 789-2.378A
Effect of Arterial Baroretlexes on Exercise Capacity
in Patients With Recent Myocardial Infarction
989-105*269A
Effect of Exercise Training in Postmyocardial
Infarction Heart Failure: One-YearFollow-Up
With Magnetic Resonance Imaging (MRI)
789-1.378A
Effects of Exercise Intensity on Short-TermExercise
Training in Patients With Acute Myocardird
Infarction 989.109.27OA
Effects of Exercise Training on Maximal and
Submaximal Enduprrce Capacity in Men Witb
Congestive Heart Failure 1098-I59o527A
Effects of Physical Training on QT Dispersion arrd
Heart Rate Variability in Patients With Acute
Myocardial Infarction 1034-56.413A
Factors Predicting Attendance at Cardiac
Rehabilitation 101O-138*31OA
Metabolic Abnormality of Calf Skeletal Muscle Is
Impmved by Localized Muscle Training
Independent of Blood Flow in Chronic Heart
Failure 1098-156.526A
Moderate Exercise Training Improves Metabolic
Activity artd ContraclOityof Dysfunctional
Myocardium in Patients With Chrmtic Coronary
Artery Disease 972-17.237A
Montreal Heart Attack Readjustment Trial
(M-HART): A Randomized Trial of
Psychosocial Intervention Following Myocardial
Infarction 1057-8.452A
Oxygen Extraction During Exercise Predicts tbe
Improvementof Exercise Capacity After
Cardiac Rehabilitation for Acute Myocardial
Infarction 989-107.269A
Probability of Being Employed ‘AVOYearsAfter
Myocardial Infarction 1057-9.452A
Prognostic Significanceof Moderate Exercise
Training in Chronic Heart Failure 1041-24.
425A
Short-TermPhysicrdTraining ImprovesExercise
Hemodyrtamicsby Reducing Exercise-Related
Left VentricularDilatation in Postmywwdial
InfarctionPatients 789-5.379A
SpontaneousChanges in Exercise Capacity
FollowingMyocardirdInfarctionand CABG:
Reduced Vs. Preserved Leti Ventricular
Function 789-3.378A
Renal circulation
Bilateral Renal Artery Stenosis Can Be Effectively
TrcaeedWith Palmaz’”Stent Revasc&arization
1075-14O.486A
Effect of Aderrosineon the Renal Circulation in
%dWS With Chronic Heart Failure 7834.
370A
Increase in Renal Blood Plow With External
Counterpulsation 1014-I57*318A
RenrdArterial Stenting: A Six-YearSingle Center
ExperienceWith a Series of 151Stented
Arteries 763-3.221A
Renal DysfmrctionIs a Ponr prognosticatorof
Patient SurvivalAfter Palmaz”’Stent
Revascrdnrizationfor Renal Artery Stenosis
1075-139.486A
Renal function
Acute Hemodynarnicand Renal Effects of the
Endothelin-1Receptnr AntagonistTAK-044in
PatientaWithout Heart Failure 1052-132.444A
Current CornrrmrrityPractices in Heart Failure:
Understandingthe Undemtilization of
Angiotensin-ConverdngEnzyme Inhibitors
1017-141*325A
Design, Synthesis, and In VivoActions of a Novel
Chimeric Peptide toB-Type (BNP) and C-Type
(CNP) Natriuretic Peptides 1074-118.483A
DnbutamineEchncardiographyfor Cardiac Risk
Stratificationin PatientaWith Chronic Renal
Disease: What Is the Warrantyon a Normal
Study? 753-4*207A
Does Renal Function ImproveFollowingDiagnosis
of MalignantPhase Hypertension? 754-60209A
Effects of arrOral, Nonpeptide, Selective Vz
Receptor VasopressinAntagonist in Patients
With Chronic Heart Failure 727-1.169A
Effects of Large Doses of Contrast Medium in
Complex CnronaryInterventions 928-13.97A
Episodic pulmonary Edema (CHF) in Association
With Global Renal IscherniaFrom Renal Artery
Stenosis (RAS): SuccessfulTreatment by Renal
Artery Stenting (PTRA) 1075-I41.486A
High Plasma HomocysteineIs a Risk Factor for
VascularComplications of End-StageRenrd
Disease and Enhances the Adverse Effects of
Smokingand Diabetes 943-135.126A
High Rate of Restenosis FollowingCoronary
Angiopkwtyin Patients With Chronic Renal
Failure 1037-82.418A
High-HomocysteineConcentrationa Risk Factor for
AtheroscleroticComplications of End Stage
Renal Disease May Be Normalizedby High
Doses of Folic Acid 919-68.43A
Increased QT IntervrdDispersion Following
Postdialytic Decrease of Potassium and
Magnesium: A Model to Study the
DepolarizationChanges Associated to
Electrolyte Abnormalities 737-6.185A
Lack of Renal Functional Reserve in Patients With
Mifd Heart Failure 783-10369A
Phartrtacokinetic,Blood pressure, mtdRenrdEffects
of Cyclosporine SandimmuneVersusNeoral
Formulation in Heart TransplantRecipients
1086-178.5O7A
Progression of Unilateral Renal Artery Stenosis Is
Associated With Deecriorationin Renal
Function 987-92.266A
Renal Artery Stent Placement: Cliaical Utility in the
Treatmentof Renal Artery Stenosis 1053-13*
446A
What Predicta Contrast NepbmpathyAfter Coronary
Intervention?Insights From the IMPACTII
Trial 1082-1OO5OOA
Renin
Activation of the Cardiac Renin-Angiotensin System
by Adenoviral Gene Delivery 703-1.53A
Deleterious Actions of Dietary Sodium Restriction
Upon the Progression of Experimental
Congestive Hart Failure 976-152.244A
Endogenous Induction of Plasminogen Activator
Inhibitor in Rabbits by Angiotensin II and Its
Hexapeptide (3-8) Fragment 941-145.123A
Nitric Oxide Inhibition and the Renin Response,to
Furosemide in Man 706-6*59A
Reperfuaion
A Prospective MuMcenterTrial Using the JJIS
Heprin-Coated Stent for Primary Reper-hrsionof
Acute Myocardial Infarction: In-Hospital and
30-Day Results of the PAMI Stent Pilot Trial
797-3.389A
Abnormal Perfusion During Acute and Delayed
IneracoronaryMyocardial Contrast
EchocardiographyAfter Myocardial Infarction:
Comparison With Thallium SPECT and
DobutarnineEchocardiography 1073-53.482A
Assessment of Vasculararrd Cellular Integrity in
Reperfused Infarcted Myocardium Using
Gadolinium-EnharrcedMR Imaging 800-4.
394A
Attenuated Success Rate of Tbmmbolysis for Acute
Myocardial Infarction by Reduced Endogenous
Fibrinolysis 962-91.156A
Can Community Hospitals Provide Effective Primary
PTCA Coverage at All Hours? 925-40*91A
Chronic Alcohol Use Attenuates
IschemiziReperfusion Injury by Activation of
Adenosine Al atrd Not A2 Receptors 1055-33.
449A
Delayed Beneficial Effects of Nitric Oxide Against
Repcrfusion Induced Coronary Endothelial
Dysfunction in a Heterotopic Rat Herat
TrarrsplantationModel 91O-173.27A
Detection of “No Reflow” Zones in Reperfnsed
Myocardial Infarction: MR Contrast Agents
Verzusa Standard FhrorescentTracer 1055-35.
449A
DiveraeEffects of Spontaneous Coronary
Repcrfusion on VentricularArrhythmia in Acute
Myocardial Infarction 1OO1-79*293A
DcKssIschernicPreconditioning (1P)Require
Repcrfusion Before the Sustained Ischemia?
901-31*11A
Early ACE-InbibitorTherapy Enhances the Benefits
of Late Coronary Artery Reperfusion on Infarct
Expaasion 1079-113.493A
Early NoninvasiveAssessment of Repertlrsion by
Myoardial Protein Release Patterns 791-2.
381A-----
Effect of Ischemia rmdReperfusion on
LysoplaamalogenAccumulation in an In Vivo
Canine Model 1055-34.449A
Effects of Residual Flow on the Recovery Room
Myocardial Srtrnaing:A Myocardial Contrast
EchocardiograpbicStudy 902-4.13A
Flow in Culprit Arteries Following PTCA Is Faster
TharrThat in Nonculprit Arteries: Timing and
Magnitude of Hyperemia 905-22*18A
HeterogeneousReperfusion, Assessed by Myocardial
Contrast EchocrrrdiographyDuring Myocardial
Infarction, Is Associated With a Substantial
Delayed Recovery of Wall Motion 1072-300
480A
ICAM-1 mRNA Expression in Ischemic and
Reperfused Canine Myocardium 1055-31.
448A
Increased Myocardial Uptake of 2-Deoxyglucose
During Reperfusion: Role of the Tramlocation
of GLUT4 945-360130A
Inhibition of Nitric Oxide Synthesis Prevents
Myocardial Stunning Following Repetitive
Ischemia in the Intact Canine Heart 945-37.
130A
Is Continuous ST Monitoring aBetter Predictor of
Outcome Than Enrolling Electrocardiogram in
Acute Myocardial Infarction? 1044-106o431A
Is the Benefit of Emergency PTCA for Acute
Myocardial Infarction Negated by Early
Reocclusion Before Discharge? 925-38*90A
KIW Abstract title, Session-abstractnumber. page number
658A SUBJECT INDEX JACC Febt-uary 1997
Late Coronary Artery Reperfusion Has Additive
Beneficial Effects on Infarct Expansion When
Combined With Early Angiotensin Converting
Enzyme Inhibitor Therapy Postmyccardial
Infarction 971-9*23SA
Microvascular Protection Witb Intravenous
NicomrrdilAugments Myucmdial Salvage in
Patients With Acute Myocardial Infarction
947-12.134A
MorroclonalAntibody toC5 Inhibits C5a And C5b-9
Generation Without Inhibition of C3 Cleavage
and Significantly Limits Myocardial lschemia
and Reperfusion Induced Tissue Damage
988-96*267A
Myoglobin and Troponins for Noninvasive
Assessing of Coronary Repmfusion After
Thrombolytic Therapy 738-5.186A
Nonblack Minorities and Outcome in the National
Registry of Myocerdial Infarction 2 (NRMI 2)
1078-105*49OA
Open Artery Reperfusion Produces Distinct Patterns
of Myocardial Blood Flow-Glucose Metabolism
Mismatch 1055-36*449A
Oxidative Stress Due to NO-Peroxynitrite Pathway
Is Involved in a Canine Model of Myocardial
Stunning 945-34.129A
Persistent Myoglobin Elevation Is Associated With
Slower Flow in Patent Culprit Arteries
Following Successful Thrombolysis 946-21.
132A
Postiscbemic Myocardial Contractile Dysfmrctionin
the Double Heart Model: Role of
Catecholamines 990-34*272A
Predictors of Slowed Nonculprit Blood Flow Post
Thrombolysis 946-3.131A
Recovery of Initially Impaired Myocmdial Perfusion
ISFrequent After primary ~CA for Acute.
Myucardial.Infarction 946-24*133A
Regular Ethanol Consumption Protects Against
MyocardirdIschemia-Reperfosion Injury by
Activation of Protein KirraseC 901-33.llA
Restoration of Myocardial Blood Flow and
Functional Improvementin Patients With Acute
Myocardial Infarction by a K+-ATPCharmel
Opener, Nicorandil 947-8. 133A
Role of Endogenous Angiotensin II in Glucose
Metabolism and Recovery of Postischemic
Mechanical Function During Reperfusion in
Isolated Working Rat Hearts 958-40*150A
Safety and Feasibility of Primary Stenting in Acute
Myoardial Infarction: In-Hospitaf and 30-Day
Results of the PAMI Stent Pilot Trial 797-4.
389A
Serum Lipoprotein (a) Level Is Related to Thmmbin
Generation and ComrraryPatency During Acute
Myo=cardialInfarction 964-85*160A
Stable Cardiodeper’essantMediatO~ Are Released
After Myncardial Ischemia During Reperfusion
1055-32*448A
Stent-Assisted Direct Balloon Angioplasty for Acute
Myocardial Infarction: Clinical and
Angiographic Follow-Up 903-9014A
Sustained Myncardial Metabolic Damage After
Coronary Reperfusion: One-YearFollow-Up
Study Using IZ31-BMIPPSPECT 1026-112*
342A
T Wave Changes After Re~fised Acute
Myocardial Infarction: A Marker of Infarct Size
1078-I27*492A
Temporal Distribution of Important ECG
Information in Patients With MI: When Should
YouTake the Next ECG After Lytics? 946-6.
131A
The Effect of a Low-MolecularWeight Supemxide
Dismutase Mimic on Infarct Size and L@I
VentricularFunction in a Canine Model of
Myocardial Infarction and Reperftrsion 712-6.
68A
The Effect of Regional Variationand Payer Stares in
the Utilization of Acute Reperfusion Therapy
for Acute Myucardial Infarction: Results From
the NRMI 2 781-5.367A
The Paradigm for Antiplatelet Effect on Continuous
12-LeadST-SegmentRecovery in Acute
MyocasrfialInfarction 738-3.185A
What Is the Clinical Outcome and Impact of
Revascularizationof TIMI 2 Plow Following
Acute MyocrrrdialInfarction? 797-2.389A
Depolarization
AbnormalMyocardial Adrenergic Innervationin
Patients With Acquired Long QT Syndrome
Using I-123-Metaicdoberrzylgmmidine737-3.
184A
Body Surface Mapping of DepolarizationPotentials
in Patients With ArrhythmogenicRight
VentricularDysplasia: principal Component
Analysis of the ST-TWaves 934-54.lIOA
DifferentialEffects of D,I-Sotalol and D-Sotalol on
IsoprerralineIncreased Delayed Rectifier
Outward K+ Current in Guinea Pig Myocytes
1019-1CO.33OA
Dual Inhibitoryand Stimulator Effects of the Class
111AntiarrbythmicAgent Bertosamil on
Voltage-ActivatedK+ Current of Human Aoial
Myocytes 1090-870513A
Effects on Depolarizationof the Chromanol 293B, a
Highly Selective Blocker of the Slow
Componentof the Delayed Rectifier K+ Current
(IKs) in Hmnanand Guinea Pig Ventricle
109O-83*512A
ExaggeratedDispersion of P-Ta and Ta-T Interval as
a Predictnr of AerialFibrillation 742-4.191A
Influenceof AutonomicToneon Circadian Variation
of Dispersion of Repd+rization and the QT
Interval 7374.184A
Influenceof Electrolyte Abnormalityon Interlead
Variabilityof VerrtricuhwDepolarizationTimes
in 12-LeadECG 956-163.148A
Lack of Association Between T WaveAltemans and
QT Dispersion in Patients at Risk for Sudden
Cardiac Death 722-4.81A
MyocrtrdialTissue Concentrationsof Amiurfarone
and DesethylamiodamneAfter Chronic
Treatment:Correlation With Local Action
PotentisdDuration 1027-178.344A
QTDispersion in Healthy Subjects 1088-I34.5O9A
QT Dispersion: Effects of T WaveEndpoints
956-164. 148A
Spatial and TemporalEffect of the Activation
Sequenceon the Re@wization Pattern Studied
by a New ElectroanatomicatMapping System
109O-93*514A
The Correlation of Left VerrtricularMaas QT
Dispersion in HypertensivePatients 965-99.
162A
Reatenosfa
A Missense Mutation of the eNOS Gene in Patients
With Coronary Heart Disease and Its Possible
IntemctionWitb ACE f/D Gene Polymorphism
for CormraryRisk 941-147.123A
A New Animal Mcdel for Remodeling FollowedUp
With Magnetic Resonance Imaging 1023-109.
337A
A RandomizedStudy of Cutting Ballmm Verxus
ConventionalBatloon Angioplasty:Pmliminmy
Results 713-6.69A
A RandomizedTrial for Treatmentof Unstable
Angina in Patients With Restenosis
Postcomnary Angioplasty 760-4.217A
Abciximab (ReoPru, Chimeric 7E3 Fab)
Cross-Spcificity With CZ,B3IntegrinReceptors:
A Potential Mechanism for the Preventionof
Restenosis 975-70.243A
Accelerated Endotlrelializationby Local Delivery of
RecombinantHuman VEGF Reduces hr-Stent
Intimal Fomration 7194.77A
AdenovirrdGene Transfer of Human Constihrtive
EndothelialNitric Oxide Synthase to Injured
ComrratyArteries 790-5*380A
AdriamycinInduces Apuptosis and Antiproliferative
Effects in Smooth Muscle Cells Fmm Human
Restenotic Lesions 1039-102.421A
Adventitia Is the PredominantSite of
Antisense-c-mycDelivery to Porcine Corona~
Arteries by Eacb of Four EndovascularDelivery
Catheterx 749-3.201A
Age of Saphenous VeinBypass Graft Does Not
Predict Need for TargetVessel Revascularization
Following PercutaneousIntervention 928-7.
96A
Angiography Versus Irrtmvascular
Ultrasound-Directed Stent Placement 7074.
60A
Angioscopic Predictors of Restenosis in Stented
Comnagf Vessels 719-2.77A
Are ACC/AHA Lesion Characteristics Predictive for
Late Angiographic Results After ComrraryStent
Placement? 973-65.239A
Are Randomized Trials Necessary to Assess
Long-TemrOutcome With New Devices for
Coronary Intervention? 108O-32.49SA
Arterial Remodeling After Directional Coronary
Atherectomy: A Volumetric Analysis Fmm the
Serial Ultrasound Restenosis (SURE) Trial
994-43*2130A
Association of Transfomring Growth Factor-Beta
Isoforms With Coronary Plaque in Patients With
Coronary Ischemia 961-121.155A
Atherectomy Specimens Obtained From Patients
With Restenotic Lesions Reveal Higher
Monocyte Chemoatractant Protein-1 Levels
Than Those With De Novo Lesions 790-4.
380A
Atherosclerosis Progression in Subjects With and
Without Postangioplasty Restenosis in QUIET
1038-7O.418A
Beta Irradiation for Restenosis After Stent
Impkuration:Dose VariationsAmong Differing
Stents 973-59.238A
Biodegradable Stent Coating With Polylactic Acid,
Hinrdin, and PrnseacylinReduces Restenosis
973-61l238A
Carotid ActeryInjury Induction of Inducible Nitric
Oxide Synthase Contributes m Neointimal
Hyperplasia in Interferon Regulator Factor-1
Knockout Mice 701-2*51A
Cessation of Smoking and Lowering of
LDL-Cholesterol Both Reduce Restenosis
Following PTCA 1054-11.448A.
ChrmricCoronary Arre~ OccIusion: Reduction.of
Restenosis- and Reocclusion-Rates by Stent
Treatment 802-3.3%A
Clinical and Angiograpbic Outcome of Directional
Coronary Atherectomy (DCA) and
Palmaz-Scbatz Stent Implantation for Ostial Left
Anterior Descending (LAD) Coronary Lesions
1060-131l457A
C1inicaland Angiographic Restenosis After
Coronary Stenting Incidence and Predictors
973-67.239A
Clinical Evaluation of the CororrmyPullback
Atherectomy Catheter: procedural Results and
Late Clinical Follow-Up 106O-15O.458A
Combined Alpha v Beta 3 and Platelet IIh/fIIa
hrtegrin Blockade Potently Limits Neointimal
Hyperplasia and Lumen Stenosis in the Porcine
Coronary Injuty Model 701-4.51A
Comparison of Stents Directional and Rotational
Atherectomy,With Ballnar Angioplasty for
Restenotic Lesions in Native Coronary Arteries
1081-24.497A
Computerized, Automatic Pressure Sensor and
Inflator Device (CAPSID): A New Technique
for Safer, Gradual Dilatation of Cororrnry
Stenosis and PTCA Pressure VolumeCurve
Analysis 928-10*96A
Contemporary Percutaneous Treatment of
Unprotected Letl Main Coronary Stenoses: An
Update Fmm the ULTIMA Registry 802-2.
3%A
Contdbution of Neointima and Adverrtitiato Final
Lumen Area in Human Coronary Arteries
Treated by Balhmn Angioplasty: A
Histopathologic Analysis 749-2*200A
Coronary Intervention in the Diabetic Patient:
ImprovedOutcome Following Stent
Implantation Versus Balloon Angioplasty 740-2
.188A
Coronary Stent Placement in Ostial Lesions:
Six-Month Clinical and Angiographic
Fo11ow-UP904-29.16A
Coronary Stent Thrombosis: Management and
Long-TermFollow-Up Result 728-6. 171A
KEY. Abstmct title, Session-abstractnumber. page number
J A CFebruary 1997 SUBJECT INDEX 659A
CormraryStenting in the Diabetic Patients: Early and
Follow-Up Results 1059-146.455A
Counseling Patients on Likelihood of Restenosis
Following Coronary Angioplasty: Trial Data
VersusClinical Practice 792-4.382A
Decreased Neointimal Proliferation by Inhibition of
VonWillebrand Factor Function 701-5*52A
Determinants of Restenosis in Complex Lesions
Treated by Rotational Atherectomy 1012-10.
314A
Directional CormuwyAtherectomy Is Superior to
PTCA for the Treatment of Palmriz-SchatzStent
Restenosis 713-2.68A
Distinct VasculurResponses to Injury in Carotid
Arteries Frnm Two Subserainsof
Sprague-DawleyRats: Role of Apuptosis Versus
Proliferation in Intima and Adventitia 790-1.
379A
Dries Diabetes InfluenceClinical Recurrence After
Coronary Stent Implantation? 740-4.188A
Does High-Pressure Stent Expansion Induce More
Restenosis? 782-1.368A
Does Lucal Iontophoretic Low-Molecular Weight
HepurinDelivery Reduce Neointimal Fonuation
After Stenting? 973-62.238A
Does the Use of Aggressive Stent Dilatation Lead to
More Late Luss and Restenosis? 782-2.368A
Doesn’t Diseased HummrCormrmySaphenous Vein
Bypass Grafts Undergo Compensatory
Enlargement? An Intravascular Ultrasound
Study 733-4.178A
Effect of Endovascular Stent Design on
Experimental Restenosis 975-53.242A
Effect of Intmcoroorwy‘gzh’ridium(1g21r)OnLate
Quantitative Angiograpbic Outcomes After
~CA 1038-72*418A
Effect of Latent Cytomegalovirus Infection of Rats
on the Neointimal Response to VascularBalloon
Injury 1039-94.42OA’
Effect of Stcnt Symmetry and Vascular Injury on
Restenosis in Coronary Stenting in the Animal
Mudel 10114 *312A
Effectivenessof Prnbucol in Preventing Restenosis
After Percutaneous Transluminal Coronary
Angioplasty in Small-Sized Cormrar’yArteries:
A Subgroup Analysis of the Probucol
Angioplasty Restenosis Trial (PART) 1038-73.
418A
Effects of p+ Emitting V“ ACT-OneNitinol Stent
on NeointimrdProliferation in Pig Comnruy
Arteries 973-58.237A
Effects of CS1 Peptide in a Porcine Coronary Model
of Restenosis 975-56.243A
Effects of Sonication With Catheter-Delivered
Low-FrequencyUltrasound on Proliferation,
Migration, and Drug Uptake of VasculurSmooth
Muscle Cells 975-54*242A
EndoluminalVersus Periadventitial Delivery of
AntifibrunectinAntibodies Implications for
Lucal Arterial Wall Delivery 1039-96*42OA
Estrogen Replacement Therapy Reduces Repeat
Revasc@ization in Postmenopausal Women
After InfracoronuryStenfing: A Long-Term
FOROW-UP1059-143o454A
Expression of Collagen mrdElastin Afeer’Coronury
Injury 1039-101.421A
Expression of Nonmuscle Myosin Heavy Chain-B
Afler Balloon Angioplasty in Atherosclerotic
YucaednMicrnpigs 975-52.242A
ExtraCellularMatrix Remodeling in Restenotic
Human Coronary Atherosclerotic Plaque of
Balloon AngioplrWy 1039-99o421A
High Pressure Increases Lute Loss After Coronary
Stenting 782-5*369A
High Rate of Restenosis Following Coronary
Angioplaaty in Patients With Chrunic Renal
Failure 1037-82.418A
High-Speed Rotational Coronary Atherectomy for
the Treatment qf Restenosis in COmnW Stents
1011-21*313A
Immediate and Short-TermResults ofebe Pilot Phase
of Stenting Atler Optimal Lesion Debulking
“The SOLD Trisl” 1036-85.415A
Impact of Cilostazol on Intimal Proliferation
FollowingDirectional Coronary Atherectomy:
A ProspectiveRandomizedTrird 803-1.397A
Impact of High InflationPressures on Six-Month
AngiographicFollow-UpAfter CorommyStent
Placement 782-4.369A
IncompleteRestoration of Luminal Dimensions
After PTCA in ReseenosticStented Segments:
An IntravaacuhuUltrasoundAnalysis 1011-1.
311A
Increase in Mean Platelet Volumeas Parameter for
Restenosis FollowingSuccessful Percutaneous
TranshrminalComnmy Angioplsaty 928-18*
9&4
Increased Restenosis in Diabetes Mellitus Following
TranscatbeterCoronaryInterventions Is Due to
ExaggeratedIntimulHyperplaaia 733-5.178A
Increased Tbmmbin Activity in Patients With
Unstable Ischemic SyndromesCorrelate With
Long-TermClinical Events After Angioplasty:
Lack of Efficacyof Lucally Delivered Urokinase
801-6.395A
Inductionof ProgrammedCell Death in Human
VascularSmuoth Muscle Cells Following
Exposure to ~ Irradiation 790-3.380A
Influenceof High-PressureStent Dilatation on Late
Angiographicand Clinical Outcome of
Pafmaz-SchatzStent Implantation 1011-19.
312A
Influenceof Hyperlipidemiaon Restenosis After
Coronary Artery Stent Implantation 921-113.
47A
Influenceof Lesion Length on Late Angiographic
Outcome and Restenotic Process After
Successful Srent Implantation 973-64.239A
Influenceof Lesion SeveritySix Months After
Angioplasfyon Late Lesion Regression: A
Five-year QuantitativeAngiographicStudy
993-12.279A
IntracoronaryBiodegradationof Drug Delivery
HydrogelLayers Does Not Reduce Myocardial
Blocd ROW 1013-25*316A
InrracoronarySteming for “Suboptimal”Results
Versus“Optimized” Ballnon Angioplasfyof
LAD Lesions 108O-36.496A
InrracoronmyStenting in Patients With Acute
Myocardial Infarction 1059-164o456A
IntracoronaryUltrasound Assessment of Balloun
Angioplasty in Intrastent Restenosis 973-69o
240A
IntrapericurdialNitric Oxide Donor Reduces
Neointimal and AdventitialThickening
FollowingPorcine Coronmy Overstretch 701-1
.51A -
Is Bigger Really Better? Associations Between
Excised Plaque Maas and Chronic Restenoais
AfferCoronary Atberectomy 106O-132*457A
Is Coronary Drug DeliveryWifbthe Needle
Injection Catheter Really Local? 993-11.279A
Late Tissue ProliferationBoth Within and
SurrmurdingPalmrez-SchatzSrents Is Associated
With Pmceduml VesselWall Injury 803-2.
397A
Lengfb-Dependencyof Phusphorothioate
Oligndeoxynucleotideson the Consequence
Specific InhibitoryEffects of In Vitro Vascular
Smooth Muscle Cell Prulifemtionand Migration
975-72.243A
Locul Application of PaclifuxelWith the Double
BullumrCatheter in the Rabbit Carotid Artery
1038-76*419A
Local Deliveryof Tissue Factor Pathway Inhibitor
(TFPI) to Reduce Neointimal Prnliferutionin the
Porcine Coronary Balluon Injury Medel 975-57
l243A
Local Drug Delivery to Pig Carntid Arteries by
Direct VesselWaOElectroportationUsing a
Novel Catheter 7494.201A
Lncal Infusion of VascularEndotbelialGrowth
Factor FollowingCoronrnyAngioplasty in
Swine 1039-98.42OA
Locally DeliveredVasculurEndotbelialGrowth
Factor (VEGF) Dues Not Inhibit Neointimal
proliferation in the Porcine Restenosis Model
701-6*52A
Long-TermFollow-Up of ‘Stent-Like’ Post-PTCA
Results (s30% Residual Diameter Stenosis) in
the Restenotic Lesions: Results of the REST
Trial 719-3.77A
Long-TermFollow-Up of Takayaau’sDisease 761-4
.218A
Luw-Dose ~-Emitting Radioactive Stents Inhibit
Neointimal Hyperplaaia in Porcine Coronary
Afieries: An Histological Assessment 973-60.
238A
Mitogenic Effect of Semtonin on Vsacuku Snruoth
Muscle Cells Is Potentiated by Low-Density
Lipoproteins 964-65.159A
Mmphologic and Pmcedurd Predictors of Diffuse
In-SrentRestenosis 719-1.76A
Multiple Stents Increases Target Vessel
RevascukirizationRates 992-27.276A
NatrirrreticPeptide Receptor Expression in the
Neointima at the Site of Percutaneous
TmnshrminrdCoronary Angioplasty 975-55.
242A
Optimal Coronary Balloon Angioplasty Vs. Stent
(OCBAS): Preliminary Results of a Randomized
Trial 1011-2.311A
Optirnsl Coronary Steneingin Diabetics: A Viable
Percutaneous Alternative to Cardiac Surgery
1059-144.455A
Outcome of Coronary Stenting in the Real World
108O-35.4%A
Oversized Balloons, Low Inflatinn Pressure, and
Prolonged Corunary Dilatation Strategy Results
in Dramatic Improvements in Angioplasfy
Results and ReseenosisRate: Early and Late
Results 928-12.97A
Pathological Changes at Site of Coronary Stenting in
Humans 1011-5.312A
Platelet GlycnproreinIIb/IIIa Monoclinal Antibody
(c7E3) Inhibits Restenotic Smonth Muscle Cell
Migration and Induces Apoptosis 790-2.379A
Platelet Inhibition WitfrOral Antagoriists to
Thrumboxane, Serotonin, and ADP Reduces
Neointimal Pmliferstion in a
Hypercholestemlemic Canine Coronary
Angioplasty Model 701-3.51A
Predictors of Mitral Restenosis Following MitraJ
Balloon Valvulnplastyin 360 Patients 1037-81•
417A
Preventionof Reucclusion After Successful Balloon
PTCAof Totally Occluded ComrmryArteries: A
Pros~ctive Randomized Pilot-Study Comparing
Ticlopidine-Aspirin Association With Aspirin
Alone 801-5.395A
Quantitative Angiographic predictors of Restenosis
After the Less Shortening Wallstent
Implumation 973-68*240A
Radiation Ssfety Aspects of a Coronary Irradiation
Pilot Study Utilizing Manuully Louded Ir-192
Sources 108I-22.497A
Radiotherapy Reduces Coronary Restenosis: Late
Follow-up 803-4*397A
Restenosis After Ballon Angioplasty and Coronary
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Study 1081-23o497A
Restenosis Is Higbly Related to Collagen Content
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Restenosis MechmrismAfter Aggressive Directional
Coronary Atberectomy Assessed by
IneravasculurUltrasound in Adjunctive Ballnmr
Angioplasty Following Coronmy Atherectomy
Study 106O-129*457A
Restenosis or Recoil? The Role of Subacute Recoil
in Perceived Restenosis 1081-21l497A
Role of Adjunctive Bslloon Angioplasty Following
Comnmy Atherectomy: A Serial Intravascular
Ultrasound Analysis Frum the ABACAS Trial
994-50.281A
Rotational AeberectomyFollowed by Balkrn
Angioplasty for Treatment of Inerastent
Restenosis: A Pilot Study Witb Quantitative
Angiographyan Intracoronary Ultrasound
1081-1l498A
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Rotational Atherectomy of Right Coronary Ostial
Stenosis: Prncedure of Choice Based on
Long-TermClinical Outcome? 1081-4*498A
Safety of Intracoronary Administrationof C-myc
Antisense After ~CA 1013-3O*317A
Single Versus Multiple Palmaz-Schatz Stent
Implantation: Immediate and Follow-Up Results
992-28.276A
Single-Dose Intramuscular Administration of
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Six-Month Angiographic Follow-Up After Stetrting
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Cornnary Stenting 707-6.60A
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383A
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AtheroscleroticMndel 1039-93*419A
Usefulness of Exercise Echneardiographyfor
Prediction of Angina Recurrence After
Coronary Angioplasty 938-95.117A
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A ComparisonAfter One-YewFollow-Upof Costs,
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A ProspectiveEvaluationof the Effect of Chronic
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181A
Abciximab (c7E3) and AngiographicRestenosis
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1012-9.314A
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96A
AngiographicPattern of In-Stent Restcnosis After
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313A
Cardiogenic Shnck: SurvivalRates From the
National Registry for Emergency
CardiopulmonaryBypass Investigators 8044.
398A
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Complete MyncardialRevasctdarizationWith
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Without CardiopulmonmyBypass 952-134*
141A
ComcmpnraryPercutaneousTreatmentof
UnprotectedLefi Main ComrraryStenoses: An
Update From the ULTIMARegistry 802-2.
3%A
Coronary Artery Bypass Grafting Vs. Spinal Cord
Stimulation in Severe Antina Pectoris 972-15.
237A
Cutring BaIlcon Angioplasty Vs. Plain OId Bakmr
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Early Revasculadzation of Asymptomaticpatients
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Impmves Left VentricularRemodeling 926-25*
92A
Effect of Ionizing Irradiationon Intimal Structure
and Endothelial Function 986-75.264A
Effect of the Patency nf Infarct-RelatedArtery on
VagalReflexes 902-3.13A
Gated Technetium-99mSPECTImaging Predicts
MyocardialViability in Revascularizedpatients
788-3.377A
HolmiumLaser TransmyecardialRevascularization
(LTMR)Attenuates Myocardial Ischemia
1072-49*4SIA
Impmvement of Coronary BlcmdFlow and Function
in Hibernating MyoerrrdiumImmediately After
Coronary Artery Bypass Grafting 952-124.
140A
Impmvement of Dnbutamine-InducedWall Motion
Abnormalities in Patients With Chronic Total
occluded Coronary Artmies After
Recamdization With Laser Guidewirc 905-24.
19A
Influence of High-Pressure Srent Dilatation on Late
Angiographic and Clinical Outcome of
Palmaz-Schatz Stent Implantation 1011-19.
312A
Is Diabetes Per Se Responsible for Worse Outcome
After Angioplasty Than Bypass Surgery Among
Diabetics? 735-5. 181A
Is Laser Wire Recanahzation of Chronic Total
Occlusions Associated With a Grcatcr Risk Than
Conventional Recrrmdization? 106O-153.459A
Laser Transmyrcardial Revascularization (LTMR)
Improves Myncardial Blnnd Flow via
Collaterals 929-162.99A
IA VentricularCavity Size Predicts Time Course of
Recovery of Systolic Function After
Revascularization 1058-2.453A
Lnng-TemrClinical Outcomes in “Low-Risk” and
“High-Risk” Patients UndergoingCoronary
Stent Implantation 973-66.239A
Multiple Stems Increases Target Vessel
RevascularizatiorrRates 992-27.276A
MyncrrrdialPerfusion Imaging Following
TrarrsmymiwdialLaser Revasctdarization 716-1
l72A
No Excess MortrdityAfter ComrraryArygioplastyin
Diabetic Patients With Multivessel Disease
After Prior Bypass Surgery 1059-145.455A
Operator Volumeand Outcomes in 12,899
Percutaneous Coronary Interventions 792-1.
382A
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Predictive Valueof FOG Imaging in Patients With
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Enrolled in a Prospective European Multicenter
Viability Study 1047-147.436A
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Fraction Early Fnllowing Successful Coronary
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Randomized Study Results 931-82.105A
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235A
Results of Histomorphological and
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The “Full Metal Jacket”: procedural Results and
Late Clinical Outcomes After Placement of
Three or More Coronary Stents 740-5.188A
What Is the Clinical Outcome and Impact of
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Episcde of Atrial Fibrillation 742-6.191A
Do Individual Patients Exhibit a Consistent Pattern
of Onset of Paroxysmal Atrial Fibrillation?
1067-91*47OA
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Risk factors
677C+T Mutation of the 5,10-Methylene
Tetrabydmfolate Reductase Gene: Relationship
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Ultrasound in Asymptomadc Familial
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Risk Factor Correlates for Coronary Artery Calcium
Using E1ectmnBeam Tomographyin
Asymptomatic Men and Women 1092-67.
516A
Risk Factors for ArrgiographicExtent of Coronary
Disease 1058-6.454A
Risk Factors for VenousThrombosis in patients With
Permanent Tmnsvenous Pacemakers 1097-72.
525A
Secondary Coronary prevention After Firat
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in ASPIRE 1077-66.488A
Serum Levels of Transfomring Growth Factor+?l
(TGF+J1) Is Depressed in Women With
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Sex Differences in Cormrary Hospitalizations 813-2
.406A
ST-SegmentElevation in Leads I and aVL in Acute
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Data From the CHAOS Trial 725-5.86A
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813-1.406A
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Study (LCAS) 951-129.139A
MontrerdHeart Attack Readjustment Trial
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Infarction 1057-8.452A
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Serotonin
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141A
MitogerricEffect of Serotonin on Vascular Smooth
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Lipoproteins 964-65.159A
The Effect of Sumatriptan on the Human Coronary
Circulation 1052-149o444A
Shock
Cardiogenic ShockDevelopingWithin4gHours
AfterThmmbolysisforAcuteAnterior
MyocardialInfarctionMayBeRelatedto
HemorrhagicCardiacTamponadeWithout
Rupture903-8.14A
CardiogenicShock:SurvivalRates From the
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CardiopulmonaryBypass Investigators 8044.
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Characteristics and Outcome of Patients With
Cardiogenic Shock Due to Right Ventricular
Dysfunction: A Report From the SHOCK Trial
Registry 1061-98.46OA
Effects of Heparin Coating of Extracorpmeal
Circuits on Release of LPS Toxicity:Modulating
Proteins During Cardiopulmonary Bypass
1064-I62*465A
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1061-1OO.46OA
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Prospective Study of Prognostic Valueof
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30A
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912-16*31A
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Thoracic Surgery 742-50191A
Sigmd transduction
Brief Episode of Coronary Ischemia Induces and
Reperfusion Sustains SAP/JNK Kinaae Activity
988-93*266A
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Protein 945-31.129A
Digital Acoustic Analysis: A Cost-Effective
Alternative to Echn=cardiographyfor Evaluating
Systolic Murmurs 1022-54.334A
Hyperglycemia Impairs the Ability of Human
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Kinase C-Dependent Pathway 1OO+5-155*3O3A
Immunolncalizationof ActivatedEpsilon Protein
Kinase C in Isolated Adult Cardiomyccytes
1029-161.345A
Involvementof JmrusKinaaes (Jak) in Umkinase
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Left VentricularHypertrophyIs Associated With
Abnormal Adenosine Al-Receptor Signaling
and Adenosine-InducedProtein Kinaae C
Activation 1084-135.5O2A
Prolonged Adenosine Exposure Elicits “Admnergic
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C-DependentMechanism 929-164.99A
Proteinase Activated Receptor-2 (PAR-2)Mediated
Mitogenic Respnnses Am Inducedby Hummr
Mast Cell Tryptases 1074-I25.484A
Regular Ethanol Consumption protects Against
Myocardial Ischemia-ReperfusionInjury by
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Fibroblasts From Patienta With Essential
Hypenension 724-6.85A
The Second Messenger Inositol
(1,4,5)-TrisphosphateMediates Infarct Size
Reduction With Preconditioningin Isolated
Rabbit Heart 776-6.360A
Sinoatrial node
Detection of Cardiac AUograftAutonomic
Functional ReinnervationUsing Measures of
Heart-Rate Variability 978-171.248A
Inductionof Sinus Node Dysfunctionand Atrial
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709Jf.63A
Long-TermFollow-UpAfter RadiofrequencySinus
Nnde Modificationfor InappropriateSinus
Tachycardia 748-1.199A
Sinus Node DystinrctionFollowingModified Fontan
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Smoking
AbnormalCoronary Vasomotionin Long-Temr
Smokers Depends on Duration and Dnseof
Smoking 714-2.70A
Both Active and Passive SmokingAlter the Elastic
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Detrimental Effect of Smoking 714-1*69A
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Acute Cigarette Smoking According to the High
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Prnpafenoneas a Single Oral Loading Dose Vs.
Placebo in Recent Onset Atrial FirbirOaton:Is it
Safe? 1051-139.443A
Transient Tacbycardia Superimposed on Bradycardia
Prolongs Depolarization in Isolated Canine
VentricularMyocytes 709-3*62A
Tetralogyof Fallot
Course in tbe Intensive Care Unit After Right
Ventrimrlotomyand Neonatal Repair of
Congenital Heart Disease 932-8401O7A
Elective Primary Repair of Acyanotic Tetralogyof
FaOotin Early Infancy: Overall Outcome and
Reduced Need for TransannularPatching
932-86. 107A
Impaired pulmonary Vascular Relaxation in
Tetmlogy of Fallot 1043-66.429A
Prolonged Depolarization and Inhomogeneous
Depolarization Increase Late Sudden Death Risk
in Postoperative Tetralogy of Fallot 722-3.81A
Thmmbin inhibitors
Additional Heparin Increases the ACT and Reduces
the Likelihood of Ahnrpt Closure During PTCA
1082-12*5OOA
Are ACTSHelpful in the Management of
Anticoagulation With Low-MolecularWeight
Heparin? 959-49.153A
Biodegradable Stent Coating With Polylactic Acid,
Hirodin, and Prostacylin Reduces Restenosis
973-61.238A
Clinical Hemorrhage and Coagulation Parameters
Following Therapy With Efegatmn Versus
Heparin in the ESCALATTrial 1034-57*413A
Differential Effects of Argatrobanand Heparin on
Hemnchron and HemoTec Activated Clotting
Times in Patients UndergoingCoronary
Interventional Procedures 1082-11.5OOA
Does Cardiac Rupture Represent a Hemorrhagic
Complication of TbrombolyticTherapy and
Thrombin Inhibition? 1015-124.319A
Enoxaparin Suppresses Platelet-Dependent Thromin
Generation In Vivo Among Patients With
Unstable Angina and Non-Q Wave Myocardial
Infarction 1OO6-157.3O4A
Hepmin Is More EffectiveThan Inogatran, a Novel
Low-Molecular Weight Thrombin Inhibitor in
Unstable Coronary Disease 1033-44o411A
IntravenousArgatroban Versus Heparin as
Co-Medication to Alteplase in the Treatment of
Acute Myocardial Infarction: Preliminary
Results of the ARGAMI Pilot Study 738-4.
185A
Low-Molecular Weight Heparin VersusRegular
Heparin in the Treatment of Patients With
Unstable Angina 1033-33.4O9A
Rebound FoOowingthe Discontinuation of Heparin
Is Not Caused by HyperactivePlatelets 1033-40
l411A
The Ecwin Clotting Time but Not the aPTT Is a
Reliable Indicator for PEG-Hirudin Blood
Levels in Patients Witb Unstable Angina
Pectoris 1033-43*411A
Tbrombin Generation During Thrombolysis With
rr-PAand Conjunctive Therapy With r-Hiradin
in Patients With Acute Myocardial Infarction
1079-111•492A
Weight Adjusted Antithrombotic Regimens
Eliminate the Nitroglycerin-Antithrombotic
Interaction 1034-53*412A
l%mmboembnlism
A Prospective Study to Predict the Transition From
Paroxysmal Atrial Fibrillation to Chronic Atrial
Fibrillation by Signal-Averaged
Elecrrucardiography 912-18.31A
Clinical Validityof Normal Compression Ultrasound
for Suspected Deep-VeinThrombosis in
Outpatients 963-I03*158A
Intranasal Antiplatelet/AntithrOmbnticEfficacyof
the Platelet GPIIb/IIIa Antagonist, DMP754
960-112*154A
Large Amount of Noniotic Contrast Media Lead to
an Increasing Thrombogenic Potential After
PTCA 1OO8-162*3O7A
Lone Fossa Ovalis Membrane Aneurysm Is an
Infrequent Finding in Adulrs With
Cardioembolic Cerebral Events 1071-44.478A
No Variableon TransesophagealEchocardiography
Perfomred at the Timeof Stroke Predicts Future
Stroke of Death: A Prospective Study 757-1.
212A
Optimized Oral Anticoagularionby Patient PT Self
MonitoringManagement 1042-119.426A
Plasma Nitric Oxide Levels Are Decreased in
Patients With Atrial Fibrillation 936-108. 113A
Relation Between Time to Achieve the Lower Limit
of APTT Range and Recurrent Venous
Thromboembolismin Patients With Venous
Thrombosis 963-107. 158A
Size or Function: Wbich Correlates Best With Left
Atrial AppendagePathology? 979-166.250A
TEE for CardiovascularSource of Emboli:
Determinationof Pretest ProbabilityUsing TTE
and Presence of Atrial Fibrillation 1097-75.
526A
TransesophagealEcbocardiographicEvaluationof
Left Atria] AppendageFunction During DDD
and VVI Pacing 935-74. 112A
Thrombolysis
A Randomized Single Blind Trial of Two-Hour
Regimens of Alteplase and Streptokinase in
Acute Massive PulmonaryEmbolism 933-60.
109A
Antecedent Angina Pectoris and In-Hospital
Outcome After Myocardial Infarction in Patients
Receiving ThrumbolyticTberapy: The Second
National Registry of Myucardial Infarction
(NRMI 2) 924-36.90A
Aspirin Inhibits L-NAME Induced Platelet
Deposition on amArterial Medial Under Arterial
Flow Conditions 734-4.180A
Attenuated Success Rate of Thrumbolysis for Acute
Myocardial Infwction by Reduced Endogenous
Fibrinolysis 962-91.156A
CardiogenicSbock DevelopingWithin 48 Hours
After Thrombolysis for Acute Anterior
Myocardial InfarctionMay Be Related to
HemombagicCardiac TamponadeWithout
Rupture 903-8.14A
Catheter-Based Site-SpecificTfrrombolysis:
EnhancedClot Lysis Using a Locally Delivered
Heparin/Urokinase“Cucktail” 1013-28*317A
Determinantsof Left VentricularDilation in Patients
ReceivingTbromboiyricTherapy for
Myocardial Infarction 924-32*89A
Direct Angioplasty (PTCA) for Myocardial
Infarction in a Center With Surgical Back-Up
220 Miles Away 971-12.236A
Direct AngioplastyMay Be Less Advantageousin
Patients Presenting Early After SymptomOnset:
Results From GUSTO IIb 781-1.366A
DiscrepancyBetween AcNal Vs. Potential
Treatment in Acute Myocardial Infarction: Use
of Thromblytics, Aspirin, Betablockcrs, and
ACE-Inhibitorsin Germany 1996;MITRA
Study 903-12*1SA
Do Patients With previous CABG Have Worse
Outcomes With ThrombnlyticTherapy? 781-6*
368A
Dces Cardiac Rupture Represent a Hemorrhagic
Complicationof ThrombolyticTherapy and
Thrombin Inhibition? 1015-124.319A
HemodynarnicBenefit of Long-TermIntermittent
UrokinaseTherapy in End-Stage Coronary
Artery Disease: First Results From a Gated
Bluud Pool Study 1058-1*453A
In-Hospital Managementof Acute Myucardial
Infarction:Results of USIK, a Nationwide
French Survey 702-1.52A
Increased Platelet AggregationDuring Coronary
Thrombolysisas a Predictor for Early and Late
Reocchrsion 1079-115.493A
Increased Thmmbin Activity in Patients Witb
Unstable Iscbemic SyndromesCorrelate With
Long-TermClinical Events After Angioplasty:
Lack of Ef6cacy of LucalIyDelivered Urokinase
801-6.395A
IntravenousArgatmban VersusHeparin as
Co-Medication to Alteplase in the Treatment of
Acute Myucardial Infarction: Preliminary
Results of the ARGAMI Pilot Study 738-4.
185A
Is aYfT the OptimalBiological Test to Evaluate
Anticoagulant Efficacyof Heparin Given as
AdjunctiveTherapy to Thrombolysis? 1034-51
.412A
Is the Benefit of Emergency PTCA for Acute
Myucardial Infarction Negated by Early
Reocclusion Before Discharge? 925-38.90A
Long-TermFollow-Up of Gender Specific Outcomes
After Thrombolytic Therapy for Acute
Myocardial Infarction From the GUSTO-I Trial
948-18.135A
Lytic Activity With Accelerated t-PA Assessed at
Bedside During Thmmholytic Therapy for
Acute Myocardial Infarction 1034-54.4I2A
Myoglobin and Trnponins for Noninvasive
Assessing of Coronary Reperfusion After
Thrombolytic Therapy 738-5.186A
Platelet-Dependent Thrombin Generation in Patients
With HypercholesteroIemia 964-84. 159A
Posterior Chest Leads (V7.9)ST? During Acure
Inferior Infarct Predicts Larger Infarct and Better
Benefit From Thrombolysis 1044-107.431A
Predictors of Not Administering Thrombolytic
Therapy to Eligible Patients With Acute
Myocardial Infarction 1032-41.35OA
Prehospital Thrombolysis After Cardiopulmonary
Resuscitation in Suspected Myocardial
Infarction 933-61*109A
Primary Angioplasty Versus Thrumbolysis With tPa
in Anterior Myocardial Infarction: Results From
a Single Center Trial 797-1l389A
Primary Coronary Angioplasty or Intravenous
Thrombolysis for Patients With Acute
Myocardial Infarction? Acute and Late
Follow-Up Results in a New Cardiac Unit
97I-10*235A
Reduction in Thrombogenicity of Cellulose
Polymer-Coated Stents by Immobilization of
Platelet-Targeted Urokinase 771-4.353A
Reperfusion Therapy in Postcoronary Anery Bypass
Graft Patients With MyrrcardialInfarction:
Clinical Experience From the National Registry
of Myocardial Infarction-2 903-7. 14A
Rheolytic Thrombectomy Versus Snrgical
Embulectomy for Treatment of Thrombosed
Hemodialysis A-V Grafts and Peripheral
Vessels: Results From a Prospective, Mukicenter
Study 1OO8-I64*3O8A
Safety and Feasibility of Rescue PTCA or Primary
PTCA in Patients With Acute Myocardial
Infarction Admitted to a Hospital Without
FTCA Facilities 797-6.390A
Ten m 14-YearFollow-Up of the Interuniversity
Cardiology Institute Trial: Improved Long-Term
Survival in Acute Myocardial Infarction Patients
Treated WmhEarly Thrombolytic Tberapy
948-14*134A
The Effect of Regional Variation and Payer Status in
the Utilization of Acme Reperfusion Therapy
for Acute Myocardial Infarction: Results From
the NRM12 781-5.367A
Thrombin Generation During Thrumbolysis With
rt-PA and Conjunctive Therapy With r-Hirudin
in Patients With Acute Myocardial Infarction
1079-111.492A
TIMI 3 Flow at Three Weeks Following Myucardial
Infarction Determines Long-Term Mortality in
Patients Randomized to Streptokinase or
Placebo 715-2.71A
Transcutaneous Ultrasound, Low Dose
Streptokinase, and EchoGen@Are Synergistic
for the Lysis of In VivoThrombotic Occlusion
1072-25*478A
Urokinase Improves Endothelium-Dependent
Relaxation in Experimental Pulmonary
Embnlism 963-106.158A
What Is the Clinical Outcome and Impact of
Revascularization of TIMI 2 Ffow Following
Acute Myocardial Infarction? 797-2.389A
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A Lung-Acting Nitric Oxide Donor Suppresses
Basal and LPS-Stimulated Tissue Factor
Pmcoagulant Activity in Human
Monocyte-DerivedMacmphages 986-80.265A
A New Biodegradable Acid Coronary Stent-Coating,
Releasing PEG-Hinrdin and a Prostacycline
Analog, Reduces Both Platelet Activation and
Plasmatic Coagulation 771-5.354A
Accelerated primary Platelet Aggregation in Acute
Myocardial Infarction: Use of a New
AggregometryEmploying Laser-Light
Scattering System 1033-32.409A
Addition of a Platelet Glycoprotein IIb/IIIa Inhihitor
to Heparin+AspirirrDecreases Ex Vivo
Thrombus Formation After Percutaneous
Coronary Intervention 974-83*240A
Additional Heparin Increases the ACT and Reduces
the Likelihood of Abrupt Closure During PTCA
1082-12.5OOA
Association of Blund Pressure With Fihrinolytic
Potential in the Framingham Offspring Study
944-47. 128A
Captopril Reduces Thrnmbus Formation in Early
Postmyocardial Infarction Stage 712-4.67A
CardioprotectiveEffect of Alcohol: Increased
Surface-LocalizedFibrinolytic Activity in
Cultured Human Endothelial Cells 919-67.43A
Circadian Rhythm of Postoperative Silent Ischemia:
Implications for Management of Patients After
VascularSurgery 761-5.218A
Clinical and Angiographic Implications of Corunary
Stenting in Thrombus-ContainingLesions
927-24. %A
Clinical Validityof Normal Compression Ultrasound
for Suspected Deep-VeinThrombosis in
Outpatients 963-103*158A
Clopidogrel, a Novel Platelet ADP-Receptor
Antagonist Inhibits Aspirin and
Ticlopidine-ResistarrtStent Thrombosis 771-3*
353A
CormraryStent Thrombosis: Management and
Long-TermFollow-UP Result 728-6.171A
Cyclic H-owVariationFrequency Predicts Arterial
Occlusion in a Rabbit Iliac Ane~ Mtiel of
Stent Thrombosis 734-6.180A
Differences in Coronary Platelet Deposition After
Stenting arrdFTCA 927-5.94A
Does Mrrltilobularityof Left Atrial Appendage
Represent an Additional Risk for Thrombus
Fomrarimrin Atrkd Fibrillation? 757-3.212A
Early Refractoriness of Platelet GPIIb-IIIa in
Myocardkd Infraction Survivors 988-102.
268A
Effectivenessof Aspirin Alone Compared With a
Combination of Ticlopine and Aspirin for the
Preventionof Subacute Stent Thrombosis After
Successful Optimized Stent Implantation 927-6
.94A
Effects of Hormone Therapy on Fibrinolytic
Potential in Postmenopausal Women 919-65.
42A
Enoxaparin Suppresses Platelet-Dependent Thromin
Generation In Vivo Among Patients With
Unstable Angina and Non-Q Wave Myocardial
Infarction 1OO6-I57*3O4A
Exercise-InducedChanges of Fibrinolytic arrd
Thrombntic Potential in Runners Following the
IOOrhBoston Marathon 962-90.156A
Fibrinogen Is an Independent Risk Factor for
Coronary Heart Disease in Women: Report From
the Stuckholm Study in Women 919-58042A
Grape Juice but Not Orange or Grapefnrit Juice
Significantly Inhibits In Vivo Platelet Activity
and Thrombosis in Stenosed Canine Coronary
Arteries 734-50180A
Hemucysteine Is Increased in Patients With Diffuse
Arhernsclerosis 943-136.126A
High-Shear Overrides the Antithrombotic Effects of
Aspirin on Stent Thrombosis 771-6*3MA
Increased Thmmbin Formation in De Novo but Not
in Destabilizing Unstable Angina During
Spontaneous Ischemic Episodes: Different
Triggers of Ischemia? 1033-41.411A
Influenceof Stent Length and Heparin Coating on
Platelet Activation:A Flow Cytometric Analysis
927-4.94A
IntegratedMechanisms of ExperimentalStent
Thrombosis 927-19.94A
brtranasal Arrtiplatelet/AntithromboticEfficacyof
the Platelet GPIIb/IIIa Antagonist, DMP754
960-112. 154A
IntravascularUltrasound Prediction of Stent
Thrombosis: Insights From the POST Registry
707-3*60A
Left VentricularThrombosis in Patients With Acute
Myocardial InfarctionAdmitted to GISSI-3
Trial 702-2.52A
Local Administrationof L-703,801With a
Composite Polymer Stent Reduces Platelet
Deposition in Canine Coronary Arteries
1038-71l418A
Local Intramural Deliveryof MK-0383, a Platelet
GPIfb/IIIaReceptor Blocker,Reduces Platelet
Depusitiun at the Site of Arterial Injury 739-4.
187A
Low Intracellular Magnesium Levels Promote
Platelet-ThrombusFormation.in Patients With
Coronary Artery Disease 734-2.179A
Mechanism of L-ArginineMyucardial Infarct
ReductionismPrimarily an Inhibitionof
Reperfusion Injury 1055-37.45OA
MonitoringPlatelet GPIIb/fIIa-FibrinInteraction
With Tissue Factor-Activated
Thromboelastography 959-48.152A
Multicenter Trial of Accurate Home Self-Testingin
Oral AnticoagulantPatients With a Novel Whole
Blood System 1097-73.525A
NonrheumaticArrial Fibrillation and Left Atrial
Thrombus Formation:Relation Between Left
ArriaIAppendageFunction, Clinical, and
HematologicalFindings 1097-76o526A
Percutaneous HydrodynamicThrombectomyWith
the Use of the HydroylserSystem 1OO8-165*
308A
Plaque Rupture in Men Is Associated With High
Serum Cholesterol 921-111.47A
Plaque Rupture Is an InfrequentCause of Sudden
Coronary Death in Women 798-3.391A
Platelet Inhibitory Effect of Feeding Grape Juice but
Not Orarrgeor Grapefruit Juice for SevenDays
in Monkeys 1OO6-I56*3O3A
Power Doppler Ultrasound in Detection of Deep
VenousThrombosis 963-104*158A
preventionof Abrupt VesselClosure Following
PTCA by IntracoronaryDipyridamole:A
prospectively RandomizedTrial in 1,094
ConsecutiveInterventions 801-4.395A
Proteinase ActivatedReceptor-2 (PAR-2)Mediated
Mitogenic RespmrsesAre Inducedby Human
Mast Cell Tryptases 1074-125.484A
Reduction in Thrombogenicityof Cellulose
Polymer-CoatedStents by Immobilizationof
Platelet-TargetedUrokinase 771-4.353A
Relation Between Time to Achieve the Lower Limit
of APTT Range and Recurrent Venom
Thrombuembolismin Patients With Venous
Thrombosis 963-107.158A
RheolyricThrombectomyVersus Surgical
Embolectomyfor Treatment of Thmmbosed
Hemodialysis A-V Grafts and Peripheral
Vessels:Results Frnm a Prospective,Multicenter
Study 1OO8-164.3O8A
Risk Factors for VenousThrombosis in Patients Witb
Permanent TrausvenousPacemakers 1097-72.
525A
Serial Charrgesin Coronary Dimensions in Acute
Thrnmbnsis in Humans: Plaque Rupture and
Erosion 760-2.216A
Sialyl Lewis X-Containing Oligosaccharide
ImprovesEndothelialDysfunctionof
Thrombosis-RelatedComnrny Artery 986-78.
264A
Soluble Fibrin as a Marker of Increased Risk in
Acute Coronary Syndromes 791-6.382A
Spermin&a Novel AntithrombnticAgent: Prevention
of Arterial Thrombosis in a Canine Model
1006-16O*3O4A
The Benefits of Brief Antecedent Ischemia on
Platelet-Mediated Thrombosis Are Mimicked by
Brief IntracoronaryAdenosine Infusion 734-1.
179A
The Ecarin Clotting Time but Not the aFTT Is a
Reliable Indicator for PEG-Hirudin Blood
Levels in Patients With Unstable Angina
Pectoris 1033-43.4I1A
The Relationship Between Thrombus and
AngiographicOutcomes Before and After PTCA
in Acute Coronary Syndromes 946-1. 130A
Three Glasses of Grape but Not Orange or
Grapefmit Juice Inhibit Ex VivoPlatelet
Aggregation in Human Volunteers 767-3.226A
Thrombin and Rheologic Factors: Clinical
Relevance for the Development of Restenosis
Following Elective PTCA in Patients With
Stable Angina Pectoris 780-4.366A
Thrombogenic Potential of Human Coronary
Atherosclerotic Plaques 798-2.390A
Ticlopidine Potenriates Abciximab’s Ability to
Inhibit ADP-Induced Platelet Aggregation In
Vitro 974-86.241A
Ticlopidine Without Coumadin Is Enough for the
Prevention of Stent Thrombosis After Elective
IntracoronaryPalmaz-Schatz Stent Implantation:
Results of NoPAIN Trial 927-20.95A
Time Release Characteristics of a Biodegradable
Stent Coating With Polylactic Acid Releasing
PEG-Hirudin and PG12-Analog 927-3.94A
Total Occlusion of Saphenous Vein Bypass Grafts
Following Transcatheter Intervention:
Six-Month Angiographic Findings From the
SAVEDTrial 904-49.17A
TrarrscutaneousUltrasound, Low Dose
Streptokinase, and EchoGen@Are Synergistic
for the Lysis of In VivoTbrombotic Occlusion
1072-25.478A
TmrrsluminalExtraction Arherectomy Vs. Ballon
Angioplasty in Acute Ischemic Syndromes
(TOPIT): Hospital Outcome and Six-Month
Status 946-23.132A
Tumor Necrosis Factor- “Alpha” and Insulin
Increases Plasminogen Activator Inhibitor-1
Production in Adipocytes 919-59.42A
Thromboxanes
Scdium Ozagrel, a Thromboxane Synthetase
Inhibitor, Prevents Acute Reocclusion and
Restenosis Following Primary Angioplasty in
Patients With Acute Myocardial Infarction
947-10. 133A
Tilt-testing, bead up
A Comparison of Patients With Chronic Fatigue
Syndrome With Patients With Syncope Referred
for Tilt Table Testing 1066-86o469A
A SimplifiedTime-Saving Head-Up Tilt Testing
Protocol With Low Dose Sublingual Isosorbide
Dinitrate for the Evaluation of Unexplained
Syncope 1066-85.469A
Additional Hemodynamic Testing Enhances the
Diagnostic Valueof Head-Up-Tilt and Outcome
of Treatment in Syncope 106I-102*461A
Aerobic Capacity, Parasympathetic Modulation, and
Orthostatic Tolerance in YoungAthletes
989-1IO*270A
Cerebral Dysautoregulation and Vasoneural
Uncoupling During VentricularTachycardia
109I-96*515A
Heart Rate Adaptation During Head-Up Tilt: A
Strong Marker for Sympathetic Reinnervation
After Heart Transplantation 978-169.248A
Intermediate-TermFollow-Up Fluid Therapy in
Patients With Vasodepressor Syncope 774-5.
358A
Multiple Triggering Mechanisms of Vasovagal
Syncope: APatient-Controlled Study 1061-101
.460A
Muscle Nerve Sympathetic Activity Controls Blond
Pressure During VasovagalPresyncope
1019-77.328A
Neurally Mediated Hypotension in Chronic Fatigue
Syndrome: Does Low-Salt Intake Play a Role?
103O-5O.348A
Selective Blunting in Endothelin-1 Release and
Hemodynamic Response to Head-Up Tilt in
Heart Transplant Recipients 978-170.248A
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Short-Duration Pharmacological Head-Up Tilt Test:
Low-Dose Isoproterenol or Nitroglycerin?
1066-84*468A
Tilt Test Hemodynamics in Tilt Positive and Tilt
Negative Children: A Comparative Study
1066-83*468A
Tomography
Accuracy of Spiral Computed Tomographyfor
Identifying Internal Mammary Artery and
Saphenous VeinBypass Graft Patency 940-101
. 121A
Determinants of Increased Tc-99m Sestamibi Lung
Uprake 1OO5-93*3O2A
Determination of Left VentricularAneurysm Surface
Area by Dynamic Three-Dimensional
Echocardiograpby 939-117.119A
Dynamic Positron Emission TomographyUsing
(R,S)-[F-18] 6-ThiahepeadecanoicAcid Detects
Presetved Myucardial Viability in Regions With
Reduced Perfusion 1OO2-101*295A
Effects of Left Bundle Branch Bluck on Cardiac
PET Imaging 1047-145*436A
Lack of Gender Differences in Tc-99m Sesrnmibi
TomographicMyocardial Perfusion Images
Obtained With Attenuation Correction and
Enhanced Acquisition Methods 1OO5-96*3O3A
Left Main Coronary Disease: Increased Sensitivity
With Quantitative Attenuation Corrected SPECT
Perfusion Imaging 1OO5-91O3O2A
Long-TemrPrognostic Utility of Stress
Technetium-99mSestamibi Myocrrrdial
Perfusion TomographyrmdCoronary
Angiography in Corona~ Afiery Bypass
Surgery Patients 768-2.227A
Maximum Likelihood Restoration of Artifactually
Reduced Myucardial Uprake Due to Intense
Hepatobiliary Activity 1OO5-95*3O3A
PET Myocardial Perfusion Imaging Significantly
Reducesthe Cost of Coronary Disease
Management 1047-141.435A
Plaque Extrusion During Balloon Angioplasty: New
Evidence From X-Ray Microtomography 749-1
l200A
Prognostic Valueof
Exercise-Redistribution-ReinfectionTballium
SPECT nrrdLow-Dose Dobutamine
Echocardiography in Left VentricularIschemic
Dysfunction 949-27.136A
Quantitation of Myocardial F-18 Deoxyglucose
Uptake Predicts Wall Motion Recove~ After
Revasculndzation 931-77.104A
Stress FOG PET Imaging as a New Approacb to the
Diagnosis of Coronmy Artery Disease in
Women 800-1.393A
‘IhnsplantrrtiOn
Altered Endothelium Dependent VasomotionAfter
Cardiac Transplantation: Correlation to Ewly
Myocardial Expression of Inducible and
ConstkrrtiveNitric Oxide Synthases and
Endothelin in Humans 743-5.193A
Assessment of Left VentricularDiastolic Function
After Lung Transplantation in Pulmonary
Hypertension Patients 1048-173*437A
Atrial Function Assessment for Bicaval and Biatrial
Anastomoses: Magnetic Resonance Imaging
Using Automatic Cardiac Analysis and Flow
Measurement IO23-106.336A
Blocd Troponin-TConcentrations Comclate With
Coronary Artmy Disease and Abnormal
Hemostasis, Fibrinolysis, and Endotbelial
Activation in Cardiac Allograft Recipients
808-3*402A
Cardiac Allograti Rejection Is an Independent Risk
Factor for Graft Coronary Artery Disease Late
After Transphrrrtation 999-153*290A
Cardiac Transplantation in Chagasic
Cardiomyopathy: CmrYouOn It? Sbould You
Do It? 708-4.61A
Comparative Valueof Dnbntamine Stress
Thallium-201 Single Photon Emission
Computed Tomographyand Echocardiography
in the Diagnosis of Cardiac Allogrnft
Arteriopatby 999-150*290A
Correlation Between Oxidized Low Density
Lipoproteinsaad Coronary ,&tery Disease in
Hemt TranspkurtPatients 808-1.402A
Correlationof Clinical Factors and Epicardial
VascularMorphologyWith Coronary Flow
Reserve in Heart TransplnatRecipients as
Assessed by InrracoronaryDoppler 953-154.
143A
Cost-Effectivenessnf Metoprolol in Idiopathic
Dilated Cardiomyopathy 1017-144.325A
Delayed BeneficialEffects of Nitric Oxide Against
Reperfusion InducedCoronary Endmbelial
Dysfunction in a HeterotopicRat Heart
TransplantationModel 91O-173*27A
Detection of Cardiac Allograft Autonomic
Functional ReinnervationUsing Measures of
Heart-Rate Variability 978-171.248A
DriesPulmonary HypertensionPrecardiac
TransplantationImpact on Posttransplant
,Exercise Capacity? 736-4.182A
Donor Heart Iscbemic Time Is a Risk Factor for
Early Manifestationof AllografrCoronary
Artery Disease 808-2.402A
DopplerTissue Imaging Isa Reliable Techniquefor
the Diagnosis of Mild Acme Rejection in Heart
TransplrmtRecipients 1049-161.438A
Effects of Bradykininon Coronary Bloud Flow and
Vasomotionin TransplantPatients 953-151.
142A
Effects of Heart Traasplanrnrionon Plasma Levels of
TNF-crin Patients With Congestive Heart
Failnre 1086-174.5O7A
Evidenceof Ventricular/VascularUncoupling in
Solid OrganTransplant Recipients With
Hypertension 708-2.61A
Graft Atherosclerosis Induces Abnormal Corunnry
VasomotorRespnnses to Alpha-Adrenergic
Stimulation 953-152.142A
Heart Rate Adaptation During Head-Up Tilt: A
Strong Marker for SympatheticReinnervation
After Heart Transplantation 978-169.248A
Heart Transplantation in Canada and Determinants
of Early and Late Mortality 91O-178*28A
HeurtTransplantation in Children With Visceral
Heterotaxyand Complex Congenital Heafi
Disease 932-65.105A
Homocysteine,a Risk Factor for Atherosclerotic and
ThromboembolicVasculacDisease, Is Higher in
Patients Who Have UndergoneOrthotropic
Cardiac Trumplantation 999-152.290A
HypercholesterolemiaIncreases Coronary Intimal
Thickeningbut DWSNot EnharrceEndothelial
DysfunctionAfter Heart Transplantation
953-150*142A
Impmved Overall (Pre and Post) Cardiac Transplant
Survivalin Infnrrcy:Strategies to Regulate
PulmonaryResistance 932-64.105A
Identification of Patients Not Requiring
EndomyocardialBiopsies Late After Cardiac
Transplantation 1086-176.5O7A
Is Tacrolimus(FK506) Superior to Cycolspurine for
Primary ImmmrosuppressionAfter Heart
Transplantation? 708-5.61A
Ki-67 Expression in Endomym%wdialBiopsies
ImprovesDetection of Acute Cardiac Allograft
Rejection 1086-173.5O6A
Low Incidence of Late Morbidity Caused by Atrial
Anatomy After Standard OrihotopicHeart
Transplantation 978-172.249A
Managementof Ischemic Herut Disease in Patients
Referred for Cardiac Transplantation 910-177.
28A
Medium-and Long-TemrHemodynamicsAfter
Biatrial and Bicaval OrrhotopicHeart
Transplantation 708-1*61A
MyocardialDysfunctionAssociated With Central
NervousSystem Catastrophes 708-3.61A
Naturally Occming Leukopeniaas a Marker for
Goud Outcome Atier Cardiac Transplantation
910-176.28A
Obesity as a Risk Factor for TransplantCoromwy
Artery Disease: The IVUS Tratb 999-154.
291A
Polymerase Chain Reaction - Positive Viral Genome
and Rejection Following Pediatric Hean
Transplantation 911-159.29A
Potential for Improved Assessment of Transplant
Graft VascnlarDisease Extent and Progression
Using Instantaneous 3-D Intracoronary
Ultrasound Imaging 953-153.143A
Prognostic Value in a Negative Stress
Echucardiogram for Cardiac Events in Patients
Undergoing Renal or Liver Transplantation
1025-86o339A
Prognostic Value of Dobutamine Stress
EchocardiographyAfter Heart Transplantation
999-149*290A
Reappraisal of the Practice of Performing
Surveillance Endomyocardial Biopies After
Heart Transplantmion:Decreased Utility for
Clinical Decision Making Over Time 1086-175
.507A
Relationship Between Dobutamine Induced
Regional Wall Motion Abnormalities and
Cnronary Flow Reserve in Heart Transplant
Patients Without Angiographic Coronary
Disease 999-151.290A
Reversal of Donor Myocardial Dysfunction by
Modulation of Coronary Perfusion Pressure
978-167.248A
Safety of Intravascular Ultrasound in Cardiac
Transplant Recipients 90642.20A
Short- and Long-TermEffects of Plasmapheresis on
Hemodynamically Significant Noncellular
Rejection Following Cardiac Transplantation
708-6*62A
Short-TemrControl of Blood Pressure Is
Independent of Sinus Node Innervation After
Cardiac Transplantation 978-168.248A
Should Dobutamine Stress Echocardiography
Replace Coronary Arreriographyfor Assessment
of Coronary Artery Disease After Heart
Transpkmtation in Children? 721-2.79A
The Effect of Hypercholesterolemia on Intimal
Thickness and EndotheIial Function After Hemt
Transplantation 1096-1OO.524A
TrmrsesophagealEchocurdiograpbicAbnormalities
Following Lung Transplantation 1048-174.
437A
Transesophageal Echographic Assessment of
Coronary Flow Reserve: Evaluation of
Endothelium hrdependent Graft Vasculopathy
After Heart Transplantation 979-163.249A
Triglyceride Levels Correlate With Microvasculm
but Not Epicardial Endothelial Dysfunction
After Heart Transplantation 808-4.402A
Vascular Remodeling Is Not Evident in Coronary
Arte~ Disease During the First Year Following
Transplantation 953-149.142A
llicrrapid regurgitation
Determinants of Tricuspid Regurgitation in Primary
Pulmonary Hypertension 916-81.37A
Evaluation of Tricuspid Regurgitant Severity:
Ecbocardiographic and Clinical Correlation
1025-96*341A
Long-TermFollow-Up of Rheumatic Patients
UndergoingTricuspid Annuloplasty With
Left-Sided Replacement 998-143.288A
Troporrin
A Comparative Study of Troponin I and Troponin T
Release in Acute MyocrrrdialInfarction 990-35
.272A
Accuracy of Serum Troponin T for predicting Acute
Cellular Rejection in OrthotropicHeart
Transplant Recipients 1086-177.5O7A
Blnnd Trnponin-TConcentrations Correlate With
Coronary Artery Disease and Abnormal
Hemostasis, Fibrinolysis, arrdEndothelial
Activation in Cardiac Allogrnft Recipients
808-3*402A
Cardiac Troponin T in Patients With Renal Failure
970-43*234A
Cardiac Troponin I, a Marker of Server Unstable
Angina: A Clinical, Electrocardiographic, and
Quantitative Angiographic Study 756-1.21OA
Clinical Significance of Elevated Levels of Cardiac
TroponinT Detected by Second Generation
Assay in Patients With Congestive Heart Failure
93O-I73*1O2A
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Concordance BetweenTroponinT and Troponin I
Values in 491 Patients With Unstable Coronary
Syndrome: A TRIM Substudy 970-42*234A
Diagnostic Use of Markers of Myocardial Injury and
IntracorormryThrombus in Patients Presenting
to a EmergencyDepartment Witb Possible
Acute Coronary Syndromes 946-4.131A
Diagnostic Utility of Tropinin-T Versus Creatine
Kinase MB for Triage of Patients Witb
Suspected Infarction 1056-18.451A
Eady Combined Electrocardiographic and
Biochemical Risk Stratification of Patients Witb
Unstable Coronary Artery Disease: A TRIM
Substudy 991-13.272A
Eady NoninvasiveAssessment of Reperfusion by
Myocardial Protein Release Patterns 791-2.
381A
Exercise Training at ConventionalWorkloadCan
Negatively Impact on the Left Ventricle in Heart
Fafiure 1-WI-23.425A
Extreme Athletic Completion Does Not Induce
Myocardial Injury 989-112.270A
Increased Levels of Cardiac Tropnnin I in Cancer
Patients 1015-13O*321A
Increased Rate of Minor Myneardial Cell Injury
After Rotablation Compared to PTCA 1012-13
.315A
IndependentLong-TermPrognostic Valueof
TroponinT for Cardiac Outcome After
Noncardic Surgery 991-16.273A
Minimal Elevation of Troparin I on Admission
Identifies Patients at Risk for Adverse Cardiac
Outcomes 991-17.273A
Myoglobin and Troponins for Noninvasive
Assessing of Cnmnary Reperfusion After
Thmmbolytic Therapy 738-5*186A
Predictive Value of Serum Cardiac TropnrrinT
(cTnT) in Pediatric Patients at Risk for
Myocardial Injury 1043-68.429A
PrehospitrdTropmtinT Test in Patients With
Suspected Acute Myocardial Infraction 991-15
.273A
Prognostic Markers in Unstable Angina:
Relationship Between Trnponin I and
C-Reactive Protein 970-39.233A
Quantitative Assessment of the Effects of Acute
Ischemia on Mymardium in Unstable Coronary
Artery Disease by,Fatty Acid Metabolic
Imaging 746-50197A
Relative Expression of Cardiac TroponinT Isoforms
in Control and Failing Human Left Ventricles
1OI6-152*323A
Serum Tropcmin-IIs More Sensitive for the
Detection of Acute Ischemic Myocardial Injury
Tban Serum Myoglobinor CK-MB 1056-15.
450A
TroponinT Release During Reperfusion Predicts
Delayed Recovery of Left VentricularFunction
After CABG 931-8O*1O4A
Use of Diagnostic Tools in a Chest Pain Evaluation
Unit: Valueof TropmrinT Testing 756-2.211A
Ultrasonic diagnosis
Anrdysisof Transmural Myocardial Intensity
Profiles Pmdrrcedby New Dodecafluoropentane
Microbubbles: Implications Regarding
Determinants ofopacitication 1OO4-105.299A
Antigen Binding Characteristics of Antibodies
Coupled to TargetedAcoustically Reflective
Immmroliposomes 1OO4-109*3OOA
Attenuation of Echo-Contrast Using AlbtmexIs
Linearly Related to Expnsed Ultrasound Power
1OO4-128*3O1A
Clinical and Pathological Characteristics of 161
Patients Witb Cardiac Tumors Diagnosed
During 1993-1994in Japan: A Mrdticenter
Study 967-59*166A
Clinical, Angiographic, and Ultrasound Predictor’sof
Stent Expansion After High-Pressure
Implantation 992-22.275A
Correlationof Scar Thickness to Myocardial Viability
in Patients With Healed Myncardial Infarction
939-120*120A
Determinants of Coronary Arterial Remodeling
Patterns: An Intravascular Ultrasound Study
798-6. 391A
Developmentof a New Generation Nasal Conduit
for TmnsnasalTransesnphageal
Echncardiography 1072-5O.481A
Does Mukilobularity of Left Atrial Appendage
Represent an Additional Risk for Thrombus
Formation in Atrial Fibrillation? 757-3.212A
Estimation of Mitral RegurgitationUsing a
Hemi-Elliptic Curve-FittingAlgorithm: In Vitro
Experiments With Native Mitral Valves
909-108*27A
Factnrs Associated With InadequateStent
Expansion: IVUS Analysis of 225 Patienta
Enrolled in the AVIDStudy 707-1l59A
High-SpeedRotational Coronary Atherectomyfor
the Treatment of Restenosis in Coronary Stents
1011-21.313A
Impact of Coronary Artery Remodelingon Clinical
Manifestations of Patients With De Novo
Coronary Artery Lesions 942-134.125A
Impact of Jet Orientation and PulmonaryVenous-
Flow Direction on Color Doppler Plow Mapping
of Mitral Regurgitation:An In Vitro Study With
Optical Dye Correlations 1093-54o518A
IncreaaedIntimal-MedialThickness (IMT) of the
Common Carotid Artery (CCA) in
AsymptomaticVolunteersWith a Positive
Exercise ECG 997-62.287A
Intra- and PostoperativeDoppler Assessment of Left
Internal Mammary Artery Flow and Graft
Patency in Patients UndergoingMinimally
InvasiveCoronary Artery Bypass Surgery
979-162.249A
Intracardiac EehocardiographyCmrQuantitatively
Image the Left Frnm a Right Ventricular
TransducerPosition 939-116.119A
Is Mild Hyperhomocyst(e)inemiaan Independent
Risk Factor for Carotid Atherosclerosis in an
AsymptomaticPopulation? 944-48. 128A
IVUS Findings in AngiographicallyOptimized
Stents in Native Vessels and VeinGrafts:
Lessons From the AVIDStudy 994-45.280A
LongitudinalRotational TomographicApproachfor
In VivoDetermination of Left Ventricular
Mass-Comparisonof a New Three-Dimensional
EchocardiograpbicMethnd to Anatomy
1094-49.521A
MicrospongeEcho Contrast EnhancesLeft Heart and
Myocardial Perfusion Studies 1OO4-108.299A
Potential for ImprovedAssessment of Transplant
Graft VascularDisease Extent and Progression
Using Instantaneous3-D Intracoronary
Ultrasound Imaging 953-153.143A
Power Doppler Ultrasound in Detection of Deep
VenousThrombosis 963-104.158A
Prognostic Criteria for Ultrasound-Guided
Compression of Femoral Arterial False
Aneurysm:A Score Scale 1OO8-163.3O7A
ProspectiveReproducibilityof an Autonomous
BoundaryDetection (ABD) Methmi in Healthy
YoungAdults 1094-26.519A
Prospective Validationof an AutonomousBoundary
Detection Method in YoungHealthy Adults
109445 .520A
Quantitative Analysis of Patent Ductus Arteriosus
Sbunt by TransesophagealImaging the Flow
ConvergenceRegion 916-82.37A
Short Pulses of UltrasoundCan Reduce
EchocotrtrastReflectivityUp to 99%:
Implicationsfor QuantitativeContrast
Echocrrrdiography 1OO4-127O3O1A
SpontaneousContrast (SC), Hypercoagulability,and
Surgical Trauma 1024-116.337A
Studies of Bubble Persistence Vs. Standard and
Hamronic Mode Acoustic Pulse Pressure for
Three New EchncontrastAgents 1004-124.
300A
Targetingand Retention of Acoustically Reflective
Immuno-LiposnmesUnder In Vitro Flow
Conditions 1094-46.52OA
The Feasibility and Incremental Valueof
Three-DimensionalIntraoperativeTEE in Valve
Surgery:A ProspectiveStudy in 40 Consecutive
Patients 784-3.371A
The Optimal Stent Implantation Trial: Final Core
Lab Angingraphic and Ultrasound Analysis
782-6.369A
Three-Dimensional Echocardiographic Study of
Right VentricularRemodeling, Mass, and
Function in Patients With Transposition of the
Great Arteries After Atrial Switch Operations
939-110*118A
Three-Dimensional Echneardiographyfor
Determining the Mechanisms of Aortic
Regurgitation: CnmprrrisonWith Surgical and
Pathological Findings 730-1.173A
Three-Dimensional Mapping of Myneardial Velocity
Gradient: A New Approach to Qttmrtify
Regional Left VentricularContractile Reserve
917-55.38A
Three-Dimensional Transesophageal
Echoeardiographyfor Determining Aortic Valve
Area in ValvularAortic Stenosis: A Prospective
Clinical Study 408-3.4A
Three-Dimensional Ultrasonic Imaging of Femoral
Artetia! Pseudoanemysms 1094-5O.521A
VaryingMorphologyof Mitral ValveCommissures,
Commissuml Fusion and Orifice in Mitral
Stennsis, Mitral Regurgitation, and Combined
Lesions in Rheumatic Valve Disease: A
Three-Dimensional Echocardiographic Study
784-2.371A
Unstable angina
A Mechanism of Elevated Circulating Level of Basic
FGF in Patients With Unstable Angina 769-5.
229A
A Randomized Trial for Treatment of Unstable
Angina in Patients With Restenosis
Postcoronmy Angioplasty 760-4.217A
Acute Myocmdial Perfusion Imaging for Chest Pain
Reduces the Length of Cardiac Work-Up: A
Randomized Trial 1095-59*522A
Admission Standard ECG for Early Risk
Stratification in Patients With Unstable
Corona~ Artery Disease: A TRIM Substudy
1057-12*453A
Cardiac Tropnnin I, a Marker of Server Unstable
Angina: A Clinical, Electrocardiographic, and
Quantitative Angiographic Study 756-1021OA
Clinical VariablesPredict Costs and Resource
Utilization in Unstable Angina 1032-4O*35OA
Combining IIbAIaInhibition and Heparin for Acute
CorrararySyndromes: Evidence of a Gradient
for Bleeding Hazard From the PARAGON
Randomized Factorially Designed Trial
1033-38*41OA
Comparison of Lesion Morphology Prnducing
Non-Q Wave Myocardial Infarction and
Unstable Angina 924-35*90A
Coronary Path-Anatomy of Patients With Acute
Coronary Ischemic Syndromes Differs
Accnrding to Gender 924-34.89A
Delaying and Preventing Ischemic Events in Patients
With Acute Corotmty Syndromes Using the
Platelet Glycoprotein IIb/IIa Inbibitor Lamifiban
1033-3I*4O9A
Diagnostic Use of Markers of Myocardial Injury and
IntracorotmryTbmmbus in Patients Presenting
to a Emergency Department With Possible
Acute Cormtary Syndromes 946-4.131A
Difference of Histopathological Findings in Stable
Angina and Acute Coronary Syndromes 924-31
.89A
Dobmamine Stress EchocardiographyFor Risk
Stratificationof Patients With Unstable Angina
991-14.273A
Early Catheterization Is Standard Strategy in
Unstable Angina/NQWMI: Results From
GUSTOIIb 1056-14045OA
Early Emergency Department Echneardiography Is a
Sensitive and Independent Predictor of Adverae
Cmdiac @tcnmes in Chest Pain Patients 756.3
.211A
Elevated Tryptase Levels During Spontaneous
Ischemic Episodes in Unstable Angina: A
Specific Madmr of Mast-Cell Involvement in
Acute Coronary Syndromes 990-33.271A
Endpoint Adjudication by a Clinical Events
Committee Can Impact the Statistical Outcome
KEX Abstmet title, Session-abstractnumber. page numher
672A SUBJECTINDEX JACC February 1997
of a Clinical Trial:ResultsFrom GUSTO-IIb
1033-39*41OA
EnoxaparirrSuppresses Platelet-DependentThromin
Generation In Vivo Among Patients With
Unstable Angina and Non-Q Wave Myncardial
Infarction 1OO6-157*3O4A
Fibrinogen, an Acute Phase Protein Is Not a Murker
of Thrombin- or Platelet-Mediated
Protbrombotic Potential in Unstuble Angina
1033-42o411A
Hemorrhage Incidence With Low-MolecrdsrWeigbt
Heparin VersusUnfractionated Heparirrin
Patients With Unstable Angina or Non-Q Wave
Myncurdial Infarction (From the ESSENCE
Study) Allegheny University Hospital, CC
1033-35o41OA
Heparirr1sMore EffectiveThan Irrogatran,a Novel
Low-Molecular Weight Thrombin Inbibitor in
Unstable Coronary Disease 103344 *411A
“Hot” Unstable Angina: Is it Worse Than Subacute
Unstable Angina? Results From the
GUARANTEE Registry 1078-103.4S9A
Impact of Coronsry Artery Remodeling on Clinical
Manifestations of Patients With De Novo
Coronary Artery Lesions 942-134.125A
Implementation of AHCPR Guidelines for Unstahle
Angina in 1996:Unfortunate Differences
Between Men and Women. Results From the
Multicenter GUARANTEE Registry 760-5.
217A
Implementation of an hrtemet/World-Wide-Web
Original Database for Suppmting Multicenter
Clinical Trials 915-11O.34A
Importance of Posterior Chest Leads in Suspected
Acute Myocardial Infarction With
Nondiagnostic Routine ECG 1078-108*49OA
Increase in MeurrPlatelet Volumeas Purameter for
Restenosis Following Successful Percutsrreous
Transluminal Coronary Angioplasty 928-18*
98A
Increased Apeptotic Activity in Human Coronary
Atherectomy Samples From Patients With
Unstable Vs. Stable Angina 772-6.355A
Increased Thrombin Formation in De Novo but Not
in Destabilizing Unstable Angina During
SpmrtaneousIschernic Episodes: Different
Triggers of Ischemia? 1033J41*411A
InflammatoryCytokines in Stable Versus Unstuble
Angina 970-38*233A
Is Elevated Plasma HistumirreLevels in the Coronary
VenousBlnnd Associated With Disease Activity
in VariantAngina? 780-6*366A
Is There a Role for IV Hepurirrin Unstable Angina
Patients Prior to FfCA? 1033-37*41OA
Less Myncurdialbut More Cerebral IscherrricEvents
in African Americans Than Caucasians With
Acute CoronarySyndromes:Results From
GUSTO-II 946-5.131A
Low-Molecular Weight HeparirrVersusRegulsr
Heparirrin the Treatment of Patients With
Unstable Angina 1033-33.4O9A
Medical Interventions in Unstable Angina: DWS
lntemational Clinicrd Practice Match
Evidence-Based Guidelines 923-138050A
Modulation of Platelet Neutmphil Interaction With
Pharmacological Inhibition of Fibrinogen
Binding to Platelet GPIRr/IIIaReceptor
960-111.154A
Morphological Correlates to the Clinical
Classification of Unstuble Angina 798-1039OA
Outcomes in GUSTO IIB in Patients With
ST-SegmentDepression VersusThose With
T-WaveInversion 760-1*216A
Previous CororruryArtery Surgery Has Little
Influence on In-Hospital Outcome in Unstable
Angina 1064-172.466A
Prognostic Markers in Unstuble Angina:
Relationship Between Troponin I mrd
C-Reactive Protein 970-39.233A
Psychological Distress Resulting From a Mosaic of
Psycho-Secial Vuriablesas a Risk Factor for
Acute Coronary Syndromes 924-37*90A
Quantitative Assessment of the Effects of Acute
Ischemia on Myocardium in Unstable Coronary
Artery Disease by Fatty Acid Metabolic
Imaging 746-50197A
Rebound Following the Discontinuationof Hepnrin
Is Not Caused by HyperactivePlatelets 1033-40
.411A
Reduction of Myocardial Damage by Prnlonged
TreatmentWith SpontaneousContrast
Low-MoleculnrWeight Heparin (LMWH) in
Unstable CoronaryArtery Disease 760-6.217A
Reduction of Recurrent Ischerrria.Witb Abciximab
During Continuous ECG-IscheruiaMonitoring
in Patients With Unstable Angina Refractory to
Starrdird Treatrrrent(CAPTURE) 781-3.367A
Relationship of Outcnmes to Treatment With
Lamifiban in Patients UndergoingPTCA:
Analysis of PARAGONA 1033-340409A
Serial Hemostatic Factor Measurements in Corona~
Interventionsfor Stable VersusUnstable Angina
902-1l 12A
Short and Long-TermPrognosis of Patients With
Suspected Myocardial InfarctionWho Present
With ST Depression 1078-104*489A
Soluble E-Selectin, ICAM-1, and VCAM-1 Levels
in Systerrricand Coronary Circulating in
Patients With VuriantAngina 791-4.381A
Soluble Fibrin as a Marker of Increased Risk in
Acute CormrurySyndrnmes 791-6.382A
The EcsrirrClotting Time but Not the aPTT Is a
Reliable Indicator for PEG-HimdirrBlnod
Levels in Patients With Unstuble Angina
Pectoris 1033-43.411A
The Effectivenessof a Chest PuirrObservation Unit
(CPU) in EmergencyTriage of Psrients at
InterrrrediateRisk for CormruryEvents: The
CHEER Trial (CHest Pain Evaluation in the ER)
756-5.211A
The Influenceof Insurmce Typeon the Use of
Prncedrrres,Medications, and Hospital Outcome
in Patients With UnstubleAngina 101O-14OC
31OA
The Predictive Valueof Fibrinogen,C-Reactive
Protein, and Intedeukin-6 on Admission in
SevereUnstable Angina 791-3*381A
TranshrrninalExtraction AtherectomyVs. Ballon
Angioplasty in Acute Ischemic Syndromes
(TOPIT): Hospital Outcome and Six-Month
stiINS 946-23.132A
Use of Diagnostic Tools in a Chest Pain Evaluation
Unit: Valueof TroponinTTesting 756-2*211A
Weight Adjusted AntithromboticRegimens
Eliminate the Nitroglycerirr-Antithrombotic
Interaction 1034-53*412A
Valvwfardisease
A Clinical Investigationof the Impnrtarrceof
Imaging Slice Location in Quantifying Aortic
RegurgitationWith MRI 909-109.27A
Accurate Mitral VulveArea Assessment in Patients
With Mitral Stenosis by Three-Dimensional
Echncurdirrgraphy784-6.372A
Alterations in Left VentricularGeometsy in Patients
With Rheumatic Mitral Stenosis: A Qrruntitative
Analysis of Regiorrnland Global Sbape
909-104*26A
An EchocardiographicStudy of the Mitrul Valvein
Patients Who Fail to Increase the Mitrul Valve
Area After Percutaneous Mitml Vahndoplasty:
Role nf Commissures and SubvalvukrrDisease
1037-8O*417A
An Optimal Method for Calculating Mitral Vslve
Area in Patients With Mitral Stenosis by the
Flow ConvergenceMethod: In Vitro Study and
Clinical Validation 1025-88.339A
Arra.lysisof a ModifiedPlow ConvergenceEquation
for Calculation of Aortic RegurgirurrtFlow Rate:
A Numerical Study 1093-53.518A
Assessment of Lmrg-TerrrrRisk Following Vascular
Surgery:Developmentand Validationof a
Prognostic Scoring System in aCohorr of 1,048
Patients 1057-7*451A
Characteristic Systolic and Diastolic Mitral Leaflet
Configurationin Patients With Incomplete
Mitral LeafletClosure: Evidence for Mitrul
ValveTethering 1018-35.327A
Clinical Substrates for Inducible Monomo~hic VT
Among Patients With Valvular Heart Disease
108543.506A
Clinical, Echocardiographic, and Exercise Predictors
of Outcome in a Prospective Study of %lvular
Aortic Stenosis 950-155. 137A
Color Doppler Energy Assessment of Aortic
RegurgitarrtFraction: An In Vitro Study
1093-52.518A
Color Doppler Imaging of the Proximal Jet Is a Good
Reflector of Vena Contract Area of Regurgitant
Jets: In Vitro Studies Using Laser-Induced
Florcscence Imaging 1025-94Q341A
Comparison of Effective Orifice Areas Derived
Using the Doppler Continuity Equation to
Directly Visualized Vena Contmcta Areas: In
Vitro Studies Using Laser-Induced Phrorescence
Imaging 711-1.65A
Digital Acoustic Analysis: A Cost-Effective
Alternative to Echocardiographyfor Evaluating
Systolic Murrrrurs 1022-54o334A
Direct Calculation of 3-D Flow Convergence Surface
Area Frnm 3-D Color Doppler Flow Maps for
Computing Aortic Regurgitant Flows: A
Chronic Animal Study 730-6*174A
EchncardiographyCan Predict the Development of
Severe Mitrul Regurgitation After Percutaneous
Mitral Valvuloplasty With the Inoue (Single
Balloon) Technique 1037-77o417A
EchocardiogruphyHas Reduced the Need of Cardiac
Catheterization in Patients With Aortic Stenosis
Prior to Aortic Surgery 1025-89.339A
Estimation of Mitral Regurgitation Using a
Hemi-Elliptic Curve-Fitting Algorithm: In Viern
Experiments With Native Mitral Valves
909-108*27A
Evaluation of Tricuspid Regurgitant Severity:
Echocurdiographicand Clinical Correlation
1025-96*341A
How Accurate Is Three-Dimensional
EchncardiographicDetermination of Aortic
ValveArea in Patients With Aorric Stenosis?
Comparison With Direct Anatomic Aortic Valve
Area Measurement at Surgery 730-30173A
Identificationof Abnormalities in Left Verrtricula
Shape Despite Normal Volumesand Function in
Chronic Aortic Regurgitation by Quantitative
Shapes Analysis: An Early Msrkerof Left
VerrrricularDecomperrsation 909-103.26A
Impact of Jet Orientation and pulmonary Venous
Flow Direction on Color Doppler Plow Mapping
of Mitral Regurgitation: An In VitrrrStrrdyWith
Optical Dye Correlations 1093-54o518A
ImprovedAccuracy of Mitral Regurgitant Flow Rate
Calculation Using a Hemielliptical Isovelnciry
Surface Area: Clinical Studies 711-2.65A
Influenceof Left Ventricular Function in Aortic
Stenosis on Risk of Valve Replacement and
Long-TermSurvival 998-146.289A
Influencesof Leti Arrial Size on pulmonary Venous
Flow in Patients With Moderate to Severe Mitral
Regurgitation 909-105.26A
Insights From Three-Dimensional Echomrdiography
Into the Mechanism of Functional Mitrul
Regurgitation: Direct In VivoDemonstration of
Leaflet Tethering Geometry 939-114.119A
Is the VenaCorrrractaArea for Stenotic and
RegurgiturrtOrifices Dependent on
Hemndynamic Vuriables?An In Vitro Study
Using Laser-Induced Fluorescence Imaging
1018-36.328A
Late Outcome After PercutrmeousMitral
Commissurotomy: Six-YerwResults of the North
American Inoue BallonrrRegistry 766-6.226A
Minimally InvasiveMitral Valve Surgery on Bypass
With Cnrdioplegic Arrest 931-7801O4A
Multilane Transthoracic Echocurdiographyin
Mitral Value Disorders: Echo-Anatomy and Its
Value 1025-9OO34OA
Multivariate Predictors of Biomechanical properties
in Myxomatous Mitral ValveDisease 1018-33o
327A
“Natural Histories” of Mitml Valve Prolapse
I08542*506A
J&X Abstract title, Session-abstract number. pagerrnmber
JACC Febmary 1997 SUBJECT INDEX 673A
New Insight Into the Determinants of Mitral
Regurgitation After Atrio-VentricularCanal
Repair: A Three-Dimensional
EchocrmdiographicStudy 721-3*80A
New Insights Into the Pathology of Degenerative
Mitral ValveIncompetence: A
Histomorphometric Study 1018-32.327A
Preservation of the Subvalvular Apparatus Improves
Long-TermLeft VentricularDimensions and
Pulmonary Artery Pressure in Patients
Undergoing Mitral ValveRepair or Replacement
Despite Comparable Left VentricularEjection
Fractious 998-144.288A
Pulmonary VenousFlow VelocityMeasurements for
the Quantitative Assessment of Mitral
Regurgitation 71I-4.66A
Pump Work in Small Size Aortic ValveMechanical
Prostheses: What Are the Hemodynamic
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950-160*138A
Quantificationof Mitral Valve Prolapse by
Tbree-Dimensional Echocardiography:
Correlation With Biomechanical Characteristics
of Excised ValveTissue 784-4.371A
Quarrtitationof Mitral Regurgitation: A New
Echo/DopplerTechnique 1025-93.34OA
Risk Factors for Recumency,Cardiac Operation, and
Death in the Late Follow-Up After Infective
Endncarditis 807-2.401A
Severity and Morphologic Abnormalities of Aortic’
and Mitral Regurgitation in the ElderIy:The
Cardiovascular Health Study (CHS) 951-130.
139A
SimplifiedContinuity Calculation of Aortic Valve
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Correction for Three-Dimensional ValveShape
711-5.66A
The Course and Outcome of Pregnancy in Women
With Stenotic Lesions Due to Congenital Heart
Defects 1065-159*467A
The Effects of VentricularHypertrophy on
Hemodynamics of Mechanical Heart Valve
prostheses: In Vitro Studies 1042-115.425A
The Fare of the Neo-Pulmonary ValveAfter the
Arterial Switch Operation in Neonates 751-4.
204A
The Feasibility and Incremental Value of
Three-Dimensional IntraoperativeTEE in Valve
Surgery: A Prospective Study in 40 Consecutive
Patients 784-3.371A
Three-Dimensional Flow Reconstruction of Irregular
Stenotic Mitral Bioprostheses: In Vitro und
Animal Studies 784-1.371A
Three-Dimensional Transesophageal
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Clinical Study 408-3.4A
TrmrsesophagealDynamic Three-Dimensional
Reconstmction of Flow Jets in Assessing
prosthetic Mitral ValveFunction 730-4.174A
ValveRing Abscess in Endocarditis: Is the Medical
Treatment Possible? 807-4.401A
VaryingMorphologyof Mitral ValveCommissures,
Commissural Fusion and Orifice in Mitral
Stenosis, Mitral Regurgitation, aud Comhined
Lesions in Rheumatic ValveDisease: A
Three-Dimensional Echocardiographic Study
784-2.371A
Valvldophlsty
An EchocardiographicStudy of the Mitral Valvein
Patients Who Fail to Increase tbe Mitml Valve
Area After Percutaneous Mitral Valvuloplasty:
Role of Commissures and Subvalvular Disease
1037-8O*417A
Critical Pulmonary ValveStenosis in the Neonate:
Initial Resuka and Follow-Up Using an
Umbilical Artery Snare Assisted Approach
954-141.144A
EchucardiographyCan Predict the Development of
Severe Mitral Regurgitation After Percutaneous
Mitral ValvuloplastyWith the Inoue (Single
Balloon) Technique 1037-77.417A
Immediate Change in Right Ventricular
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Analysis of Regional and Glnbal Shape
909-1(J4*26A
Amplitudes mrdflrrations nfPropagated Mitral
Flow Waves Are Related toLeft Ventricular
Diastolic Properties: In Vitro Findings 1093-51
l517A
AssessmentofLeft VentricularDiastolic Function
AfcerLung Trarsplantarionin pulmonary
Hypertension Patients 1048-173.437A
Atrial Pacing: What Effectnn Cardiac Function?
935-73.112A
Bedside Stratification of Mortality Risk in Acute
Myocardial Infarction Using Doppler
Ultrasound 756-4.211A
Beneficial Effects ofImidapril onCardiac
Sarcoplasmic Reticuhrm Ca2+-Pump andGene
Expression in Congestive Heart Faihrre inRats
1016-153*323A
Biochemical ScreeningforLeft Ventricular
Dysfunction 1OO9-I34.3O9A
BiventricularDysfunction in Femses Wirh
Congenital Heart Disease 1087-167.5O8A
Both RepetetiveStmrning and Hibernation Are
Present in ChrorriclschemicLeft Ventricular
Dysfunction: Serial Flow-Function Studies ina
Chronic Canine Model 1072-45.48OA
Brain Natriuretic Peptide Improves Diastolic
Function in the Normal andFailinx Heart
908-171*25A
Calmrlatiouof the Intramyucardial Relative Gradient
of the Diastolic VelocityProfileby
Computerized Pulsed Doppler Tissue Imaging
Analysis of the Left VentricularMyocardial
Wall Relaxation Under Physiologic Conditions.
107O-22*476A
Can Cornnary Flow Reserve Predict the Presence of
Viable Myocardium After Myocardial
Infarction? 906-40.19A
Cardiac b2-Adrenergic Receptor Stimulation
918-101l41A
Carvedilnl Improves Left VentricularRegional Wall
Motion in Patients With Heart Failure of
Ischemic Etiology 727-4.169A
Characterization of Different Time Cnurses nf Left
and Right VentricularRecovery After Lung
Transplantation 907-148.23A
Clinical Usefulness of Dual SPECT Imaging of
TC.99MSes[amibi a“d IZ31.IPPAfor Predicting
Myocardial Viability After Thrombolysed
Myucardial Infarction 946-20.132A
Comparison of Cnlor Doppler M-Mode Indices to
Established Pulsed Doppler Indices of Left
VentriculruDiastolic Function 1OO3-118*298A
Comparison of Gated SPECT to X-Ray Contrast
Angiographic VentricularVnlume
Measurements 1073-54.482A
Comparison of Treatment Patterns and Outcomes in
Heart Failure Patients With Systolic Versus
Diastolic Left VentricularDysfmrctimr 71O-6*
64A
Contemporary Patterns of Practice and Outcomes in
Congestive Heart Failure Patients Treated in a
Specialized Clinic 977-159.246A
Correlation of Technetium-99m-SestamibiLung
Uptake With Corunary Artery Disease Severity
and Left VentricularFunction 985-28.261A
DevelopmentalChanges in Ventricular-Vascular
Coupling in Piglets 1043-61.428A
Diastolic Dysfunction in Patients With Cystic
Fibrosis 907-162*23A
Diastolic Left VentricularFunction in Patients Witb
Reiiactory Angina Pectoris After Low-Dose
Intermittent Urokinase Therapy 1058-5*454A
Differences in Regional Mechanical Function
Between Concentric and Eccentric Left
VentricularHypertrophy:A Study Using
Magnetic Resonance Tissue Tagging 1062-79.
463A
Different Early Diastolic Pressure Gradients in Left
Ventricular Inflowand OutflowTracts:
Modification by Inormpy and Ischemia
929-172. lOOA
Different Effects of Exercise aad Dobutamine Stress
on Regional and Global Left VentricularShape
1025-85l339A
Dilated CardiomyopathyRelated to Human
ImmuncdeficiencyVirusInfection: A Clinical
and EchocardiographicStudy 765-1.223A
DivergentTime-DependentEffects of Tumor
Necrosis Factor-a on Relaxation Restitution and
Tau in Closed-Chest Dogs 758-2.213A
Do Alterations in Load and Cmdiac Output Affect
Regional Shape and Global Geometry of a
Normal Left Ventricle?A Quantitative
EchocardingraphicShape Analysis Study
939-118. 119A
DobutamineRadiomrclideVentriculography:
Predicting nf VentricularFunction Improvement
After Bypass Surgery in Patients With Ischemic
Cardiomyopathy 1073-52.481A
Downregrdationin HibernatingMyocadiumIs a
Time-DependentProcess and Preservationof
Structural Integrity Requires Early
Revascuhwizarion 1015-128.32OA
Duration of Pulmonary VenousArnal Reversal arrd
Mitral a-WaveCaa Predict ElevatedEnd
Diastolic Pressure in Children 1087-I69.5O8A
Dynamic Three-DimensionaJTrmrsthoracic
EchocardiographicEvaluationof the Total Mass
of the Left VentricleUsing Three Different
MyocardialTissue EncndingTechniques
1094-48*521A
Early Cardiac Changes in Children With Arterial
Hypertension 965-97.162A
EchocardiographicDiastolic Function: A Sensitive
NoninvasiveApproachfor the Detection of
CoronaryArtery Disease in Women 747-2.
197A
Echocadiographic Evidence of Transmural
Contracting Gradient: The Role of Ventricular
Geometry to Maintain Normal Chamber
Function in Human Hypertension 965-80.
161A
EchocardiographicRight VentricularVolumesUsing
a Crescentic, Difference-of-EllipsoidsModel
1048-175l437A
Effect of Increased Aftedoad on Global and
Regional Mechanical Heterogeneityof Left
Ventricle 995-68.283*
Effect nf Ryanodineon Mechanical and Relaxation
Restitution in Closed-Chest Dogs: Insights Into
Calcium Handlirig 758-4.214A
Effect of Vesnarinoneun Cardiac Function in
Patients With Severe Congestive Heart Failure
1017-142*325A
Effects of Critical Coronary Stenosis on Systolic
Left VentricularFunction Quantifiedby
Pressure-VolumeRelations During Dobutamine
929-168099A
Effects of ‘RepeatedLate Exercise-Induced
MyocardialStnnning cmL&l Ventricular
Function 1015-126.320A
Evidence nf RegionrdDifferences in Left Ventricular
IsovohrmicRate of Relaxation in a Canine
Mudel 758-5.214A
Feasibility and Long-TermOutcome of ICD
Implantation in Patients With Left Ventricular
Ejection Fraction <20% 983-128.256A
18F.2.Deoxyglucose (FDG)UtilizationIS
Regionally Increased in Fasting Pigs With
HibernationMyncardium 945-35*130A
Force-FrequencyRelationship in Normal Subjects
aad in Patients Wirh Heart Failure 1084-145*
504A
Gated SPECT LVEFMeasurements Using a
Dual-DetectorCamera and a Weight-Adjusted
Dosage of Thallium-201 985-50.263A
How Does Interstitial, Myncardial, and Perivascular
Fibrosis Contribute to Left Ventricukw
Dysfunction in Hypertension? 929-171• I(IOA
Identificationof Abnormalities in Left Ventricular
Shape Despite Normal VolumesrmdFunction in
ChrmricAortic Regurgitationby Quantitative
Shapes Analysis: An Early Marker of Left
VentricuiwDecompensation 909-103*26A
Impact of Diabetes on Cardiac Structure and
Function in American Indiaus: The Strong Heart
Study 1054-1OO448A
Impact of Respiratory Variations on Ventricular
Interaction Studied by Doppler Tissue Imaging
1049-165.439A
Improvement of Diastolic Left VentricularFunction
by Dobutamine Is Associated With the Presence
of Viable Myocardium in Patients With
Ischemic Cardiomyopathy 1015-122.319A
Improving Impedance Cardiographic Lead
Configuration by Using a Detailed 3-D Finite
Element Model of Thorax 1022-53.334A
Inhaled Nitric Oxide Isa Negative Right Ventricular
(RV) hrorrope in Primary Pulmonary
Hypertension 907-161.23A
Insights Into the Left VenrncularRelaxation Prncess
From the Analysis Mitral E Wave Acceleration
Time 979-164.250A
Intracardiac EchucardiographyCan Quantitatively
Image the Left From a Rigbt Ventricular
Transducer Position 939-116.119A
IntraoperativeEchocardiography in Left Ventricular
Remodeling Surgery 711-6.66A
Intravenous Dodecafloumpentaae Impmves
Determination of Left Ventricular Function
During Transthoracic Echncardiography
1094-28*52OA
Is There a Fhrid Mechanical Explanation for Critical
Orifice Areas in Aortic Valve Stenosis? An In
Vitro Study 950-159.138A
Ischemia and Infarction Contribute to Right
VentricuhwDysfunction Noted 10 to 20 Years
After the Mustard Operation for Transposition
of the Great Arteries 794-1.385A
Left VenrricrdarApical Remodeling in Chagas’
Heart Disease Dismpts the Optimal Global
Pmlate-Ellipsoid LV Geometry: Evidence Frnm
a Quantitative Echocardiographic Regional and
Global Shape Analysis Study 1OO3-121*299A
Left VentricularCavity Size predicts Time Course of
Recovery of Systolic Function After
Revascularization 1058-2*453A
Left VentricularDysfunction After Open Repair of
Simple Defects in Infants and Children:
QuantitritionWith a Conductance Catheter After
Bypass 1043-63*428A
Left Venrncular Ejection Fraction in Patients With
Normal and Distorted Left Ventricular
Geometry: Three-Dimensional
Echocardiography Versus Biplane Mcdified
Simpson’s Merhnd With Comparison to
Radionuclide Angiography 705-3.57A
Left VentricularOutflow Tract Gradient a Potential
Cause for Dyspneain the Elderly 1062-77.
462A
Left VentricularVolumehy 2-D Echocardiography:
Better Preoperative Assessment for Left
VentricularFunction in Patients With Mitral and
Aortic Regurgitation 1093-57*519A
Limitation of End-Systolic Elastance in Evaluation
of Contractile Function in Piglets 1043-62.
428A
Long-TermEffects of DDD Pacing on Hyperrrophy
mrdLeft Ventricular Systolic Function in
Hy~rtrophic Obstructive Cardiomyopathy
796-2.388A
Longimdinal Rotational Tomographic Approach for
In VivoDetermination of Left Ventricular
Mass-Comparison of a New Three-Dimensional
EchucardiographicMethod to Anatomy
1094-49. 521A
LY366634a Novel Sodium Channel Activator,
Improves Left VentricularFunction in Dogs
With Chronic Heart Failure 809-4.403A
Magnetic Resonance Imaging Assessment of
Regional Myocardial Fiber and Cross-Fiber
Strain 995-69.284A
Mechanoenergetic Effects of EMD 57033 Under
Normal and Acidotic Conditions in Isolated,
Blood Perfused Rabbit Hearts 809-1.402A
Microvasculacprotection With Intravenous
Nicorandil Augments Myncardial Salvage in
Patients With Acute Myocardial Infarction
947-12. 134A
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New Real-Time Interactive Cardiac Magnetic
Resonance Imaging System Is Useful in
Subjects With Suboptimal Echocardiographic
Studies 759-5.216A
NG-Monomethyl-L-Arginine(L-NMMA) Improves
Left Ventricular Systolic Function Late After
Cardiopulmonary Bypass in Neonatal Pigs
929-163l99A
Plasma Atrial Natriuretic Peptide and Brain
Natriuretic Peptide Levels in Chronic Aortic
Regurgitation 1085-4O.5O5A
Postinfarction Large Akinetic Scar: Benefitsof
EndoventricrdarPatch Plasty Repair inpatients
Witb Severe Left Ventricular Dysfrrnction
952-123.140A
Postresuscitatinn Left VentricularDiastolic
Dysfunction Successfully Treated With
Dobutamine 8IO-104O3A
Prediction ofImprovementof Global Function After
Revascularization inpatients With Ischemic Left
VentricularDysfunction: Detectionby
F18-FluorodeoxyglucoseSPECT 788-6.377A
Prognostic ValuerrfResting Left VentricularEjection
Fraction Early Following Successful Coronary
Artery Bypass Surgery 952-122.140A
Progression of Left VentricularDilation Following
First QWaveand Non-Q Wave Myocardial
Infarction 926-28.92A
Prospective Reproducibility ofan Arrtonomous
BoundaryDetection (ABD)Methodin Healthy
YoungAdults 1094-26o519A
Prospective Validation ofan Autonomous Boundary
Detection Method in YoungHealthy Adults
1094-45. 520A
Protective Action of Aprotinin During
Cardiopulmonary Bypass: Biochemical and
Hemodynamic Effects 93 I-7901O4A
Quantitative Assessment of Regional Left
VentricularFunction by Transesophageal Tissue
Doppler Echocardiography 1070-21.476A
Quantitative Echocardiographic Analysis of
Regional and Global Shape of the Human Right
Ventricle: 1)Description of the Method and 2)
Characterization nf Normal Right Ventricular
Shape 1003-114.297A
Recruitable Myocardial Deformation During
DobrrtamineStimulatirmby Magnetic
ResonanceImagingWith Tagging 1023-103.
335A
Relation Between Perfusion, Metabolism, and
Contractile Reserve in Repethive Myocardial
Stunning 1050-155.441A
Relationship Between Peak Oxygen Consumption
and RightVentricrdar Ejection Fraction inTwo
Different, Matched, Case-Controlled Groupsof
Severe Congestive HeartFailure Patients 736-5
l183A
Relative Contribution ofTransmitral and
IntravenrricularPressure Gradients During Early
Diastolic Filling 929-17O.1OOA
Reproducibility and Day-to-Day Variabilities of
Three-Dimensional Echocardiographyfor Left
VentricularVolumesand Ejection Fraction
Calculation With Comparison to Magnetic
Resonance Imaging 705-2.56A
Response of the Intact Left Ventricleto Increased
Afterload Does Not Depend on a Concomitant
Increase in Coronary Perfusion Pressure
929-161.98A
Response to Dobutamine by Magnetic Resonance
TaggingPredicts Recovery of Dysfunctional
Myocardium Postinfm’ction:A Quantitative
Approach 1023-104.336A
Reversal of Donor Myocardial Dysfunction by
Modulation of Cornnary Perfusion Pressure
978-167.248A
Right Ventricular Dysfunction Following Successful
Resuscitation From Prolonged Cardiac Arrest
955-167. 146A
Role of Endogenous Angiotensin II in Glucose
Metabolism and Recovery of Postischemic
Mechanical Function During Reperfrrsionin
Isolated Working Rat Heacts 958-40.150A
Short-TenrrPhysical Training Improves Exercise
Hemodynamics by Reducing Exercise-Related
Left VentricularDilatation in Postmyocardial
Infarction Patients 789-5.379A
Softwurefor Segmental Analysis of Color Kinesis
Images: New Tool for Objective Evaluationof
Regional Left VentricularFunction 1250-2.7A
The EndogenorrsNatriuretic Peptide System
Modulates Diastolic Function in Experimental
Heart Failure 1083-117.501A
The NatrirrreticPeptides as Diagnostic Mwkers of
Systolic Dysfunction:Comparison With a
Simple Clinical Score 93O-178.1O3A
Three-DimensionalEcbocardiograpbicStudy of
Right VentricularRemodeling,Mass, and
Function in Patients With Transpositionof the
Great Arteries After Atrial Switch Operations
939-110. 118A
Three-DimensionalEchocardiographyImproves
Accuracy and Reproducibilityof Left
VentricularEjection Fraction Estimates by an
InexperiencedReader 1094-47.521A
Three-DimensionalMapping of Myocardial Velocity
Gradient: A New Approach to Quantify
Regional Left VentricukuContractile Reserve
917-55l 38A
TroponinT Release During Reperfusion Predicts
Delayed Recnveryof Left VentricularFunction
After CABG 931-8O.1O4A
VagalReflexesand Left VentricularFunction in
Pnstmyocardial InfarctionPatients: Results
From the ATRAMIStudy 1078-123.49IA
Validationof An Automated Methodologyfor
Determining Left VentricularEjection Fraction
From Gated SPECT 985-49.263A
Validationof the ConductanceCatheter in the Right
Ventriclein HyperplasticLeft Hean Syndrome
1043-6O.428A
Ventricular remodeling
A Double Blind RandomizedPlacebo Controlled
Study of Ramipril Vs. Spironolactoneon Left
VentricularRemodeling After Acute Myocardial
Infarction 947-9.133A
Abnormal Calcium Handling PropertyProgresses
From the Adjacent to Remote Noninfarcted
MyocardiumAfter Myocardial Infarction
1084-136.5O2A
Alterations in Left VentricularGeometry in Patients
With Rheumatic Mitral Stenosis: A Quantitative
Analysis of Regional and Global Shape
909-104.26A
Altered Myocardial Expressionof TumorNecrosis
Factor-a After Mechanical Support in Patients
With Severe Idiopathic Dilated Cardiomyopathy
804-2.398A
C-Reactive Protein as a Predictor of Infarct
Expansion and Cardiac Rupture After a First Q
WaveAcute Myocardial Infarction 926-30.
93A
Can Left VentricularDiameters Be Used to Assess
Left VentricularRemodeling? IOO3-11O.296A
Coronary Flow Reserve in Infarct Related Artery mrd
Left VentricularRemodeling in Patients With
Anterior Myocardial Infarction 926-26.92A
Determinants of Left VentricularDilation in Patients
ReceivingThmmbolytic Therapy for
Myocardial hrfnrction 924-32.89A
Differences in Regional Mechanical Function
Between Concentric and Eccentric Left
VentricularHypertrophy:A Study Using
Magnetic Resonance TissueTagging 1062-79.
463A
Different Effects of Exercise and Dnbutamine Stress
on Regional and Global Left VentricularShape
1025-85l339A
Early Left VentricularMass Regression Measuredby
3-D Echocardiographyin HypefiensiveSubjects
Is Associated With Improvementof
Doppler-MeasuredMitral Inflow 1076-62.
487A
Early Left VentricularMass Regression Measured by
3-D Echncardiographyin HypertensiveSubjects
Is Independentof Reduction in Left Ventricular
Vnlume 1062-81.463A
Effect of Vesnarinoneon Cardiac Function in
Patients With Severe Congestive Heart Failure
1017-142*325A
Left VentricularApical Remodeling in Chagas’
Heart Disease Disrupts the Optimal Global
Prolate-Ellipsoid LV Geometry: Evidence From
a Quantitative Echocardiographic Regional and
Global Shape Analysis Study 1003-121.299A
Magnetic Resonance Imaging Assessment of
Regional Myocardial Fiber and Cross-Fiber
Strain 995-69.284A
Pmtial Left Ventricrdectomyin Severe Idiopathic
Dilated Cardiomyopathy: Assessment of
Shor’-TenrrResults on Shape and Systolic
Function by Magnetic Resonance Imaging
759-6*216A
Preliminary Observations With Ventricular
Remodeling Surgery for Refractory Congestive
Heart Failure 71O-4.64A
ProgrammedCell Death in Cbmnic Heart Failure:
Detection, Characterization, and Clinical
Correlations 1040-25.422A
Progression of Left VentricularDilation Following
First QWaveand Non-Q Wave Myocardial
Infarction 926-28.92A
Quantitative EchocirrdiograpbicAnalysis of
Regional and Global Sbape of the Human Right
Ventricle: 1) Description of the Method and 2)
Characterization of Normal Right Ventricular
Shape 1OO3-1I4.297A
Regional Wall Stress Following Myocardial
Infarction Estimated by
Echocardiography-BasedStructural Analysis
1015-125l 320A
Small Myocardial Infarction May Cause Late
VentricularDilation and Dysfunction Possibly
Due to Chronic Infarct Expansion 926-27.92A
The Effects of Antihypertensive Drugs on
Susceptibility to VentricularArrhythmias,
Regression of Left Ventricular Hypertrophy of
Cardiac Fibrosis, and Postinfarction Mortality
976-154.245A
Time to Treatment Influences Recovery of Left
VentricularFunction Following Successful
Primary Angiopkrstyin Patients Witb Acute
Myocardial Infarction 772-3.355A
VentricularReduction Surgery as a Treatment for
Idiopathic Dilated Cardiomyopathy 1064169.
466A
Ventricular tachycardia
Body Surface Mapping of Depolarization Potentials
in Patients With Arrhythmogenic Right
VentricularDysplasia: Principal Component
Analysis oftbe ST-T Waves 934-54.11OA
Cerebral Dysarrtoregulationand Vasoneural
Uncoupling During VentricularTachycardia
1091-96*515A
Circadian and Weekly Variationof Ventricular
Tachycardias Is Different in Patients With
CoronaV Afiery Disease and Idiopathic Dilated
Cardiomyopathy 1069-I26.474A
Comna~ Venous Mapping in Patients With
Sustained VentricularTachycardia 750-4.202A
Correlation WaveforrrrAnalysis to Discriminate
VentricularTachycardiaFrom Sinus Rhythm
Using Stored Electrograms From Implantable
Defibrillator 983-1300256A
Differences in Circadian Variations of Ventricular
Tachycardiaand Premature Ventricular
Complexes 1OO1-8O.293A
Differentiationof Rigbt VentricularOutflow Tract
and Left Basal VentricularTachycardia:
ElectrocardiographicCriteria 1OO1-77.293A
Does Left VentricularFunction Influence QT
Dispersion in Patients With Previous Myocardial
Infarction and VentricularTachyarrhythmias?
1088-150. 510A
Dynamics of Ca2+ Transients in Initiation of Early
Afterdepolarizations and Triggered Ventricular
Tachycardia:Effects of Ryanodine and
Verapamilin Isolated Rabbit Hearts 1090-85.
512A
Effect of ATP-SensitiveK+ Channel Opener
Nicorandil in a Canine Model of Proarrhythmia
1090-86. 513A
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Effect of Isoproterenol on Paced QRS Morphology:
Implications for Pace Mapping 1021-65*332A
Efficacy and Safety of IntravenouslyAdministered
Dofetilide in the Acute Terminationof Atrial
Fibrillation and Flutter: A Mukicenter,
Randomized, Double-Blind, and
Placebo-Controlle dTrial 1051-135o442A
Empiric Versus Tested Antitachycardia Pacing:
Results From a Prospective Study Including 200
Patients 720-3.78A
Entrainment Criteria for the Prediction of
Termination of VentricularTachycardia in
Patients WithCoronary Artery Disease 786-4.
374A
EntrainmerrtMapping and RadiOfrequencyAblation
of VentricularTachycardia in Right Ventricular
Dysplasia 786-6.375A
Facilitation ofBundle Branch Reentry After
Prosthetic Valve Replacement 1042-121*427A
Factors AssociatedWith Shock Deliveryinthe
Mukicenter Automatic Defibrillator
ImplantationTrial (MADIT) 720-6.79A
Heart Rate Vwiability Preceding Spontaneous
VentricularTachycardia 1068-114.472A
Implantable Defibrillator Event Rates in Patients
Witb Syncope ofUnkn0wnt3rigin and Induced
Sustained VentricularTachycardia: Comparison
With Patients Witb Documented Ventricular
Tachycardia 983-131.257A
Improved Safety of Transvenous Atrial Defibrillation
During Wide QRS Tachycardiaby Introduction
ofa Delay Interval 745-2.195A
Intracardiac Ultrasound Guidance of Multipolar
Atrial and Ventricular Mapping Basket
Applications 750-2*202A
Is Inducible Sustained Monomorphic Ventricular
Tachycardia a Reliable Endpoint for Treatment
Decisions in Patients With Asymptomatic
Nonsustained VentricularTacbycardiaand
Ejection Fraction S40Percent? 1091-95*515A
Is Pacing During Postinfarction Ventricular
Tachycardia Necessaryto Identify Optimal Sites
for Catheter Ablation? 786-10374A
Is Procainamide Faihrreat Electrophysiologic
Testing Really inappropriate Marker for
Dnrg-Resistant VentricrrlarTacbyarrhythmias?
914-129.33A
Magnetic ResonanceImaging inpatients With
ArrhythmogenicRight VentricularDysplasia
1091-940514A
Noncontact Mapping ofHuman VTConfrrms That
Successful Ablation Sites Activate Late During
Sinus Rhythm 750-3*202A
Patient Selection for VentricularRemodeling
Surgery:Evolving Criteria and Outcomes
977-160.246A
Pectoral Implantation of Automatic Defibrillator
(ICD’S):General Anesthesia Vs. Conscious
Sedation 1068-112.472A
Percutaneous High-DensityEndocardialMappingto
Facilitate RadiofrequencyCatheter Ablationof
VentricularTachycardiain Patients 750-1.
202A
Predictors ofTacbyarrhythmias During Dobutamine
Stress Test: A Study uf 1,164Patients With
Suspected Myocardial Ischemia 1068-115*
473A
Prolonged Depokwizationand Inbomogeneous
DepolarizationIncrease Late Sudden Death Risk
in PostoperativeTetmlogyofFallot 722-3.81A
Palsed CumentDelivery Combined With Saline
IrrigationProducesDeeperRadiofrequency
Lesions WirhotrtSteem ”Pop” 786-3.374A
RadiofrequencyCatheterAbMion furManagement
of SymptomaticEctopic Ventriculw Activity:Is
VentricularEctopy a Potential Target for
Ablation? 1021-64.332A
RadiofrequencyCatheter Ablation ofIdiopathic Left
VentricularTachycardiaWith tbe Aidof
Pnrkinje Potentials Recorded During Sinus
Rhythm at Sites With Exact ECGPace Mapping
1021-66*333A
RadiofreqtrencyCatheterAblation ofVentricular
TachycardiasUsing aNew NonfluOroscOpic
MappingTechnique:FirstResuks 786-5.375A
RelationshipofInducedto SpontaneousVT:
implications forATPTherapy 937-122.114A
Response to Pacing atSites ofIsolatedDiastolic
Potentials During VentricularTachycardiain
Patients With Prior Myocardial Infarction 750-5
l202A
Signal-AveragedECG in tbe Multicenter Automatic
DefrbrillatorImpIantationTrial (MADIT)
912-16.31A
Standard Vs. Saline Irrigated-Tip Radiofrequency
Ablatimr:Lesion Size in Normal Vs. Scar Tissue
786-20374A
TemperatureProfile During Cooled Radiofrequency
Ablation 1021-69o333A
Tbe Economic Impact ofProphylactic Defibrillator..
983-129.256A
Torsades De Pointes Associated With Intravenous
Haloperidol uncritically III Patients: Incidence
and Influenceon Lengtb of Hospital Stay
914-133l 34A
VentricularTachycardia in a Closed-Chest Ovine
Model in the Chronic Phase After Myocardial
Infarction 1001-78*293A
Worldwide Experience With the Electrugram Width
Featare for Improved Detection in an
Implantable Pacer-Ca.rdioverter-Defibrilkitor
937-129. 115A
YohimbineFacilities Induction of Ventricular
Tacbycardiaof Parkinje Origin in the Ischemic
Canine Heart 1OI9-8O*329A
Viruses
Association of EB Viras Infection and Kawasaki
Disease: A Prospective Serological Study
911-156.29A
Contractile Dysfunction and Myocardial
ProinflammatoryCytokine Expressionin
CoxsackievirasMyocarditis 758-6.214A
Effect ofLatent Cytomegalovir’asinfection ofRats
onthe Neointimal Response to VascularBalluon
Injury 1039-94*42OA
Gene Transferofa Human Hypertrophic
Cardiomyopathy Mutation Into Adult Cardiac
Myocytes Induces Sarcomere Disamay and
Impairs Contractility 726-3.87A
Polymerase Chain Reaction – Positive Viral Genome
and Rejection Following Pediatric Heart
Transplantation 911-159.29A
Wolff-Parkinson-White syndrome
“AtrioventricularGroove” Tachycardias in Small
Children: Clinical Characteristics and Treatment
Strategies 954-147.146A
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